Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABHD2	LABH2	ENSG00000140526	"Abhydrolase domain containing 2, acylglycerol lipase"	P08910	15	89087459-89202355	"Enzymes, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 331.8;Hepatocytes: 402.5;Late spermatids: 462.1;Oligodendrocyte precursor cells: 421.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 69.8;neutrophil: 52.2"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HEL: 340.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005999	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	Nucleoplasm	"HPA005999: AB_1078080"	"unprognostic (6.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.41e-3)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.18e-7)"	"unprognostic (4.17e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	18.5	36.3	20.0	20.2	20.9	34.9	22.5	40.2	27.2	19.5	130.3	21.1	47.9	20.7	56.1	17.4	23.4	47.2	36.1	29.0	20.3	22.4	137.6	45.3	14.7	13.3	32.4	24.5	57.9	18.4	14.0	11.1	13.5	44.2	18.9	14.5	12.7	18.6	21.8	13.1	35.9	22.4	11.0	24.6	72.9	52.0	24.2	15.5	17.1	46.3	16.1	31.1	9.6	16.4	33.0	62.3	14.7	16.3	29.2	39.0	8.2	21.4	62.5	19.8	18.6	15.7	55.3	9.4	23.9	27.4	54.1	42.6	32.4	26.4	28.0	48.1	15.8	340.5	14.0	12.8	14.8	24.2	74.4	20.1	18.6	70.1	45.5	33.7	25.3	20.7	30.3	27.4	56.3	13.3	15.0	5.8	6.6	76.9	18.1	20.7	32.2	71.9	27.0	51.5	25.2	39.0	41.4	19.4	34.4	13.5	21.7	18.6	38.6	70.9	23.7	24.2	55.8	23.5	49.3	10.9	58.2	21.5	55.4	8.4	13.4	69.8	3.5	11.3	2.1	2.4	3.2	3.4	7.1	2.2	3.2	3.2	52.2	11.2	17.8	5.7	8.7	6.9	20.0	20.9	40.2	27.2	29.0	20.3	13.3	32.4	13.5	11.0	24.2	16.4	43.4	96.1	118.1	87.5	10.7	18.6	47.3	27.0	7.4	25.5	26.6	17.8	52.0	130.1	82.1	42.3	18.8	4.6	53.7	65.9	1.9	48.9	331.8	28.3	36.8	27.7	48.7	40.8	103.6	85.2	7.7	26.6	103.0	25.9	60.7	18.5	21.0	402.5	40.8	20.2	114.7	58.7	87.5	59.2	26.6	462.1	32.9	67.3	58.7	46.9	46.4	45.5	36.0	421.2	54.4	106.4	38.0	59.8	27.4	171.1	53.1	18.0	158.0	14.7	78.9	36.1	53.4	119.8	13.2	20.8	17.5	2.6	24.5	35.2	38.7	117.5
AC104389.6		ENSG00000284931	"Novel protein"		11	5248270-5254783	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in many"	24	"placenta: 4358.4"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HEL: 7590.9"									HPA043234	Uncertain					NA	NA					"Cluster 36: HEL - Hemostasis"				"HPA043234: AB_2678378"																		0.7	2.9	0.4	0.0	0.4	184.3	3.3	0.4	2.0	0.0	0.5	0.1	0.1	0.1	0.4	0.8	1.1	6.7	0.0	0.4	0.5	0.3	2.3	0.7	0.0	0.7	0.4	0.3	2.9	0.6		4358.4	0.9	0.5	0.2	0.0	0.7	0.1	5.1	0.0	0.2	1.8	0.7	0.0	0.0	0.2	0.5	3.9	0.4	5.3	0.0	0.2		0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7590.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1682.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.4	0.4	0.4	2.0	0.4	0.5	0.7	0.4	0.9	0.7	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACKR1	"CCBP1, CD234, DARC, Dfy, FY, GPD"	ENSG00000213088	"Atypical chemokine receptor 1 (Duffy blood group)"	Q16570	1	159203307-159206500	"Blood group antigen proteins, CD markers, G-protein coupled receptors, Predicted membrane proteins"		"Blood group antigen, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 320.5;breast: 278.2"	"Group enriched"	"Detected in many"	5	"Adipocytes: 383.6;Endothelial cells: 523.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEL: 44.4;HSkMC: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016421, HPA017672"	Enhanced					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA016421: AB_1849219, HPA017672: AB_1849221"	"unprognostic (8.74e-3)"	"prognostic favorable (2.52e-5)"	"unprognostic (9.73e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.34e-3)"	"unprognostic (3.84e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (7.80e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.82e-3)"	"unprognostic (5.17e-3)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.30e-2)"	320.5	13.4	17.7	42.0	21.8	14.5	278.2	34.6	25.5	141.7	21.6	67.0	15.3	125.0	21.5	63.6	121.2	59.2	42.2	18.4	18.6	34.5	1.8	146.8	49.3	21.4	17.7	21.4	15.8	9.7	11.6	10.4	23.2	72.9	19.4	23.7	61.3	24.5	51.7	85.3	60.9	107.7	24.9	82.1	57.0	8.6	17.0	33.2	47.7	30.2	40.8	112.4	113.1	22.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	44.4	0.0	0.0	5.5	0.0	0.0	30.7	0.0	0.0	3.9	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.5	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	21.8	34.6	25.5	18.4	18.6	21.4	17.7	23.2	24.9	17.0	22.0	383.6	6.4	10.8	1.6	1.0	0.0	1.7	0.0	2.8	78.4	3.6	3.7	15.1	0.0	1.8	0.0	2.1	0.4	0.8	0.0	0.0	0.0	2.2	0.4	1.0	523.8	0.0	81.3	3.6	9.8	0.2	18.9	0.0	0.4	5.1	0.0	7.5	0.0	1.1	6.7	3.2	0.0	0.0	0.8	0.0	3.7	1.2	2.2	0.0	1.0	0.0	5.9	0.0	0.5	0.3	0.0	0.0	0.4	0.1	2.2	0.0	0.1	0.7	3.7	0.0	3.9	4.5	0.2	0.5	4.0	0.0	0.1	1.1	0.1	0.0	2.3
ADRA2A	"ADRA2, ADRA2R, ADRAR"	ENSG00000150594	"Adrenoceptor alpha 2A"	P08913	10	111077029-111080907	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 50.5;cervix: 46.6"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 52.9;Paneth cells: 105.9;Smooth muscle cells: 118.7"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 17.7"	"Region enhanced"	"Detected in all"		"pons: 26.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.5;ASC TERT1: 12.9;HEL: 20.3;HeLa: 10.7;HSkMC: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (3.87e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (8.06e-4)"	"unprognostic (1.36e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.64e-3)"	"unprognostic (5.86e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.08e-6)"	"unprognostic (1.45e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.89e-3)"	50.5	1.7	3.4	4.9	3.4	0.0	32.9	1.6	4.3	46.6	7.7	7.4	10.0	6.8	1.6	2.9	4.1	19.9	2.1	3.4	7.4	6.0	1.1	4.3	11.2	5.9	5.8	18.1	30.5	1.3	2.3	3.7	26.8	6.9	3.7	0.0	7.0	6.1	1.0	10.9	4.9	2.8	1.4	14.7	3.7	5.0	3.2	1.0	9.0	0.6	13.1	15.9	23.4	6.1	0.0	0.0	0.0	0.0	10.5	12.9	0.0	0.1	0.0	1.1	2.5	0.0	0.0	0.0	0.1	6.1	0.0	0.0	0.0	0.0	1.0	0.0	0.1	20.3	10.7	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.4	1.6	4.3	3.4	7.4	5.9	5.8	26.8	1.4	3.2	6.1	8.3	0.0	1.3	1.0	0.0	10.3	0.4	0.0	1.2	0.0	17.2	12.2	1.5	52.9	1.3	0.0	0.0	0.1	0.0	11.7	0.0	5.9	3.5	6.9	9.1	4.9	12.4	0.0	2.2	3.3	0.1	7.3	10.7	25.8	7.0	19.4	0.7	0.0	0.1	0.0	5.9	3.5	0.0	0.3	17.3	1.2	22.4	7.3	28.4	1.0	0.0	0.0	0.0	0.0	0.2	0.3	105.9	4.9	0.0	0.9	3.5	0.6	0.0	0.0	6.6	3.1	118.7	5.4	0.1	0.2	6.1	0.1	1.2	8.5	8.6	1.1
AGPAT5	"FLJ11210, LPAAT-e, LPAAT-epsilon"	ENSG00000155189	"1-acylglycerol-3-phosphate O-acyltransferase 5"	Q9NUQ2	8	6708642-6761503	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 83.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010644, HPA010950, HPA011646"	Approved		Supported	Mitochondria		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 43: Testis - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA010644: AB_1844647, HPA010950: AB_1844648, HPA011646: "	"unprognostic (1.05e-3)"	"unprognostic (4.69e-1)"	"prognostic favorable (8.82e-4)"	"unprognostic (2.05e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (4.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.98e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.09e-3)"	5.4	11.8	6.7	2.9	6.8	2.3	4.9	7.2	8.3	6.5	6.1	8.0	3.1	6.6	7.9	8.5	7.4	1.8	3.4	6.6	7.4	7.2	10.0	4.5	4.1	7.8	7.4	5.8	6.4	3.3	10.3	4.1	7.6	6.0	4.2	5.2	5.0	5.6	11.3	3.5	6.7	2.9	7.6	4.8	6.9	22.5	7.1	4.7	4.0	2.7	3.7	4.7	5.8	8.7	8.5	7.0	15.3	6.8	3.4	5.2	9.4	4.3	4.6	7.9	7.0	4.6	7.3	21.8	3.2	3.3	10.8	11.0	9.5	9.5	11.2	4.6	6.6	27.4	7.0	10.5	9.1	12.4	10.0	7.6	10.0	6.7	9.8	8.2	13.6	9.5	19.9	10.7	11.4	6.3	23.5	20.1	20.4	13.6	5.8	15.0	15.0	8.2	7.9	13.1	24.4	14.8	4.1	7.9	9.4	8.1	3.6	20.5	5.5	10.8	5.4	4.4	12.4	4.0	12.8	11.3	7.3	13.8	12.9	1.8	1.9	1.2	0.7	2.4	1.6	4.4	1.3	1.4	1.2	5.1	0.9	1.1	0.2	2.7	2.2	4.4	1.2	1.4	6.7	6.8	7.2	8.3	6.6	7.4	7.8	7.4	7.6	7.6	7.1	8.7	15.7	3.2	4.4	58.8	46.5	9.1	18.8	14.2	19.4	7.8	14.2	10.5	5.8	11.5	9.0	7.3	2.1	9.4	23.5	17.4	3.9	11.2	40.0	30.0	27.9	22.3	22.1	50.0	45.0	10.0	14.2	10.4	27.0	83.6	18.9	10.6	10.4	41.9	12.2	6.7	46.8	10.1	14.2	16.0	4.6	34.7	15.8	12.6	7.2	33.7	7.5	42.3	6.2	56.8	60.2	10.2	16.0	15.4	22.3	30.4	9.8	22.5	14.6	9.8	6.6	14.0	24.7	26.2	10.9	30.9	10.4	18.5	17.4	15.0	25.2	11.9
AL353671.1		ENSG00000288684	"Novel protein"		9	32455323-32552603	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 5.4"	"Low cell line specificity"	"Detected in some"											"HPA047193, HPA073217"	Uncertain		Approved	"Plasma membrane,Cytosol"		No	NA			"Cluster 9: Neutrophils - Innate immune response"		"Cluster 36: HEL - Hemostasis"		"Plasma membrane, Cytosol"		"HPA047193: AB_2679978, HPA073217: "																		0.7	0.1	0.5	0.3	0.5	0.2	0.2	0.4	0.5	0.4	0.5	0.3	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.3	0.6	0.3	0.5	0.2	0.0	0.9	0.9	0.1	0.0	0.8		0.1	0.9	0.2	0.2	0.0	0.2	0.4	0.4	0.2	0.3	0.2	0.5	0.2	0.2	0.1	0.8	0.5	0.1	0.5	0.1	0.2		0.9	0.3	0.5	0.6	0.1	0.8	0.7	0.2	1.4	0.7	0.7	1.4	0.7	0.0	0.4	0.2	0.6	0.9	0.1	0.2	0.7	0.0	1.3	0.4	1.8	0.7	0.0	0.4	0.8	0.1	0.7	0.5	0.6	1.0	0.8	1.1	1.3	0.2	0.1	0.7	0.0	0.3	0.7	0.3	0.9	0.1	1.4	0.3	0.1	0.3	0.7	0.6	1.4	0.5	0.2	0.2	0.1	0.1	0.0	0.5	0.6	0.5	0.6	0.4	0.3	0.5	0.4	0.4	0.2	0.0	1.7	0.4	1.6	0.5	0.4	0.3	0.5	0.5	0.6	0.3	0.3	0.6	0.5	5.4	0.4	0.3	0.1	0.8	0.3	0.5	0.5	0.4	0.5	0.3	0.6	0.9	0.9	0.9	0.5	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL512785.2		ENSG00000254706	"Novel protein"		1	162365407-162383531	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 7.6;HEL: 12.0"	"Low region specificity"	"Detected in all"							"HPA052251, HPA074060"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"		Nucleoplasm		"HPA052251: AB_2681775, HPA074060: "	"unprognostic (1.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.50e-1)"		"unprognostic (9.12e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.57e-1)"		"unprognostic (3.42e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.96e-1)"	"unprognostic (7.61e-3)"	"unprognostic (6.07e-2)"		"unprognostic (1.19e-2)"	"unprognostic (6.10e-2)"	1.1	0.6	0.5	0.3	1.2	1.2	1.8	2.3	0.6	1.9	3.5	2.1	2.1	0.9	0.0	1.0	1.2	2.4	0.7	0.6	1.4	1.2	2.7	1.0	0.2	3.8	1.6	0.3	3.2	1.0	0.4	0.7	2.5	1.1	0.5	0.0	5.0	3.9	0.2	1.1	1.4	0.7	2.6	0.1	2.1	1.5	1.4	0.2	0.1	0.2	0.1	0.7	0.3	4.1	7.6	0.0	4.0	4.4	0.2	0.0	0.0	0.8	0.5	0.4	0.0	1.7	2.6	0.0	5.8	0.0	1.5	3.0	0.4	0.5	0.0	0.1	3.9	12.0	0.0	2.8	0.1	0.2	0.0	0.8	0.2	0.0	0.5	0.7	1.5	0.9	1.2	0.2	0.2	2.7	0.4	0.0	3.5	2.1	3.0	0.3	0.1	0.0	1.4	2.7	1.7	1.9	2.6	0.4	1.9	0.5	4.3	0.0	2.1	0.1	1.0	0.1	1.8	5.8	0.0	0.0	0.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	2.3	0.6	0.6	1.4	3.8	1.6	2.5	2.6	1.4	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALOX12	12S-LOX	ENSG00000108839	"Arachidonate 12-lipoxygenase, 12S type"	P18054	17	6996049-7010754	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Dioxygenase, Hydrolase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 34.6;esophagus: 49.4;vagina: 105.7"	"Cell type enriched"	"Detected in some"	6	"Macrophages: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"A-431: 25.5;HEL: 40.4"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 4.4"					"HPA010691, CAB019287, HPA064819"	Enhanced		Supported	"Nuclear speckles,Vesicles,Cytosol"		NA	NA		49000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Nuclear speckles, Vesicles"	"CAB019287: , HPA010691: AB_1844756, HPA064819: "	"unprognostic (3.61e-3)"	"unprognostic (6.93e-2)"	"unprognostic (7.17e-5)"	"unprognostic (9.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.96e-5)"	"unprognostic (4.01e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.47e-2)"	1.0	1.5	0.9	3.2	1.5	4.7	0.3	0.1	1.4	34.6	0.6	0.4	1.8	2.2	0.0	49.4	1.2	3.1	1.4	0.4	0.4	0.5	0.2	1.1	3.9	1.3	0.7	1.3	1.9	0.0	0.1	1.1	1.0	0.8	0.1	3.1	20.2	0.0	1.6	21.7	2.0	0.2	0.1	3.3	1.1	1.3	1.2	0.0	1.9	0.1	3.8	1.5	105.7	3.4	25.5	4.2	1.9	1.4	0.0	0.0	1.7	1.6	0.0	0.0	0.0	3.7	0.9	1.3	0.9	0.0	1.4	3.2	0.0	0.1	0.0	2.8	3.2	40.4	6.8	2.8	0.1	0.4	6.5	0.0	0.1	0.0	0.0	2.4	0.0	2.8	2.7	1.4	0.0	0.3	0.5	0.9	1.3	0.2	0.8	1.4	0.8	0.7	0.0	3.2	0.1	0.9	0.7	0.8	0.4	2.4	1.5	1.1	4.6	2.2	1.2	2.1	1.1	0.8	0.3	0.7	1.2	3.0	1.0	2.1	0.9	1.8	0.7	0.4	0.5	1.1	0.5	0.7	0.7	0.6	0.2	0.3	4.5	0.7	0.4	1.3	0.3	13.6	0.9	1.5	0.1	1.4	0.4	0.4	1.3	0.7	1.0	0.1	1.2	3.4	0.0	0.0	0.0	2.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	17.3	0.0	1.0	0.8	0.0	0.0	2.5	2.4	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	2.5	1.1	0.0	0.1	0.1	0.0	2.0
ALX4	"FPP, KIAA1788, PFM, PFM2"	ENSG00000052850	"ALX homeobox 4"	Q9H161	11	44260440-44310139	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 1.8;choroid plexus: 1.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 20.4;Fibroblasts: 4.3;Leydig cells: 4.7;Microglial cells: 6.5;Skeletal myocytes: 5.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.0;BJ: 3.4;HAP1: 4.7;HEK 293: 4.8;HEL: 6.8;K-562: 3.2;SiHa: 7.0"	"Region enriched"	"Detected in some"	8	"olfactory bulb: 9.0"	"Region enriched"	"Detected in single"	31	"olfactory bulb: 9.0"	HPA001903			Supported	Nucleoplasm		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA001903: AB_2666495"	"unprognostic (7.56e-5)"	"unprognostic (1.69e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.74e-1)"	"unprognostic (7.24e-3)"	"unprognostic (2.63e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.33e-4)"	"unprognostic (5.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.34e-6)"	"unprognostic (3.62e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.03e-1)"	0.4	0.0	0.1	0.0	0.1	0.0	1.8	0.1	0.4	0.4	1.9	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.7	0.0	1.0	0.9	0.0	0.3	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.5	0.0	4.0	0.0	0.0	0.0	3.4	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.7	0.0	0.0	1.0	4.8	6.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.0	0.2	0.3	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	1.1	1.3	20.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.3	0.6	4.7	0.1	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
AMHR2	"MISR2, MISRII"	ENSG00000135409	"Anti-Mullerian hormone receptor type 2"	Q16671	12	53423855-53431672	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 41.5;ovary: 33.1"	"Group enriched"	"Detected in some"	4	"granulocytes: 26.0;Granulosa cells: 36.1;Theca cells: 94.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"HEL: 40.1;K-562: 22.2"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	11	"hippocampal formation: 9.4"	"HPA060228, HPA069636"			Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 51: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Nucleoplasm, Cytosol"	"HPA060228: AB_2684227, HPA069636: AB_2686163"	"unprognostic (5.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.97e-1)"	0.6	41.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.3	0.4	0.1	0.5	0.0	0.3	0.0	0.9	0.4	0.0	0.0	0.2	33.1	12.5	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	4.2	0.1	0.1	0.0	0.0	5.7	0.7	9.1	0.5	0.0	0.0	1.8	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	40.1	0.0	0.8	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	22.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	3.5	2.6	0.0	0.1	1.5	0.0	4.2	0.1	2.1	0.1	2.7	0.0	0.1	26.0	36.1	11.4	0.3	0.1	0.0	0.0	0.0	0.0	1.2	0.0	2.5	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.1	0.3	0.0	0.0	0.3	0.8	94.9	0.1	0.0
ANKRD27	"DKFZp434L0718, FLJ00040, VARP"	ENSG00000105186	"Ankyrin repeat domain 27"	Q96NW4	19	32597006-32676597	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 137.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042769	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	Vesicles	Cytosol	"HPA042769: AB_10796584"	"unprognostic (2.16e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (9.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.90e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.07e-1)"	"unprognostic (2.26e-2)"	8.9	7.4	10.8	8.9	12.9	10.4	8.7	12.1	12.6	10.3	21.5	17.2	7.6	10.0	8.8	14.3	8.0	7.7	9.6	11.8	9.8	9.7	4.4	10.3	11.1	12.0	12.9	8.3	7.2	9.3	6.8	13.6	12.4	12.3	11.9	11.7	9.7	13.5	20.7	12.4	10.7	11.6	8.9	9.0	11.0	17.3	12.1	16.7	13.3	10.8	11.5	16.9	11.1	11.8	32.0	36.0	11.5	20.8	23.5	18.0	28.1	18.0	18.0	19.4	25.4	28.8	19.0	34.7	16.5	23.0	20.4	19.4	29.6	22.3	32.0	47.3	15.1	137.9	13.7	23.9	29.4	53.5	47.6	13.1	28.8	20.9	33.8	13.5	19.7	25.3	37.5	76.3	15.1	31.5	20.8	46.2	6.0	40.2	13.8	30.6	15.6	12.7	15.6	30.5	21.3	8.6	17.6	29.6	21.0	15.2	12.4	25.7	18.5	21.1	22.4	19.6	28.0	19.7	12.7	23.8	21.0	51.8	13.8	36.5	11.1	28.5	13.9	15.7	17.5	7.5	14.3	15.6	12.6	6.9	10.9	11.7	9.0	30.6	13.3	6.2	13.2	13.3	10.8	12.9	12.1	12.6	11.8	9.8	12.0	12.9	12.4	8.9	12.1	11.8	6.8	16.0	9.4	18.3	10.0	15.6	5.5	5.6	14.2	9.4	9.0	5.1	9.2	7.2	5.7	9.2	20.9	14.9	9.7	9.3	0.0	3.3	5.1	7.5	9.4	7.1	9.1	26.5	35.5	5.9	10.6	7.6	5.6	11.6	12.0	10.1	4.6	4.8	8.4	11.8	16.3	9.6	8.2	12.0	12.1	16.2	10.8	8.7	16.0	12.2	6.0	5.8	9.2	11.1	18.7	7.1	10.3	9.4	8.0	10.0	10.8	7.7	7.1	14.7	0.0	6.8	9.3	4.1	17.1	14.7	15.5	15.2	14.0	7.2	8.9	8.4
APLNR	"AGTRL1, APJ, APJR, FLJ90771"	ENSG00000134817	"Apelin receptor"	P35414	11	57233577-57237235	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Angiogenesis, Gastrulation, Host-virus interaction"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 268.8;lymphoid tissue: 101.0;placenta: 88.1"	"Group enriched"	"Detected in some"	7	"Adipocytes: 67.6;Endothelial cells: 98.5"	"Cancer enhanced"	"Detected in all"		"glioma: 50.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"AF22: 4.9;HEL: 4.3;K-562: 1.3;NTERA-2: 1.8;SuSa: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB025842	Approved					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB025842: "	"unprognostic (5.06e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.68e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.27e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.13e-3)"	17.3	3.7	47.1	9.4	46.3	0.1	10.6	52.0	45.7	2.3	22.7	5.4	4.5	3.5	0.3	4.1	1.2	13.0	23.7	48.3	130.5	5.7	18.5	8.1	9.6	268.8	97.4	0.7	2.0	2.9	2.4	88.1	92.2	1.0	6.0	0.0	3.5	1.9	15.2	7.1	4.2	9.9	99.9	101.0	3.2	1.4	92.7	4.1	9.5	10.8	4.2	6.2	1.7	122.4	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.1	46.3	52.0	45.7	48.3	130.5	268.8	97.4	92.2	99.9	92.7	122.4	67.6	0.0	0.0	6.5	0.6	2.3	0.1	0.0	0.0	0.0	0.5	0.6	3.2	1.5	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.3	0.3	98.5	0.0	0.0	0.0	0.2	0.1	2.6	0.0	0.5	0.0	0.0	10.4	0.0	0.2	0.0	0.0	0.0	0.0	0.8	2.6	0.2	0.0	0.5	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	2.7	0.0	0.0	0.3	3.1	0.1	0.2	2.7	0.0	0.1
ARHGAP6	rhoGAPX-1	ENSG00000047648	"Rho GTPase activating protein 6"	O43182	X	11117651-11665920	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 44.3;Microglial cells: 127.4;Oligodendrocyte precursor cells: 60.3;Prostatic glandular cells: 54.4;Sertoli cells: 46.0;Skeletal myocytes: 62.3;Smooth muscle cells: 44.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 12.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 26.2;ASC TERT1: 34.2;HEL: 36.4;HMC-1: 24.7;HSkMC: 33.8;K-562: 26.5;RT4: 20.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001798, HPA036779, HPA064390"	Enhanced		Supported	Cytosol	"Intracellular and membrane"	NA	NA		350000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"HPA001798: , HPA036779: AB_10672229, HPA064390: AB_2685253"	"unprognostic (2.36e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.31e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.46e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.59e-1)"	"prognostic favorable (1.55e-8)"	"unprognostic (1.60e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.28e-2)"	"unprognostic (7.99e-4)"	10.8	1.1	9.0	1.7	5.1	0.7	5.6	2.0	4.2	7.6	3.2	13.9	2.1	10.5	8.2	3.8	8.4	4.2	4.0	5.0	5.8	6.5	0.9	9.6	1.2	3.2	4.0	16.4	1.9	1.2	3.2	7.0	3.2	27.6	3.9	1.0	2.6	30.9	9.6	2.5	4.7	12.9	2.6	5.9	4.1	1.9	6.1	1.0	25.4	8.1	0.8	10.4	5.7	3.8	0.0	0.0	2.4	0.0	26.2	34.2	0.6	0.4	0.6	1.4	0.9	0.4	0.0	0.0	0.0	5.0	0.0	0.1	0.9	0.0	1.2	0.6	0.5	36.4	0.4	0.0	9.7	0.1	24.7	33.8	0.0	2.5	0.1	3.1	0.7	0.1	26.5	12.3	1.5	0.0	0.0	0.2	0.7	0.2	0.4	0.1	11.6	15.7	8.3	20.3	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.4	0.3	1.6	0.7	7.1	0.2	0.7	0.0	0.0	0.5	0.2	4.0	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	9.0	5.1	2.0	4.2	5.0	5.8	3.2	4.0	3.2	2.6	6.1	3.8	9.6	0.0	1.7	10.4	5.3	2.0	16.9	0.3	2.8	4.3	2.3	3.3	4.7	0.0	2.6	33.1	0.0	0.6	0.4	0.0	25.4	0.0	0.1	0.1	5.1	9.2	1.2	2.1	5.5	1.1	0.7	29.1	3.6	0.2	40.0	3.0	8.2	0.0	4.9	0.0	44.3	0.4	0.0	2.2	18.9	0.9	16.1	29.1	5.4	127.4	3.4	7.2	0.0	60.3	3.5	0.7	0.0	10.1	4.9	54.4	0.0	7.4	5.6	0.7	46.0	62.3	44.4	0.2	0.4	4.5	1.7	0.0	1.2	2.1	0.0	22.3
ARRB1	ARR1	ENSG00000137486	"Arrestin beta 1"	P49407	11	75260122-75351705	"Predicted intracellular proteins, Transporters"	"Protein transport, Transcription, Transcription regulation, Transport"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 136.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 42.5;granulocytes: 49.5;monocytes: 136.8"	"Cell line enhanced"	"Detected in many"		"HEL: 168.9;RH-30: 114.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003763, HPA049318, HPA070249"	Approved		Supported	Nucleoplasm		NA	NA		1500000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB003763: AB_562248, HPA049318: AB_2680711, HPA070249: AB_2732151"	"unprognostic (3.40e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.27e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.26e-1)"	30.7	7.1	49.7	21.9	49.4	15.7	24.1	28.3	49.5	10.0	0.0	26.4	21.9	10.2	6.1	19.0	15.9	12.9	17.6	54.3	43.6	14.2	10.1	53.0	15.3	41.1	55.6	16.2	24.5	3.8	4.1	25.1	49.4	16.3	22.5	5.3	12.7	9.7	11.4	16.8	27.2	21.8	23.2	40.1	33.9	4.3	49.9	9.9	8.8	10.9	10.3	16.5	11.0	36.7	5.1	23.6	24.2	12.0	20.2	17.6	48.8	5.0	17.2	6.2	4.3	34.5	23.9	2.0	58.9	4.5	4.7	1.1	9.5	0.1	2.4	0.2	5.5	168.9	3.3	20.6	5.5	5.1	63.9	8.9	1.2	10.3	0.0	7.4	70.4	6.1	83.5	0.2	12.2	14.1	3.1	58.4	17.8	76.9	7.1	18.8	114.4	6.8	26.8	20.4	12.5	13.5	8.7	61.7	15.0	49.3	44.8	27.6	61.0	4.7	5.9	19.3	0.6	0.1	0.1	0.1	3.5	78.0	5.8	33.7	65.7	45.9	11.6	106.5	4.3	0.4	5.5	6.6	42.5	0.2	5.0	6.6	49.5	14.8	136.8	0.9	5.7	41.1	49.7	49.4	28.3	49.5	54.3	43.6	41.1	55.6	49.4	23.2	49.9	36.7	24.2	28.9	14.8	52.2	1.9	1.9	2.0	1.9	2.8	3.1	9.0	14.7	4.6	8.6	5.8	3.7	6.2	41.7	10.7	38.5	1.9	5.0	2.6	0.8	4.3	19.4	5.4	10.3	35.6	8.4	4.1	9.1	17.3	0.9	23.5	2.3	25.7	2.1	39.6	0.0	48.9	11.1	8.2	55.2	17.9	21.4	15.8	31.2	3.6	55.3	42.1	0.2	29.9	8.0	23.9	9.2	19.1	16.6	1.0	3.6	29.9	0.2	4.7	1.1	13.1	4.5	7.7	0.2	0.8	1.0	3.0	33.7	5.9	9.4	20.0	2.8
ASH2L	"ASH2, ASH2L1, ASH2L2, Bre2"	ENSG00000129691	"ASH2 like, histone lysine methyltransferase complex subunit"	Q9UBL3	8	38105493-38144076	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 69.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 200.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042289	Approved		Supported	"Nucleoplasm,Plasma membrane"		Yes	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA042289: AB_10795608"	"unprognostic (9.39e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.67e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.04e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.10e-2)"	"unprognostic (9.73e-3)"	"prognostic favorable (4.25e-4)"	"unprognostic (9.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.54e-1)"	28.9	18.9	19.7	17.9	20.3	31.6	21.4	19.2	21.5	19.9	14.7	22.5	18.2	22.0	17.1	23.8	20.1	17.4	21.3	20.2	17.4	23.3	23.6	18.5	27.9	16.7	16.1	26.2	17.7	24.8	12.0	22.1	16.7	19.9	22.3	21.7	20.6	21.0	32.4	20.4	18.3	24.2	16.5	18.9	22.1	41.3	19.0	33.6	21.1	27.7	28.3	18.5	16.1	18.1	45.6	23.3	39.8	39.8	26.3	34.0	49.8	44.1	45.7	53.5	47.0	24.9	21.1	51.4	38.2	37.1	27.2	27.5	49.0	24.8	50.4	20.3	22.4	200.3	22.9	51.7	39.4	32.0	41.3	28.6	22.9	25.0	27.7	28.1	43.9	48.0	138.2	40.0	53.7	26.1	91.9	40.7	51.7	39.3	15.6	38.2	42.9	23.4	28.9	33.1	18.3	32.4	33.5	22.5	38.4	37.1	27.4	40.4	33.5	35.3	35.0	50.4	37.6	37.8	48.7	44.9	35.2	44.7	49.7	39.9	23.0	55.9	16.8	26.8	18.1	19.6	18.8	20.0	27.7	19.2	19.3	18.4	19.2	26.1	25.8	15.8	21.3	21.6	19.7	20.3	19.2	21.5	20.2	17.4	16.7	16.1	16.7	16.5	19.0	18.1	11.1	12.8	15.8	18.3	14.3	6.9	9.3	13.3	10.8	12.9	9.6	8.0	18.1	8.6	15.9	12.9	10.4	37.0	15.9	11.5	7.9	21.2	10.8	12.7	13.2	14.0	10.8	62.1	19.7	28.7	37.2	17.3	8.6	10.8	19.6	38.2	12.8	11.9	24.2	6.7	21.4	11.6	12.2	17.2	5.7	13.0	23.3	17.0	23.2	15.9	29.2	17.8	19.6	17.6	16.5	21.3	8.9	20.7	8.4	6.2	12.8	17.1	18.0	15.5	13.1	14.6	20.7	69.6	33.9	11.6	6.8	30.9	11.9	37.3	10.9	7.4
ATP7B	WND	ENSG00000123191	"ATPase copper transporting beta"	P35670	13	51930436-52012125	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"	Translocase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 22.9;Early spermatids: 30.2;Excitatory neurons: 24.5;Hepatocytes: 23.6;Inhibitory neurons: 25.4;Late spermatids: 74.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 32.8;CACO-2: 21.1;HEL: 53.0;RPTEC TERT1: 22.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA009137, HPA013187"	Supported		Supported	"Golgi apparatus"		NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 36: HEL - Hemostasis"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"		"HPA009137: AB_2668214, HPA013187: AB_1845206"	"unprognostic (1.13e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (3.49e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.77e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.26e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.40e-1)"	3.6	0.9	1.3	0.6	1.2	2.2	1.7	2.0	2.1	1.8	0.8	2.9	10.6	1.5	0.1	0.7	2.0	7.0	2.1	2.5	1.4	2.2	8.6	1.4	0.3	0.8	1.2	1.9	2.0	6.4	1.2	7.1	1.1	2.0	2.7	3.7	3.0	0.9	1.1	1.0	6.0	1.7	0.5	0.4	4.4	8.4	1.7	0.7	1.2	1.8	0.2	1.6	1.2	0.7	0.8	2.8	5.2	4.5	1.0	0.8	32.8	1.5	0.5	1.6	1.2	21.1	0.1	0.1	0.6	2.7	3.6	0.3	4.0	4.4	1.0	0.4	7.5	53.0	0.5	14.7	1.4	0.6	11.8	1.9	4.7	0.2	2.0	2.1	3.7	3.7	14.4	0.2	1.5	1.0	0.2	0.9	1.7	6.6	1.8	2.0	1.4	0.0	22.5	3.4	3.3	2.2	1.9	2.8	1.8	5.5	8.0	0.5	2.0	0.3	1.7	2.8	0.6	0.6	0.7	0.2	0.1	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	2.0	2.1	2.5	1.4	0.8	1.2	1.1	0.5	1.7	0.7	5.4	6.4	0.0	10.7	0.9	0.4	0.7	1.7	0.0	3.1	2.3	1.8	2.1	4.3	5.2	1.8	22.9	14.3	1.8	6.6	0.0	1.6	30.2	2.4	1.3	2.7	2.4	4.2	24.5	1.0	5.5	2.1	9.2	4.2	0.0	13.3	3.9	23.6	2.3	0.0	25.4	3.4	4.1	0.8	0.3	74.2	2.1	0.2	1.8	15.0	0.2	0.2	0.0	12.1	4.3	2.0	3.0	0.7	0.2	1.3	11.4	2.2	4.3	6.1	6.6	1.0	1.4	2.2	1.7	0.7	0.4	4.5	0.2	0.4	5.0	1.2
AUNIP	"AIBp, C1orf135, MGC2603"	ENSG00000127423	"Aurora kinase A and ninein interacting protein"	Q9H7T9	1	25831913-25859458	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 6.2;testis: 16.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 52.8;Late spermatids: 127.0;Spermatocytes: 54.9;Spermatogonia: 47.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028730	Uncertain		Supported	Centrosome		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 34: Spermatids - Unknown function"	Centrosome		"HPA028730: AB_10670830"	"unprognostic (8.05e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.96e-3)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (9.51e-2)"	"unprognostic (8.86e-2)"	"unprognostic (9.70e-6)"	"unprognostic (5.00e-3)"	"unprognostic (9.06e-3)"	"unprognostic (4.59e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.01e-6)"	"unprognostic (3.61e-2)"	"unprognostic (4.41e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.62e-1)"	0.2	0.9	0.5	0.9	0.4	6.2	0.4	0.8	0.9	0.3	0.0	0.7	0.9	0.3	0.5	1.4	0.2	0.2	0.6	0.6	0.0	0.4	0.5	0.3	1.2	0.3	0.0	0.2	0.2	0.0	0.4	1.8	0.4	0.3	0.9	0.9	0.3	0.1	0.7	0.5	0.8	0.3	0.0	0.7	0.5	16.0	0.1	1.3	0.2	0.0	1.7	0.3	0.5	0.6	19.8	5.6	8.8	11.3	0.4	0.6	8.5	11.1	5.1	22.0	17.9	4.7	15.0	19.0	8.3	4.0	7.7	15.7	23.9	10.8	17.6	11.0	17.7	42.0	8.8	7.3	0.2	20.7	18.3	0.5	5.3	13.5	9.2	1.7	5.0	14.7	25.7	9.5	6.2	10.5	15.2	17.3	15.2	13.1	6.6	12.4	16.3	12.1	6.9	6.4	12.3	5.9	15.4	17.5	12.4	9.7	6.3	10.8	2.1	6.5	9.7	13.5	10.0	3.6	7.6	14.2	4.5	34.3	10.6	1.5	0.7	0.5	0.1	1.0	0.1	0.2	0.2	0.2	0.6	0.3	0.2	0.3	0.5	0.3	0.6	0.4	0.8	0.3	0.5	0.4	0.8	0.9	0.6	0.0	0.3	0.0	0.4	0.0	0.1	0.6	0.1	0.0	0.0	1.6	0.3	0.4	0.1	1.4	0.6	0.0	0.3	0.6	1.4	0.0	0.2	0.0	2.1	8.9	0.3	0.2	0.0	0.4	52.8	0.3	0.4	0.5	0.0	13.0	3.8	0.5	11.1	0.7	0.0	0.3	0.0	1.4	0.0	0.0	2.1	0.0	1.7	0.5	0.0	0.3	1.2	127.0	2.1	0.7	0.0	0.0	1.1	0.2	0.0	1.5	0.8	0.6	0.0	0.7	1.1	0.2	0.0	0.2	0.0	0.3	0.0	0.1	0.5	54.9	47.4	1.7	0.4	7.4	0.5	0.4	1.0	0.2
BEND4	"CCDC4, FLJ35632, FLJ43965"	ENSG00000188848	"BEN domain containing 4"	Q6ZU67	4	42110853-42152878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.6;prostate: 3.3;testis: 9.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 8.1;Inhibitory neurons: 6.2;Muller glia cells: 10.7;Spermatogonia: 38.3"	"Group enriched"	"Detected in some"	43	"prostate cancer: 6.3;testis cancer: 5.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 33.2;HEK 293: 7.9;HEL: 21.1;MOLT-4: 13.1;SuSa: 15.4;U-698: 13.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036850	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA036850: AB_10600787"	"unprognostic (3.62e-4)"	"unprognostic (3.82e-1)"	"unprognostic (4.82e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.54e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.24e-1)"	0.0	0.0	0.7	1.1	0.7	0.8	0.0	0.0	1.3	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	1.3	1.1	0.0	0.1	0.2	2.1	1.2	3.6	0.1	0.0	0.0	1.0	0.3	2.8	3.3	0.2	1.1	0.0	0.0	0.0	0.0	1.2	0.1	0.1	1.2	0.2	9.4	0.7	1.1	0.0	0.0	1.6	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.0	33.2	0.0	0.0	0.0	7.9	21.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.4	0.0	7.0	0.0	0.1	0.0	0.0	13.1	0.0	6.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	4.7	0.8	0.0	0.0	0.0	15.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	1.3	1.3	1.1	1.2	3.6	2.8	0.1	0.7	0.4	0.4	0.0	0.0	0.0	8.1	0.0	0.1	0.0	0.0	1.2	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.6	0.0	3.4	4.4	0.0	0.0	0.3	0.0	0.0	0.0	4.8	2.5	0.0	0.0	3.3	6.2	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.1	10.7	0.0	3.5	0.2	0.0	0.0	0.0	3.9	1.7	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.6	38.3	0.0	0.0	0.0	1.5	2.2	0.0	0.0
BUB1	"BUB1A, BUB1L, hBUB1"	ENSG00000169679	"BUB1 mitotic checkpoint serine/threonine kinase"	O43683	2	110637528-110678063	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 11.9;lymphoid tissue: 27.5;testis: 30.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 24.8;Granulosa cells: 66.1;Plasma cells: 35.2;Spermatocytes: 85.6;Spermatogonia: 20.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 221.5"	"Region enhanced"	"Detected in single"		"white matter: 1.7"	"Not detected"	"Not detected"			HPA006123			Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA006123: AB_1845498"	"unprognostic (7.74e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.72e-3)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (1.61e-1)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (1.03e-5)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.37e-5)"	"unprognostic (1.76e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.45e-2)"	"unprognostic (3.64e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	0.5	0.4	0.1	8.4	0.3	11.9	1.2	0.1	0.1	0.9	0.0	4.3	4.0	1.0	3.5	4.7	0.5	0.9	0.6	0.1	0.1	0.3	0.6	1.2	15.9	0.1	0.6	0.4	0.2	0.7	0.0	3.2	0.3	0.3	5.7	0.1	0.9	0.1	0.1	2.7	3.5	2.2	0.0	5.6	1.9	30.3	0.4	27.5	0.4	0.2	17.0	2.4	1.6	0.3	96.0	29.4	68.5	46.8	3.8	5.3	38.8	50.9	32.9	85.6	62.3	58.3	55.0	64.7	30.9	30.1	80.1	43.2	93.9	35.0	105.7	51.4	45.6	221.5	26.2	50.6	0.8	63.5	57.0	1.7	2.8	65.2	33.1	12.7	49.8	73.2	96.8	126.5	76.8	33.7	126.3	39.0	71.2	39.4	55.3	69.3	64.2	102.7	18.3	27.0	48.3	21.4	34.2	31.4	27.2	44.1	24.0	60.6	19.1	39.7	57.5	28.8	69.0	67.3	65.5	75.4	24.2	48.6	69.8	1.1	0.0	0.2	0.2	0.0	0.3	0.5	0.9	0.5	0.1	0.5	0.6	0.4	0.0	0.5	0.0	0.9	1.5	0.3	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.6	0.3	0.0	0.4	0.3	0.2	0.0	1.5	0.0	5.5	0.5	0.5	2.0	0.6	0.0	0.9	0.8	1.1	0.0	1.6	0.0	0.0	5.8	2.5	2.4	0.0	0.3	13.5	4.5	1.5	1.1	0.0	24.8	0.2	0.0	9.8	2.2	2.0	2.2	0.0	66.1	1.8	0.3	8.1	0.0	0.2	3.1	4.1	1.6	1.4	7.5	0.3	2.0	0.0	0.0	0.6	0.0	0.0	0.5	1.0	0.1	0.0	0.4	35.2	0.5	0.3	0.1	1.8	0.0	6.6	0.2	3.7	85.6	20.0	4.0	0.4	0.7	2.9	0.5	5.9	0.9
C1orf141		ENSG00000203963	"Chromosome 1 open reading frame 141"	Q5JVX7	1	67092165-67231853	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 9.7;testis: 15.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 117.8;Granulosa cells: 23.1;Late spermatids: 94.7;Muller glia cells: 63.0;Respiratory ciliated cells: 53.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	44	"HEL: 14.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035316			Uncertain	"Intermediate filaments"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 36: HEL - Hemostasis"	"Cluster 49: Ciliated cells - Cilium organization"	"Intermediate filaments"		"HPA035316: AB_10600886"					"unprognostic (1.48e-1)"			"unprognostic (8.09e-2)"		"unprognostic (2.71e-1)"	"unprognostic (2.79e-3)"			"unprognostic (1.01e-1)"	"unprognostic (2.20e-2)"			0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.2	0.6	0.2	2.7	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.3	0.6	0.0	0.0	1.0	0.0	1.3	0.9	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	15.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	14.7	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.2	0.6	0.3	0.6	1.3	0.9	0.5	1.1	0.3	0.6	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.0	0.2	0.0	9.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	117.8	3.8	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.1	0.0	23.1	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.0	94.7	1.8	0.2	0.0	0.0	0.0	63.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	53.8	2.1	0.0	0.0	1.4	8.8	0.9	0.0	0.0	0.1	0.0	4.0	0.0	0.0
C1orf226	FLJ13137	ENSG00000239887	"Chromosome 1 open reading frame 226"	A1L170	1	162378841-162386812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 21.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 29.2;Early spermatids: 22.7;Hepatocytes: 30.0;Late spermatids: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 14.0;HEL: 18.4;OE19: 16.0"					"Low region specificity"	"Detected in all"			"HPA052251, HPA074060"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA052251: AB_2681775, HPA074060: "	"prognostic favorable (2.60e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.59e-2)"	"unprognostic (6.71e-3)"	"unprognostic (9.80e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-3)"	"prognostic favorable (4.44e-5)"	"unprognostic (9.34e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.13e-4)"	1.9	9.6	3.5	1.1	3.6	2.0	8.1	4.6	3.1	3.8	5.1	9.3	5.6	2.4	2.4	4.1	3.2	3.4	3.4	3.7	5.1	11.3	21.9	2.5	0.4	7.2	4.0	1.2	3.7	4.0	9.9	2.4	5.3	4.8	9.7	7.0	8.5	7.7	0.6	5.2	7.9	2.4	5.8	0.6	8.7	4.0	3.5	0.4	0.8	0.6	1.5	2.5	2.2	7.3	14.0	0.9	13.1	8.9	0.4	0.0	0.2	0.9	1.4	0.8	0.5	2.0	7.2	0.0	9.5	0.3	4.7	10.3	3.7	0.9	0.7	0.1	4.4	18.4	0.8	10.2	0.3	0.0	0.0	1.4	1.1	0.0	0.5	3.9	3.2	2.3	1.7	0.1	0.2	5.6	0.5	0.0	6.3	16.0	7.5	0.3	2.2	0.0	12.1	7.0	5.9	3.7	4.6	1.6	3.1	5.3	5.7	0.9	3.1	0.1	1.4	0.1	4.0	6.3	0.0	0.0	2.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.6	4.6	3.1	3.7	5.1	7.2	4.0	5.3	5.8	3.5	7.3	2.5	3.2	2.6	0.3	0.1	0.8	1.7	1.1	0.6	0.8	10.3	14.9	3.4	4.3	2.4	14.7	29.2	0.1	0.1	11.6	0.0	0.9	22.7	2.6	1.1	2.2	2.4	0.0	2.8	2.3	0.1	0.7	0.0	4.2	0.0	3.4	4.2	30.0	0.1	6.7	1.8	11.6	4.1	1.0	0.7	38.4	2.1	0.1	0.0	3.7	0.0	5.0	0.0	6.6	3.7	1.7	3.6	1.9	0.0	2.6	7.7	0.2	2.7	0.4	0.0	0.2	0.6	1.1	0.9	0.6	1.4	0.1	0.3	0.5	7.1	2.5
C2orf66	UNQ6411	ENSG00000187944	"Chromosome 2 open reading frame 66"		2	196804417-196809355	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"adrenal gland: 3.9;brain: 5.1;pituitary gland: 3.7"	"Cell type enriched"	"Detected in some"	7	"Early spermatids: 36.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 9.0;RT4: 2.2;TIME: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA020869	Uncertain		Uncertain	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA020869: AB_1851545"	"unprognostic (1.19e-1)"	"unprognostic (4.85e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.80e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.10e-3)"	"unprognostic (4.54e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.75e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.86e-2)"	2.8	3.9	2.1	0.2	1.8	0.1	0.4	1.4	2.2	0.0	1.7	0.3	0.0	0.1	0.4	0.2	0.6	0.3	0.5	2.0	4.2	0.2	0.1	0.3	0.0	2.3	5.1	0.3	0.4	0.1	3.7	0.0	2.9	0.3	0.1	1.8	0.1	0.1	0.0	1.2	0.3	0.0	1.5	0.1	0.2	1.5	2.8	0.1	0.1	0.0	0.1	0.3	0.2	1.6	0.0	0.1	0.2	0.8	0.2	0.2	0.0	0.3	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.2	0.4	9.0	0.3	0.1	0.0	0.1	0.8	0.2	1.2	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.4	2.2	0.3	0.0	0.0	0.0	0.2	0.3	0.0	0.1	2.1	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.8	1.4	2.2	2.0	4.2	2.3	5.1	2.9	1.5	2.8	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	4.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1
C3orf20	DKFZP434N1817	ENSG00000131379	"Chromosome 3 open reading frame 20"	Q8ND61	3	14675141-14773036	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"testis: 6.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 5.9;Early spermatids: 19.3;Excitatory neurons: 8.4;Inhibitory neurons: 6.9;Late spermatids: 34.6;Oligodendrocytes: 7.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Daudi: 4.0;HEL: 8.2;U-698: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039584	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA039584: AB_10795152"	"unprognostic (1.23e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.76e-3)"	"unprognostic (1.81e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.08e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-4)"	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.6	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	8.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.2	0.5	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.2	0.1	0.1	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	34.6	0.6	0.1	0.0	0.0	0.0	0.0	0.0	2.5	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CA1	Car1	ENSG00000133742	"Carbonic anhydrase 1"	P00915	8	85327608-85379014	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	55	"bone marrow: 1798.9;intestine: 2109.9"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 11487.3"	"Group enriched"	"Detected in some"	10	"colorectal cancer: 3.4;stomach cancer: 0.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	987	"HEL: 1022.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006558, CAB025790"	Enhanced					NA	NA		4600000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB025790: , HPA006558: AB_1845989"	"unprognostic (1.44e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.03e-2)"		"unprognostic (1.73e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.61e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	2.0	0.4	0.4	0.5	0.3	1798.9	2.1	1.0	1.5	0.3	0.0	1023.3	0.2	1.6	0.1	0.7	2.2	0.3	1.6	0.2	0.2	2.0	6.7	5.9	0.2	0.3	0.3	0.4	0.3	0.1	1.9	20.7	0.3	0.4	2109.9	0.4	1.1	1.8	1.0	1.4	1.8	30.7	0.1	35.4	2.3	0.2	0.5	0.5	0.9	3.4	0.1	0.4	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1022.7	0.0	0.5	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.4	0.3	1.0	1.5	0.2	0.2	0.3	0.3	0.3	0.1	0.5	0.6	0.0	0.0	0.0	4.2	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.8	0.0	0.0	0.0	0.0	0.0	2565.3	0.0	0.0	0.5	0.1	0.0	0.5	45.8	11487.3	11.8	0.0	0.0	0.1	0.0	0.1	22.3	0.0	4.2	4.4	0.0	0.0	12.1	159.4	0.0	11.4	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	1.0	13.0	2.2	0.0	754.9	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.4	0.1	298.4	0.0
CABP7	MGC57793	ENSG00000100314	"Calcium binding protein 7"	Q86V35	22	29720003-29731833	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 38.2"	"Cell type enriched"	"Detected in some"	19	"Cardiomyocytes: 28.6"	"Group enriched"	"Detected in some"	4	"glioma: 2.3;ovarian cancer: 1.0;pancreatic cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HEL: 10.3;SCLC-21H: 9.7;SH-SY5Y: 3.1;U-2 OS: 3.1"	"Group enriched"	"Detected in all"	4	"cerebellum: 74.4;hippocampal formation: 204.8;midbrain: 60.3;pons and medulla: 110.0"	"Region enhanced"	"Detected in all"		"hippocampal formation: 51.0"	HPA016439	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA016439: AB_2669357"	"unprognostic (1.88e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.05e-3)"	"unprognostic (7.96e-2)"	"unprognostic (8.69e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.44e-7)"	"unprognostic (1.25e-4)"	"unprognostic (3.60e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.72e-3)"	0.1	5.6	3.1	0.0	3.0	0.2	0.1	19.8	35.0	0.1	0.6	0.8	0.4	0.1	0.0	0.1	0.1	0.0	0.2	38.2	4.2	0.2	0.3	0.1	0.1	27.7	14.8	0.1	3.1	0.0	0.4	0.0	30.0	0.4	0.0	1.0	0.2	0.0	0.1	0.2	1.5	0.0	22.2	0.4	0.3	0.6	3.9	0.0	0.3	0.0	0.0	0.1	0.1	16.5	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.5	10.3	0.3	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.0	0.0	9.7	3.1	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.1	3.1	0.1	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.1	3.1	3.0	19.8	35.0	38.2	4.2	27.7	14.8	30.0	22.2	3.9	16.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	28.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.8	0.0	0.0	1.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	1.1	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	1.5	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.0
CATSPERD	"MGC39581, TMEM146"	ENSG00000174898	"Cation channel sperm associated auxiliary subunit delta"	Q86XM0	19	5720637-5778734	"Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 8.7"	"Group enriched"	"Detected in some"	6	"Early spermatids: 120.2;Endometrial ciliated cells: 67.5;Late spermatids: 165.8;Respiratory ciliated cells: 149.9"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	62	"HEL: 7.6"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA024056	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA024056: AB_1858093"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"		"unprognostic (3.77e-3)"	"unprognostic (9.91e-2)"	"unprognostic (3.74e-2)"		"unprognostic (6.85e-2)"	"unprognostic (2.63e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.50e-1)"	"unprognostic (5.95e-8)"	"unprognostic (2.54e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.74e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.2	0.2	0.1	0.0	0.1	0.0	2.2	0.7	0.0	0.4	0.2	4.7	0.0	0.0	0.3	0.6	0.5	0.0	6.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	120.2	67.5	0.7	0.5	0.0	0.0	1.3	0.2	0.1	0.4	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	8.2	0.3	0.0	165.8	0.6	0.2	0.0	1.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.4	0.1	0.2	0.0	0.0	149.9	0.0	0.0	0.5	2.0	18.7	1.2	0.0	1.4	0.3	0.1	0.0	0.0	0.1
CCDC171	"bA536D16.1, bA778P13.1, C9orf93, Em:AL513423.1, FLJ39267, FLJ46740"	ENSG00000164989	"Coiled-coil domain containing 171"	Q6TFL3	9	15553043-16061663	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 11.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 194.5;Excitatory neurons: 92.4;Inhibitory neurons: 70.6;Late spermatids: 172.4;Spermatocytes: 148.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 7.5;HEL: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019803, HPA019806, HPA024133"	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA019803: AB_1845846, HPA019806: AB_1845847, HPA024133: AB_1845848"	"unprognostic (1.35e-2)"	"unprognostic (2.03e-4)"	"unprognostic (7.22e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.76e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.91e-3)"	0.8	1.1	2.3	0.7	2.8	2.1	1.6	3.7	3.2	1.4	0.0	0.9	0.8	5.8	1.1	1.0	2.0	1.5	1.0	2.5	0.3	1.2	0.4	1.1	1.1	1.5	0.3	2.9	1.3	1.4	1.1	0.9	2.0	1.1	1.1	5.5	0.8	1.2	0.8	2.4	1.0	3.3	0.2	0.6	1.4	11.3	0.5	4.8	2.0	1.1	1.0	0.8	0.9	3.3	1.4	0.7	1.6	1.6	0.9	1.9	1.0	1.0	0.8	1.0	1.1	0.4	0.6	7.5	0.5	0.6	1.9	0.3	0.7	1.0	1.1	1.6	0.7	11.7	1.2	1.0	1.3	1.6	1.4	1.1	1.9	0.8	1.5	0.8	0.5	4.1	0.3	2.0	1.2	0.5	3.3	1.5	1.3	0.6	1.6	3.8	1.2	0.2	0.7	1.1	2.3	1.1	2.1	0.7	2.8	1.3	0.9	1.1	0.8	2.1	1.2	0.6	0.7	1.1	1.4	4.8	0.9	1.0	1.5	2.4	0.2	0.0	0.2	0.2	0.6	0.2	0.2	0.2	0.2	0.6	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.0	2.3	2.8	3.7	3.2	2.5	0.3	1.5	0.3	2.0	0.2	0.5	3.3	4.4	0.0	7.5	56.8	2.6	2.8	5.8	1.8	7.4	27.7	5.0	8.0	8.5	0.0	5.9	3.7	16.7	6.7	1.4	3.6	5.9	2.9	194.5	24.3	7.8	3.8	1.2	3.8	92.4	3.5	4.1	5.7	8.2	12.9	1.3	7.6	3.3	0.8	1.9	10.1	70.6	3.5	6.1	1.0	1.1	172.4	5.9	2.1	0.0	16.9	1.6	12.5	5.2	54.8	63.1	2.5	1.0	6.0	1.9	0.8	2.8	2.1	12.0	44.0	13.1	11.6	5.7	148.2	40.6	5.4	3.3	5.6	3.6	10.7	4.9	3.7
CCDC173	"C2orf77, LOC129881"	ENSG00000154479	"Coiled-coil domain containing 173"	Q0VFZ6	2	169645425-169694405	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 22.2;testis: 80.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 939.2;Endometrial ciliated cells: 118.1;Late spermatids: 133.4;Respiratory ciliated cells: 232.6;Spermatocytes: 460.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HEL: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042995, HPA048454"	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA042995: AB_2678260, HPA048454: AB_2680400"	"unprognostic (1.66e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.20e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.56e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.26e-6)"	"unprognostic (8.73e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.41e-1)"	0.3	0.3	7.4	0.7	7.8	3.6	1.3	4.4	11.6	1.0	22.2	0.2	0.6	1.2	1.1	0.2	14.9	0.5	0.1	8.7	7.1	0.9	0.4	2.5	0.2	13.7	16.6	0.8	1.4	1.6	2.6	0.1	9.6	0.4	0.4	6.7	0.2	0.8	0.1	0.2	0.4	0.6	11.3	0.1	0.4	80.2	8.1	0.2	3.4	0.0	0.0	0.2	0.2	9.6	0.5	0.8	0.8	0.2	0.0	0.1	0.9	0.4	0.0	0.4	0.1	0.3	0.1	0.1	0.1	0.0	0.7	0.6	0.7	1.0	0.7	0.1	0.5	11.1	0.7	0.3	0.0	1.1	2.5	0.0	0.1	1.4	0.0	0.6	0.0	0.6	2.5	0.1	0.0	1.2	0.2	0.3	0.2	0.3	0.6	0.0	0.0	0.0	0.3	0.5	2.7	0.7	0.1	0.0	0.0	0.3	0.6	0.1	0.0	0.2	0.1	0.7	0.4	0.4	0.3	0.3	0.6	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.4	7.8	4.4	11.6	8.7	7.1	13.7	16.6	9.6	11.3	8.1	9.6	1.5	9.6	8.3	12.7	1.6	0.1	2.5	3.8	1.2	13.3	2.2	3.9	0.6	0.0	31.7	1.8	8.4	0.2	4.1	0.1	5.9	0.4	939.2	118.1	3.3	1.2	0.0	0.0	5.8	0.4	2.6	3.5	1.5	2.3	2.5	0.5	1.4	0.8	0.0	0.0	2.3	0.7	8.2	0.3	0.2	133.4	7.5	1.0	1.8	2.8	0.0	7.3	0.0	1.5	0.5	0.1	0.0	6.8	1.9	0.5	0.0	3.2	232.6	13.7	13.1	21.2	1.8	460.3	13.7	0.0	0.0	0.1	3.3	0.1	0.1	0.9
CCNDBP1	"DIP1, GCIP, HHM"	ENSG00000166946	"Cyclin D1 binding protein 1"	O95273	15	43185118-43197177	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 20.0"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 362.7;Erythroid cells: 361.2;Syncytiotrophoblasts: 1055.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	8	"HEL: 13.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020664, HPA041065"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Nuclear bodies"	"CAB020664: , HPA041065: AB_2677282"	"unprognostic (4.48e-1)"	"unprognostic (3.98e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.68e-2)"	3.2	1.4	2.3	1.3	2.1	20.0	2.1	3.8	2.6	1.4	1.9	1.7	1.5	1.4	2.1	1.2	2.0	1.0	1.3	2.0	2.4	1.5	1.7	2.7	2.2	2.4	2.3	0.7	1.3	1.1	1.2	1.4	2.5	1.3	1.9	1.8	1.5	1.1	1.7	2.8	2.6	1.2	1.8	2.6	2.1	0.9	2.6	1.5	1.7	1.2	1.9	1.7	1.1	2.4	0.2	0.2	0.4	0.2	1.3	0.8	0.4	0.3	1.6	0.3	0.3	0.4	0.3	0.5	0.4	1.1	0.1	0.5	1.1	0.5	0.2	0.7	1.1	13.5	0.6	0.5	0.9	0.7	0.7	1.5	1.2	0.1	0.2	1.3	1.0	0.2	0.8	0.4	0.4	0.0	0.4	1.4	0.9	0.5	0.3	0.4	0.5	1.2	1.7	0.6	0.6	0.9	0.5	0.4	0.3	0.5	0.0	1.1	1.2	0.2	0.1	1.0	0.2	1.4	0.6	0.1	1.3	1.4	0.4	21.8	1.9	5.6	5.1	3.7	5.4	4.7	5.5	5.2	1.8	5.3	5.6	5.9	6.2	4.8	9.5	3.0	8.4	1.8	2.3	2.1	3.8	2.6	2.0	2.4	2.4	2.3	2.5	1.8	2.6	2.4	59.8	48.1	54.9	11.1	81.8	34.7	55.7	83.3	25.0	28.9	38.0	40.9	52.6	40.0	78.6	29.5	20.9	362.7	92.0	63.6	90.1	64.0	24.2	61.6	33.8	45.2	46.2	361.2	20.7	59.3	82.1	55.9	45.3	37.0	57.0	40.2	53.6	31.0	85.4	45.4	17.8	47.7	154.6	83.5	36.2	12.6	47.2	57.1	64.0	11.2	137.8	55.9	74.2	9.5	23.4	68.6	55.8	29.3	54.2	42.1	85.8	47.5	128.0	66.0	46.0	35.2	49.4	124.3	61.6	27.8	40.3	1055.9	85.9	37.8	42.2	88.5
CCRL2	"ACKR5, CKRX, CRAM-A, CRAM-B, HCR"	ENSG00000121797	"C-C motif chemokine receptor like 2"	O00421	3	46407166-46412997	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 35.0;Erythroid cells: 26.5;Hofbauer cells: 42.7;Kupffer cells: 22.1;Langerhans cells: 36.5;Macrophages: 56.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 21.0;OE19: 8.4;PC-3: 15.3;RT4: 8.3;TIME: 15.4;U-266/84: 8.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043238	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"			"HPA043238: AB_10794924"	"unprognostic (3.94e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (3.72e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (9.67e-5)"	11.7	1.6	2.1	11.4	2.1	9.0	8.4	2.2	3.7	2.3	2.2	11.5	11.7	1.2	0.6	0.9	1.1	5.5	2.7	2.1	2.2	2.2	4.4	12.4	4.9	2.8	2.3	0.5	1.5	0.8	0.8	5.1	3.1	0.8	10.4	0.2	0.9	0.8	1.1	0.7	12.1	2.5	2.6	8.5	5.5	0.3	2.9	7.7	1.3	1.1	3.8	6.0	1.1	3.3	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	1.2	0.0	0.2	0.0	0.0	2.8	0.0	0.0	0.3	0.7	4.6	0.0	21.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	5.0	0.2	0.0	7.2	4.2	2.8	0.1	5.0	0.0	1.6	2.6	0.0	8.4	15.3	0.4	0.3	0.0	0.0	8.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	15.4	0.6	0.3	0.7	0.3	0.0	8.6	0.2	7.5	6.5	0.0	8.7	15.4	4.3	2.8	22.1	3.4	1.7	1.6	4.7	9.9	3.9	1.0	2.5	2.6	6.7	10.1	3.0	4.7	5.0	2.1	2.1	2.2	3.7	2.1	2.2	2.8	2.3	3.1	2.6	2.9	3.3	35.0	0.0	4.7	0.0	4.4	2.0	0.2	0.2	0.0	0.0	0.4	0.4	1.1	1.5	1.2	0.0	0.0	0.3	4.5	19.5	0.0	0.6	0.1	0.1	0.2	12.1	0.0	26.5	0.0	8.8	1.2	1.4	4.6	0.1	9.5	0.1	6.4	0.4	42.7	0.0	0.0	16.6	0.0	22.1	36.5	0.0	0.0	56.2	1.8	1.9	6.7	0.0	0.0	0.0	0.0	9.8	12.4	0.0	4.2	0.2	17.2	0.2	0.6	0.0	0.0	0.6	0.5	0.0	0.0	0.0	1.1	2.5	6.4	0.4	9.2	1.1
CCT8	"C21orf112, Cctq, PRED71"	ENSG00000156261	"Chaperonin containing TCP1 subunit 8"	P50990	21	29055805-29073797	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018520, HPA021051, HPA029426"	Enhanced		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		No	No		1100000	"Cluster 44: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 10: Non-specific - Unknown function"	"Intermediate filaments"	"Nucleoplasm, Cytosol"	"HPA018520: AB_1846204, HPA021051: AB_1846205, HPA029426: AB_10601796"	"unprognostic (3.41e-3)"	"unprognostic (2.75e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.25e-3)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (8.78e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.01e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	72.7	125.0	62.5	99.1	67.0	99.5	100.4	70.3	84.0	78.5	78.0	87.9	77.9	74.8	88.2	83.7	80.9	64.3	116.3	66.9	74.7	102.7	92.7	70.1	140.8	64.5	65.3	88.0	95.3	100.0	40.6	107.0	69.0	77.1	102.1	71.3	70.7	72.5	121.1	75.0	78.6	85.5	66.7	88.9	68.8	79.1	68.7	141.2	78.5	145.2	154.3	122.3	50.3	66.1	437.4	243.1	319.4	233.3	220.4	302.3	350.9	340.5	219.1	386.2	317.5	548.6	269.0	858.8	229.1	237.1	466.8	174.4	632.2	391.7	441.1	364.0	348.1	1185.2	289.8	384.3	227.0	609.0	335.6	229.0	244.9	448.6	372.6	278.6	368.1	379.7	935.8	519.0	404.1	270.9	456.6	359.4	572.6	433.6	310.6	411.7	596.5	547.4	409.1	283.2	316.7	231.6	334.1	356.6	364.7	347.5	319.9	526.7	267.4	221.3	613.7	216.7	439.7	329.2	651.8	695.1	256.3	704.5	339.0	79.9	110.1	54.4	56.9	120.9	79.6	79.8	76.3	73.4	133.3	61.8	85.5	82.1	11.5	87.7	132.2	83.5	92.7	127.4	62.5	67.0	70.3	84.0	66.9	74.7	64.5	65.3	69.0	66.7	68.7	66.1	66.9	64.1	61.7	15.0	120.1	143.1	197.6	278.6	70.0	85.6	88.4	76.5	75.7	90.1	150.0	75.4	18.8	268.9	122.1	67.3	144.8	194.1	17.0	106.6	92.8	94.8	97.0	150.2	26.7	138.0	275.8	93.4	52.0	73.7	112.8	135.6	55.3	53.4	170.5	77.4	31.3	106.2	201.4	115.6	122.4	20.5	84.2	109.9	115.6	26.2	226.6	96.1	97.9	13.6	21.4	131.2	92.1	92.9	130.7	185.9	107.4	189.7	147.7	84.6	105.2	88.7	214.7	170.1	176.8	90.2	131.4	285.3	105.1	254.5	161.1	170.6
CD200R1	"CD200R, HCRTR2, MOX2R, OX2R"	ENSG00000163606	"CD200 receptor 1"	Q8TD46	3	112921205-112975103	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 7.9"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 14.8;granulocytes: 15.2;Hepatic stellate cells: 14.6;Hofbauer cells: 31.8;Langerhans cells: 19.9;T-cells: 12.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	4	"basophil: 234.9"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 234.9"	"Cell line enriched"	"Detected in some"	8	"HEL: 25.5"									HPA068512			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		2000000	"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"HPA068512: AB_2732784"	"unprognostic (1.49e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.06e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.77e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.12e-3)"	1.7	1.2	0.3	3.0	0.4	1.7	1.4	0.2	0.6	0.7	0.7	1.5	1.6	0.7	0.3	3.8	0.5	1.9	0.6	0.4	0.3	0.5	2.4	1.9	4.4	0.3	0.2	0.3	0.5	0.5	0.2	5.3	0.3	0.6	2.3	0.1	0.6	0.7	0.1	2.6	2.0	1.1	0.2	7.9	1.5	0.7	0.2	3.4	0.5	0.9	4.6	1.9	0.5	0.2	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.3	25.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.0	1.2	0.0	234.9	2.9	53.6	4.0	1.3	7.0	9.9	13.8	7.9	22.9	5.6	13.4	6.1	0.8	2.5	0.4	0.5	4.3	5.2	0.3	0.4	0.2	0.6	0.4	0.3	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.0	1.1	1.6	4.4	1.9	0.1	0.0	14.8	0.0	0.2	0.3	0.3	0.0	0.1	0.0	0.0	0.3	1.9	0.0	0.0	0.0	0.1	1.0	0.1	0.5	0.0	4.0	5.7	0.0	0.2	0.9	0.0	0.1	15.2	0.0	14.6	0.1	31.8	0.0	2.2	0.0	0.0	6.7	19.9	0.0	0.0	9.1	5.4	5.6	5.2	0.0	0.0	1.0	0.7	0.1	0.0	0.0	2.7	0.1	0.0	0.1	1.2	0.0	0.0	0.3	0.4	0.8	0.3	5.8	0.9	0.7	12.4	0.0	0.0	0.2
CD226	"DNAM-1, DNAM1, PTA1, TLiSA1"	ENSG00000150637	"CD226 molecule"	Q15762	18	69831158-69961803	"CD markers, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 20.2;parathyroid gland: 62.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 52.1;Macrophages: 24.4;Microglial cells: 22.5;NK-cells: 90.6;Oligodendrocytes: 26.6;T-cells: 43.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"gdT-cell: 36.6;MAIT T-cell: 13.4;memory CD4 T-cell: 28.8;memory CD8 T-cell: 22.5;naive CD4 T-cell: 15.8;naive CD8 T-cell: 17.3;NK-cell: 29.7;T-reg: 11.3"	"Group enriched"	"Detected in many"	11	"NK-cells: 29.7;T-cells: 36.6"	"Group enriched"	"Detected in some"	6	"HEL: 100.0;HMC-1: 42.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA015715, HPA015865"	Supported		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	No		20000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Centriolar satellite"	"HPA015715: AB_1846278, HPA015865: "	"unprognostic (1.42e-4)"	"unprognostic (1.30e-3)"	"unprognostic (9.01e-3)"	"unprognostic (3.49e-5)"	"unprognostic (4.15e-1)"	"unprognostic (9.52e-4)"	"unprognostic (3.68e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.31e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.58e-2)"	1.1	0.6	1.1	5.7	6.4	4.4	1.5	1.5	2.4	1.1	0.0	1.8	2.3	1.3	0.5	1.6	1.3	3.0	0.5	0.7	2.0	1.5	4.2	4.2	9.7	3.1	3.3	0.9	0.5	62.4	0.6	0.5	3.2	1.0	2.4	1.4	1.5	0.4	0.7	0.3	3.1	1.6	2.2	20.2	3.2	1.2	5.5	6.4	0.7	0.6	7.1	3.1	0.4	3.2	0.0	0.1	0.3	0.3	0.0	0.0	0.1	0.6	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.4	0.2	5.3	0.1	100.0	0.3	0.1	0.0	0.7	42.6	0.0	1.1	0.2	0.6	0.2	0.0	0.9	0.3	9.3	0.4	0.0	0.8	0.4	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.5	0.8	0.3	0.1	0.2	11.5	0.4	0.0	0.3	0.2	0.5	0.3	0.1	1.2	36.6	1.0	13.4	0.8	28.8	22.5	2.9	0.1	15.8	17.3	1.6	29.7	1.3	0.1	11.3	13.2	1.1	6.4	1.5	2.4	0.7	2.0	3.1	3.3	3.2	2.2	5.5	3.2	0.6	3.2	3.6	3.3	3.2	0.0	0.3	0.0	0.0	3.4	0.5	0.8	2.5	0.0	0.7	0.0	0.0	0.1	52.1	0.2	0.0	0.0	8.4	0.9	1.7	1.0	0.0	3.2	4.6	0.4	0.0	1.3	3.1	0.5	13.9	1.3	3.3	0.4	1.6	0.0	3.1	0.1	0.0	16.7	2.7	8.2	0.9	24.4	0.0	22.5	14.7	0.8	90.6	2.0	26.6	0.2	0.1	0.7	13.4	0.3	0.0	0.3	1.5	3.6	0.0	1.8	0.6	0.4	0.8	0.0	0.4	0.0	43.2	0.5	0.1	0.2
CENPJ	"BM032, CPAP, LAP, LIP1, MCPH6, Sas-4, SASS4, SCKL4"	ENSG00000151849	"Centromere protein J"	Q9HC77	13	24882279-24922889	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Dwarfism, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 16.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 135.8;Spermatocytes: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076638			Supported	Centrosome		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 29: Early spermatids - Spermatogenesis"	Centrosome		"HPA076638: "	"unprognostic (2.69e-1)"	"unprognostic (3.17e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.15e-5)"	"unprognostic (7.41e-2)"	"unprognostic (1.50e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (7.36e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-1)"	2.6	1.3	1.3	2.4	1.7	4.4	3.3	4.2	3.3	3.7	0.2	3.5	4.2	4.1	2.3	2.2	3.5	1.6	1.6	1.4	1.2	1.2	1.5	2.4	5.0	1.5	1.3	3.5	1.1	0.9	0.7	3.7	1.7	2.4	4.3	1.8	1.5	1.7	2.2	5.0	3.6	3.9	1.0	2.5	2.1	16.3	1.6	3.5	11.0	1.6	4.1	3.3	2.4	1.6	4.5	3.9	14.9	16.4	2.4	3.5	9.0	11.5	5.5	5.5	5.1	8.0	8.3	8.9	3.5	3.1	4.4	12.9	11.4	6.8	11.2	7.9	7.2	34.0	13.1	6.7	0.9	15.3	10.2	1.0	2.5	5.1	4.1	3.1	5.9	7.3	8.3	13.5	8.8	7.7	8.4	23.8	10.2	13.3	5.9	11.3	10.0	4.4	3.1	7.6	8.5	7.5	5.3	6.9	4.8	12.1	2.9	9.4	4.3	8.8	5.6	12.9	7.2	4.9	8.3	8.4	4.3	11.6	10.8	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	1.3	1.7	4.2	3.3	1.4	1.2	1.5	1.3	1.7	1.0	1.6	1.6	7.5	3.2	10.5	6.2	6.7	2.0	4.3	5.8	5.7	8.0	3.8	5.2	6.9	1.5	9.1	3.7	4.2	8.5	7.0	10.8	0.0	2.6	135.8	7.0	13.6	6.3	0.0	17.9	20.1	2.9	14.9	8.4	2.6	13.2	5.1	21.3	2.2	1.4	4.3	3.3	18.4	3.7	2.0	1.6	3.5	24.7	6.5	5.9	0.0	8.4	6.6	3.4	4.1	16.6	13.8	1.9	6.9	5.7	12.6	2.3	8.2	1.1	6.1	2.3	6.6	8.6	10.3	63.5	36.3	5.4	1.3	2.9	6.1	5.2	5.6	2.3
CFAP161	"C15orf26, FLJ38615"	ENSG00000156206	"Cilia and flagella associated protein 161"	Q6P656	15	81007033-81149179	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 34.8;fallopian tube: 15.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 18.1;Endometrial ciliated cells: 26.5;Late spermatids: 5.4;Respiratory ciliated cells: 23.3;Spermatocytes: 15.6"	"Cancer enriched"	"Detected in some"	4	"endometrial cancer: 2.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"HEL: 84.4;K-562: 29.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA076975	Supported					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 36: HEL - Hemostasis"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA076975: "	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.07e-2)"	"prognostic favorable (3.05e-4)"	"unprognostic (1.57e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.29e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.24e-2)"	"unprognostic (6.22e-2)"	0.4	0.1	0.8	0.1	1.2	0.6	0.2	4.3	1.1	0.6	34.8	0.1	0.0	0.6	0.6	0.1	15.8	0.2	0.6	1.2	0.6	0.3	0.2	2.7	0.1	2.5	3.5	0.1	0.2	0.3	1.7	1.3	2.0	0.1	0.0	1.3	0.2	0.2	0.2	0.5	0.1	0.2	3.0	0.5	0.2	6.4	1.2	0.0	0.6	0.8	0.2	0.2	0.1	1.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.2	0.3	0.0	0.0	0.2	0.2	0.0	0.2	0.2	0.3	0.0	84.4	0.2	0.2	0.0	0.0	11.0	0.0	0.0	0.3	1.0	0.0	1.7	0.0	29.2	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	1.2	0.2	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	1.4	0.1	0.0	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	3.4	0.8	1.2	4.3	1.1	1.2	0.6	2.5	3.5	2.0	3.0	1.2	1.0	0.2	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	26.5	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	2.8	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	23.3	0.6	0.0	0.0	0.0	15.6	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2
CFAP45	"CCDC19, NESG1"	ENSG00000213085	"Cilia and flagella associated protein 45"	Q9UL16	1	159872364-159900165	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 13.5;fallopian tube: 44.8;testis: 28.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 256.4;Endometrial ciliated cells: 98.2;Late spermatids: 57.4;Respiratory ciliated cells: 166.9;Spermatocytes: 43.7"	"Cancer enriched"	"Detected in many"	4	"endometrial cancer: 10.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"eosinophil: 3.0;neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 9.0;HEL: 12.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042204, HPA043618"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA042204: AB_10966555, HPA043618: AB_10959305"	"unprognostic (1.88e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.95e-1)"	"unprognostic (5.18e-3)"	"unprognostic (4.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.80e-4)"	"unprognostic (2.57e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-12)"	"unprognostic (2.95e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.65e-1)"	0.6	0.1	1.8	0.4	1.3	0.8	0.6	1.0	0.9	2.7	13.5	0.3	0.2	1.4	0.0	0.4	44.8	0.2	0.8	1.7	1.8	0.7	0.1	5.0	0.2	7.9	7.0	0.3	0.2	0.1	0.4	0.4	4.7	0.4	0.1	0.0	0.3	0.4	0.2	0.5	0.3	0.4	5.9	0.7	0.6	28.4	2.3	0.3	0.7	0.1	0.2	0.5	0.3	4.1	2.1	0.4	0.0	0.0	0.1	0.2	9.0	1.1	1.3	1.9	0.8	1.5	2.7	0.8	0.4	0.3	1.0	1.3	0.2	0.3	1.1	0.3	0.2	12.2	0.5	0.0	0.4	1.1	0.4	0.8	0.6	2.1	0.7	2.8	1.4	0.2	1.3	0.4	0.3	3.0	0.2	0.9	0.5	1.7	1.0	0.0	0.9	0.4	0.1	0.5	0.8	0.1	1.0	3.2	0.3	2.6	3.1	0.2	1.8	0.8	2.4	1.6	2.0	0.8	0.0	0.2	4.3	0.3	0.7	0.0	0.1	3.0	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.3	0.0	0.2	2.4	0.0	0.0	0.1	0.0	0.1	1.8	1.3	1.0	0.9	1.7	1.8	7.9	7.0	4.7	5.9	2.3	4.1	2.0	0.0	4.8	0.0	0.4	0.0	0.9	0.0	0.6	0.1	1.4	0.9	5.5	0.0	29.7	5.5	0.0	1.6	0.6	0.0	0.0	1.9	256.4	98.2	1.3	3.2	0.0	0.0	0.1	2.2	7.4	1.2	0.0	3.2	3.8	0.1	1.4	0.0	0.4	0.0	0.1	0.1	0.0	0.6	0.0	57.4	2.1	4.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	1.6	0.0	1.5	3.2	1.3	0.1	0.4	166.9	0.0	0.0	0.7	0.9	43.7	3.1	1.2	0.0	0.8	1.2	0.6	0.1	1.1
CLVS2	"bA160A10.4, C6orf212, C6orf213, RLBP1L2"	ENSG00000146352	"Clavesin 2"	Q5SYC1	6	122996235-123072925	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 41.1"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 137.8;Inhibitory neurons: 171.5;Muller glia cells: 60.8"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Region enriched"	"Detected in many"	4	"cerebellum: 41.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HEL: 12.2;SCLC-21H: 9.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043764	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA043764: AB_10960281"	"unprognostic (1.35e-1)"		"unprognostic (3.28e-2)"		"unprognostic (4.68e-2)"				"unprognostic (3.60e-1)"		"unprognostic (2.38e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.72e-3)"	"unprognostic (9.60e-2)"		"unprognostic (8.71e-2)"	0.0	0.9	5.8	0.0	5.7	0.0	0.0	41.1	9.2	0.2	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	5.8	8.5	0.0	0.0	0.0	0.0	5.3	0.3	0.0	0.0	0.0	1.9	0.0	5.2	3.0	0.1	8.2	0.0	0.1	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.1	0.2	1.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.7	41.1	9.2	5.8	8.5	5.3	0.3	5.2	0.0	0.2	1.9	0.4	0.0	0.0	22.2	0.0	0.0	17.9	0.0	0.0	5.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.9	0.0	0.0	0.3	0.0	0.0	137.8	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	171.5	0.0	0.0	0.0	0.0	0.7	0.3	0.2	0.0	2.8	0.0	60.8	0.0	27.2	4.0	0.0	0.0	0.4	0.0	4.6	0.0	0.0	0.0	4.8	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.6
CMAS		ENSG00000111726	"Cytidine monophosphate N-acetylneuraminic acid synthetase"	Q8NFW8	12	22046218-22065674	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 532.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039905	Supported		Uncertain	Nucleoli,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 45: Intestine - Brush border"	"Cluster 36: HEL - Hemostasis"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	Nucleoli	"HPA039905: AB_10795237"	"unprognostic (5.54e-2)"	"unprognostic (4.10e-2)"	"unprognostic (4.25e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.44e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.03e-1)"	19.7	57.0	46.6	23.2	51.1	47.9	32.9	40.3	57.8	29.2	35.8	77.8	66.2	23.5	69.0	71.6	21.8	24.4	42.6	51.2	57.3	28.9	72.2	18.1	24.2	43.8	57.1	25.3	42.5	79.4	30.0	34.0	57.1	36.7	71.9	24.8	32.6	26.7	44.0	29.3	63.6	27.7	41.8	20.1	29.7	69.9	49.0	19.8	23.8	41.1	26.1	24.2	40.3	44.0	63.4	50.2	59.5	29.3	47.0	57.5	88.8	43.2	46.2	45.0	47.2	114.1	72.0	56.5	41.3	37.3	83.9	50.9	35.8	60.1	60.7	75.0	45.4	169.1	38.8	57.2	43.2	45.4	85.5	38.5	56.4	58.1	86.3	61.5	61.3	58.7	108.8	28.1	80.9	83.8	52.0	105.3	147.5	69.4	69.5	36.2	63.6	53.7	56.0	67.8	23.8	42.0	34.2	59.6	51.9	120.2	82.3	62.0	45.5	51.2	42.4	46.2	81.1	19.4	26.0	74.9	83.6	34.6	54.3	22.7	27.3	32.1	20.4	29.7	26.1	19.0	26.9	27.0	31.5	18.2	24.2	24.6	2.8	36.9	27.4	20.2	33.8	25.5	46.6	51.1	40.3	57.8	51.2	57.3	43.8	57.1	57.1	41.8	49.0	44.0	21.5	12.8	17.5	12.4	19.2	29.2	76.8	117.2	14.8	38.3	31.9	21.2	72.7	41.5	102.3	23.9	4.2	175.2	17.8	158.1	76.3	56.6	12.4	17.2	19.6	36.8	41.6	153.9	38.7	83.6	141.3	41.7	21.9	20.0	22.8	28.2	34.2	63.6	66.2	35.3	29.2	118.2	93.6	29.8	22.0	19.0	25.4	32.5	44.4	8.4	45.3	33.4	26.8	16.6	25.5	79.7	156.2	27.8	16.7	112.3	133.6	87.0	82.5	20.4	19.7	30.4	42.3	112.2	97.1	52.3	44.5	532.6	24.6	63.0	90.8	190.6
CMPK2	"NDK, TYKi, UMP-CMPK2"	ENSG00000134326	"Cytidine/uridine monophosphate kinase 2"	Q5EBM0	2	6840570-6866635	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.6;salivary gland: 8.5"	"Cell type enriched"	"Detected in many"	4	"Erythroid cells: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 4.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 12.8;BJ hTERT+ SV40 Large T+ RasG12V: 11.9;HEL: 20.3;MOLT-4: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041430	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria	Nucleoplasm	"HPA041430: AB_10796674"	"unprognostic (2.37e-1)"	"unprognostic (6.07e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (1.82e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.54e-3)"	"unprognostic (7.39e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.69e-2)"	"unprognostic (4.32e-2)"	2.1	1.4	1.7	1.4	2.8	6.4	1.8	0.7	1.8	1.4	1.7	1.3	1.6	0.9	0.3	0.7	0.7	0.8	2.1	1.2	1.9	1.1	0.9	2.8	1.3	6.0	3.0	0.4	1.3	0.9	1.1	1.6	3.2	0.7	0.6	0.1	8.5	0.7	1.1	0.4	2.2	0.9	10.6	3.5	2.9	2.0	2.0	1.9	1.2	1.6	0.7	0.9	0.6	1.5	0.3	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.2	12.8	11.9	0.0	1.4	3.1	0.8	0.0	3.3	0.2	0.0	0.0	0.0	0.3	0.2	20.3	0.0	0.0	0.0	0.6	1.8	0.1	0.0	0.2	0.0	0.0	0.0	2.0	5.8	0.1	0.0	0.1	11.8	3.6	0.3	0.0	1.0	3.6	0.0	0.0	0.0	0.4	0.4	0.5	0.2	0.0	1.9	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	3.3	0.4	0.0	0.0	3.6	0.8	3.1	1.6	4.9	0.3	3.9	0.2	1.1	0.2	0.2	1.1	0.1	0.2	0.3	1.1	0.5	2.0	0.1	0.4	0.7	1.7	2.8	0.7	1.8	1.2	1.9	6.0	3.0	3.2	10.6	2.0	1.5	20.8	3.2	7.5	0.0	1.9	0.4	0.9	0.5	0.0	1.5	1.7	1.3	1.6	0.0	0.5	1.8	0.0	3.0	3.4	10.0	1.9	2.6	4.0	5.4	0.8	11.7	7.2	86.3	1.9	6.6	2.9	2.7	11.2	1.0	2.5	1.7	7.1	1.4	19.5	0.0	2.5	2.5	0.0	12.3	2.8	1.6	1.5	11.3	0.0	9.4	11.9	5.3	3.1	1.5	0.2	6.2	8.4	5.7	2.1	1.0	8.4	0.7	4.1	0.2	0.0	2.2	2.0	2.7	4.4	0.7	0.4	0.8	4.5	1.6	1.6	2.0
CMTM5	"CKLFSF5, FLJ37521"	ENSG00000166091	"CKLF like MARVEL transmembrane domain containing 5"	Q96DZ9	14	23376773-23379772	"Predicted membrane proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 182.4;choroid plexus: 49.5"	"Cell type enhanced"	"Detected in some"		"Macrophages: 93.7;Muller glia cells: 32.0;Oligodendrocyte precursor cells: 20.6;Oligodendrocytes: 106.2"	"Group enriched"	"Detected in some"	37	"glioma: 8.4;melanoma: 3.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 20.8"	"Lineage enriched"	"Detected in many"	19	"granulocytes: 20.8"	"Cell line enriched"	"Detected in some"	7	"HEL: 91.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052338	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA		540000	"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Golgi apparatus, Vesicles"		"HPA052338: AB_2681793"	"unprognostic (2.73e-3)"	"unprognostic (1.51e-1)"	"unprognostic (5.24e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.63e-1)"	"unprognostic (6.40e-2)"		"unprognostic (8.34e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.40e-2)"	"unprognostic (6.24e-4)"	"unprognostic (3.03e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.11e-2)"	1.1	1.0	75.6	0.5	119.1	8.2	0.9	123.8	101.7	2.8	49.5	5.8	0.5	0.8	1.1	1.2	1.2	2.1	22.7	73.9	85.2	0.5	0.3	1.5	0.2	150.9	106.2	0.8	0.2	0.1	0.6	0.7	135.2	2.1	0.8	2.3	2.2	3.2	3.1	0.7	1.7	0.8	113.4	2.8	1.4	0.1	110.2	0.1	0.5	0.9	0.0	1.2	2.6	182.4	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	91.8	0.0	0.0	0.2	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.2	20.8	0.7	0.9	0.1	0.4	0.0	0.1	0.2	0.0	0.3	0.1	0.0	0.0	4.2	0.0	0.0	1.0	0.4	30.0	75.6	119.1	123.8	101.7	73.9	85.2	150.9	106.2	135.2	113.4	110.2	182.4	0.5	0.0	0.0	6.5	0.4	1.0	0.1	0.0	1.2	0.2	1.3	5.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.2	0.0	0.0	1.3	0.4	0.0	0.0	93.7	5.4	0.0	1.5	32.0	0.0	20.6	106.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	3.4	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.1
CNRIP1	"C2orf32, CRIP1, CRIP1a, CRIP1b, DKFZP566K1924"	ENSG00000119865	"Cannabinoid receptor interacting protein 1"	Q96F85	2	68284171-68320051	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 72.2;Erythroid cells: 116.2;granulocytes: 122.9"	"Cancer enhanced"	"Detected in all"		"glioma: 14.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	109	"basophil: 12.2"	"Lineage enriched"	"Detected in single"	109	"granulocytes: 12.2"	"Cell line enhanced"	"Detected in many"		"HEL: 158.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035337			Approved	Cytosol		NA	NA		54000	"Cluster 38: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA035337: AB_10601359"	"unprognostic (1.23e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.51e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.58e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.04e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.38e-3)"	27.4	6.4	59.0	5.9	62.3	6.1	20.2	50.9	71.6	30.1	29.6	17.1	3.5	22.4	6.1	5.3	24.2	8.5	16.0	65.1	51.8	10.3	2.9	18.3	5.1	40.4	45.1	31.2	3.0	1.8	15.4	12.1	44.3	15.1	4.6	29.6	5.8	8.9	6.6	8.1	10.9	9.3	44.7	10.2	10.6	2.6	52.7	2.7	8.9	7.0	2.9	20.7	19.2	51.8	0.0	1.1	9.0	0.0	34.1	24.6	0.1	34.5	26.6	30.6	22.3	0.0	0.0	0.0	1.2	33.2	22.6	0.0	0.7	0.2	32.6	0.0	8.1	158.7	2.3	0.0	34.7	0.1	21.7	22.1	0.0	20.0	11.5	18.7	47.8	0.0	0.2	0.1	23.4	0.1	0.0	0.4	16.3	0.0	15.6	0.0	13.2	0.0	0.0	0.0	45.8	47.8	2.2	0.0	28.3	0.1	0.0	1.7	51.4	21.1	12.9	18.5	51.0	0.0	0.0	0.1	16.9	0.0	15.5	12.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	59.0	62.3	50.9	71.6	65.1	51.8	40.4	45.1	44.3	44.7	52.7	51.8	50.2	0.0	4.3	15.0	0.6	12.9	0.4	0.0	4.6	72.2	0.6	1.7	2.1	0.0	0.6	0.0	22.9	1.2	0.1	0.0	0.0	0.4	0.7	1.9	30.4	60.6	0.0	116.2	48.8	0.2	9.3	44.4	0.5	0.6	122.9	1.3	36.4	0.8	56.3	28.6	39.5	0.0	0.0	25.7	40.9	2.6	45.4	13.9	37.4	16.9	2.5	42.0	0.0	24.1	19.6	0.5	0.0	42.5	0.5	1.2	0.0	0.1	0.0	54.3	46.0	18.7	41.9	0.7	0.5	0.7	10.7	2.1	3.8	27.3	0.0	1.0
CNTLN	"bA340N12.1, C9orf101, C9orf39, FLJ20276"	ENSG00000044459	Centlein	Q9NXG0	9	17134982-17503923	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 91.8;Spermatocytes: 84.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 3.9"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.9"	"Cell line enhanced"	"Detected in many"		"HEL: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007201, HPA036728, HPA036729"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Centrosome	"Nucleoplasm, Cytosol"	"HPA007201: AB_2667775, HPA036728: AB_10670847, HPA036729: AB_10670240"	"unprognostic (1.97e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.07e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.38e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.80e-2)"	4.4	2.4	2.3	2.1	2.4	7.3	3.5	7.7	2.2	5.0	3.3	4.5	1.2	7.1	2.4	2.7	4.3	4.2	2.3	1.7	2.6	2.4	10.5	2.8	2.7	2.7	3.1	8.8	1.7	4.4	2.2	3.6	3.0	2.7	2.2	2.1	1.6	3.2	1.6	1.9	2.2	4.5	2.6	3.9	1.9	5.2	2.5	2.8	3.1	2.5	1.6	3.5	3.5	2.8	8.3	5.6	12.1	6.8	5.8	13.6	0.4	9.5	6.3	7.0	9.5	0.4	2.7	6.0	1.5	6.6	7.5	0.3	14.1	3.9	10.9	0.3	4.9	35.5	11.7	2.0	6.4	4.9	7.4	8.6	2.0	5.8	5.7	6.5	10.0	2.2	1.3	1.1	11.3	0.6	4.0	7.8	9.4	1.4	10.3	5.8	11.2	3.0	4.1	2.0	7.6	7.9	11.6	0.2	3.0	4.8	2.3	12.3	7.5	9.5	3.7	10.4	8.3	4.7	6.1	0.1	4.4	6.1	4.4	0.2	1.3	0.0	0.0	1.6	0.0	0.1	0.1	0.0	0.7	0.1	0.0	0.0	0.1	0.5	3.9	0.7	0.1	0.2	2.3	2.4	7.7	2.2	1.7	2.6	2.7	3.1	3.0	2.6	2.5	2.8	32.0	6.4	17.6	59.7	1.6	8.8	13.7	6.1	13.1	12.3	3.6	5.8	13.4	7.2	3.4	9.2	0.0	2.5	1.1	2.4	5.9	10.1	16.3	23.4	30.7	24.9	2.4	17.1	20.3	12.0	5.2	29.2	4.1	17.0	7.6	42.4	20.0	38.8	18.4	20.2	37.2	5.9	4.1	40.3	11.6	8.8	45.7	24.0	8.8	91.8	31.0	21.4	1.0	70.4	29.6	4.0	0.8	30.9	1.8	3.8	5.3	8.5	6.7	8.1	13.1	34.2	21.3	84.3	48.9	5.3	5.5	1.0	1.7	31.6	5.5	6.3
CPA3		ENSG00000163751	"Carboxypeptidase A3"	P15088	3	148865296-148897203	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 112.0;lung: 86.3"	"Cell type enriched"	"Detected in some"	26	"granulocytes: 4422.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	1534	"basophil: 1115.4"	"Lineage enriched"	"Detected in single"	5518	"granulocytes: 1115.4"	"Cell line enriched"	"Detected in some"	45	"HEL: 303.3"	"Not detected"	"Not detected"							"HPA006479, HPA008689, CAB020712"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"	"Golgi apparatus"	Nucleoplasm	"CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.30e-3)"	"unprognostic (3.50e-3)"	"unprognostic (5.18e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.69e-3)"	18.2	2.6	0.0	19.9	0.4	25.7	20.9	0.0	0.0	59.4	0.3	39.2	27.3	26.1	19.3	41.1	6.6	112.0	6.2	0.0	0.0	3.3	2.7	86.3	11.2	0.0	0.0	0.9	21.0	2.8	0.9	1.7	0.0	18.5	56.6	0.0	12.1	15.1	1.6	17.7	45.9	25.7	0.0	1.1	45.3	3.8	0.0	14.9	0.9	10.2	15.1	54.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	303.3	0.0	0.0	0.2	0.2	6.7	0.2	0.0	0.1	0.3	0.5	3.8	0.0	0.1	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1115.4	0.0	0.7	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	2.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.1	163.9	0.0	0.5	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	0.0	16.0	0.0	1.6	0.0	3.5	0.5	0.0	4422.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	5.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	6.7	0.3	0.0	0.0	8.7	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.3	0.0	41.7	0.0	0.0	0.3
CPOX	"CPO, CPX, HCP"	ENSG00000080819	"Coproporphyrinogen oxidase"	P36551	3	98579446-98593648	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Oxidoreductase	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 352.8;Extravillous trophoblasts: 75.9;Oligodendrocytes: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HEL: 166.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015736, HPA054448"			Supported	Mitochondria		No	No		170000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria		"HPA015736: AB_1847194, HPA054448: AB_2682490"	"unprognostic (2.14e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (1.62e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.57e-1)"	8.1	10.0	19.7	11.4	28.2	44.1	7.2	24.0	31.7	9.1	13.5	10.0	21.2	10.1	7.2	16.1	7.4	8.1	8.6	19.5	22.4	6.5	35.3	7.5	12.3	30.8	24.9	10.7	7.2	9.5	5.4	18.0	29.8	8.4	12.0	4.5	7.6	7.9	11.2	13.1	15.2	9.0	24.5	9.5	9.4	4.7	25.1	12.8	7.1	9.8	12.3	8.1	10.9	41.8	47.9	22.9	19.9	35.4	36.5	26.9	56.6	30.0	21.7	30.7	34.7	38.2	14.7	5.0	33.1	16.2	33.6	34.1	24.9	32.8	51.9	15.4	21.6	166.4	12.9	49.9	18.5	35.7	37.8	21.2	27.0	29.0	12.0	35.9	29.6	20.2	32.2	20.9	29.1	14.8	36.2	30.4	23.4	26.6	41.0	25.4	45.0	22.1	26.2	19.8	13.1	13.0	32.0	10.9	96.2	22.1	16.7	22.5	24.9	45.1	44.0	26.1	22.4	31.6	26.8	26.7	44.6	38.3	33.7	0.0	0.6	0.0	0.3	0.3	0.7	0.5	0.6	0.8	0.5	0.5	0.2	0.8	0.0	0.6	0.2	0.3	0.3	0.2	19.7	28.2	24.0	31.7	19.5	22.4	30.8	24.9	29.8	24.5	25.1	41.8	6.4	3.2	8.7	9.1	5.6	7.4	3.9	7.3	11.4	4.3	6.0	4.6	8.0	7.2	4.2	3.7	8.4	23.9	6.5	7.9	1.9	3.7	0.1	5.2	8.6	7.4	8.4	352.8	17.7	1.7	75.9	9.4	10.2	5.0	1.3	7.0	11.7	36.4	12.7	0.0	12.3	9.1	4.1	11.3	10.0	0.2	7.5	11.4	12.4	11.2	12.7	5.8	3.1	13.0	99.1	3.2	4.1	7.9	10.4	5.2	9.4	6.3	5.0	5.0	13.1	6.4	7.2	0.3	6.1	12.2	10.2	10.7	12.7	9.7	9.9	4.2
CRISP3	"Aeg2, CRISP-3, CRS3, dJ442L6.3, SGP28"	ENSG00000096006	"Cysteine rich secretory protein 3"	P54108	6	49727376-49744437	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"fallopian tube: 1203.8;salivary gland: 2310.0"	"Group enriched"	"Detected in some"	7	"Endometrial ciliated cells: 182.2;Glandular and luminal cells: 551.5"	"Group enriched"	"Detected in many"	7	"breast cancer: 31.9;pancreatic cancer: 59.8;prostate cancer: 85.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"neutrophil: 2.5;non-classical monocyte: 1.2"	"Group enriched"	"Detected in many"	19	"granulocytes: 2.5;monocytes: 1.2"	"Group enriched"	"Detected in some"	20	"HEL: 12.3;RT4: 4.1;SK-BR-3: 9.3;T-47d: 4.4"					"Not detected"	"Not detected"			HPA054392	Supported				"Secreted in other tissues"	NA	NA		420000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 36: HEL - Hemostasis"	"Cluster 44: Endometrium - Transcription"			"HPA054392: AB_2682472"	"unprognostic (1.28e-2)"	"unprognostic (7.01e-2)"		"unprognostic (8.93e-2)"		"unprognostic (5.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.22e-4)"	"unprognostic (5.30e-2)"	"unprognostic (6.70e-2)"	"unprognostic (9.16e-2)"	"unprognostic (4.34e-3)"		"unprognostic (1.91e-1)"			"unprognostic (1.93e-1)"	0.3	0.6	0.0	0.0	0.0	381.8	3.9	0.0	0.0	61.0	0.0	0.1	0.4	1.7	0.1	266.8	1203.8	23.1	0.8	0.0	0.0	0.1	0.9	1.3	0.0	0.0	0.0	0.5	5.5	0.0	0.5	0.6	0.0	2.9	0.0	0.0	2310.0	111.9	0.3	3.9	0.2	0.0	0.0	2.5	0.3	0.2	0.0	0.3	0.2	0.0	4.0	4.7	140.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	9.3	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.0	2.1	5.6	0.0	21.5	13.1	3.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	182.2	47.2	0.8	0.0	0.4	0.0	3.7	0.0	0.2	0.0	551.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	1.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	26.8
CRPPA	"hCG_1745121, ISPD, Nip"	ENSG00000214960	"CDP-L-ribitol pyrophosphorylase A"	A4D126	7	16087525-16502504	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"choroid plexus: 27.0"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 8.0;Cytotrophoblasts: 3.5;Extravillous trophoblasts: 10.6;Syncytiotrophoblasts: 2.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	29	"basophil: 13.8"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 13.8"	"Cell line enhanced"	"Detected in many"		"HEL: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053554			Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA053554: AB_2682185"	"unprognostic (4.65e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.07e-1)"	"prognostic favorable (1.38e-11)"	"unprognostic (4.01e-2)"	"unprognostic (1.78e-4)"	"unprognostic (6.26e-2)"	"unprognostic (2.79e-1)"	1.1	1.2	1.3	0.8	1.8	1.6	0.9	0.7	3.7	1.3	27.0	1.0	0.6	1.0	0.5	0.5	0.9	1.1	2.6	3.8	1.1	2.9	4.1	1.0	1.4	0.8	0.8	0.7	1.5	1.1	0.7	1.0	0.8	1.0	1.2	1.2	1.2	0.8	1.5	1.2	0.6	1.2	0.2	0.9	3.5	2.2	3.2	1.2	0.8	1.3	1.4	1.1	0.5	2.0	0.4	2.2	1.0	1.6	1.0	1.3	6.8	1.5	1.4	1.5	1.3	2.2	1.9	4.3	3.2	2.7	0.9	2.5	1.2	0.0	2.9	1.5	0.9	9.6	1.4	0.7	1.5	1.9	2.4	2.2	0.8	1.6	0.4	0.9	1.2	3.0	3.2	0.2	4.2	0.7	3.0	1.2	1.8	1.1	0.5	1.1	1.9	0.2	2.1	0.8	1.5	0.9	1.4	2.1	1.7	2.5	1.6	2.0	2.0	1.9	1.5	0.4	1.7	0.4	0.0	4.8	1.5	2.3	2.2	13.8	0.1	0.4	0.2	0.0	0.1	0.2	0.1	0.2	0.0	0.4	0.3	0.2	0.4	0.4	0.1	0.3	0.1	0.0	1.3	1.8	0.7	3.7	3.8	1.1	0.8	0.8	0.8	0.2	3.2	2.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	3.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	10.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0
CRYBA4		ENSG00000196431	"Crystallin beta A4"	P53673	22	26621963-26630669	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.5;testis: 1.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 3.3;NK-cells: 1.0;Spermatogonia: 3.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.0;testis cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HEL: 7.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 4.3;hippocampal formation: 4.0"	HPA071178	Supported					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA071178: AB_2686354"	"unprognostic (6.69e-2)"	"unprognostic (3.94e-3)"	"unprognostic (5.61e-5)"	"unprognostic (1.74e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.05e-6)"	"unprognostic (2.86e-1)"	"unprognostic (1.20e-6)"	"unprognostic (1.87e-2)"	"unprognostic (7.23e-2)"	"unprognostic (7.71e-2)"	"unprognostic (3.70e-1)"	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.2	0.0	0.0	0.3	0.1	0.0	0.5	0.1
CRYGD	CRYG4	ENSG00000118231	"Crystallin gamma D"	P07320	2	208121607-208124524	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Eye lens protein"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"ovary: 8.0"	"Cell type enriched"	"Detected in some"	4	"Granulosa cells: 140.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"HEL: 10.0"					"Not detected"	"Not detected"			"HPA041269, HPA043386"	Supported		Approved	Vesicles,Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Cytosol"		"HPA041269: AB_2732491, HPA043386: "					"unprognostic (4.49e-2)"						"unprognostic (2.64e-1)"				"unprognostic (3.62e-1)"			0.0	0.0	0.5	0.0	0.4	1.3	0.0	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.5	0.6	0.0	0.0	0.0	0.0	0.5	0.7	8.0	0.0	0.0	0.4	0.0	0.6	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.8	0.5	0.6	0.5	0.7	0.6	0.3	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.1	0.0	4.6	0.3	0.0	0.1	0.9	0.0	0.0	0.0	140.2	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	4.2	0.0	0.4	0.0	0.0	0.0	34.5	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.9	0.1	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
CST9L	"bA218C14.1, CTES7B"	ENSG00000101435	"Cystatin 9 like"	Q9H4G1	20	23564732-23568484	"Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	337	"epididymis: 26.4;testis: 87.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 4.0;Late spermatids: 13.2;Leydig cells: 2.5;Peritubular cells: 1.5;Spermatocytes: 1.6"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"HEL: 2.1"					"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (2.10e-2)"																	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTR9	"KIAA0155, p150TSP, SH2BP1, TSBP"	ENSG00000198730	"CTR9 homolog, Paf1/RNA polymerase II complex component"	Q6PD62	11	10751246-10801625	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 186.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061027, HPA068122"	Supported		Enhanced	Nucleoplasm		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"HPA061027: AB_2684418, HPA068122: AB_2685959"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.27e-2)"	"prognostic favorable (3.65e-6)"	"unprognostic (6.88e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-1)"	15.4	20.6	10.0	21.0	10.2	23.7	18.8	9.9	11.3	19.9	13.4	16.9	16.2	22.2	48.0	17.5	16.8	15.3	17.2	10.4	10.8	22.5	25.2	17.2	26.3	10.0	12.0	22.0	13.3	30.0	12.5	20.3	10.5	17.6	18.1	29.2	18.3	16.1	17.9	19.2	16.8	16.4	9.7	22.5	17.2	27.0	10.4	30.3	23.2	15.1	26.0	21.8	11.8	11.0	40.5	30.9	43.5	41.4	93.1	37.0	21.2	43.9	29.2	34.8	36.5	51.1	83.9	36.7	23.6	36.6	42.3	40.9	54.0	36.2	56.7	56.7	64.6	186.6	31.0	29.2	29.7	74.1	98.8	34.6	28.8	22.5	30.1	32.1	40.6	34.5	77.0	43.2	42.6	18.3	47.5	28.9	36.0	48.7	38.2	43.6	52.9	25.1	29.9	54.8	19.9	47.4	39.6	38.9	31.3	41.5	34.6	32.3	40.2	29.2	30.0	51.7	24.0	23.6	59.8	39.5	31.2	49.5	30.5	54.4	15.4	31.3	20.0	17.7	26.3	16.7	21.4	19.7	18.1	17.0	20.1	19.6	11.3	26.7	18.3	9.0	19.4	15.8	10.0	10.2	9.9	11.3	10.4	10.8	10.0	12.0	10.5	9.7	10.4	11.0	51.5	57.7	48.8	14.7	49.0	87.2	46.2	29.7	64.3	34.0	30.2	31.6	49.2	31.5	41.7	25.8	56.3	37.9	42.7	30.7	19.6	26.9	28.5	34.0	38.0	37.7	26.9	25.5	16.5	24.5	24.8	36.4	15.8	52.4	85.9	33.2	28.5	38.6	29.1	63.9	21.4	45.1	32.6	32.3	23.6	13.1	33.5	36.1	12.4	15.0	31.8	31.1	29.9	20.6	18.6	26.9	17.5	31.2	37.2	26.1	22.8	18.3	33.7	45.9	26.3	47.8	33.1	100.3	71.3	51.1	81.1	45.7	48.0	56.4	25.3	31.5
DDX6	"HLR2, RCK, Rck/p54"	ENSG00000110367	"DEAD-box helicase 6"	P26196	11	118747763-118791164	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004668, HPA024201, HPA026644"	Approved		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA		19000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	"Cytoplasmic bodies"	Cytosol	"CAB004668: AB_436960, HPA024201: AB_10603562, HPA026644: AB_1847582"	"unprognostic (1.26e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.82e-2)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (3.43e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.58e-2)"	"unprognostic (4.55e-2)"	31.5	28.4	29.1	34.9	36.0	69.0	34.9	50.7	31.9	33.2	12.7	30.0	23.7	30.5	30.5	33.1	29.1	23.6	37.2	31.5	35.4	30.6	34.2	27.3	49.0	28.4	29.3	48.8	30.7	28.3	17.3	31.6	25.2	32.9	27.9	48.7	32.4	29.2	43.2	27.2	26.2	30.6	29.9	45.4	29.9	28.8	37.1	54.9	37.5	41.9	60.9	30.0	21.9	36.6	33.9	50.4	73.6	71.7	64.0	64.8	47.2	45.6	62.0	43.0	40.4	72.1	50.9	77.6	47.1	78.8	44.3	53.2	88.8	69.1	69.0	62.7	17.4	154.5	30.8	57.1	42.0	110.9	55.8	67.1	49.5	63.5	100.8	54.8	69.1	53.2	72.5	110.4	59.2	96.8	81.0	52.1	53.3	50.1	33.6	89.3	59.2	60.1	50.1	92.7	48.7	63.9	84.7	67.2	28.5	56.2	79.2	44.2	81.2	67.2	38.4	39.8	47.6	34.1	47.8	91.7	26.8	52.2	59.2	13.8	4.8	13.2	10.2	6.2	12.3	12.1	10.0	10.8	5.1	12.0	12.2	11.0	19.0	8.3	12.4	7.1	9.9	6.8	29.1	36.0	50.7	31.9	31.5	35.4	28.4	29.3	25.2	29.9	37.1	36.6	84.6	60.9	57.9	37.9	140.1	30.2	75.2	31.3	69.4	82.2	49.8	43.2	116.9	42.9	41.4	44.1	50.1	38.4	184.0	58.6	31.3	32.2	4.2	77.3	81.5	64.6	85.7	88.2	57.3	35.5	36.5	55.6	42.3	91.7	52.5	54.2	61.8	41.5	38.3	62.2	60.9	59.8	42.7	66.9	44.3	10.5	54.0	70.1	33.8	68.4	75.9	90.0	119.4	50.3	80.9	51.2	57.0	45.1	106.0	49.8	57.2	41.3	35.9	91.3	39.5	92.6	69.7	71.1	76.8	73.4	30.5	76.5	130.2	48.8	53.1	78.2
DENND4C	"bA513M16.3, C9orf55, C9orf55B, FLJ20686, RAB10GEF"	ENSG00000137145	"DENN domain containing 4C"	Q5VZ89	9	19230435-19374281	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 120.9;Oligodendrocyte precursor cells: 107.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014917, HPA015096"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 31: Skin - Epidermis development"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus, Vesicles, Cytosol"		"HPA014917: AB_2261659, HPA015096: AB_1845831"	"unprognostic (4.57e-2)"	"unprognostic (1.73e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.39e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (3.27e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	21.7	11.9	5.9	9.2	7.0	10.6	21.7	14.1	6.3	17.2	8.0	17.4	25.1	17.2	14.3	14.5	16.4	13.8	14.5	5.3	5.6	13.9	15.2	18.0	11.8	5.9	5.7	21.4	12.9	19.0	8.7	19.6	5.7	16.1	19.8	11.8	15.1	13.4	10.6	29.6	22.4	14.6	5.8	12.7	19.8	11.2	7.2	17.7	17.3	12.4	11.2	16.6	16.0	6.6	17.7	17.5	11.7	15.3	26.6	28.5	21.4	10.0	14.9	10.2	13.7	8.4	11.6	7.5	8.3	13.6	11.8	9.4	13.7	9.4	12.0	47.2	7.8	34.4	18.5	10.4	13.4	8.3	18.8	11.7	18.7	9.0	15.5	21.6	20.2	9.9	9.4	8.5	13.1	7.4	13.8	18.8	9.0	24.7	8.5	12.6	6.6	10.9	29.2	34.1	10.9	8.5	8.4	20.1	7.4	11.0	12.1	11.3	18.5	8.9	5.2	10.0	10.5	5.8	14.9	4.0	7.7	7.6	5.2	8.3	1.6	1.9	5.4	0.8	7.0	1.7	4.6	5.5	3.1	2.3	4.3	5.0	0.9	6.4	0.9	3.2	3.8	2.4	5.9	7.0	14.1	6.3	5.3	5.6	5.9	5.7	5.7	5.8	7.2	6.6	28.6	9.6	11.5	85.8	21.3	51.2	16.7	18.0	65.4	20.9	16.0	11.0	12.4	14.3	21.6	16.5	60.5	29.4	22.6	26.6	1.9	9.8	7.7	12.7	15.5	22.9	19.8	9.7	78.6	12.5	13.5	24.0	47.4	20.4	27.1	24.8	51.0	11.5	19.0	23.5	87.2	22.6	24.4	23.9	22.0	5.2	18.6	32.2	21.4	120.9	8.5	13.6	27.8	107.1	69.1	12.1	20.9	20.3	14.1	19.4	26.4	4.9	21.6	16.3	0.0	19.5	16.2	3.3	6.8	30.9	49.3	16.1	28.2	12.0	23.3	23.2
DIP2A	"C21orf106, Dip2, KIAA0184"	ENSG00000160305	"Disco interacting protein 2 homolog A"	Q14689	21	46458891-46570015	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	"Developmental protein, Ligase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 159.6;Oligodendrocytes: 143.0;Rod photoreceptor cells: 206.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052516	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA052516: AB_2681859"	"unprognostic (1.05e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.88e-2)"	"unprognostic (7.30e-2)"	"prognostic favorable (9.35e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.05e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.78e-3)"	5.6	5.4	4.1	6.1	7.7	9.8	5.2	5.0	6.8	6.5	2.9	6.1	6.6	5.8	2.1	6.6	6.3	4.5	8.4	6.0	6.4	3.5	2.9	5.5	7.2	7.6	6.4	7.2	6.7	5.1	4.9	5.9	7.7	6.9	4.1	10.6	6.9	4.0	6.8	6.7	7.4	5.0	3.4	8.9	7.2	7.3	7.8	6.4	5.2	6.6	4.8	5.1	6.1	15.8	14.3	9.5	17.4	8.2	7.9	7.4	10.8	9.7	7.4	9.5	7.7	17.0	10.5	5.9	9.1	10.1	9.8	7.3	7.9	13.4	5.6	23.4	11.1	20.1	15.8	10.1	5.4	7.3	10.3	6.8	8.8	10.2	11.2	7.3	14.1	11.4	13.4	13.9	7.9	13.3	11.7	10.9	9.5	12.6	9.4	11.6	7.0	12.4	5.6	13.2	9.3	5.8	15.0	9.8	8.4	4.6	10.3	7.0	19.0	7.8	5.5	11.2	7.2	13.9	7.6	5.4	8.3	12.3	12.8	11.9	5.2	12.4	14.4	6.5	9.4	3.3	6.5	9.9	2.9	3.6	4.5	9.3	10.3	10.1	7.4	10.6	5.8	4.6	4.1	7.7	5.0	6.8	6.0	6.4	7.6	6.4	7.7	3.4	7.8	15.8	35.3	41.7	19.2	40.8	18.6	14.7	9.3	13.8	23.9	55.9	18.0	16.6	30.7	18.6	20.5	14.7	116.7	11.3	97.0	23.9	9.8	10.7	18.8	21.3	32.8	33.2	24.0	12.8	86.9	11.0	9.5	23.2	50.0	25.7	13.3	34.9	34.2	11.2	18.0	18.5	101.8	21.7	4.1	39.9	17.3	25.6	23.9	26.5	7.2	119.9	21.4	16.3	159.6	68.9	143.0	20.9	15.7	22.2	58.4	19.3	23.4	8.0	26.4	206.8	26.3	31.4	18.3	54.2	38.3	20.7	17.6	11.2	63.1	19.1	23.1	13.3
DMAC1	"C9orf123, MGC4730, TMEM261"	ENSG00000137038	"Distal membrane arm assembly complex 1"	Q96GE9	9	7796500-7888380	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 500.8;Hofbauer cells: 221.7;Proximal tubular cells: 254.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA014585	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 7: Non-specific - Mitochondria"			"HPA014585: AB_1845803"	"unprognostic (1.48e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.23e-3)"	"prognostic favorable (4.15e-4)"	"unprognostic (2.78e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.65e-1)"	"prognostic favorable (1.96e-11)"	"unprognostic (1.75e-1)"	"unprognostic (4.19e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.41e-2)"	10.6	11.9	16.8	7.7	17.0	6.2	12.4	17.5	21.0	9.3	9.0	12.6	9.8	10.0	11.8	9.3	11.0	6.3	25.4	16.3	17.8	15.9	10.2	7.2	10.0	15.2	15.0	13.2	9.2	21.8	12.3	8.1	15.6	11.9	9.9	9.0	14.3	11.6	43.1	8.5	9.1	8.1	15.1	10.4	10.7	7.0	16.0	20.6	11.8	29.8	8.9	11.5	8.3	16.9	18.5	21.8	19.7	12.3	15.4	19.1	13.3	11.0	7.7	11.5	10.4	9.9	11.3	27.1	5.6	9.8	15.0	9.8	21.2	18.8	11.6	16.2	24.3	49.3	32.7	31.8	15.6	17.2	6.7	24.1	13.2	9.1	13.9	10.6	11.0	24.3	9.2	5.6	12.2	15.7	25.1	39.7	17.5	15.6	10.5	19.0	11.1	16.4	13.2	17.6	31.5	17.6	12.0	8.0	14.1	13.5	10.5	10.5	14.0	8.8	14.2	11.6	7.7	7.0	12.0	14.5	7.4	14.3	9.0	2.0	10.1	4.5	11.5	12.2	17.4	26.5	15.7	12.3	12.6	22.5	20.5	16.5	1.6	20.8	9.8	13.1	19.9	19.6	16.8	17.0	17.5	21.0	16.3	17.8	15.2	15.0	15.6	15.1	16.0	16.9	42.2	70.5	48.5	0.0	15.7	0.0	0.0	0.0	0.0	0.0	69.5	81.5	0.0	0.0	24.1	101.2	0.0	113.6	13.9	0.0	500.8	94.2	0.0	81.4	64.3	30.0	0.0	0.0	0.0	90.7	96.3	32.8	0.0	58.6	27.8	127.7	0.0	0.0	221.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.0	0.0	25.8	0.0	0.0	0.0	0.0	62.4	0.0	0.0	3.1	0.0	0.0	254.7	70.7	0.0	0.0	0.0	29.6	0.0	0.0	0.0	0.0	55.4	17.3	79.3	0.0	0.0
DMTN	"DMT, EPB49"	ENSG00000158856	"Dematin actin binding protein"	Q08495	8	22048995-22082527	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 192.5"	"Cell type enriched"	"Detected in many"	5	"Erythroid cells: 248.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"gdT-cell: 1.7;MAIT T-cell: 1.7;memory CD4 T-cell: 3.8;memory CD8 T-cell: 1.6;naive CD4 T-cell: 1.5;naive CD8 T-cell: 1.5;neutrophil: 1.2;T-reg: 3.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.2;T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"A549: 68.9;HEL: 225.9;Hep G2: 63.9;HMC-1: 65.6;OE19: 67.3;RPTEC TERT1: 87.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024290, HPA058487"	Uncertain					NA	NA		2400000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA024290: AB_1847601, HPA058487: "	"unprognostic (6.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (7.92e-5)"	"unprognostic (2.88e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (3.85e-9)"	"unprognostic (3.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.07e-2)"	35.7	29.8	104.2	6.1	134.6	136.6	21.8	0.0	192.5	13.5	0.0	33.1	9.2	15.3	14.4	18.9	30.4	13.5	71.5	142.1	36.9	67.5	28.2	20.1	3.4	27.0	14.0	3.4	29.6	54.9	109.6	7.4	27.1	25.0	15.2	23.0	22.9	20.4	66.4	24.3	14.0	14.0	0.0	19.3	23.8	11.7	32.4	3.0	39.1	41.4	3.7	12.9	12.4	90.5	44.1	68.9	0.5	1.4	1.1	0.3	5.4	4.6	4.3	14.5	4.3	29.9	26.7	0.4	43.8	0.8	0.9	14.8	2.1	2.7	6.5	0.4	13.0	225.9	5.3	63.9	1.3	0.1	65.6	0.7	29.3	0.2	0.3	8.5	14.7	2.0	21.7	2.2	0.1	18.9	5.7	0.5	1.8	67.3	6.1	0.0	0.6	3.1	87.2	12.3	15.6	21.8	7.3	0.9	3.2	3.5	11.2	2.2	26.1	0.0	22.0	0.3	24.0	0.1	0.2	0.7	0.3	0.2	15.4	0.0	0.1	0.2	1.7	0.0	1.7	0.0	3.8	1.6	0.1	0.0	1.5	1.5	1.2	0.0	0.0	0.3	3.3	9.3	104.2	134.6	0.0	192.5	142.1	36.9	27.0	14.0	27.1	0.0	32.4	90.5	9.3	3.2	10.7	10.7	1.5	2.3	4.0	3.9	1.2	34.6	9.9	5.7	37.8	0.0	5.1	7.3	12.5	0.1	2.7	15.3	19.6	11.4	12.7	11.2	1.7	10.2	20.5	248.6	45.7	11.4	1.7	2.4	7.7	12.7	0.0	4.1	3.9	15.8	0.5	28.6	29.7	8.7	0.0	1.0	1.6	7.7	0.3	44.5	14.2	5.6	1.3	2.6	0.0	1.5	4.3	18.2	10.0	2.6	1.4	3.7	1.8	29.6	9.3	7.3	0.0	1.4	5.7	1.4	2.4	3.8	5.7	0.1	6.4	0.3	13.3	4.8
DNAAF3	"C19orf51, CILD2, FLJ36139, FLJ40069, PCD, PF22"	ENSG00000167646	"Dynein axonemal assembly factor 3"	Q8N9W5	19	55158661-55166722	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"fallopian tube: 40.8;testis: 65.4"	"Group enriched"	"Detected in many"	5	"Early spermatids: 395.2;Late spermatids: 722.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 26.2;HEL: 31.6;K-562: 25.3;U-937: 18.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056220			Approved	"Nuclear bodies,Mitochondria"		No	No				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria	"Nuclear bodies"	"HPA056220: AB_2683071"	"unprognostic (1.71e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.10e-2)"	"unprognostic (9.93e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (1.83e-5)"	"unprognostic (1.35e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.35e-2)"	"unprognostic (8.03e-2)"	0.4	1.8	1.5	0.0	1.2	0.0	0.6	0.9	0.7	2.5	6.1	0.3	0.1	0.9	3.4	0.6	40.8	0.6	5.0	1.5	2.3	2.7	0.6	4.3	0.1	4.0	8.2	0.2	1.6	3.5	0.7	0.1	4.7	0.3	0.1	0.4	0.4	0.9	0.1	0.9	0.3	0.2	3.1	0.3	0.3	65.4	1.5	0.5	2.3	0.0	0.1	0.1	0.4	2.1	8.8	6.6	0.6	6.7	0.1	0.0	0.6	0.1	0.2	1.0	0.7	0.3	4.0	10.5	2.5	0.3	1.9	10.1	1.5	3.0	0.4	0.0	26.2	31.6	0.5	0.5	0.2	13.6	3.1	0.2	4.0	1.7	2.2	0.9	0.5	4.7	25.3	13.9	0.4	5.9	0.4	0.3	0.5	9.5	15.0	16.5	1.0	3.2	5.4	0.2	0.8	2.6	1.1	1.1	1.6	0.2	8.3	0.4	1.0	0.8	3.9	4.0	0.2	0.4	2.5	0.6	4.9	18.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	1.2	0.9	0.7	1.5	2.3	4.0	8.2	4.7	3.1	1.5	2.1	0.2	0.0	0.5	0.0	0.0	3.2	0.0	4.7	4.6	0.0	1.1	0.6	3.0	1.5	7.5	7.3	0.0	0.0	0.0	0.3	7.9	2.7	395.2	55.8	0.5	0.6	0.0	0.0	0.5	1.0	0.1	1.2	0.0	1.3	0.0	1.9	0.7	0.4	0.2	0.0	0.5	0.5	12.2	0.0	0.4	722.0	4.4	4.2	0.0	0.0	0.0	2.1	0.0	0.5	0.1	0.2	0.1	3.0	0.0	0.1	0.0	5.1	75.2	0.0	0.0	0.0	2.3	104.8	18.6	0.3	1.3	0.0	0.1	1.1	0.4	0.2
DNAJC6	"KIAA0473, PARK19"	ENSG00000116675	"DnaJ heat shock protein family (Hsp40) member C6"	O75061	1	65248219-65415871	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Chaperone, Hydrolase, Protein phosphatase"	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 81.5;retina: 52.8"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1038.1"	"Cancer enriched"	"Detected in many"	4	"glioma: 5.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 62.1;HEL: 165.8;K-562: 65.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031182, HPA054917"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA031182: AB_10611957, HPA054917: AB_2682641"	"unprognostic (6.99e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.19e-1)"	"unprognostic (7.94e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.87e-4)"	"unprognostic (2.98e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.14e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.67e-3)"	1.5	11.1	34.7	0.9	43.3	4.7	1.1	33.7	46.9	0.8	0.0	2.1	1.0	0.6	0.4	0.3	1.1	1.0	8.9	42.1	48.0	7.7	0.4	1.5	0.2	60.2	51.3	0.5	2.1	1.0	12.6	7.4	67.6	1.1	1.7	52.8	0.7	0.7	0.4	1.1	1.0	0.9	27.2	2.1	1.7	2.2	42.0	0.8	1.7	0.8	0.3	1.1	0.9	81.5	10.4	2.8	0.1	4.4	2.1	0.5	23.4	20.1	33.1	32.6	31.7	2.7	0.5	9.9	1.7	8.3	8.0	2.5	14.6	3.3	25.8	62.1	6.9	165.8	5.1	0.6	0.2	5.6	3.9	2.7	2.2	3.3	13.8	6.0	0.7	8.0	65.5	1.2	6.6	1.9	2.1	0.0	6.5	0.0	2.2	0.0	4.9	0.4	23.7	0.0	39.4	27.0	11.9	15.5	5.4	37.4	7.5	0.3	6.5	4.8	3.3	0.6	5.9	6.0	4.1	3.0	13.4	4.1	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.7	43.3	33.7	46.9	42.1	48.0	60.2	51.3	67.6	27.2	42.0	81.5	0.8	0.0	0.5	49.3	0.5	1.3	0.4	0.5	0.0	30.4	0.6	0.3	28.0	2.8	0.2	0.0	14.6	8.9	1.5	0.4	1.9	0.8	2.0	1.8	0.5	3.7	7.2	19.4	237.4	0.7	2.1	5.8	1.5	3.0	0.0	0.6	0.4	0.1	1.2	52.2	237.6	1.9	2.0	0.0	0.8	1.9	0.0	0.7	7.2	18.7	1.1	4.1	0.0	136.7	1038.1	0.4	0.2	0.0	0.9	1.7	0.0	7.2	1.2	21.6	0.0	0.2	8.5	1.7	2.5	0.0	0.3	7.4	0.6	6.9	0.6	0.2
DPF3	"BAF45c, cer-d4, Cerd4, FLJ14079"	ENSG00000205683	"Double PHD fingers 3"	Q92784	14	72619296-72894116	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.5;retina: 18.0;skeletal muscle: 26.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 104.5;Cone photoreceptor cells: 108.4;Early spermatids: 58.5;Oligodendrocyte precursor cells: 123.1;Oligodendrocytes: 115.7;Rod photoreceptor cells: 85.5"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.7;BJ hTERT+ SV40 Large T+: 12.2;HEL: 31.5;Karpas-707: 12.4"	"Region enhanced"	"Detected in all"		"cerebellum: 49.5"	"Low region specificity"	"Detected in all"			"HPA066790, HPA070601"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA066790: AB_2685724, HPA070601: AB_2686284"	"unprognostic (2.38e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.98e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.54e-2)"	"unprognostic (9.71e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.85e-3)"	"unprognostic (4.08e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.96e-1)"	0.3	1.4	2.8	0.5	6.7	2.6	0.4	35.5	5.1	0.4	0.0	2.0	0.2	0.2	0.0	0.6	0.3	0.3	14.2	10.2	3.8	1.4	3.0	0.2	0.8	12.0	5.9	13.7	0.3	5.1	0.6	0.3	12.6	0.1	1.5	18.0	0.4	0.2	26.5	0.5	1.3	0.5	4.4	1.0	0.5	3.5	5.7	0.3	0.4	9.1	1.0	0.2	0.2	7.7	2.1	0.0	1.6	0.1	0.2	2.9	17.7	5.4	5.1	12.2	4.7	0.1	0.2	0.2	0.3	1.7	0.2	0.1	1.7	0.8	7.4	0.3	0.6	31.5	0.2	0.0	0.5	0.2	0.5	0.7	0.3	2.8	2.0	2.0	4.0	3.4	2.8	12.4	3.9	0.1	2.7	0.3	0.0	0.0	1.8	6.9	0.8	0.4	2.1	0.0	1.2	0.7	0.0	0.1	0.0	0.5	0.0	0.0	8.7	6.0	0.0	2.2	0.6	4.3	1.2	0.4	0.5	1.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	6.7	35.5	5.1	10.2	3.8	12.0	5.9	12.6	4.4	5.7	7.7	0.8	0.0	0.0	104.5	6.0	0.6	0.1	0.0	0.0	10.5	1.1	0.9	38.4	1.5	0.0	0.0	108.4	2.6	2.6	7.5	1.9	0.1	58.5	0.1	0.8	2.9	0.0	8.6	17.7	0.4	1.3	2.8	0.0	0.1	4.5	43.2	1.1	4.4	0.4	6.7	21.7	3.4	0.0	0.8	0.7	34.3	0.3	1.7	0.0	8.4	0.1	8.6	2.1	123.1	115.7	0.7	5.1	4.9	2.6	0.1	2.7	10.7	0.0	85.5	0.0	2.6	3.5	4.5	1.2	0.3	0.3	0.1	3.8	14.5	7.4	0.0
DYRK1A	"DYRK, DYRK1, MNBH"	ENSG00000157540	"Dual specificity tyrosine phosphorylation regulated kinase 1A"	Q13627	21	37365573-37526358	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 156.7;Inhibitory neurons: 158.4;Microglial cells: 176.1;Oligodendrocyte precursor cells: 158.3;Oligodendrocytes: 157.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015323, HPA015810"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Nucleoli fibrillar center"	"HPA015323: AB_1847922, HPA015810: AB_1847921"	"unprognostic (2.71e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.95e-2)"	"unprognostic (7.39e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.40e-2)"	23.1	20.4	17.8	22.5	19.9	71.4	22.3	29.9	20.7	23.9	22.2	22.2	18.7	26.6	22.0	18.8	22.6	19.9	28.9	21.3	19.2	19.9	19.8	22.3	30.1	12.1	14.7	29.6	21.5	27.8	20.2	23.0	13.3	18.8	21.6	27.8	21.3	19.2	49.4	24.2	21.7	24.1	12.8	30.4	22.8	29.9	18.6	45.8	25.7	45.2	26.7	24.3	21.1	20.9	23.5	18.2	36.3	25.6	17.1	18.8	32.7	20.8	26.0	20.3	22.0	25.7	19.7	31.7	13.8	37.0	27.1	15.8	27.3	21.2	24.4	49.7	11.6	93.6	30.9	16.1	26.5	36.9	32.3	18.7	24.3	26.5	41.2	23.5	22.3	44.2	36.4	70.4	22.2	23.6	49.3	25.9	38.5	24.1	10.8	62.8	19.7	29.6	22.3	30.4	36.5	20.4	47.1	31.6	33.2	12.2	29.9	34.8	27.8	27.6	8.3	17.2	17.4	47.7	41.6	44.9	22.0	41.8	30.7	3.1	0.5	0.8	1.2	0.8	0.7	1.1	1.3	1.0	0.7	1.0	1.4	1.3	2.3	0.5	1.1	1.3	1.3	0.3	17.8	19.9	29.9	20.7	21.3	19.2	12.1	14.7	13.3	12.8	18.6	20.9	36.8	19.2	25.5	114.3	28.8	37.5	24.1	15.7	18.2	32.7	28.3	18.0	73.0	20.0	23.0	11.0	27.1	10.3	43.0	30.1	0.0	13.5	29.7	44.2	39.3	31.9	21.4	26.1	156.7	14.6	12.4	25.2	21.4	71.4	24.7	35.9	27.1	18.1	15.8	47.1	158.4	18.8	14.2	25.0	27.7	22.2	16.1	32.4	24.9	176.1	18.8	16.4	21.6	158.3	157.2	21.2	22.4	19.5	33.8	29.8	17.1	9.9	27.9	21.8	13.1	38.4	32.5	15.3	24.7	24.6	31.7	15.3	36.8	21.3	19.3	37.2
ECT2L	"ARHGEF32, C6orf91, FBXO49, LFDH"	ENSG00000203734	"Epithelial cell transforming 2 like"	Q008S8	6	138795911-138904070	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"fallopian tube: 8.7"	"Cell type enriched"	"Detected in some"	6	"Respiratory ciliated cells: 91.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEL: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA035488	Uncertain					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 36: HEL - Hemostasis"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA035488: AB_10672865"	"unprognostic (2.88e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.53e-3)"	"unprognostic (3.48e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.03e-2)"	"unprognostic (5.90e-4)"	"unprognostic (2.32e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.27e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.65e-3)"	0.1	0.3	1.2	0.1	0.4	0.3	0.3	0.8	0.7	0.4	1.7	0.1	0.0	0.2	0.0	0.1	8.7	0.0	1.7	1.3	0.4	0.0	0.0	1.5	0.1	1.9	1.6	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.4	0.2	0.0	0.2	0.4	0.0	0.1	1.2	0.1	0.1	0.4	0.5	0.0	0.1	0.0	0.0	0.3	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.8	0.7	1.3	0.4	1.9	1.6	0.6	1.2	0.5	0.7	0.2	0.0	1.1	2.3	0.1	0.5	0.7	1.6	0.0	2.1	0.3	0.1	2.3	0.0	12.7	0.0	2.1	0.1	0.6	0.1	0.0	0.0	5.1	15.0	0.5	0.8	0.0	0.0	6.1	0.0	0.0	0.9	0.0	1.4	0.0	0.3	0.0	0.0	0.1	0.0	6.7	0.0	0.0	0.0	0.4	5.4	0.0	0.1	0.0	1.0	0.0	2.0	0.0	2.0	3.2	0.0	0.0	0.0	0.4	0.3	0.0	0.0	91.4	3.2	0.0	1.2	0.5	0.5	0.1	0.0	0.0	0.3	0.6	0.2	0.0	0.3
EI24	"EPG4, PIG8, TP53I8"	ENSG00000149547	"EI24 autophagy associated transmembrane protein"	O14681	11	125569280-125584684	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 461.9"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 575.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 760.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047165, HPA051029"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 36: HEL - Hemostasis"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Cytosol"	"Golgi apparatus"	"HPA047165: AB_2679965, HPA051029: AB_2681317"	"unprognostic (2.04e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.38e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (3.50e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.01e-1)"	53.4	32.6	61.1	36.2	62.5	23.2	72.6	59.7	72.4	51.3	59.8	77.8	49.6	46.2	57.4	80.8	50.8	46.3	55.7	60.2	61.5	61.0	248.4	45.0	28.4	60.2	62.5	42.4	101.8	461.9	30.6	48.5	60.2	49.6	80.4	39.4	75.3	58.0	119.5	70.2	49.3	62.5	62.4	30.5	59.7	33.1	64.4	35.3	40.5	104.6	42.3	78.9	48.4	61.0	156.6	115.6	129.5	160.5	207.7	155.9	162.4	159.6	116.8	104.3	93.4	178.9	303.4	158.0	264.0	146.5	110.8	176.1	199.0	326.8	135.2	42.0	142.6	760.9	77.2	179.9	154.1	170.9	78.4	147.5	292.7	157.4	230.2	102.8	223.9	85.1	351.1	61.1	149.4	113.8	79.0	96.4	173.6	398.3	139.5	113.9	155.4	132.8	177.0	272.4	120.1	116.9	187.1	215.5	63.4	212.3	436.4	165.7	195.2	133.8	93.3	94.7	128.7	39.7	84.8	200.5	58.5	256.1	182.2	4.3	7.0	5.9	7.2	6.7	7.2	8.4	5.7	9.0	10.9	6.3	8.1	6.7	0.8	6.5	4.9	14.5	9.1	5.3	61.1	62.5	59.7	72.4	60.2	61.5	60.2	62.5	60.2	62.4	64.4	61.0	73.5	32.1	38.3	13.4	34.8	120.6	130.3	132.6	120.1	58.9	148.8	100.6	61.9	124.4	69.5	110.3	37.5	166.9	32.4	66.4	144.8	178.6	31.1	34.4	59.3	87.1	98.4	102.7	25.1	181.8	201.2	80.1	87.7	46.5	27.3	76.2	74.6	575.0	110.5	82.4	24.0	115.3	105.8	49.8	96.1	49.7	71.4	40.9	90.7	11.2	40.9	107.1	50.4	13.0	23.0	182.1	67.6	72.2	79.1	270.0	68.5	122.7	43.9	36.9	46.0	60.8	80.1	95.9	112.3	176.3	181.4	140.1	31.0	71.3	135.7	189.4
EPB42	"MGC116735, MGC116737, PA"	ENSG00000166947	"Erythrocyte membrane protein band 4.2"	P16452	15	43197227-43221018	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape, Erythrocyte maturation"		"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"bone marrow: 98.9"	"Cell type enriched"	"Detected in many"	33	"Erythroid cells: 480.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	91	"HEL: 85.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040261	Supported		Uncertain	Nucleoplasm,Cytosol		NA	NA		1400000		"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Cytosol"		"HPA040261: AB_10673441"	"unprognostic (8.45e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.95e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.48e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.47e-3)"	3.1	0.0	0.0	0.0	0.0	98.9	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.4	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	2.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	1.9	1.5	0.5	0.0	4.0	0.0	0.0	0.6	1.5	0.5	0.0	6.2	4.5	0.0	1.5	0.0	0.0	14.4	0.0	0.0	1.2	0.0	480.0	0.1	0.0	2.3	0.8	0.0	0.0	4.5	0.0	2.5	1.1	1.1	6.7	0.1	0.9	4.1	2.2	2.8	10.5	2.8	1.1	1.8	0.0	3.6	2.5	14.4	0.0	0.0	0.0	1.7	0.7	0.4	1.5	2.4	0.0	0.6	8.4	6.6	1.0	1.0	13.5	4.6	0.0	2.8	6.7	3.8	0.0	0.8	2.0
EPC2	DKFZP566F2124	ENSG00000135999	"Enhancer of polycomb homolog 2"	Q52LR7	2	148644440-148787569	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 125.7;Oligodendrocytes: 99.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036759	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA036759: AB_10672365"	"unprognostic (1.65e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.83e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.21e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.91e-2)"	16.4	14.0	9.6	13.5	10.9	50.3	17.2	22.0	13.4	18.2	7.8	12.4	9.7	25.5	14.1	12.2	15.3	15.3	15.5	9.9	11.3	12.9	12.7	14.6	18.0	9.6	9.9	31.9	9.8	12.1	9.9	18.5	9.9	16.2	13.9	14.0	11.5	15.5	15.9	11.7	10.5	19.1	9.7	15.9	12.0	14.2	11.5	23.1	19.3	18.5	15.9	15.6	14.0	14.5	9.2	7.0	23.8	14.8	15.7	19.5	17.9	15.9	21.4	25.3	21.2	14.1	12.0	19.8	7.8	18.7	10.9	12.1	20.7	12.7	31.1	17.6	15.4	38.9	11.0	19.8	16.0	29.7	22.7	20.5	22.1	25.8	25.3	15.6	15.9	15.9	20.9	33.4	16.0	14.7	20.2	19.8	24.3	8.7	13.6	20.7	22.1	18.2	12.7	25.6	32.5	23.6	19.6	12.0	29.8	16.6	7.7	25.8	19.2	20.2	17.7	14.0	13.6	20.3	17.0	25.0	16.0	17.4	21.9	0.1	0.9	1.2	0.9	0.7	1.3	0.8	1.4	0.8	0.9	0.8	1.5	1.1	4.5	0.3	2.0	1.0	1.4	0.5	9.6	10.9	22.0	13.4	9.9	11.3	9.6	9.9	9.9	9.7	11.5	14.5	24.2	25.6	13.6	60.1	21.1	14.0	26.4	4.8	4.0	19.6	15.4	17.1	22.0	8.6	15.1	9.2	6.2	11.3	27.5	8.4	3.9	9.1	28.5	23.5	25.9	17.0	18.0	15.8	79.2	8.8	11.7	20.7	8.6	27.3	6.3	15.6	7.9	5.0	8.6	8.4	75.3	9.2	2.0	16.1	10.2	5.5	23.9	17.7	12.4	70.3	11.3	14.1	20.6	125.7	99.3	9.3	9.1	23.0	10.7	20.3	6.3	6.7	9.8	15.7	13.1	44.4	25.4	19.3	18.6	7.8	15.6	20.1	25.2	16.3	8.1	23.6
ETS2		ENSG00000157557	"ETS proto-oncogene 2, transcription factor"	P15036	21	38805183-38824955	"Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 701.0;Basal squamous epithelial cells: 863.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 33.6;granulocytes: 37.0;monocytes: 32.4"	"Cell line enhanced"	"Detected in many"		"HEL: 309.0;hTCEpi: 269.6;hTERT-HME1: 210.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003176			Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA003176: AB_2666824"	"unprognostic (2.06e-1)"	"unprognostic (5.91e-2)"	"unprognostic (9.16e-3)"	"unprognostic (5.33e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.88e-3)"	"unprognostic (7.36e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.10e-2)"	109.9	29.7	51.4	95.5	43.3	167.1	87.7	31.6	72.5	89.6	61.4	119.3	131.3	77.5	27.9	90.6	72.5	132.1	68.0	50.9	43.2	66.1	230.7	185.5	38.0	50.0	39.9	65.7	37.5	61.9	56.6	73.6	45.0	80.1	146.5	7.5	50.3	45.7	149.7	248.3	179.7	78.0	47.9	201.0	72.7	7.6	54.0	43.7	62.5	42.8	34.8	210.2	103.6	44.4	120.1	26.2	16.6	5.6	18.8	61.3	49.2	27.4	154.1	36.2	46.5	23.0	35.1	24.7	13.3	25.0	48.5	35.7	28.0	71.2	63.8	24.5	12.0	309.0	152.6	62.2	196.9	18.4	28.2	39.8	269.6	49.6	210.2	22.0	28.3	17.2	31.3	0.2	14.4	20.1	54.1	22.2	56.0	39.3	18.2	189.6	10.2	25.2	50.2	74.4	14.2	18.4	78.4	32.8	6.2	5.7	1.9	36.3	30.8	83.0	13.0	55.3	60.5	0.5	0.3	25.2	20.7	69.4	70.8	21.0	19.5	7.0	3.2	24.9	3.9	0.4	3.0	4.7	33.6	0.4	3.2	3.2	37.0	0.3	32.4	8.1	0.3	8.9	51.4	43.3	31.6	72.5	50.9	43.2	50.0	39.9	45.0	47.9	54.0	44.4	253.0	51.3	156.6	6.2	10.8	427.4	701.0	150.8	863.4	2.1	84.2	69.7	25.6	51.5	141.9	51.5	0.0	58.4	17.5	150.7	11.7	73.7	4.0	241.1	127.4	312.7	91.8	36.4	39.6	108.5	109.3	98.7	161.1	497.9	51.3	0.9	242.0	262.4	62.1	0.0	10.7	266.0	79.3	150.8	291.7	2.0	18.0	253.4	67.6	74.0	41.0	1.5	3.1	4.0	3.1	127.6	175.1	24.8	21.0	184.0	162.2	47.2	107.9	1.6	52.6	81.8	108.8	0.6	3.3	522.6	486.4	177.6	28.8	8.2	243.3	338.7
EXOC3L4	C14orf73	ENSG00000205436	"Exocyst complex component 3 like 4"	Q17RC7	14	103100144-103110559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 19.1;liver: 41.1"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 8.6;Gastric mucus-secreting cells: 21.9;Hepatocytes: 25.1;Proximal enterocytes: 30.2;Proximal tubular cells: 12.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.4;HEL: 3.8;Hep G2: 2.7;RPMI-8226: 2.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA043661	Approved					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 45: Enterocytes - Digestion"			"HPA043661: AB_10965693"	"unprognostic (8.71e-2)"	"unprognostic (7.42e-3)"	"prognostic unfavorable (1.43e-5)"	"unprognostic (8.20e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.53e-3)"	"unprognostic (6.64e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.12e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.81e-4)"	0.7	0.3	0.0	2.7	0.0	0.2	0.2	0.0	0.1	0.5	0.1	2.8	19.1	0.2	0.0	0.5	0.4	3.0	0.8	0.0	0.0	3.9	41.1	1.7	6.5	0.0	0.0	0.3	1.5	0.0	0.2	0.9	0.0	1.3	1.3	0.0	0.7	0.3	0.3	0.1	9.7	0.2	0.0	5.1	4.6	0.2	0.0	3.7	0.3	0.0	2.8	0.8	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.6	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	3.4	0.0	3.8	0.0	2.7	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.2	0.6	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.2	1.3	0.0	0.0	0.2	0.1	1.1	8.6	0.6	0.0	0.0	0.0	0.0	6.3	0.0	2.3	0.1	0.3	0.2	0.3	1.2	0.0	0.0	4.1	3.2	2.2	21.9	0.3	0.0	0.8	0.4	25.1	0.2	0.0	0.0	5.3	0.0	0.8	0.3	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.6	1.5	2.1	0.2	30.2	12.3	1.5	0.0	0.0	6.4	0.8	0.1	2.0	0.0	0.4	0.3	0.2	2.2	5.1	0.7
F2RL3	PAR4	ENSG00000127533	"F2R like thrombin or trypsin receptor 3"	Q96RI0	19	16888999-16892606	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 19.0;lung: 33.4;thyroid gland: 19.2"	"Cell type enriched"	"Detected in some"	4	"Adipocytes: 110.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"HEL: 30.7;HMC-1: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031401, HPA042340"			Supported	"Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"		"HPA031401: , HPA042340: "	"unprognostic (6.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.31e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.28e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.00e-3)"	"prognostic favorable (6.25e-4)"	"unprognostic (2.37e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.11e-2)"	19.0	2.6	0.7	1.5	0.7	1.3	18.0	1.9	0.7	1.1	1.2	4.3	1.5	1.6	1.6	1.5	1.5	2.8	5.6	0.6	0.7	9.8	0.5	33.4	2.3	0.5	0.6	0.8	9.3	1.1	2.7	1.0	0.5	1.4	1.3	1.2	1.2	0.5	3.2	3.1	4.9	1.0	0.0	1.3	5.0	1.7	1.2	0.4	19.2	0.6	0.9	1.9	1.2	1.3	0.3	0.3	0.8	0.4	0.1	0.2	0.9	0.4	0.1	0.2	0.2	0.5	0.8	0.6	0.6	0.3	0.3	0.6	0.2	0.3	0.3	0.4	0.4	30.7	1.3	0.5	0.2	0.3	11.6	0.0	0.1	0.3	0.2	0.4	0.9	0.6	2.5	1.1	0.2	0.5	0.4	2.9	0.4	0.4	0.3	0.3	0.2	1.0	0.3	0.6	0.5	0.3	0.3	0.2	0.1	0.7	0.6	2.0	1.2	0.6	0.6	0.4	0.3	0.5	0.4	0.6	0.3	0.5	0.4	3.3	0.9	0.7	0.9	0.4	0.8	1.6	1.0	0.8	0.3	1.8	1.4	1.3	2.2	1.8	0.6	1.7	0.8	1.4	0.7	0.7	1.9	0.7	0.6	0.7	0.5	0.6	0.5	0.0	1.2	1.3	110.4	0.0	1.1	0.0	0.3	0.4	0.3	0.3	0.0	0.0	0.3	0.3	0.7	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.9	27.5	0.0	0.8	0.0	0.5	0.0	2.7	0.0	0.2	7.0	0.3	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.3	1.0	0.4	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.0	0.6	0.0	0.1	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.1	0.4	0.5	0.1	0.3	0.2	0.3
FAM207A	"C21orf70, PRED56"	ENSG00000160256	"Family with sequence similarity 207 member A"	Q9NSI2	21	44940012-44976989	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034178, HPA036354, HPA036559"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"CAB034178: AB_1564323, HPA036354: AB_10672242, HPA036559: "	"unprognostic (1.83e-1)"	"unprognostic (9.07e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-3)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (3.23e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.12e-1)"	"unprognostic (5.77e-2)"	19.8	20.9	9.8	11.3	11.0	12.6	17.6	13.9	16.1	14.3	5.7	22.3	11.1	15.1	2.1	17.9	14.5	2.2	53.6	10.6	9.8	20.3	31.1	13.0	9.3	11.1	10.8	11.6	21.5	6.0	9.4	5.3	10.7	14.2	3.7	6.1	15.7	5.7	43.3	18.5	14.3	4.8	7.7	23.8	20.2	27.3	12.3	9.4	10.5	14.4	6.5	21.4	13.4	10.0	48.4	51.9	17.2	22.2	8.3	11.4	40.9	32.4	8.7	24.4	19.6	88.1	14.8	49.0	68.7	11.5	35.5	31.8	23.9	35.5	9.7	35.9	72.8	144.6	36.4	75.2	33.1	47.7	18.1	19.9	20.4	22.0	19.2	10.5	26.7	41.6	83.9	33.5	18.6	86.7	45.2	74.3	58.2	36.0	72.1	44.0	18.4	85.7	23.5	19.0	84.0	35.7	43.0	50.7	51.4	12.2	35.4	33.8	35.2	20.4	42.3	27.5	70.8	70.0	65.5	47.6	16.3	81.1	29.1	3.1	4.0	4.1	1.8	4.1	1.8	7.7	3.2	4.3	3.8	5.0	3.5	3.5	2.4	4.4	4.7	8.9	4.0	2.3	9.8	11.0	13.9	16.1	10.6	9.8	11.1	10.8	10.7	7.7	12.3	10.0	13.8	0.0	7.5	5.5	25.6	19.2	31.7	35.3	27.9	22.7	41.4	57.7	22.6	34.3	22.7	18.4	4.2	36.9	28.8	60.0	46.9	68.1	14.8	30.6	30.1	23.3	26.4	29.2	3.2	63.5	70.7	23.3	16.8	20.9	10.2	48.6	26.4	56.3	68.4	6.7	3.8	34.3	12.2	33.3	18.4	38.5	14.6	24.9	24.9	1.0	51.7	36.9	41.2	6.0	2.9	59.3	34.8	12.8	29.4	77.9	84.1	90.2	15.2	18.3	32.9	17.7	36.2	82.0	42.0	35.1	21.0	30.8	19.5	70.7	44.3	39.9
FCER1A	FCE1A	ENSG00000179639	"Fc fragment of IgE receptor Ia"	P12319	1	159289714-159308224	"FDA approved drug targets, Predicted membrane proteins"		"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 33.6"	"Cell type enriched"	"Detected in many"	7	"Langerhans cells: 1962.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	8	"basophil: 21557.7"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 21557.7"	"Cell line enriched"	"Detected in some"	99	"HEL: 447.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB022102, HPA036051, CAB055526"	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"			"CAB022102: , CAB055526: , HPA036051: AB_2674919"	"unprognostic (1.78e-2)"	"unprognostic (2.26e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.44e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.44e-1)"	"unprognostic (7.20e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.39e-2)"	3.9	1.7	0.4	5.7	0.4	14.2	17.3	0.5	0.8	10.6	0.5	7.0	7.1	7.1	5.4	23.0	2.9	14.9	3.2	0.4	0.6	4.7	4.4	14.5	2.5	0.6	0.5	0.7	1.2	2.6	0.8	0.2	0.7	5.9	10.7	0.1	4.0	9.1	2.8	33.6	8.8	7.4	0.4	8.0	3.5	2.3	0.6	4.8	1.2	3.9	10.9	11.9	2.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	447.9	0.0	0.0	0.0	0.5	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21557.7	14.4	36.4	0.4	4.1	4.4	2.8	4.4	1.5	2645.6	3.1	2.3	3.4	17.2	14.6	11.0	361.0	2.8	132.1	0.4	0.4	0.5	0.8	0.4	0.6	0.6	0.5	0.7	0.4	0.6	0.5	1.6	6.4	33.1	0.3	5.5	37.7	0.1	0.0	0.6	0.0	0.6	1.8	0.6	0.0	1.8	0.0	0.0	0.0	76.8	0.0	0.0	0.0	0.3	0.1	0.0	3.4	0.0	37.8	0.0	0.0	0.1	4.2	0.0	0.1	270.7	0.0	0.0	0.0	6.4	0.0	0.1	0.0	0.0	4.0	1962.9	1.1	0.0	169.1	46.2	0.0	46.8	0.0	3.1	0.0	0.0	0.0	0.1	0.0	1.3	0.1	0.0	0.0	1.5	0.0	13.1	0.1	2.6	0.1	0.3	0.2	34.1	0.0	6.8	0.0	0.0	0.0
FLI1	"EWSR2, SIC-1"	ENSG00000151702	"Fli-1 proto-oncogene, ETS transcription factor"	Q01543	11	128686535-128813267	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 65.7;Endothelial cells: 84.2;Hepatic stellate cells: 64.6;Kupffer cells: 86.4;Microglial cells: 231.4;monocytes: 68.4;NK-cells: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 113.9;HUVEC TERT2: 60.5;REH: 49.8;TIME: 63.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065030, HPA073099"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		Yes	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA065030: , HPA073099: AB_2686572"	"unprognostic (1.38e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.74e-2)"	"unprognostic (6.22e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.32e-3)"	"unprognostic (2.97e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (4.79e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.79e-2)"	10.2	1.9	3.7	10.9	2.3	12.2	6.0	2.1	2.8	5.7	1.2	3.7	3.2	4.6	1.1	2.8	2.7	6.1	6.2	1.8	2.9	2.1	2.8	10.8	12.3	4.7	2.7	1.2	1.7	3.5	0.7	12.5	4.3	1.9	2.9	0.5	2.2	2.2	2.8	1.7	4.0	5.9	3.5	35.8	4.3	0.9	3.9	17.2	2.9	6.6	10.4	6.7	1.9	2.8	0.2	0.0	5.6	0.0	0.8	1.0	0.1	3.3	9.2	3.8	3.1	0.0	0.0	18.5	31.7	11.1	1.1	0.1	0.8	13.5	4.1	9.0	0.2	113.9	0.5	0.0	6.0	13.7	14.6	0.8	1.1	7.7	17.3	11.1	60.5	25.6	0.0	23.3	0.8	0.0	13.3	8.1	1.8	0.0	3.1	49.8	0.1	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.0	20.4	63.0	0.7	0.0	0.2	3.5	7.3	16.4	16.6	0.1	31.8	5.2	34.5	15.5	24.5	10.1	15.3	11.9	6.8	8.9	8.2	19.1	6.0	3.7	8.2	11.8	12.3	19.1	3.3	11.1	20.1	3.7	2.3	2.1	2.8	1.8	2.9	4.7	2.7	4.3	3.5	3.9	2.8	53.4	6.4	5.3	0.3	65.7	5.1	0.3	1.7	2.2	0.0	0.7	1.3	5.5	5.7	0.1	1.8	0.0	0.4	43.1	0.0	0.0	0.0	0.5	0.4	0.6	84.2	0.0	23.4	0.3	0.0	0.4	5.9	2.0	0.3	22.8	0.0	64.6	1.3	43.2	0.0	1.5	0.1	0.0	86.4	24.7	0.5	1.8	60.3	7.2	231.4	68.4	0.1	93.7	4.0	0.7	0.0	0.0	0.7	56.9	0.3	0.0	0.4	0.8	0.4	6.6	2.1	3.1	0.2	0.1	0.6	4.1	0.3	52.8	0.9	0.2	0.4
FO393400.1		ENSG00000285382	"Novel protein"		20	32632183-32743567	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Group enriched"	"Detected in some"	4	"brain: 1.8;choroid plexus: 1.0;retina: 1.4"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"HEL: 4.6"									HPA054119			Approved	Vesicles		NA	NA					"Cluster 36: HEL - Hemostasis"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"HPA054119: AB_2682388"																		0.0	0.0	1.4	0.0	1.4	0.0	0.1	1.5	1.8	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	1.5	0.1	0.3	0.0	0.0	1.4	1.4	0.0	0.1	0.0		0.0	1.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0		1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.4	1.5	1.8	1.3	1.5	1.4	1.4	1.5	1.3	1.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXL2NB	"C3orf72, FLJ43329"	ENSG00000206262	"FOXL2 neighbor"	Q6ZUU3	3	138947217-138953990	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"ovary: 50.1;parathyroid gland: 32.7"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 2.0;Granulosa cells: 3.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.4;fHDF/TERT166: 9.2;HEL: 8.7;hTCEpi: 4.4;SiHa: 6.6"									"HPA061017, HPA071790"			Enhanced	"Nucleoli fibrillar center"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoli fibrillar center"		"HPA061017: AB_2684415, HPA071790: AB_2686447"	"unprognostic (3.32e-1)"	"unprognostic (1.13e-1)"		"unprognostic (3.86e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.40e-5)"		"unprognostic (3.30e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.16e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.41e-10)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.22e-2)"	0.1	1.8	1.2	0.3	1.0	0.8	0.2	2.0	1.6	16.4	0.6	0.2	0.2	17.9	2.0	0.4	14.9	0.2	0.1	1.1	1.0	0.1	0.1	0.1	0.7	0.9	0.9	50.1	0.9	32.7	8.4	0.4	1.2	0.2	0.2	0.6	0.2	1.1	0.3	0.8	0.2	4.2	0.3	0.4	0.2	0.8	1.2	0.1	0.2	0.1	0.5	0.0	3.4	1.2	1.8	1.1	0.5	4.4	0.2	0.1	2.0	0.1	0.0	0.2	0.0	0.2	0.4	0.2	0.9	9.2	0.1	0.5	0.2	0.0	0.2	0.1	0.2	8.7	3.0	0.2	0.0	0.2	0.3	0.1	4.4	0.1	0.1	0.4	0.0	0.2	3.4	0.3	2.5	0.3	0.1	0.3	0.3	0.1	0.1	0.1	0.0	0.1	0.4	1.2	0.2	0.1	6.6	0.2	0.1	0.7	0.2	2.6	0.2	0.3	0.2	0.2	0.1	0.4	0.2	0.2	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	1.2	1.0	2.0	1.6	1.1	1.0	0.9	0.9	1.2	0.3	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0
FP565260.1		ENSG00000275464	"Periodic tryptophan protein 2 homolog"		21	5130871-5154658	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 9.1;Ductal cells: 9.3;Exocrine glandular cells: 8.0;granulocytes: 5.1;Hofbauer cells: 6.3;Pancreatic endocrine cells: 8.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 102.4"									HPA024573	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 2: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoli	Cytosol	"HPA024573: AB_1855963"	"unprognostic (3.37e-3)"	"unprognostic (4.09e-2)"	"unprognostic (4.43e-1)"	"unprognostic (9.66e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.30e-3)"	"unprognostic (8.40e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.11e-1)"	9.2	9.2	6.4	9.9	8.8	12.1	7.4	7.2	8.0	5.9	4.9	8.5	9.1	6.8	1.7	8.3	7.8	7.3	7.5	7.1	6.8	9.0	6.8	7.1	13.4	7.6	7.2	6.7	7.7	6.5	6.0	7.9	9.1	6.5	8.4	3.5	6.7	4.7	10.1	8.6	8.2	7.3	6.8	11.5	7.6	7.1	7.2	6.7	6.6	3.2	5.3	11.4	7.1	13.7	32.0	24.0	15.4	24.2	6.6	5.0	9.1	0.2	0.0	0.1	0.1	0.4	20.1	0.3	14.1	10.5	20.8	21.0	42.9	19.0	0.0	7.4	15.1	102.4	12.4	11.9	10.4	47.6	29.1	17.8	22.5	25.5	20.1	5.0	20.1	16.5	56.8	11.6	6.6	28.4	34.4	33.1	60.4	36.5	29.3	54.0	14.2	28.8	13.5	25.3	16.6	27.3	25.5	38.4	14.9	4.2	31.5	24.9	10.2	12.0	29.7	0.3	32.9	13.9	16.0	63.5	20.4	62.3	16.7	3.3	7.3	6.9	18.5	12.6	21.2	11.0	11.3	13.5	8.7	11.2	11.1	15.2	4.1	9.9	18.2	5.5	8.5	11.6	6.4	8.8	7.2	8.0	7.1	6.8	7.6	7.2	9.1	6.8	7.2	13.7	0.9	0.0	9.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.5	1.9	0.0	0.0	2.5	0.0	0.0	2.7	1.1	0.8	0.0	9.3	0.0	0.8	1.1	0.9	0.0	0.0	0.0	8.0	1.4	0.9	0.0	0.9	5.1	0.6	0.0	0.0	6.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	3.1	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.3	1.2	0.4	0.9	0.0
FPR3	"FMLPY, FPRH1, FPRL2, RMLP-R-I"	ENSG00000187474	"Formyl peptide receptor 3"	P25089	19	51795157-51826190	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 28.2"	"Group enriched"	"Detected in some"	15	"Hofbauer cells: 56.5;Kupffer cells: 97.4;Langerhans cells: 223.6;Macrophages: 66.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	20	"classical monocyte: 2.3;intermediate monocyte: 6.7;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	44	"dendritic cells: 2.4;monocytes: 6.7"	"Group enriched"	"Detected in some"	5	"HEL: 10.0;hTERT-RPE1: 2.7"	"Not detected"	"Not detected"													NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (3.77e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (9.13e-4)"	"unprognostic (1.96e-1)"	"unprognostic (4.28e-2)"	10.6	12.1	0.6	23.9	1.1	0.4	5.3	0.5	2.4	5.5	2.2	12.6	11.2	3.7	1.5	5.7	2.0	18.8	3.8	0.6	0.7	3.2	21.3	28.2	13.9	3.1	1.0	1.7	2.3	2.2	0.9	5.6	2.8	2.5	18.2	0.3	2.4	2.9	0.9	2.7	14.4	8.9	1.2	16.3	7.1	2.7	6.0	8.1	2.2	2.0	11.0	17.4	1.2	3.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	6.7	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.6	1.1	0.5	2.4	0.6	0.7	3.1	1.0	2.8	1.2	6.0	3.9	0.5	0.0	1.7	0.3	2.7	5.6	0.0	0.0	0.0	0.1	0.1	0.5	0.2	0.0	2.5	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.4	0.8	0.0	0.0	0.0	0.0	1.1	1.5	56.5	0.0	0.2	0.0	0.0	97.4	223.6	0.2	0.3	66.6	7.2	1.0	3.7	0.0	0.0	0.0	0.7	0.0	0.0	1.2	0.4	0.1	0.0	0.0	1.5	0.1	0.0	0.3	0.5	0.0	0.1	0.4	4.5	0.8	0.6	0.0	0.0	0.1
FREM1	"C9orf143, C9orf145, C9orf154, DKFZp686M16108, FLJ25461, TILRR"	ENSG00000164946	"FRAS1 related extracellular matrix 1"	Q5H8C1	9	14737152-14910995	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Developmental protein"	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 36.4"	"Group enriched"	"Detected in many"	7	"Early spermatids: 73.7;Inhibitory neurons: 126.1;Late spermatids: 144.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"HEL: 163.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"	NA	NA		58000		"Cluster 68: Epididymis - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.13e-5)"	"unprognostic (2.59e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.27e-3)"	"unprognostic (2.50e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.62e-2)"	"unprognostic (6.23e-2)"	"unprognostic (8.95e-13)"	"unprognostic (2.28e-3)"	"unprognostic (8.53e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.86e-1)"	5.3	2.5	0.9	0.8	1.1	0.2	4.8	4.2	1.3	5.0	2.0	6.4	2.1	19.7	36.4	1.0	4.1	3.7	6.4	1.1	1.3	17.0	0.9	2.4	0.0	2.0	1.3	1.4	6.6	5.0	1.0	5.5	1.2	1.1	1.7	1.3	0.8	3.4	0.9	3.3	5.4	14.2	3.0	0.4	1.0	4.2	1.2	1.2	0.7	0.8	0.5	2.1	2.3	3.8	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	163.8	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.4	3.7	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	4.2	1.3	1.1	1.3	2.0	1.3	1.2	3.0	1.2	3.8	0.4	0.0	0.6	13.1	0.3	1.3	0.2	0.0	0.6	2.0	0.1	0.1	2.9	2.8	0.0	1.8	0.0	0.5	0.0	0.2	0.0	0.3	73.7	1.5	7.7	0.4	0.0	3.0	16.2	0.0	0.3	11.2	0.5	1.3	5.1	0.2	3.9	0.0	0.5	0.0	126.1	2.4	0.0	0.6	1.2	144.7	0.6	0.1	0.0	6.5	0.6	4.0	0.0	7.1	4.3	0.2	0.0	1.5	0.0	0.1	13.0	1.3	0.0	0.1	0.0	0.6	2.8	0.8	0.9	0.0	1.1	0.3	0.1	6.1	4.7	0.1
GAD1	GAD	ENSG00000128683	"Glutamate decarboxylase 1"	Q99259	2	170813213-170861151	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Decarboxylase, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"brain: 98.5;parathyroid gland: 46.3;retina: 29.7"	"Group enriched"	"Detected in many"	8	"Inhibitory neurons: 392.8;Oligodendrocyte precursor cells: 146.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 20.1;HEL: 64.5"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"olfactory bulb: 547.6"	"CAB004415, HPA048871, HPA058412, CAB078176"	Enhanced	Supported	Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Plasma membrane, Cytosol"		"CAB004415: AB_627650, CAB078176: AB_2665792, HPA048871: , HPA058412: AB_2683710"	"unprognostic (1.28e-1)"	"prognostic favorable (7.31e-4)"	"unprognostic (1.87e-2)"	"prognostic favorable (8.61e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.97e-7)"	"unprognostic (1.51e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.27e-4)"	"unprognostic (6.75e-2)"	"unprognostic (9.18e-3)"	"unprognostic (6.90e-5)"	"unprognostic (2.93e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.08e-3)"	0.2	3.0	22.1	0.0	29.9	3.3	0.1	15.5	33.0	1.0	0.0	0.0	0.0	1.6	4.3	0.4	0.2	0.1	0.0	17.1	98.5	4.8	0.1	0.2	0.1	12.4	41.6	0.2	0.2	46.3	5.0	0.4	17.6	0.8	0.1	29.7	0.1	0.3	0.0	0.2	0.1	0.0	12.7	0.1	0.0	3.2	31.1	0.8	0.1	0.0	0.2	0.6	0.4	14.2	18.2	0.7	0.0	7.3	0.0	0.0	0.1	0.4	0.0	2.6	1.7	4.6	6.7	0.0	0.9	0.5	2.9	20.1	2.3	0.6	1.6	2.8	13.4	64.5	6.0	0.2	0.0	0.3	1.1	0.0	5.5	0.0	2.3	0.6	0.1	0.5	17.0	0.3	0.8	1.5	0.0	0.0	8.1	9.7	6.7	1.0	4.6	0.4	8.5	9.4	6.7	2.1	12.6	0.0	3.5	0.6	0.2	0.0	0.0	12.0	1.7	2.4	7.0	0.0	0.0	0.1	11.5	3.2	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	29.9	15.5	33.0	17.1	98.5	12.4	41.6	17.6	12.7	31.1	14.2	0.0	0.0	0.0	14.7	0.0	0.3	2.1	7.7	2.2	32.5	0.1	0.1	1.3	0.0	3.6	0.0	10.4	0.0	0.0	0.2	7.9	4.5	5.6	4.4	0.4	0.4	3.0	5.5	2.6	5.6	0.1	0.2	0.0	2.9	0.0	5.5	0.0	0.0	4.0	5.0	392.8	0.3	2.0	0.8	0.4	6.2	0.6	0.5	0.0	7.5	0.0	4.9	0.0	146.8	7.6	2.9	0.0	0.0	0.1	0.9	0.0	0.0	4.7	6.0	0.0	0.0	1.2	4.4	7.7	0.6	0.1	0.5	0.0	0.1	0.1	0.4
GCOM1	"FLJ30973, GRINL1A, MYZAP-POLR2M"	ENSG00000137878	"GRINL1A complex locus 1"		15	57591908-57714745	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"heart muscle: 20.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Cardiomyocytes: 3.9;Gastric mucus-secreting cells: 4.1;Granulosa cells: 5.7;Paneth cells: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 1.4;naive CD4 T-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 49.0;RT4: 19.1;TIME: 20.4"									"HPA039827, HPA068141"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA039827: AB_10673364, HPA068141: AB_2685962"	"unprognostic (1.10e-1)"	"unprognostic (3.62e-4)"	"unprognostic (1.10e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.69e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.22e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.03e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.78e-2)"	5.2	9.1	0.4	2.0	0.7	3.0	2.4	3.9	0.3	1.8	0.0	3.8	5.9	3.1	0.1	14.8	0.8	2.1	20.1	0.2	1.7	1.5	0.6	7.0	2.0	3.3	0.7	2.3	9.1	0.4	0.0	10.3	3.5	2.9	3.6	0.9	3.7	2.4	6.4	5.7	7.2	2.5	0.0	3.4	7.0	2.1	1.2	0.5	0.7	1.1	4.7	9.9	0.6	0.2	6.3	1.3	0.1	5.8	0.3	0.0	1.4	0.8	5.1	1.6	1.7	4.0	5.6	0.0	0.7	0.0	5.0	3.4	0.0	4.2	1.6	0.0	0.2	49.0	1.4	0.2	0.0	0.1	0.1	0.2	2.2	0.4	11.7	0.2	6.3	0.1	2.4	0.1	0.3	1.1	0.0	0.0	0.1	12.0	0.6	0.0	10.7	0.0	0.0	19.1	0.0	1.9	1.2	2.7	0.0	0.7	5.3	0.2	20.4	0.4	3.1	0.4	0.3	0.2	0.0	0.0	3.1	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.5	0.2	0.0	0.2	1.4	1.4	0.0	0.1	0.0	0.7	0.0	0.1	2.1	0.4	0.7	3.9	0.3	0.2	1.7	3.3	0.7	3.5	0.0	1.2	0.2	2.7	3.2	0.5	0.3	0.4	0.0	0.3	0.0	1.8	0.0	0.5	0.3	3.9	0.0	0.6	0.0	0.0	0.1	0.0	1.7	0.0	1.8	0.2	0.4	1.0	1.8	0.0	0.0	0.2	1.1	0.1	0.2	4.1	1.4	0.0	5.7	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	1.1	0.4	0.0	0.3	1.8	0.0	0.7	0.0	0.0	0.5	0.0	1.6	4.8	1.5	0.0	0.4	1.4	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.1	0.6	0.1	0.1	0.0	1.1	0.5	0.9
GDPD1	"FLJ37451, GDE4"	ENSG00000153982	"Glycerophosphodiester phosphodiesterase domain containing 1"	Q8N9F7	17	59220467-59275970	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 34.3;Early spermatids: 47.2;Excitatory neurons: 65.1;Inhibitory neurons: 63.9;Oligodendrocyte precursor cells: 34.2;Oligodendrocytes: 36.5;Spermatocytes: 52.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 22.3;K-562: 12.5;SCLC-21H: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 36: HEL - Hemostasis"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (8.33e-2)"	"unprognostic (6.63e-3)"	"unprognostic (2.68e-2)"	"unprognostic (5.98e-3)"	"unprognostic (7.12e-2)"	"unprognostic (5.35e-2)"	"unprognostic (4.85e-6)"	"prognostic favorable (2.98e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.25e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.28e-3)"	0.8	1.8	4.7	0.9	4.3	1.5	1.8	7.0	8.4	1.1	1.9	1.8	5.7	1.5	0.7	0.8	1.4	1.8	1.1	5.1	4.7	2.0	1.0	2.3	0.9	5.9	5.4	0.9	1.1	5.9	1.8	1.3	6.3	2.0	1.5	5.8	2.3	1.5	1.7	1.4	4.2	1.3	2.8	1.5	5.2	8.6	5.1	1.6	2.6	0.7	1.1	1.3	0.8	5.4	0.8	1.0	4.2	3.2	0.6	0.2	2.6	0.5	1.6	0.4	3.3	0.0	1.3	2.0	4.7	0.1	3.0	0.6	6.6	1.1	1.9	2.6	6.8	22.3	0.7	3.2	2.0	1.0	3.2	0.6	5.4	2.1	0.6	1.9	1.9	4.9	12.5	1.3	0.8	1.0	3.9	0.4	0.8	6.6	1.1	2.4	0.4	2.1	2.0	1.2	12.5	3.4	1.0	0.4	4.6	1.3	3.0	1.4	1.6	0.2	1.3	0.2	0.4	3.7	2.3	0.7	1.0	1.2	1.4	2.4	0.5	0.3	0.5	0.7	0.4	0.3	0.4	0.6	0.2	0.5	0.5	0.7	0.9	0.8	0.7	0.7	0.3	0.3	4.7	4.3	7.0	8.4	5.1	4.7	5.9	5.4	6.3	2.8	5.1	5.4	1.6	3.2	8.2	34.3	1.3	0.5	1.5	1.2	1.8	6.1	1.6	1.0	3.1	0.0	8.7	5.5	10.4	0.4	3.2	0.9	0.0	2.2	47.2	1.8	0.4	1.4	1.2	11.3	65.1	1.8	5.5	1.1	9.2	0.7	0.0	4.0	0.7	0.6	1.9	6.7	63.9	3.1	6.1	2.6	1.0	8.3	0.6	3.0	1.8	2.8	2.7	2.3	3.1	34.2	36.5	1.6	2.0	1.5	0.9	1.2	7.6	0.5	5.6	4.4	0.0	1.6	5.7	52.4	17.7	0.5	0.4	2.3	2.5	2.2	1.2	1.6
GOLGA8R		ENSG00000186399	"Golgin A8 family member R"	I6L899	15	30403740-30414162	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 69.3;NK-cells: 23.7;Sertoli cells: 13.1;Spermatocytes: 20.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HEL: 23.9;THP-1: 7.6;U-937: 8.0"															NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 36: HEL - Hemostasis"	"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (1.13e-1)"	"unprognostic (8.96e-3)"	"unprognostic (1.27e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.09e-2)"	"unprognostic (9.79e-4)"	"unprognostic (2.29e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.80e-2)"	"unprognostic (9.68e-2)"	2.9	1.8	0.4	1.1	0.9	3.8	2.6	0.3	0.9	3.0	1.1	2.7	0.7	3.1	1.5	1.7	3.1	1.0	3.3	0.2	0.7	1.6	2.4	2.2	0.6	1.0	0.6	5.5	3.8	1.3	5.2	0.4	0.9	2.0	0.4	1.2	2.7	0.6	2.2	2.1	2.4	0.9	0.4	1.7	2.2	6.1	1.2	0.3	8.8	0.8	0.5	2.9	2.9	1.4	0.1	0.0	0.1	0.0	0.0	1.6	0.0	0.6	0.3	0.0	0.2	0.0	0.1	0.3	0.2	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	23.9	0.0	0.0	0.3	0.0	0.0	0.4	0.4	0.1	0.0	1.4	0.1	0.2	0.1	0.1	0.1	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.1	0.1	7.6	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	8.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.9	0.3	0.9	0.2	0.7	1.0	0.6	0.9	0.4	1.2	1.4	0.6	0.0	1.5	0.3	1.2	0.0	0.2	0.0	0.0	3.2	0.2	0.3	0.8	1.5	1.3	0.0	0.0	0.2	4.1	0.1	0.0	0.1	69.3	4.0	1.2	0.8	0.0	0.4	0.2	0.0	0.0	1.1	0.0	0.8	1.3	1.8	0.4	0.4	0.3	8.4	0.2	0.1	0.0	0.8	0.0	4.9	1.2	0.9	0.0	1.0	1.6	1.1	23.7	0.5	1.4	0.1	0.1	0.4	1.2	0.2	0.5	0.1	0.7	3.6	13.1	1.7	1.0	20.4	1.9	0.0	0.0	0.0	2.8	1.5	0.3	0.3
GP1BA	"CD42b, GP1B, GPIbalpha"	ENSG00000185245	"Glycoprotein Ib platelet subunit alpha"	P07359	17	4932277-4935023	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"		"Bernard Soulier syndrome, Disease variant, von Willebrand disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.9;lymphoid tissue: 14.7"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 3.9;Macrophages: 14.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 2.8"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.1"	"Immune cell enriched"	"Detected in single"	13	"basophil: 7.0"	"Lineage enriched"	"Detected in single"	43	"granulocytes: 7.0"	"Cell line enriched"	"Detected in some"	24	"HEL: 71.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002496, HPA013316"	Supported					NA	NA		1600000000	"Cluster 34: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"			"CAB002496: AB_563748, HPA013316: AB_1855459"	"unprognostic (4.87e-4)"	"unprognostic (8.21e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.59e-3)"	"unprognostic (7.30e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.54e-4)"	"unprognostic (1.27e-1)"	"unprognostic (4.85e-3)"	"unprognostic (4.58e-3)"	"unprognostic (2.56e-1)"	"unprognostic (3.53e-4)"	"unprognostic (8.35e-2)"	0.5	0.1	0.1	3.8	0.4	4.9	0.4	2.1	0.2	0.4	0.1	0.7	1.2	0.3	0.0	0.5	0.4	0.3	0.5	0.1	0.0	0.5	0.8	1.5	14.7	0.1	0.0	0.4	0.3	0.0	0.2	0.3	0.1	0.4	0.5	2.3	0.9	0.0	2.7	2.4	1.8	0.0	0.0	3.6	0.8	0.4	0.1	0.6	0.4	0.0	7.7	0.4	0.5	0.0	0.1	2.3	0.5	0.3	0.0	0.0	1.1	0.3	0.0	0.0	0.0	2.2	0.3	2.3	0.7	0.0	0.0	2.3	0.0	0.0	0.0	0.8	1.8	71.6	1.2	0.0	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.7	0.0	1.3	0.7	0.7	0.0	0.8	0.6	0.3	0.3	0.2	0.4	1.2	0.5	0.3	0.0	1.4	0.1	0.3	0.9	0.0	0.3	0.6	2.9	1.3	0.3	0.4	0.4	1.5	0.2	1.2	0.5	1.7	1.0	1.1	0.7	7.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	2.2	0.1	0.4	2.1	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.3	1.5	0.6	0.4	0.0	1.8	0.2	0.5	1.1	0.0	0.2	0.0	2.1	0.3	0.4	0.1	3.9	0.2	0.3	0.8	1.8	0.5	0.0	1.7	0.2	0.0	0.2	0.7	0.0	2.4	0.0	0.1	2.5	0.9	0.1	0.0	0.2	0.0	0.0	0.9	3.3	0.6	0.3	14.2	0.0	0.0	2.6	0.3	1.0	0.0	0.1	0.0	0.0	1.9	0.3	0.4	0.3	0.9	0.0	2.7	0.0	1.4	0.5	1.0	0.6	0.0	1.8	0.3	1.0	0.1	0.1	0.3
GP5	CD42d	ENSG00000178732	"Glycoprotein V platelet"	P40197	3	194394821-194398354	"CD markers, Plasma proteins, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.1"	"Cell type enhanced"	"Detected in single"		"Paneth cells: 1.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"HEL: 16.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA072646			Approved	Cytosol		NA	NA		270000000	"Cluster 32: T-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 58: T-cells - T-cell receptor"	Cytosol		"HPA072646: "	"unprognostic (3.74e-2)"	"unprognostic (3.40e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.94e-1)"	0.1	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.3	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
GP6	GPVI	ENSG00000088053	"Glycoprotein VI platelet"	Q9HCN6	19	55013705-55038264	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 2.7"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 6.2;Early spermatids: 14.3;Excitatory neurons: 9.9;Inhibitory neurons: 10.2;Late spermatids: 8.7;Macrophages: 10.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"HEL: 9.4;K-562: 4.1;U-2 OS: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047611, HPA066482"	Approved		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		44000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"		"HPA047611: , HPA066482: AB_2685674"	"unprognostic (3.06e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.74e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.50e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.44e-3)"	"unprognostic (2.70e-2)"	0.1	0.0	0.1	0.0	0.1	0.9	0.2	0.7	0.5	0.5	0.0	0.2	0.0	0.2	0.0	1.4	0.4	0.0	0.7	0.1	0.0	0.5	0.2	0.9	0.0	0.0	0.0	0.3	0.2	0.1	0.3	0.1	0.1	0.4	0.0	0.2	0.4	0.1	0.1	1.2	0.1	0.0	0.0	0.9	0.2	2.7	0.0	0.0	0.4	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.3	9.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	4.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	2.5	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.2	0.1	0.1	0.7	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	3.6	0.0	0.0	0.3	0.3	0.0	2.0	0.3	0.4	0.7	1.5	0.3	0.0	6.2	0.1	0.4	0.7	0.0	0.1	14.3	1.4	0.4	1.2	0.0	0.0	9.9	0.4	0.3	0.6	0.0	2.2	1.3	0.8	3.3	0.2	0.1	3.3	10.2	0.0	0.0	0.8	0.2	8.7	0.3	10.3	0.0	1.0	0.3	0.4	2.1	1.5	1.5	0.2	0.1	0.0	0.0	0.4	0.1	0.0	1.9	2.6	0.0	0.4	0.2	1.4	1.2	0.0	0.1	0.5	0.4	0.0	0.3	0.7
GP9	"CD42a, GPIX"	ENSG00000169704	"Glycoprotein IX platelet"	P14770	3	129060779-129062406	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"		"Bernard Soulier syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.1;lung: 3.2;lymphoid tissue: 8.9"	"Cell type enriched"	"Detected in some"	8	"Macrophages: 151.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basophil: 29.5;neutrophil: 13.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 29.5"	"Cell line enriched"	"Detected in some"	14	"HEL: 85.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA063182	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		2600000	"Cluster 34: Basophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA063182: AB_2684956"			"unprognostic (1.70e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.10e-1)"			"unprognostic (3.80e-2)"		"unprognostic (2.50e-2)"		"unprognostic (3.24e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.47e-2)"		"unprognostic (8.70e-2)"		0.1	0.0	0.0	0.0	0.0	5.1	0.1	0.0	0.3	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.9	0.1	1.8	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	1.2	0.2	0.2	0.7	0.3	0.0	0.0	0.3	0.6	0.1	0.1	0.0	13.9	0.0	0.2	3.0	0.0	51.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.1	0.0	0.0	14.4	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	2.9	0.1	1.7	0.0	0.0	0.6	0.0	1.3	0.0	18.3	0.0	151.9	0.0	0.0	4.1	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.7	0.3	0.0
GPR158	KIAA1136	ENSG00000151025	"G protein-coupled receptor 158"	Q5T848	10	25174802-25602229	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 24.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 367.4;Horizontal cells: 144.7;Inhibitory neurons: 301.9;Oligodendrocyte precursor cells: 419.7;Oligodendrocytes: 101.6"	"Cancer enhanced"	"Detected in many"		"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 21.3;T-47d: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013185	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA013185: AB_2113957"	"unprognostic (4.43e-2)"	"unprognostic (3.14e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.66e-5)"	"unprognostic (5.67e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-2)"	"unprognostic (8.09e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.60e-6)"	"unprognostic (8.36e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.21e-3)"	"unprognostic (3.90e-1)"	0.0	0.7	2.6	0.1	12.7	0.0	0.0	24.9	8.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	2.4	0.0	0.0	0.0	0.0	8.5	4.7	0.0	0.0	0.2	1.4	0.3	8.8	0.1	0.1	4.5	0.0	0.2	0.0	0.0	0.2	0.0	2.3	0.0	0.1	0.5	7.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	2.6	0.0	21.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.5	0.0	0.3	0.2	0.0	0.0	1.2	0.0	0.5	1.1	1.9	0.0	5.6	0.0	0.0	0.0	0.5	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	12.7	24.9	8.6	3.5	2.4	8.5	4.7	8.8	2.3	7.0	4.3	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	19.9	0.0	0.1	0.1	0.0	0.0	367.4	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	144.7	301.9	0.0	0.0	0.0	0.0	12.0	0.0	0.1	0.0	10.3	0.0	26.2	0.0	419.7	101.6	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	3.8	0.0	0.1	0.1	1.8	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
GPR85	SREB2	ENSG00000164604	"G protein-coupled receptor 85"	P60893	7	113078331-113087778	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 39.1;choroid plexus: 19.8;retina: 12.1;skeletal muscle: 31.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 36.7;Early spermatids: 183.6;Horizontal cells: 84.1;Microglial cells: 40.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"HEL: 107.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 36: HEL - Hemostasis"	"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (3.80e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.98e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.41e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.34e-5)"	"unprognostic (5.89e-3)"	"unprognostic (9.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-2)"	1.7	0.7	28.4	0.9	28.7	1.6	0.6	28.0	39.1	0.4	19.8	0.5	0.7	0.7	0.6	0.4	1.4	3.8	2.5	30.5	25.3	0.7	4.2	2.0	1.3	26.6	25.4	0.2	1.3	1.1	2.1	4.7	26.5	0.8	0.3	12.1	2.5	0.5	31.9	0.5	0.7	0.8	25.7	3.6	0.6	3.1	27.6	0.3	0.6	0.2	0.6	1.9	0.3	27.3	0.2	0.2	0.6	0.6	2.1	3.1	0.6	2.8	4.2	5.7	7.4	0.1	0.9	0.3	0.7	2.5	1.8	0.5	0.6	2.5	12.1	0.4	0.3	107.7	1.2	0.3	1.0	19.7	0.7	4.1	0.6	9.9	0.2	0.2	0.3	0.8	0.5	0.9	6.8	0.3	2.0	13.1	1.2	0.1	0.5	0.5	1.3	0.5	0.1	1.3	2.8	2.3	0.2	1.4	1.0	0.6	0.6	4.6	0.3	6.3	0.9	1.7	2.5	2.2	0.3	1.2	7.6	7.5	2.6	0.6	0.2	0.2	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.4	0.1	0.1	0.1	28.4	28.7	28.0	39.1	30.5	25.3	26.6	25.4	26.5	25.7	27.6	27.3	2.0	0.0	1.5	1.3	0.3	8.8	13.9	0.4	1.8	36.7	3.6	2.5	3.9	0.0	0.7	0.0	0.0	0.2	0.2	0.0	0.0	0.1	183.6	0.9	1.7	14.1	0.0	0.0	9.1	0.2	0.9	3.4	0.0	0.8	1.3	0.6	0.4	0.2	13.2	84.1	6.5	0.2	0.0	7.2	11.3	21.0	1.2	2.8	10.6	40.3	0.3	1.6	1.0	6.6	1.0	0.1	0.0	0.4	0.0	14.8	0.0	0.3	0.6	4.3	0.0	14.4	4.4	5.3	0.5	0.1	10.5	0.4	1.8	0.7	0.0	10.3
GRID1	"GluD1, KIAA1220"	ENSG00000182771	"Glutamate ionotropic receptor delta type subunit 1"	Q9ULK0	10	85599552-86366795	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.4"	"Group enriched"	"Detected in some"	19	"Astrocytes: 149.8;Excitatory neurons: 284.5;Inhibitory neurons: 301.2;Oligodendrocyte precursor cells: 316.2;Oligodendrocytes: 534.1"	"Group enriched"	"Detected in many"	5	"glioma: 3.6;thyroid cancer: 6.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.4;HEL: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 36: HEL - Hemostasis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"				"unprognostic (7.60e-2)"	"unprognostic (2.75e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.31e-2)"	"unprognostic (4.24e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.30e-2)"	"unprognostic (8.26e-2)"	"unprognostic (4.58e-9)"	"unprognostic (3.15e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.65e-3)"	0.6	0.9	5.3	0.1	5.7	0.0	0.8	3.9	6.9	1.5	0.1	0.3	0.3	1.0	0.7	0.2	1.2	0.2	0.2	5.5	5.4	0.1	0.1	0.4	0.3	5.4	5.4	0.3	0.2	0.2	0.2	0.7	4.8	0.4	0.1	0.7	0.1	0.9	0.2	0.4	0.3	0.4	5.6	0.0	0.4	0.9	5.7	0.1	2.0	0.0	0.2	0.1	0.6	7.4	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	2.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.6	2.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	5.7	3.9	6.9	5.5	5.4	5.4	5.4	4.8	5.6	5.7	7.4	1.1	3.2	0.5	149.8	0.0	0.5	0.1	0.1	2.2	10.5	0.0	0.1	1.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.3	1.0	0.0	0.3	0.3	0.0	0.0	284.5	0.2	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	301.2	0.0	0.0	0.0	0.4	3.0	2.1	0.2	5.4	15.9	0.0	0.8	0.0	316.2	534.1	0.0	0.0	4.5	0.0	0.2	0.0	0.0	0.0	0.5	13.1	0.2	5.7	0.1	0.9	0.2	0.0	0.1	0.1	0.0	0.0	0.0
GRIK4	"GluK4, GRIK, KA1"	ENSG00000149403	"Glutamate ionotropic receptor kainate type subunit 4"	Q16099	11	120511746-120988906	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 10.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 82.9;Cone photoreceptor cells: 35.5;Excitatory neurons: 115.6;Inhibitory neurons: 43.7;Oligodendrocyte precursor cells: 196.1;Oligodendrocytes: 108.3"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 6.1;HEL: 18.9;T-47d: 4.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074453	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA074453: AB_2732255"	"unprognostic (9.63e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.64e-4)"	"unprognostic (1.48e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.84e-11)"	"unprognostic (1.35e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.58e-2)"	0.0	1.7	6.8	0.0	6.5	0.0	0.4	5.6	6.4	0.1	0.9	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.3	10.3	6.0	0.2	0.0	1.5	0.1	7.2	6.2	2.8	0.0	0.0	1.6	0.2	7.3	0.3	0.1	1.0	0.1	0.0	0.0	0.2	0.1	0.1	4.9	0.4	0.0	0.8	9.6	0.1	2.0	0.1	0.1	0.1	0.2	5.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	6.1	0.6	18.9	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.6	4.7	0.0	0.2	0.0	0.2	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	6.5	5.6	6.4	10.3	6.0	7.2	6.2	7.3	4.9	9.6	5.5	0.0	0.0	0.6	82.9	0.1	0.0	0.1	0.0	1.2	0.8	0.5	0.5	1.6	0.0	0.0	0.0	35.5	0.0	0.7	0.0	0.0	0.0	4.4	0.3	0.0	0.2	0.0	0.0	115.6	0.0	0.0	0.7	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	43.7	0.0	0.0	0.8	0.0	7.5	0.3	1.0	0.0	4.7	0.2	0.0	8.2	196.1	108.3	0.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	7.8	0.2	0.8	3.3	0.1	0.0	0.1	0.4	0.1	0.0	0.5
GTDC1	"FLJ11753, Hmat-Xa"	ENSG00000121964	"Glycosyltransferase like domain containing 1"	Q4AE62	2	143938068-144332568	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 330.7;Inhibitory neurons: 188.0;Microglial cells: 130.2;Oligodendrocyte precursor cells: 196.6;Oligodendrocytes: 399.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036694			Approved	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA036694: AB_10671709"	"unprognostic (1.44e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.00e-3)"	"unprognostic (3.36e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-7)"	"unprognostic (8.01e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.22e-3)"	"unprognostic (6.96e-2)"	"prognostic unfavorable (6.60e-4)"	"unprognostic (2.44e-1)"	"unprognostic (8.23e-2)"	"unprognostic (6.31e-3)"	"unprognostic (1.89e-1)"	15.2	12.6	15.9	7.5	18.0	14.2	9.4	11.7	21.1	11.8	4.2	7.1	4.2	6.7	9.4	7.4	5.8	10.1	15.7	17.3	14.3	9.6	6.7	7.8	11.0	15.4	14.7	12.0	7.2	7.4	4.2	9.5	15.4	6.1	6.7	7.7	6.1	5.8	10.0	5.1	4.8	5.9	17.2	13.5	5.2	12.2	14.3	8.7	10.5	11.3	11.6	9.5	5.5	24.1	6.9	2.8	20.0	3.7	20.1	18.4	6.0	4.7	11.9	10.3	14.2	3.1	6.3	14.8	3.3	8.5	6.6	1.9	4.0	7.1	21.9	19.2	4.7	23.0	2.6	3.3	8.3	9.4	12.0	12.8	17.1	11.1	16.2	7.0	14.9	6.1	4.2	16.8	23.7	3.2	2.5	10.3	5.7	5.3	4.5	7.0	10.4	4.0	11.4	14.0	10.2	7.9	9.1	7.7	9.3	12.4	5.1	10.5	9.2	11.4	8.3	5.1	6.0	10.6	0.0	8.5	6.6	6.2	15.6	2.3	2.6	7.9	5.5	2.4	11.8	4.3	3.6	9.3	2.1	3.5	0.8	5.9	11.3	8.5	2.7	0.7	5.1	3.6	15.9	18.0	11.7	21.1	17.3	14.3	15.4	14.7	15.4	17.2	14.3	24.1	7.7	9.6	23.2	82.3	11.2	7.1	4.4	6.4	4.0	20.4	5.2	5.0	18.5	4.3	14.9	5.5	4.2	4.1	13.6	6.1	5.9	4.5	9.9	3.3	11.4	9.6	4.2	9.4	330.7	10.5	5.2	16.0	4.6	5.6	17.7	15.5	20.3	3.8	10.2	18.5	188.0	3.2	4.1	18.3	11.8	7.7	12.8	16.4	5.4	130.2	11.6	10.8	18.6	196.6	399.6	9.4	4.0	13.9	8.6	4.2	2.6	7.7	13.4	3.9	13.1	25.2	17.0	5.4	23.5	4.9	4.7	4.2	19.7	14.8	3.7	8.7
GTPBP8	HSPC135	ENSG00000163607	"GTP binding protein 8 (putative)"	Q8N3Z3	3	112990984-113015060	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 79.8;Spermatocytes: 79.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034831, HPA058631"	Approved		Enhanced	Mitochondria		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA034831: AB_10671506, HPA058631: AB_2683783"	"unprognostic (1.98e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.21e-2)"	"prognostic favorable (3.07e-5)"	"unprognostic (7.10e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.57e-1)"	"unprognostic (2.69e-1)"	5.3	5.7	3.6	6.1	4.3	8.4	5.6	4.6	4.9	4.6	4.6	6.0	6.6	5.6	3.7	7.4	4.4	5.2	11.9	3.9	3.9	7.3	5.9	4.3	11.2	4.3	3.8	6.7	6.8	8.9	4.5	6.1	4.2	5.7	7.1	4.2	6.5	3.7	20.0	4.8	6.0	5.5	4.4	4.9	7.5	14.4	3.9	9.7	10.1	18.3	8.1	5.9	4.7	6.4	25.5	10.8	15.7	16.5	9.2	15.6	11.5	17.9	14.7	17.0	20.5	18.6	10.4	16.8	9.7	10.0	14.2	17.1	21.0	17.1	23.5	7.0	13.4	46.5	11.4	11.6	8.4	28.9	10.5	11.9	11.9	9.6	7.0	19.2	16.1	19.9	16.4	19.5	18.0	8.8	18.5	14.4	32.8	13.2	20.8	16.1	14.7	10.4	14.4	16.3	17.5	18.2	14.2	11.3	25.7	13.7	12.3	19.6	9.8	12.7	19.4	4.5	16.0	13.1	17.4	24.0	12.7	23.6	14.0	7.9	4.3	2.9	6.4	3.0	5.7	4.2	7.8	6.3	8.1	3.6	9.9	6.5	0.7	8.7	2.7	3.7	5.4	4.5	3.6	4.3	4.6	4.9	3.9	3.9	4.3	3.8	4.2	4.4	3.9	6.4	13.1	16.0	15.4	2.9	16.9	13.5	15.9	28.8	8.0	11.5	12.9	12.4	25.8	10.0	19.5	5.5	6.2	28.3	27.1	10.4	23.5	16.3	79.8	17.7	12.9	11.6	10.2	22.7	5.5	18.3	25.1	13.3	12.8	18.3	19.7	20.0	17.9	7.7	22.7	10.1	6.3	10.3	28.5	16.7	14.8	35.5	11.8	13.6	10.6	4.7	18.3	10.4	13.4	7.1	6.9	16.5	12.2	5.7	17.1	12.8	17.7	29.6	16.0	14.0	0.0	17.4	15.8	79.7	28.1	16.1	12.1	15.2	22.5	34.9	12.0	18.9
GYPA	"CD235a, GPA, MN, MNS"	ENSG00000170180	"Glycophorin A (MNS blood group)"	P02724	4	144109303-144140751	"Blood group antigen proteins, CD markers, Predicted membrane proteins"	"Host-virus interaction"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"bone marrow: 156.3"	"Cell type enriched"	"Detected in some"	350	"Erythroid cells: 1995.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebral cortex: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	203	"HEL: 149.1;K-562: 37.7"									"CAB002658, HPA014811"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		15000000		"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB002658: , HPA014811: AB_1849827"					"unprognostic (1.60e-1)"								"unprognostic (2.47e-2)"					0.1	0.1	0.1	0.0	0.1	156.3	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	2.3	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	149.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.7	0.0	0.0	0.0	0.0	1995.6	2.4	0.0	2.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	1.7	0.0	0.0	0.9	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.0	0.0
GYPB	"CD235b, GPB, MNS, SS"	ENSG00000250361	"Glycophorin B (MNS blood group)"	P06028	4	143996104-144019380	"Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"bone marrow: 63.2"	"Cell type enriched"	"Detected in some"	450	"Erythroid cells: 1351.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HEL: 159.0"														"Intracellular and membrane"	NA	NA				"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"																					0.2	0.0	0.0	0.0	0.3	63.2	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.4	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	159.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	0.0	0.0	0.2	0.1	0.1	0.0	1351.4	3.0	0.0	1.2	0.2	0.0	0.0	0.0	2.1	0.0	0.9	1.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.0
GYPE	"GPE, MNS"	ENSG00000197465	"Glycophorin E (MNS blood group)"	P15421	4	143870864-143905563	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	4	"bone marrow: 13.3"	"Cell type enriched"	"Detected in some"	11	"Erythroid cells: 188.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.4"	"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	12	"HEL: 120.9;K-562: 39.8"															NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"				"unprognostic (2.17e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.09e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.10e-4)"	"unprognostic (7.81e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.49e-2)"	1.4	0.3	0.1	1.4	0.8	13.3	0.7	0.0	1.4	0.7	0.0	0.2	0.0	0.3	0.7	0.3	0.2	0.7	1.4	0.6	0.0	0.4	0.1	2.9	1.1	0.0	0.0	0.0	0.1	0.2	0.2	0.8	0.0	0.3	0.4	0.2	0.3	0.6	0.1	0.4	0.9	0.4	0.0	3.2	0.3	0.5	0.0	1.1	0.7	0.0	2.5	0.7	0.2	0.1	0.0	0.0	0.0	0.0	6.8	6.6	0.0	2.8	6.4	1.4	1.8	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.2	0.0	1.6	0.0	0.0	120.9	0.0	0.0	1.3	0.0	0.0	0.8	0.0	0.0	0.0	1.5	0.0	0.0	39.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.9	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	16.0	1.5	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.1	0.0	188.4	5.3	0.0	0.2	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.8	0.5	0.3	0.0	0.3	3.6	1.0	0.0	0.0	1.0	6.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.3	0.0	0.0	0.1	0.3	0.7	0.0	0.0
HAUS6	"dgt6, FAM29A, FLJ20060, KIAA1574"	ENSG00000147874	"HAUS augmin like complex subunit 6"	Q7Z4H7	9	19053141-19102904	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 124.9;Spermatocytes: 68.9;Spermatogonia: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 215.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020960, HPA020965"	Approved		Approved	"Nuclear speckles,Centriolar satellite,Cytosol"		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 29: Early spermatids - Spermatogenesis"	"Centriolar satellite, Cytosol"	"Nuclear speckles"	"HPA020960: AB_1848393, HPA020965: AB_1848394"	"unprognostic (1.58e-1)"	"unprognostic (9.85e-2)"	"unprognostic (6.04e-3)"	"unprognostic (6.51e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (3.13e-5)"	"unprognostic (2.52e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.03e-1)"	5.3	6.5	5.2	7.9	7.3	17.0	9.2	8.9	7.4	5.4	4.2	5.8	4.0	7.1	6.2	5.2	4.7	5.1	5.2	5.1	6.2	4.1	6.9	4.7	11.4	6.4	6.2	8.2	3.9	6.1	3.0	6.9	6.6	5.6	6.2	9.1	4.5	5.6	4.4	8.1	5.2	7.2	6.1	6.9	4.3	24.0	6.1	15.1	5.3	7.2	10.7	6.2	4.2	9.3	34.7	23.7	46.4	36.3	17.4	20.9	25.1	36.5	25.5	32.7	49.9	12.2	15.4	40.5	13.1	21.1	25.0	14.2	43.3	21.3	50.4	36.8	20.9	215.8	42.1	27.8	11.6	29.0	46.7	13.0	21.5	30.9	66.9	16.9	24.0	40.4	29.8	25.7	37.8	11.3	56.6	49.1	49.9	19.4	23.2	43.3	31.8	16.4	18.0	19.8	27.1	37.3	16.4	15.0	23.6	29.5	11.6	36.1	24.1	29.3	17.7	25.5	42.2	10.2	24.0	39.7	27.3	24.0	13.0	9.8	1.5	1.6	2.8	1.5	3.9	2.3	2.8	3.6	1.5	2.3	3.3	2.9	2.3	5.0	1.4	1.8	3.7	1.7	5.2	7.3	8.9	7.4	5.1	6.2	6.4	6.2	6.6	6.1	6.1	9.3	15.9	19.2	12.5	7.8	14.3	9.7	12.6	8.7	9.1	11.8	9.4	9.3	8.4	5.7	7.2	9.2	10.4	10.5	21.9	5.6	0.0	9.8	124.9	11.8	14.4	11.6	2.4	34.1	10.3	6.1	15.3	9.5	5.6	15.3	11.4	23.8	3.9	6.8	8.2	11.8	10.2	4.6	2.0	5.8	7.7	28.2	11.8	14.5	8.8	10.3	8.2	13.5	12.3	7.1	16.8	9.0	3.4	8.2	17.3	14.6	4.5	3.2	3.6	9.7	6.6	16.2	10.1	68.9	56.0	9.1	8.1	4.9	18.2	11.0	9.4	9.4
HBA2	HBA-T2	ENSG00000188536	"Hemoglobin subunit alpha 2"	P69905	16	172876-173710	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"		"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 38218.6"	"Cell type enriched"	"Detected in many"	22	"Erythroid cells: 198314.0"	"Cancer enhanced"	"Detected in all"		"glioma: 59.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 315.1;neutrophil: 955.3;plasmacytoid DC: 486.7"	"Group enriched"	"Detected in all"	7	"dendritic cells: 486.7;granulocytes: 955.3"	"Group enriched"	"Detected in some"	18	"HEL: 1196.2;K-562: 328.3"									"CAB038417, HPA043780"	Enhanced					NA	NA		14000000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB038417: , HPA043780: AB_2678667"	"unprognostic (1.57e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.73e-2)"	"unprognostic (8.92e-2)"	1592.0	322.5	162.6	186.3	292.4	38218.6	545.3	268.0	377.0	573.3	570.7	254.0	21.6	85.9	5.9	432.5	570.5	147.6	2590.3	86.6	156.5	2302.8	1853.6	4204.3	9.7	210.6	249.2	288.5	141.3	11.4	807.8	3618.9	260.6	302.7	26.7	4.0	305.4	131.9	568.3	188.5	154.3	12.9	316.4	8125.4	264.0	185.0	185.4	34.6	1192.5	1744.6	10.1	325.2	632.8	179.9	0.0	0.2	0.0	0.0	0.0	0.7	0.4	0.4	0.1	0.0	0.0	3.2	0.0	1.9	4.9	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.6	1196.2	0.5	0.0	0.0	0.2	1.7	0.4	0.1	0.4	0.0	0.0	0.0	0.1	328.3	0.0	0.1	0.6	0.0	0.3	0.1	0.5	0.0	0.0	0.0	43.4	0.0	0.9	11.9	9.7	1.1	0.0	0.0	0.1	1.4	0.2	5.6	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.3	0.6	0.2	119.6	28.1	315.1	99.6	1.7	3.7	39.2	8.5	7.1	42.5	19.1	22.8	73.9	955.3	49.5	3.3	486.7	1.0	15003.3	162.6	292.4	268.0	377.0	86.6	156.5	210.6	249.2	260.6	316.4	185.4	179.9	184.7	3.2	1.5	0.0	97.6	44.4	0.4	0.1	0.6	1.7	20.2	22.2	6.8	70.1	0.7	0.0	0.0	0.0	162.2	6.9	54.8	0.0	3.4	0.6	0.8	50.9	3.0	198314.0	0.0	0.0	0.0	241.0	4.1	0.9	1.3	0.3	142.8	131.2	0.0	0.0	0.0	7.5	4.1	770.6	149.6	16.9	0.0	402.9	8790.3	0.0	37.5	2.3	954.7	0.0	0.0	0.0	3.6	0.0	0.3	0.2	0.1	29.6	2.5	58.6	0.0	25.2	171.5	1.0	9.9	1.1	44.6	0.0	306.3	0.1	5.0	0.1
HBS1L	"DKFZp434g247, EF-1a, eRF3c, ERFS, HBS1, HSPC276, KIAA1038"	ENSG00000112339	"HBS1 like translational GTPase"	Q9Y450	6	134960378-135103056	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis, Translation regulation"	"Elongation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 198.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029728, HPA029729"	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA		9200	"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 36: HEL - Hemostasis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies, Cytosol"		"HPA029728: AB_10611112, HPA029729: AB_10601228"	"unprognostic (3.68e-3)"	"unprognostic (6.39e-2)"	"prognostic favorable (6.77e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.73e-2)"	"unprognostic (3.84e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.20e-2)"	35.3	32.5	29.7	31.2	51.8	82.5	39.7	37.9	48.1	31.8	23.6	29.9	23.0	31.8	23.0	43.9	29.9	26.6	50.9	28.3	44.6	36.9	63.1	24.5	40.3	41.2	34.7	32.6	39.5	47.1	17.1	35.4	43.0	28.7	29.5	44.8	42.3	29.4	167.2	26.9	26.9	38.5	33.2	23.5	29.6	32.8	39.4	65.5	38.6	123.4	43.4	34.0	20.0	87.1	63.9	41.9	85.7	124.8	76.7	67.9	65.4	125.5	107.7	116.7	143.6	70.7	46.8	109.5	55.3	111.9	84.3	46.6	121.1	92.4	181.2	111.8	82.9	335.3	113.6	95.5	91.9	209.5	87.9	67.8	68.7	111.0	135.0	87.2	98.5	128.2	182.7	89.4	125.1	60.0	129.6	53.0	55.4	75.6	45.3	120.0	95.3	74.9	72.3	59.7	84.2	57.4	85.6	88.7	88.4	67.4	74.1	124.6	93.6	82.4	85.5	103.3	134.8	202.5	158.3	184.8	125.5	106.8	104.9	108.7	47.8	52.0	44.0	44.9	48.9	49.3	51.2	44.2	55.9	42.7	68.9	57.0	22.0	66.4	44.9	44.6	67.5	57.7	29.7	51.8	37.9	48.1	28.3	44.6	41.2	34.7	43.0	33.2	39.4	87.1	25.9	25.6	25.7	27.1	32.0	27.3	26.9	23.2	31.3	42.7	22.1	17.8	56.0	17.2	30.4	11.0	14.6	32.2	36.8	11.1	25.4	25.2	36.3	27.1	28.9	24.4	16.3	58.0	61.4	20.4	33.7	26.2	20.4	27.1	60.0	23.9	18.2	39.3	13.5	21.9	56.2	11.1	16.2	18.0	18.9	12.6	18.6	17.6	30.2	29.0	28.0	26.5	19.6	47.3	198.7	18.7	12.3	22.2	53.7	21.6	13.9	23.5	24.0	26.6	39.5	36.6	25.9	28.3	25.8	24.9	18.6	40.5	34.5	27.5	14.6	25.7
HERC2	"D15F37S1, jdf2, p528"	ENSG00000128731	"HECT and RLD domain containing E3 ubiquitin protein ligase 2"	O95714	15	28111040-28322179	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 54.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017188, HPA048389, HPA074166"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 59: Non-specific - Translation"	"Cluster 36: HEL - Hemostasis"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Plasma membrane"	"CAB017188: , HPA048389: AB_2680382, HPA074166: "	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.64e-2)"	"unprognostic (6.62e-2)"	"unprognostic (5.74e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.60e-2)"	"prognostic favorable (1.41e-7)"	"unprognostic (7.66e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.71e-1)"	5.3	5.7	2.5	2.3	2.9	4.0	4.9	1.5	3.1	5.5	3.0	9.3	2.6	7.6	1.7	5.2	6.1	2.2	7.4	2.3	1.1	3.7	3.7	5.1	2.3	2.0	1.8	8.3	6.1	5.4	6.3	2.7	2.7	4.4	2.8	5.3	4.8	2.9	14.2	5.3	6.1	3.7	0.4	4.3	6.3	4.8	2.7	4.4	5.8	9.3	2.4	5.6	5.0	6.2	8.5	16.5	11.2	4.7	9.2	6.9	3.2	6.0	7.1	7.6	7.3	8.6	1.1	8.5	7.2	10.4	11.5	8.5	12.0	5.9	5.6	5.2	7.8	54.0	20.2	2.9	3.5	12.8	4.1	5.7	4.5	9.0	11.2	4.9	10.2	7.0	21.2	3.4	7.3	3.9	2.9	4.3	3.4	6.4	7.1	10.2	16.0	0.7	2.6	18.2	12.3	7.1	14.6	4.1	4.5	5.8	4.8	14.8	15.3	14.0	9.2	5.5	9.1	2.2	3.3	7.7	6.5	5.9	7.6	0.1	0.2	0.1	0.3	0.0	0.1	0.2	0.1	0.1	0.2	0.4	0.2	0.1	0.0	0.1	0.1	0.6	0.2	0.1	2.5	2.9	1.5	3.1	2.3	1.1	2.0	1.8	2.7	0.4	2.7	6.2	56.2	22.4	23.5	68.9	34.3	16.4	15.3	18.1	27.9	107.9	39.1	31.2	66.6	21.5	23.6	64.4	148.0	25.9	28.5	31.8	1.9	28.7	13.0	35.0	55.8	73.3	28.1	67.9	88.9	30.4	15.5	34.3	43.3	29.6	3.8	135.0	38.9	36.7	19.0	122.8	82.9	32.1	16.2	22.3	20.7	15.8	56.2	22.1	69.4	84.3	26.9	41.0	45.3	65.9	89.7	36.6	30.8	52.3	56.6	20.5	31.1	19.8	19.6	142.9	65.7	46.0	43.2	72.5	66.4	38.3	21.0	17.8	30.0	62.7	35.5	11.5
HINFP	"DKFZP434F162, HiNF-P, MIZF, ZNF743"	ENSG00000172273	"Histone H4 transcription factor"	Q9BQA5	11	119121580-119136059	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA061008	Uncertain					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA061008: AB_2684414"	"unprognostic (2.79e-1)"	"unprognostic (2.63e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.41e-2)"	"unprognostic (8.39e-2)"	"unprognostic (7.44e-2)"	"prognostic unfavorable (4.44e-8)"	"unprognostic (4.17e-2)"	"unprognostic (7.39e-2)"	"unprognostic (3.78e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.95e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.72e-1)"	"prognostic favorable (5.26e-4)"	"unprognostic (1.25e-2)"	5.1	4.8	8.4	4.6	9.8	4.6	5.2	12.4	9.9	6.2	7.8	7.5	6.9	5.7	4.4	5.5	7.1	3.8	5.5	8.5	7.7	6.7	4.3	5.1	6.8	8.6	7.8	6.8	7.1	6.0	5.2	4.3	8.6	5.7	7.1	11.0	6.6	5.1	9.2	8.6	7.1	5.8	6.7	7.1	6.7	6.6	9.4	11.5	6.2	8.1	7.0	6.5	5.5	11.9	5.9	9.4	10.3	9.6	8.4	5.7	9.3	4.5	7.1	10.1	11.1	17.0	12.9	7.6	15.7	6.3	11.2	13.7	18.0	4.5	6.7	16.9	8.9	39.1	6.8	5.8	9.9	11.7	9.0	8.0	16.0	10.6	9.2	11.7	8.1	14.1	15.7	12.9	5.7	11.5	14.7	10.5	9.1	10.7	8.6	14.5	11.4	8.7	6.8	5.5	14.6	7.1	7.7	11.3	6.3	10.0	15.4	13.3	6.1	8.9	3.5	6.0	5.5	6.1	6.8	8.3	3.3	10.0	6.8	12.8	12.9	9.3	10.0	10.2	11.2	10.0	12.3	11.9	16.5	12.5	16.3	10.0	8.0	17.2	6.9	7.9	16.6	10.4	8.4	9.8	12.4	9.9	8.5	7.7	8.6	7.8	8.6	6.7	9.4	11.9	7.9	0.0	8.8	12.4	11.0	14.4	7.4	10.3	10.8	19.1	12.6	8.6	5.5	8.6	9.2	9.2	35.5	7.4	13.8	17.6	5.9	9.4	9.4	8.3	8.7	10.3	8.4	7.8	16.6	11.0	8.0	7.5	7.1	8.2	5.1	11.3	12.1	4.5	5.4	15.2	16.2	9.7	4.1	7.2	9.5	3.4	8.4	7.2	8.8	4.7	18.1	9.6	12.3	7.5	9.1	9.3	10.3	6.4	12.4	8.6	15.5	5.6	9.5	29.5	0.0	7.4	9.2	38.6	31.8	7.7	16.3	8.3	11.6	12.4	10.7	6.5
HNRNPUL2	"DKFZp762N1910, HNRPUL2"	ENSG00000214753	"Heterogeneous nuclear ribonucleoprotein U like 2"	Q1KMD3	11	62712630-62727457	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA041632, HPA056696, HPA067699"	Supported		Enhanced	Nucleoplasm		NA	NA		88000	"Cluster 6: Non-specific - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 36: HEL - Hemostasis"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA041632: AB_10960896, HPA056696: AB_2683211, HPA067699: AB_2685891"	"unprognostic (3.06e-3)"	"unprognostic (2.31e-1)"	"unprognostic (7.48e-2)"	"unprognostic (9.27e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.35e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.45e-2)"	30.4	20.9	44.3	28.6	45.4	27.3	26.2	47.3	52.3	28.7	37.2	40.5	29.0	32.5	36.3	37.2	29.1	17.1	33.1	45.0	43.1	26.8	21.1	25.8	35.1	42.3	43.8	26.5	32.5	24.7	20.9	25.1	43.0	26.6	28.0	37.5	30.6	30.2	48.6	39.8	35.2	28.3	42.4	34.1	31.3	16.7	45.5	47.4	24.3	35.9	37.6	34.2	28.2	44.2	110.9	49.8	83.5	50.3	45.1	55.3	14.4	70.2	41.5	52.1	40.2	34.4	37.5	129.1	36.5	57.9	45.0	62.2	51.2	66.3	69.1	59.1	27.8	123.0	64.9	39.1	41.2	127.8	78.1	43.8	50.7	50.2	61.4	41.0	64.8	33.5	46.6	47.8	61.0	63.5	128.1	114.1	39.8	41.4	42.9	88.6	77.0	62.3	65.4	65.2	48.4	56.3	71.7	57.8	75.3	39.3	43.5	55.6	72.8	61.0	28.2	77.4	74.4	60.8	54.3	124.6	55.3	62.1	57.5	1.1	0.8	1.3	1.4	0.6	1.0	1.0	1.0	1.2	0.5	1.3	0.8	0.9	1.0	0.8	1.4	1.4	1.0	0.5	44.3	45.4	47.3	52.3	45.0	43.1	42.3	43.8	43.0	42.4	45.5	44.2	21.1	28.9	12.1	0.0	19.0	29.4	15.0	20.2	13.6	31.3	25.0	18.7	43.8	30.0	17.5	53.3	10.4	27.9	32.4	68.8	5.9	27.4	9.9	20.8	26.3	30.6	38.4	23.5	0.0	36.0	26.9	23.0	19.4	29.7	15.2	28.0	37.5	40.7	37.9	42.1	0.0	48.3	22.4	54.1	29.4	6.9	42.0	27.6	14.2	0.0	38.0	18.2	24.7	0.0	0.0	35.0	42.7	45.9	12.5	24.1	59.6	25.6	16.1	19.7	32.9	22.8	27.5	15.6	20.1	19.6	32.1	25.2	19.8	20.6	58.6	17.4
HPGDS	"GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS"	ENSG00000163106	"Hematopoietic prostaglandin D synthase"	O60760	4	94298535-94342876	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 18.7"	"Group enriched"	"Detected in many"	18	"granulocytes: 1056.2;Hofbauer cells: 631.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	28	"basophil: 18.1"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 18.1"	"Group enriched"	"Detected in some"	8	"HEL: 46.2;HMC-1: 13.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA024035	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		250000	"Cluster 46: Basophils - DNA binding"	"Cluster 19: Lung - Lung function"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"	"Vesicles, Cytosol"	Nucleoplasm	"HPA024035: AB_1855743"	"unprognostic (5.71e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.01e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.75e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	3.4	1.9	2.2	1.1	2.1	1.1	4.0	2.3	3.1	3.5	2.1	5.1	5.8	2.4	2.3	2.9	1.4	6.9	1.8	2.3	2.3	1.5	0.8	9.4	0.6	2.7	2.6	0.5	0.5	0.8	0.4	18.7	2.9	2.6	5.3	0.1	1.5	1.3	0.5	3.3	5.6	3.3	2.6	0.3	2.8	0.7	3.1	2.0	0.3	1.7	0.9	4.8	1.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.2	0.0	0.0	0.0	3.5	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.1	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	2.2	2.1	2.3	3.1	2.3	2.3	2.7	2.6	2.9	2.6	3.1	3.5	0.3	12.8	44.7	1.0	0.2	4.1	0.8	0.0	0.6	0.0	0.2	0.8	0.3	0.0	3.7	0.0	0.0	3.6	0.7	0.5	0.0	0.5	0.1	0.2	0.0	2.0	7.1	12.2	0.8	0.0	3.0	3.0	3.6	0.0	1056.2	0.0	0.0	0.0	631.9	0.0	0.6	0.0	0.0	11.4	13.1	0.0	0.3	16.3	3.6	32.8	0.1	0.0	0.0	0.0	0.5	0.1	1.2	0.4	2.1	3.9	0.0	0.0	1.5	0.1	0.0	0.6	0.4	0.0	0.1	0.0	5.4	5.5	20.5	0.3	0.9	0.2
HPSE2	"HPA2, HPR2, UFS"	ENSG00000172987	"Heparanase 2 (inactive)"	Q8WWQ2	10	98457077-99235862	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.6;cervix: 36.7;vagina: 27.6"	"Cell type enriched"	"Detected in some"	9	"Astrocytes: 900.7"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 4.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"BJ hTERT+: 10.2;HEL: 20.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA044603	Uncertain				"Secreted to extracellular matrix"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA044603: AB_10794051"	"unprognostic (2.44e-1)"	"unprognostic (4.28e-3)"	"unprognostic (4.83e-3)"	"unprognostic (6.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.82e-2)"	"unprognostic (4.03e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.86e-4)"	"unprognostic (5.79e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.39e-3)"	"unprognostic (6.13e-3)"	2.0	0.0	9.9	2.0	20.9	0.0	5.2	15.4	7.6	36.7	3.6	2.9	2.7	4.5	0.0	14.3	1.8	1.4	0.1	5.8	21.1	3.5	0.0	2.2	0.0	23.2	29.6	0.2	0.0	0.0	0.3	1.5	21.5	11.1	3.0	0.0	2.4	4.2	0.3	3.2	5.2	1.7	16.5	0.0	4.6	2.7	28.5	0.1	0.1	3.0	0.4	18.3	27.6	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	10.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	20.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.9	20.9	15.4	7.6	5.8	21.1	23.2	29.6	21.5	16.5	28.5	11.9	0.3	0.0	0.0	900.7	0.0	0.0	4.8	0.0	0.0	0.0	0.2	0.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.4	24.8	0.3	0.0	0.0	6.4	0.0	0.0	4.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	97.3	0.2	0.0	0.0	0.0	48.6	0.3	0.0	0.0	40.3	0.0	0.0	0.0	16.6	4.6	0.0	0.0	0.4	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.9	1.9	11.5	2.1	0.0	0.1	0.0	0.2	0.8	0.0	0.7
ICAM4	"CD242, LW"	ENSG00000105371	"Intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)"	Q14773	19	10286955-10288522	"Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Blood group antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 13.4;lung: 9.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 24.9;Alveolar cells type 1: 67.3;Alveolar cells type 2: 76.5;Erythroid cells: 46.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in many"	6	"non-classical monocyte: 215.4"	"Lineage enriched"	"Detected in many"	7	"monocytes: 215.4"	"Cell line enhanced"	"Detected in some"		"HEL: 71.0;HMC-1: 17.1;K-562: 37.4;NB-4: 30.7;U-937: 17.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 11: Alveolar cells - Smell perception"																					0.9	0.3	0.3	0.8	0.4	13.4	0.4	0.3	1.0	0.2	0.0	0.7	0.9	0.3	0.2	0.3	0.4	1.1	0.6	0.3	0.0	0.3	0.8	9.3	1.0	0.6	0.0	0.5	0.1	0.3	0.1	1.8	0.3	0.7	0.5	0.7	1.0	0.4	0.4	0.5	0.9	0.4	0.0	1.2	1.5	0.3	0.1	1.1	0.3	0.1	1.4	1.8	0.2	0.5	0.2	0.1	0.3	0.4	0.0	0.0	5.9	0.6	0.2	0.0	0.0	7.8	0.4	0.8	0.8	0.0	0.3	0.6	0.1	0.1	0.1	0.6	0.2	71.0	0.6	10.6	1.9	1.2	17.1	0.4	0.0	0.2	0.2	0.0	0.1	11.2	37.4	3.1	0.1	0.2	2.0	30.7	0.2	0.0	0.3	5.2	2.9	13.6	0.1	0.3	0.1	0.2	0.6	0.1	0.3	0.8	0.2	2.1	0.4	0.2	0.1	0.5	0.0	1.0	2.0	0.2	0.6	17.1	0.4	24.0	10.0	10.2	0.9	38.5	1.8	2.2	1.1	0.8	30.8	2.2	1.3	0.3	2.3	0.5	215.4	10.2	2.6	9.1	0.3	0.4	0.3	1.0	0.3	0.0	0.6	0.0	0.3	0.0	0.1	0.5	24.9	67.3	76.5	0.3	2.3	1.0	1.9	8.0	1.2	0.0	4.9	3.6	0.0	0.0	21.0	0.0	0.0	0.3	3.0	0.4	0.0	0.6	0.0	2.9	2.0	18.3	0.0	46.7	0.0	2.1	0.6	10.3	1.5	5.6	22.1	0.0	2.5	0.2	5.6	0.0	0.0	0.0	0.0	5.5	6.9	0.0	0.0	16.8	5.4	0.0	14.6	0.2	0.0	0.0	0.0	0.9	0.0	0.0	17.5	1.4	0.0	0.1	4.4	0.1	0.0	9.1	3.3	0.0	1.0	0.7	1.3	0.8	1.8	0.2	0.0	2.4
IFT172	"BBS20, NPHP17, osm-1, SLB, wim"	ENSG00000138002	"Intraflagellar transport 172"	Q9UG01	2	27444377-27489805	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Ciliopathy, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 439.9;Late spermatids: 703.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044893	Uncertain					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 36: HEL - Hemostasis"	"Cluster 34: Spermatids - Unknown function"			"HPA044893: AB_10795009"	"unprognostic (1.05e-3)"	"unprognostic (6.52e-2)"	"unprognostic (7.04e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (6.05e-6)"	"unprognostic (6.86e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.32e-2)"	"unprognostic (9.52e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.47e-2)"	3.1	3.3	2.2	2.5	2.6	1.8	4.0	2.5	2.4	5.2	11.8	4.6	1.8	4.5	1.6	2.4	17.0	3.2	4.3	2.3	2.8	4.5	1.5	4.9	2.0	3.6	3.6	8.9	4.8	13.0	9.9	2.4	3.5	3.6	2.1	5.7	4.2	4.2	3.6	2.9	2.7	3.8	2.4	3.9	3.5	12.5	2.4	2.7	5.9	3.9	2.1	3.6	3.4	3.7	5.8	5.3	7.1	10.0	12.6	10.6	4.5	5.5	4.0	6.5	5.5	4.8	4.6	6.3	8.3	7.3	3.9	6.4	13.4	6.7	6.2	3.1	9.4	16.1	9.4	5.6	7.3	7.8	3.4	8.6	3.0	10.3	3.8	9.0	10.8	7.3	5.3	2.2	2.4	4.5	4.4	3.8	5.0	4.6	5.5	0.0	3.7	3.5	5.0	3.7	5.5	8.8	2.8	4.8	9.7	6.0	4.8	4.6	11.6	2.9	1.7	3.7	8.3	2.8	1.7	6.7	11.9	2.3	5.7	0.0	0.4	0.3	0.4	0.6	0.3	0.7	0.2	0.4	0.9	0.5	0.3	0.3	0.0	0.9	0.1	0.4	0.2	0.4	2.2	2.6	2.5	2.4	2.3	2.8	3.6	3.6	3.5	2.4	2.4	3.7	5.2	3.2	9.4	53.5	3.1	2.0	16.6	35.3	8.6	15.4	17.2	12.1	6.3	38.6	32.7	23.9	52.1	1.0	1.7	82.4	0.0	34.4	439.9	59.0	7.1	4.5	34.7	7.6	63.2	98.7	0.6	5.9	23.9	14.2	0.0	11.0	5.7	1.2	1.7	5.0	64.3	96.4	57.0	3.2	1.6	703.6	12.8	2.8	5.4	11.2	1.9	7.1	5.2	24.6	44.9	104.9	106.3	10.9	2.4	7.5	142.0	2.3	154.6	41.7	0.0	11.7	8.5	22.6	6.6	10.1	1.4	0.4	2.8	10.1	75.1	39.8
IGHD2-15	"D2, IGHD215"	ENSG00000211918	"Immunoglobulin heavy diversity 2-15"		14	105897957-105897987	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"bone marrow: 2.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"endometrial cancer: 3.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	8	"naive B-cell: 39.9"	"Lineage enriched"	"Detected in single"	400	"B-cells: 39.9"	"Cell line enriched"	"Detected in single"	28	"HEL: 2.7"															NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"																						0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHD3-9	"DXP1, IGHD39"	ENSG00000211924	"Immunoglobulin heavy diversity 3-9"		14	105904681-105904711	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 11.9;stomach 1: 4.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	214	"memory B-cell: 8.9;naive B-cell: 33.8"	"Lineage enriched"	"Detected in single"	339	"B-cells: 33.8"	"Cell line enriched"	"Detected in some"	5	"HEL: 5.5"															NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"												"unprognostic (1.74e-1)"						"unprognostic (1.50e-1)"	"unprognostic (9.31e-2)"			0.0	0.0	0.0	2.8	0.0	0.5	0.0	0.0	0.1	0.0	0.0	2.1	1.6	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.9	0.4	0.0	0.0	2.0	0.0	0.1	2.8	4.8	0.0	0.1	2.2	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGLV4-60		ENSG00000211639	"Immunoglobulin lambda variable 4-60"	A0A075B6I1	22	22162199-22162681	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 193.1;lymphoid tissue: 116.3;urinary bladder: 185.2"	"Cell type enriched"	"Detected in some"	152	"Plasma cells: 1125.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	78	"memory B-cell: 79.4;naive B-cell: 48.9"	"Lineage enriched"	"Detected in single"	96	"B-cells: 79.4"	"Group enriched"	"Detected in some"	4	"Daudi: 7.8;HEL: 13.3;U-698: 3.9"														"Immunoglobulin genes"	NA	NA		120000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (2.57e-4)"	"unprognostic (5.46e-3)"	"unprognostic (9.43e-3)"	"unprognostic (1.26e-2)"		"prognostic favorable (1.89e-4)"	"unprognostic (3.06e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (1.87e-6)"	"unprognostic (1.78e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.19e-1)"	"unprognostic (2.60e-1)"	1.8	1.9	0.0	32.9	0.0	18.1	36.6	0.0	0.2	3.3	0.1	70.7	193.1	1.5	0.0	12.3	1.9	3.4	11.4	0.0	0.0	3.1	3.9	43.5	116.3	0.0	0.0	4.6	1.1	0.4	0.2	0.2	0.1	1.1	73.3	0.0	37.9	0.8	0.1	0.1	86.8	2.1	0.0	80.3	37.7	1.7	0.0	18.3	1.7	0.0	112.0	185.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	3.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.4	0.1	0.0	0.0	48.9	0.0	0.0	0.8	0.0	0.0	0.0	0.4	3.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1125.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
IL17B	"IL-17B, IL-20, MGC138900, MGC138901, NIRF, ZCYTO7"	ENSG00000127743	"Interleukin 17B"	Q9UHF5	5	149371324-149404202	"Cancer-related genes, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 44.8;Peritubular cells: 13.2;Sertoli cells: 26.3;Smooth muscle cells: 7.6;Theca cells: 9.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"basophil: 1.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"HEL: 1.3;Karpas-707: 1.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042441	Uncertain				"Secreted to blood"	NA	NA	75000		"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 36: HEL - Hemostasis"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA042441: AB_10797014"	"unprognostic (2.83e-4)"	"unprognostic (2.71e-2)"	"unprognostic (4.90e-3)"	"unprognostic (9.22e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.03e-2)"	"unprognostic (9.62e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.54e-2)"	"unprognostic (9.30e-3)"	"unprognostic (3.22e-1)"	"unprognostic (6.98e-8)"	"unprognostic (2.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.10e-1)"	1.4	2.2	0.0	1.0	0.0	0.2	2.9	0.5	0.1	3.2	0.0	3.1	0.3	4.3	0.0	1.5	1.1	0.4	1.1	0.0	0.0	0.7	0.0	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.1	2.4	0.1	0.4	2.8	2.1	0.3	0.9	1.3	2.2	0.0	0.6	0.8	3.7	0.0	0.0	0.1	0.2	0.0	1.4	0.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.8	44.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.3	0.0	0.0	0.1	0.2	0.6	1.3	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.0	1.0	1.1	3.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	26.3	0.6	7.6	0.1	0.1	0.0	0.3	0.0	0.0	9.9	0.0	0.1
INSL6	RIF1	ENSG00000120210	"Insulin like 6"	Q9Y581	9	5123880-5185647	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"retina: 6.8;testis: 14.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 134.0;Excitatory neurons: 22.0;Inhibitory neurons: 26.2;Late spermatids: 17.9;Microglial cells: 21.5;Spermatocytes: 35.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.1;Karpas-707: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021364	Enhanced				"Secreted to blood"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA021364: AB_1851807"	"unprognostic (3.85e-4)"	"unprognostic (7.41e-4)"						"unprognostic (1.28e-1)"		"unprognostic (1.94e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.30e-1)"		"unprognostic (2.52e-3)"	0.1	0.3	0.5	0.6	0.7	1.5	0.0	1.1	1.2	0.0	0.1	0.2	0.3	0.4	0.0	0.4	0.1	0.5	0.5	0.4	0.9	0.1	0.1	0.2	1.0	0.6	0.2	0.4	0.0	0.0	0.0	0.8	0.6	0.2	0.0	6.8	0.2	0.0	0.3	1.0	0.2	0.0	0.1	1.1	0.6	14.9	0.5	0.1	0.2	0.0	0.1	0.1	0.0	1.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	1.1	0.3	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.3	1.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.2	0.2	0.1	0.2	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.7	1.1	1.2	0.4	0.9	0.6	0.2	0.6	0.1	0.5	1.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	134.0	0.1	0.0	0.1	0.0	0.0	22.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	26.2	0.0	0.0	0.0	0.0	17.9	1.2	0.0	0.0	21.5	0.0	0.0	0.0	9.5	8.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	35.7	10.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0
ITLN2	HL-2	ENSG00000158764	"Intelectin 2"	Q8WWU7	1	160945025-160954809	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"intestine: 408.3"	"Cell type enriched"	"Detected in some"	4	"Alveolar cells type 1: 76.9"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 2.8;testis cancer: 4.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 11.9;HHSteC: 1.9;HMC-1: 3.4;SK-MEL-30: 4.0;SuSa: 3.8"					"Low region specificity"	"Detected in all"			"HPA006683, HPA067326"	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 11: Alveolar cells - Smell perception"			"HPA006683: AB_2129681, HPA067326: AB_2732764"		"unprognostic (1.42e-1)"	"unprognostic (9.62e-3)"	"unprognostic (4.61e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.84e-4)"	"unprognostic (2.47e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.01e-1)"		"unprognostic (1.84e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.91e-2)"	6.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	238.7	0.1	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.1	0.4	11.7	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.1	0.0	0.2	408.3	0.0	0.0	0.0	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	1.9	0.0	3.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.7	0.0	0.0	4.0	3.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.9	5.3	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.4	0.3	1.4	0.0	0.2	0.0	0.4	11.0	0.3	0.1	0.0	0.0	5.0	0.0	0.3	0.0	0.2	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	5.3	0.0	0.6	14.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.3	6.3	17.5	0.4
ITSN2	"KIAA1256, PRO2015, SH3D1B, SH3P18, SWA, SWAP"	ENSG00000198399	"Intersectin 2"	Q9NZM3	2	24202864-24360536	"Predicted intracellular proteins"	"Differentiation, Endocytosis, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036475	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Plasma membrane"		"HPA036475: AB_10670718"	"unprognostic (2.36e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.95e-2)"	"unprognostic (4.64e-1)"	"prognostic favorable (2.98e-4)"	"unprognostic (3.32e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.12e-2)"	23.1	21.4	11.0	35.8	11.1	73.6	15.3	6.6	12.3	22.1	17.5	19.5	17.6	19.5	12.9	36.7	15.4	19.0	20.0	10.3	10.3	21.2	27.4	27.0	53.3	12.1	12.5	16.4	67.0	18.7	16.2	24.7	11.8	17.8	20.1	16.0	18.4	15.0	23.3	26.5	22.4	18.0	9.4	43.3	24.7	15.2	15.3	30.0	50.7	18.9	50.9	22.2	24.5	15.7	41.2	19.7	4.8	14.2	13.6	18.1	43.5	24.5	22.8	11.1	13.2	19.2	21.4	63.6	21.2	20.4	32.7	18.2	21.9	15.5	18.3	50.8	21.0	86.1	12.6	21.4	22.9	44.7	47.6	14.2	17.7	19.4	33.7	21.1	35.3	23.7	25.0	46.7	17.6	16.9	18.4	21.7	8.9	24.9	19.1	22.8	55.7	19.0	19.6	76.0	3.3	9.9	19.4	20.6	29.5	19.2	14.1	23.7	49.1	23.6	20.6	19.6	22.9	50.6	60.4	65.0	18.8	40.4	21.0	69.6	30.4	56.2	31.1	37.0	32.8	68.7	26.8	27.7	28.7	73.1	27.4	24.6	112.8	26.5	59.3	18.9	31.2	20.3	11.0	11.1	6.6	12.3	10.3	10.3	12.1	12.5	11.8	9.4	15.3	15.7	62.6	96.1	103.3	64.6	143.2	51.7	82.0	21.7	41.5	23.7	21.9	20.2	70.5	22.8	48.5	29.5	20.9	26.1	88.6	42.5	17.6	53.0	4.3	42.8	21.5	62.8	24.5	33.2	114.7	75.5	35.3	40.7	53.0	62.1	103.9	30.4	39.3	27.8	42.4	13.5	98.2	28.6	26.4	93.1	111.1	7.6	30.1	102.2	24.9	132.1	107.1	16.0	105.0	104.0	140.5	88.3	48.4	18.0	85.2	74.9	40.1	27.0	35.3	33.2	13.1	54.2	40.3	95.6	58.8	36.4	58.1	24.2	94.9	28.3	24.6	116.6
JAK2	JTK10	ENSG00000096968	"Janus kinase 2"	O60674	9	4984390-5129948	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Chromatin regulator, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 93.4;Inhibitory neurons: 122.3;Microglial cells: 106.8;Oligodendrocyte precursor cells: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 132.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 132.5"	"Group enriched"	"Detected in many"	5	"ASC diff: 42.2;HDLM-2: 75.0;HEL: 154.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013089, HPA040820, HPA043870"	Approved		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"CAB013089: AB_2533647, HPA040820: AB_2677151, HPA043870: AB_2678708"	"unprognostic (2.24e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.85e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.37e-3)"	15.6	7.6	3.2	19.2	3.7	21.7	8.9	6.3	9.1	8.5	1.1	6.7	6.5	11.3	8.6	8.8	8.0	10.5	24.5	2.7	3.1	6.8	4.5	10.9	18.2	3.3	1.8	11.5	3.8	6.5	2.9	11.0	2.0	6.8	6.5	12.8	4.0	6.2	9.8	11.2	7.7	9.5	3.5	17.6	13.4	9.8	1.7	7.5	4.8	8.9	12.7	11.7	9.1	3.9	6.8	3.7	3.7	6.3	42.2	12.4	1.1	9.1	8.6	7.2	4.6	1.2	2.0	0.3	2.1	5.4	5.4	2.3	4.4	5.1	4.9	75.0	1.4	154.7	7.6	1.7	10.0	10.5	7.1	9.5	2.1	2.8	4.5	7.6	6.6	5.1	10.9	17.4	11.6	2.2	2.9	12.8	3.3	3.3	4.3	5.1	8.2	2.2	4.7	3.5	4.2	2.4	2.6	3.5	2.8	3.6	2.0	15.4	13.1	10.2	3.6	10.7	6.4	3.1	6.4	1.5	13.6	4.7	5.3	132.5	20.5	38.2	5.6	20.1	4.5	5.6	4.1	3.1	26.5	4.9	2.2	2.8	19.2	9.6	16.4	9.7	4.5	7.7	3.2	3.7	6.3	9.1	2.7	3.1	3.3	1.8	2.0	3.5	1.7	3.9	14.3	16.0	7.9	31.6	12.9	9.7	3.3	4.9	10.8	8.0	5.2	3.4	30.0	0.0	6.7	7.3	8.4	1.9	13.9	11.7	1.9	3.3	8.6	5.1	11.2	9.4	3.0	19.8	93.4	3.9	0.9	8.9	38.7	5.6	14.0	11.4	4.6	1.9	14.2	8.4	122.3	4.5	0.0	33.6	28.8	7.1	23.6	38.9	5.4	106.8	49.5	12.6	8.2	69.9	42.3	7.0	20.9	33.4	10.7	3.0	3.9	3.3	7.1	11.2	0.0	9.7	12.5	15.0	5.5	11.6	8.4	3.4	10.4	5.1	4.1	4.5
KDM5D	"HY, HYA, JARID1D, KIAA0234, SMCY"	ENSG00000012817	"Lysine demethylase 5D"	Q9BY66	Y	19703865-19744939	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 46.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 60.4;U-698: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA049086			Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 64: Macrophages - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoli fibrillar center"		"HPA049086: "			"unprognostic (8.38e-2)"		"unprognostic (2.20e-1)"	"prognostic favorable (3.58e-5)"	"unprognostic (6.08e-3)"	"unprognostic (1.50e-2)"	"unprognostic (3.10e-2)"		"unprognostic (4.57e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.00e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.80e-2)"	16.0	29.9	2.3	11.8	2.4	17.4	12.8	3.2	13.2	0.0	5.3	22.2	18.0	0.0	15.2	12.3	0.0	11.7	13.3	2.2	2.5	12.1	12.7	16.7	8.7	2.9	2.0	0.0	18.9	4.9	16.2	9.2	2.8	25.5	21.6	9.0	15.6	18.0	15.7	12.9	35.2	0.0	1.6	30.8	16.0	12.1	2.6	0.0	18.6	25.7	20.5	19.9	0.0	4.4	0.1	8.0	0.0	0.0	0.0	0.0	15.9	15.4	12.9	8.6	9.4	0.0	0.0	0.3	0.0	12.6	0.0	0.0	0.0	0.0	9.4	22.6	0.0	60.4	0.0	18.5	11.5	0.1	0.0	12.9	12.9	0.0	0.0	0.0	0.0	10.6	0.0	0.0	20.1	0.0	24.6	0.1	11.6	0.0	0.1	0.0	10.1	10.9	17.0	28.7	13.2	0.1	0.0	0.0	5.9	27.2	0.0	12.5	18.9	25.9	0.2	0.2	6.6	24.2	16.6	51.4	2.5	0.1	0.0	0.0	1.8	2.1	2.3	1.1	1.7	3.2	2.2	2.2	1.7	2.6	2.4	1.9	0.2	1.9	0.9	2.6	1.8	1.3	2.3	2.4	3.2	13.2	2.2	2.5	2.9	2.0	2.8	1.6	2.6	4.4	0.0	19.2	16.5	9.4	22.2	6.4	9.2	5.3	18.2	39.9	0.0	0.0	12.2	2.8	7.7	18.4	20.9	7.0	14.6	2.8	5.9	5.4	0.8	0.0	0.0	10.8	3.5	22.7	26.0	0.0	2.5	10.6	19.9	0.0	11.4	0.0	13.2	3.1	4.8	13.5	23.2	5.8	2.0	7.6	12.1	3.8	36.7	10.3	10.6	10.3	14.5	7.5	13.4	12.1	15.2	1.7	5.0	33.8	46.3	8.6	13.9	4.2	5.5	30.5	26.3	8.5	8.5	3.3	9.7	12.2	10.9	5.6	16.4	0.0	6.6	8.8
KIAA2026	FLJ20375	ENSG00000183354	KIAA2026	Q5HYC2	9	5881596-6008482	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002109	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	"Vesicles, Cytosol"	Nucleoplasm	"HPA002109: AB_1078071"	"unprognostic (7.42e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.74e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.41e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (8.34e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.00e-2)"	6.8	5.1	13.5	5.6	17.2	6.4	6.2	24.1	11.7	7.8	25.1	6.4	4.8	7.9	5.8	6.1	6.4	5.7	5.7	9.9	12.1	6.1	4.9	5.9	6.7	11.6	13.3	10.2	5.2	8.6	6.2	6.9	11.9	6.2	5.0	10.4	6.1	5.4	9.5	8.2	5.6	6.3	10.3	8.1	6.5	11.5	12.6	8.3	8.4	9.5	5.9	6.2	7.1	17.0	7.1	3.5	7.2	4.6	5.4	8.5	3.2	4.6	6.8	4.4	4.0	2.3	4.0	8.8	1.7	5.8	5.5	3.5	4.2	3.9	6.5	19.2	3.0	26.5	8.4	3.7	4.2	9.4	11.6	5.3	5.0	3.9	6.4	8.3	6.9	5.7	2.8	16.2	5.5	2.2	5.1	17.2	4.0	4.1	2.8	5.3	4.6	4.5	4.8	4.9	9.3	5.3	4.3	4.0	3.7	4.9	4.1	12.6	7.8	8.4	4.7	4.2	5.3	11.1	9.5	8.8	4.3	4.3	2.3	5.0	2.3	7.0	4.2	1.9	4.8	5.9	4.1	3.8	0.9	3.8	4.5	4.8	6.0	4.8	4.5	2.9	2.6	0.8	13.5	17.2	24.1	11.7	9.9	12.1	11.6	13.3	11.9	10.3	12.6	17.0	47.8	44.8	34.0	99.9	40.3	44.6	29.9	21.4	37.5	89.0	33.5	25.5	53.7	42.9	22.1	38.6	79.2	17.1	51.9	31.0	7.9	18.2	33.0	28.3	40.9	39.7	38.5	18.7	97.8	13.4	10.6	33.2	31.1	46.7	20.2	43.5	29.3	18.7	16.9	45.4	119.1	34.7	16.2	25.5	28.8	17.2	70.5	31.9	23.2	113.4	55.1	47.7	95.8	116.1	170.1	18.4	29.1	76.3	35.4	34.4	30.1	11.9	18.2	81.5	46.0	45.8	40.1	127.7	121.2	38.3	52.4	30.0	45.1	38.7	28.5	42.0
KLRG1	"2F1, CLEC15A, MAFA, MAFA-L"	ENSG00000139187	"Killer cell lectin like receptor G1"	Q96E93	12	8950044-9010760	"Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 10.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 93.7;granulocytes: 118.9;NK-cells: 164.8;T-cells: 109.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 390.9;MAIT T-cell: 461.3"	"Lineage enriched"	"Detected in all"	22	"T-cells: 461.3"	"Cell line enhanced"	"Detected in many"		"HEL: 25.1;NTERA-2: 22.1;U-937: 17.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051403, HPA076494"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA051403: , HPA076494: AB_2686800"	"unprognostic (1.54e-2)"	"unprognostic (8.42e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.53e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.45e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.17e-2)"	"unprognostic (4.96e-2)"	"unprognostic (7.86e-2)"	4.1	1.7	2.4	3.8	2.6	3.0	2.5	4.3	2.9	1.3	1.4	1.5	1.0	1.2	2.1	1.0	1.0	3.3	2.0	2.1	3.2	1.4	3.0	2.2	10.4	2.5	3.4	1.0	0.5	0.4	1.1	0.6	2.3	1.1	1.9	1.3	1.6	0.7	1.7	1.0	2.2	1.6	1.7	8.8	1.6	1.1	2.6	2.5	1.0	1.8	5.0	2.4	0.8	3.8	0.2	3.1	1.6	2.3	3.0	0.7	1.4	0.5	0.3	0.4	1.1	1.1	1.1	4.9	0.1	0.4	2.1	0.2	3.3	0.5	0.4	3.6	1.9	25.1	0.4	1.6	0.8	1.1	1.6	1.4	0.4	0.5	0.0	0.4	7.6	2.5	1.4	0.4	0.2	0.7	1.0	2.0	22.1	1.0	1.7	1.2	1.0	0.0	0.5	0.4	0.4	4.4	1.1	0.5	1.6	4.3	0.3	1.7	0.8	0.7	1.0	0.6	1.4	1.4	4.1	2.6	1.8	17.3	0.2	17.5	2.6	1.5	390.9	2.9	461.3	4.2	85.1	237.7	8.2	5.0	23.5	147.7	5.7	20.9	5.4	3.9	8.7	99.7	2.4	2.6	4.3	2.9	2.1	3.2	2.5	3.4	2.3	1.7	2.6	3.8	12.7	0.0	4.3	2.9	4.7	0.4	0.4	0.0	4.0	5.0	1.0	0.9	2.8	1.5	0.1	0.0	8.4	1.0	93.7	0.1	1.9	0.7	1.6	0.8	0.6	2.9	1.2	24.6	3.8	0.2	0.5	1.3	0.5	0.5	118.9	0.9	25.7	2.0	3.4	5.0	3.6	0.1	0.0	9.1	1.4	3.1	0.6	3.7	1.8	2.8	5.4	1.8	164.8	9.5	6.2	0.3	0.1	0.0	16.9	0.2	0.3	3.1	0.1	3.9	0.0	2.1	1.0	7.8	7.3	1.3	0.0	0.3	109.3	0.7	0.6	0.1
KRI1	FLJ12949	ENSG00000129347	"KRI1 homolog"	Q8N9T8	19	10553085-10566031	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 177.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043110, HPA043574"	Approved		Enhanced	Nucleoli		Yes	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA043110: AB_2678321, HPA043574: AB_2678561"	"unprognostic (6.38e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (6.70e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.10e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (3.46e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (4.89e-10)"	"unprognostic (2.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.02e-1)"	12.3	11.5	10.6	20.0	11.3	17.1	12.6	11.0	11.8	16.6	11.6	14.3	10.0	13.8	7.6	16.8	14.4	7.1	12.1	10.2	12.0	12.7	13.6	11.2	22.3	11.3	11.0	14.8	15.6	10.3	13.4	8.7	11.1	15.6	7.5	33.8	13.0	8.7	22.3	20.9	17.4	7.3	10.3	22.3	12.5	16.1	11.2	30.6	14.6	9.7	15.1	15.9	15.9	11.9	37.7	17.6	23.6	35.0	13.2	14.3	16.6	34.0	16.1	21.6	20.2	27.1	13.6	55.7	39.2	14.1	18.4	29.1	30.3	27.3	23.9	60.2	67.1	177.2	39.6	18.1	23.4	69.6	61.7	17.7	21.7	31.8	31.4	18.4	13.9	33.2	50.4	56.4	18.7	33.5	72.7	104.3	38.2	30.3	45.0	30.0	30.7	28.4	18.1	32.6	39.2	18.2	40.2	23.4	25.7	20.7	29.5	50.0	16.8	27.9	23.0	74.4	71.9	38.7	48.5	39.7	23.2	56.3	41.6	2.2	4.9	2.9	11.9	5.7	11.0	7.4	7.9	9.7	6.8	8.3	8.7	9.5	0.8	10.3	3.0	16.0	6.5	4.8	10.6	11.3	11.0	11.8	10.2	12.0	11.3	11.0	11.1	10.3	11.2	11.9	8.9	16.0	25.5	6.2	20.4	13.5	11.4	12.2	40.9	15.4	6.4	9.5	8.6	8.6	17.5	14.7	39.6	11.4	15.0	9.5	1.9	8.5	4.6	9.0	17.6	11.0	9.6	26.1	4.0	7.5	8.9	11.0	16.3	10.4	19.6	12.3	10.4	9.0	8.0	11.8	3.7	10.1	8.2	12.5	6.1	5.8	8.4	10.5	8.8	5.6	9.2	11.6	24.7	6.0	7.7	5.6	7.6	9.1	17.4	10.8	9.0	5.0	16.0	55.0	0.0	13.5	9.3	25.3	16.8	28.1	13.8	4.5	26.8	9.0	12.7	8.2
L2HGDH	"C14orf160, FLJ12618"	ENSG00000087299	"L-2-hydroxyglutarate dehydrogenase"	Q9H9P8	14	50237563-50312229	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 56.3;Excitatory neurons: 60.5;Inhibitory neurons: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065409, HPA069708"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 9: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA065409: AB_2685485, HPA069708: AB_2686179"	"unprognostic (1.74e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.33e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.97e-1)"	"prognostic favorable (9.75e-10)"	"unprognostic (1.24e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-2)"	4.6	2.5	2.9	2.2	2.9	2.7	3.7	6.1	5.5	2.3	1.3	4.3	4.7	2.4	3.0	5.1	3.1	2.0	5.2	2.7	2.5	19.6	12.6	1.8	2.6	1.2	2.4	2.5	3.9	6.1	2.3	1.7	1.1	3.3	5.0	11.4	2.8	3.2	15.5	5.1	3.6	2.5	1.2	1.3	4.3	3.9	2.4	3.0	4.8	14.7	3.4	2.4	2.3	4.1	24.3	16.6	6.8	6.6	3.3	2.2	19.1	7.9	4.4	12.2	14.3	26.8	10.8	19.0	9.0	3.2	9.7	17.4	20.6	8.2	13.5	15.2	11.9	41.1	10.9	3.7	3.1	14.7	13.7	2.0	5.2	8.1	7.0	3.1	5.3	19.3	14.7	11.6	3.2	29.0	16.7	6.7	9.9	20.6	17.6	15.6	22.0	14.8	11.4	28.0	13.8	9.9	23.3	17.5	10.4	9.0	22.9	4.0	5.0	7.7	21.5	9.0	10.6	10.5	25.6	26.3	4.3	7.3	8.8	8.6	0.4	0.9	0.9	0.1	2.2	0.8	1.1	1.0	0.6	0.6	1.3	1.7	0.5	1.7	0.1	1.0	1.6	0.5	2.9	2.9	6.1	5.5	2.7	2.5	1.2	2.4	1.1	1.2	2.4	4.1	1.9	41.7	19.2	16.6	5.1	3.7	2.7	2.1	8.6	15.5	3.9	2.2	14.7	2.8	20.4	12.9	56.3	6.4	6.1	4.8	15.6	3.8	35.1	5.2	2.8	4.6	7.8	7.4	60.5	4.2	6.6	5.3	7.7	5.6	18.9	6.0	2.9	14.2	2.1	11.8	61.4	4.3	0.0	2.7	0.6	8.8	2.5	3.3	1.8	13.1	2.4	6.1	7.2	20.6	18.9	2.5	3.6	4.5	3.3	2.7	6.0	21.7	18.4	40.3	0.0	5.8	3.9	14.3	12.6	10.5	6.3	4.9	5.0	4.6	7.6	2.1
LANCL3	FLJ42925	ENSG00000147036	"LanC like 3"	Q6ZV70	X	37571569-37684463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 8.8;Inhibitory neurons: 20.4;Squamous epithelial cells: 10.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"basophil: 3.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.8"	"Cell line enhanced"	"Detected in some"		"HEL: 11.8;HMC-1: 3.6;K-562: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005470, HPA076575"	Approved		Approved	Mitochondria		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA005470: AB_2134886, HPA076575: AB_2732315"	"unprognostic (6.76e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.90e-5)"	"unprognostic (4.01e-3)"	"unprognostic (7.93e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.08e-2)"	0.2	0.2	0.1	0.1	0.4	0.2	0.1	2.6	1.0	0.4	0.0	1.0	0.1	0.2	0.0	1.5	0.1	0.1	0.1	0.6	3.7	0.2	0.0	0.3	0.1	1.0	1.6	0.0	0.0	0.0	0.5	0.0	1.0	0.1	0.5	0.6	0.4	0.2	0.2	0.7	0.2	0.1	0.5	0.1	0.6	0.2	2.5	0.1	0.1	0.1	0.2	0.3	1.1	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.7	1.5	0.2	0.0	0.0	0.2	11.8	1.1	0.0	0.0	0.0	3.6	0.0	0.3	0.0	0.0	0.0	0.2	0.0	3.0	0.0	0.6	0.0	0.1	0.2	0.2	0.1	1.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.8	0.0	0.0	1.1	0.5	0.0	0.0	1.8	0.0	0.3	3.8	0.0	0.2	0.4	0.0	0.3	0.0	0.1	0.8	0.0	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.3	0.3	0.1	0.4	2.6	1.0	0.6	3.7	1.0	1.6	1.0	0.5	2.5	0.5	1.3	3.2	4.1	2.9	0.1	8.8	1.2	1.8	6.8	0.8	0.6	0.4	0.9	0.0	1.2	0.0	0.0	0.0	3.0	6.6	0.0	0.0	0.1	0.3	0.6	1.1	1.8	0.8	3.1	0.2	0.2	0.4	4.1	0.7	1.3	0.1	0.0	0.2	0.1	3.3	20.4	0.4	2.0	0.3	0.5	0.0	0.3	0.2	0.0	1.0	0.2	0.5	4.1	1.0	2.0	2.1	1.4	1.5	0.2	0.7	1.6	0.2	0.0	1.4	0.0	1.8	0.9	0.7	3.1	10.1	4.4	0.1	1.4	0.2	1.0	2.5
LCA5	C6orf152	ENSG00000135338	"Lebercilin LCA5"	Q86VQ0	6	79484991-79537458	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 52.6;Respiratory ciliated cells: 89.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 14.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029053, HPA029055"	Supported					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 36: HEL - Hemostasis"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA029053: AB_10602020, HPA029055: AB_2672889"	"unprognostic (8.96e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.34e-3)"	"unprognostic (6.83e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (4.69e-4)"	"unprognostic (7.09e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.39e-2)"	"unprognostic (3.21e-2)"	3.2	1.9	4.4	1.6	3.9	3.6	4.9	4.0	5.0	4.2	16.9	2.5	1.0	5.4	3.7	3.0	9.6	3.0	2.4	6.0	4.6	2.8	1.2	4.0	1.5	4.5	5.8	7.3	2.5	17.2	3.6	3.3	5.1	3.9	1.6	13.7	5.5	4.7	1.1	1.0	1.3	4.2	5.3	1.7	1.6	6.9	2.8	1.1	6.3	2.0	1.0	3.5	2.8	6.1	1.7	1.3	3.9	2.2	4.8	5.3	1.7	3.0	3.6	1.8	3.7	9.9	1.9	0.4	3.9	2.4	3.4	1.8	2.9	1.8	3.3	0.0	2.2	14.6	1.9	1.4	5.0	0.3	1.2	5.0	2.0	3.1	4.0	7.0	5.6	0.1	2.3	0.9	3.0	0.0	0.0	0.0	1.1	1.0	1.5	0.0	6.8	0.7	3.9	0.5	2.9	3.5	2.7	0.4	1.9	4.8	0.3	0.8	3.9	1.9	2.2	0.6	2.6	3.7	1.4	0.0	0.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	3.9	4.0	5.0	6.0	4.6	4.5	5.8	5.1	5.3	2.8	6.1	6.7	16.0	11.5	17.0	1.1	1.0	12.5	5.9	11.4	12.4	6.5	15.2	5.1	11.5	17.5	11.0	22.9	8.0	0.1	0.1	0.0	15.9	17.3	52.6	8.6	14.4	2.4	4.6	32.8	4.9	3.6	12.0	0.5	3.7	1.3	6.3	9.3	0.1	1.1	10.1	16.2	0.3	8.2	1.3	0.9	5.3	18.0	1.0	3.6	4.7	0.2	13.4	0.0	24.6	21.9	7.1	0.1	15.8	1.6	6.2	0.1	3.3	89.7	30.4	6.6	14.0	12.1	18.0	11.4	5.5	1.0	12.3	1.2	8.4	0.6	9.5
LDB1	"CLIM2, NLI"	ENSG00000198728	"LIM domain binding 1"	Q86U70	10	102106489-102120368	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034488	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA034488: AB_10669783"	"unprognostic (8.83e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.54e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.09e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.26e-2)"	41.3	38.0	48.0	42.9	51.2	122.4	44.0	42.8	57.4	89.1	55.8	73.8	31.1	81.5	38.1	54.1	68.9	49.1	60.6	49.4	47.0	40.5	20.5	46.6	61.5	42.1	42.2	117.9	29.4	55.6	52.3	49.1	40.0	58.4	27.5	41.6	65.6	71.6	52.5	149.9	51.7	52.8	38.2	60.8	44.4	30.6	45.8	59.3	49.5	31.6	55.3	65.4	72.4	48.5	42.6	53.5	105.8	128.0	41.3	44.6	52.7	43.8	70.2	48.7	42.3	38.3	36.3	64.8	60.8	56.7	23.0	85.8	48.9	87.3	25.9	55.7	46.9	208.2	62.7	38.6	49.0	56.1	67.8	97.4	70.0	40.2	46.3	177.3	52.0	59.7	128.3	69.1	38.6	41.9	101.1	89.5	52.1	20.4	26.4	112.0	68.4	46.9	46.7	47.3	42.6	103.8	30.9	34.1	51.6	69.0	162.5	36.3	53.8	29.5	60.0	26.8	37.3	58.7	54.4	44.3	49.7	125.7	27.2	2.9	2.0	1.9	2.1	2.9	1.3	2.0	1.5	2.1	1.3	2.4	2.0	1.6	4.8	2.0	4.9	1.4	1.6	1.3	48.0	51.2	42.8	57.4	49.4	47.0	42.1	42.2	40.0	38.2	45.8	48.5	6.4	32.1	11.0	5.2	8.1	22.8	2.8	4.6	17.6	18.5	8.4	7.9	9.1	2.8	6.9	3.7	4.2	4.8	11.7	3.2	0.0	7.7	2.1	7.7	11.1	6.9	8.3	17.0	9.8	5.6	6.3	7.0	5.6	9.3	9.5	9.5	5.3	2.2	8.9	15.2	10.4	1.4	4.1	5.4	7.5	3.0	6.2	7.3	3.6	12.2	4.0	11.8	6.2	5.5	6.6	7.5	2.0	6.4	7.7	2.7	1.9	1.4	3.5	6.1	0.0	6.9	8.2	7.6	7.3	10.7	21.2	7.8	10.0	10.3	2.6	2.0
LRRC34	MGC27085	ENSG00000171757	"Leucine rich repeat containing 34"	Q8IZ02	3	169793003-169812986	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 12.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 137.9;Respiratory ciliated cells: 129.6;Spermatocytes: 104.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 8.1;HL-60: 8.9;JURKAT: 7.1;NTERA-2: 7.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA035747	Approved		Approved	"Cell Junctions,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 36: HEL - Hemostasis"	"Cluster 49: Ciliated cells - Cilium organization"	"Cell Junctions, Microtubules"	"Cytokinetic bridge, Mitotic spindle"	"HPA035747: AB_10670120"	"unprognostic (1.04e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (5.64e-2)"	"unprognostic (9.74e-3)"	"unprognostic (5.46e-2)"	"unprognostic (9.74e-2)"	"unprognostic (8.24e-2)"	"unprognostic (6.39e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.79e-1)"	1.5	0.4	1.6	0.6	2.1	1.4	1.1	1.6	2.7	0.9	2.8	0.5	0.2	0.7	0.3	0.2	5.5	0.3	1.1	1.2	2.1	0.7	0.2	1.0	0.8	2.1	2.5	0.8	0.2	0.3	2.8	0.2	2.2	0.6	0.1	5.6	0.3	0.7	0.4	0.5	0.4	0.2	2.1	0.7	0.4	12.8	1.9	0.6	0.9	0.4	0.3	0.4	0.4	1.8	2.3	0.4	0.5	0.0	0.9	3.0	0.0	0.9	1.9	2.4	2.1	0.1	0.0	1.5	0.1	0.6	3.1	0.0	1.8	0.0	0.8	0.4	5.6	8.1	0.2	0.0	0.6	8.9	1.8	0.9	0.4	0.8	0.0	0.1	1.6	7.1	0.2	0.0	0.9	0.0	0.8	1.1	7.7	0.0	2.6	4.0	0.0	0.4	2.1	0.2	4.0	3.1	0.5	0.3	0.0	0.2	0.0	4.2	0.5	0.4	0.0	0.3	0.1	0.1	0.1	1.9	3.5	0.1	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.1	1.6	2.1	1.6	2.7	1.2	2.1	2.1	2.5	2.2	2.1	1.9	1.8	3.9	3.2	2.6	8.5	1.5	0.4	0.9	5.3	0.0	6.9	0.4	0.9	3.2	0.0	12.9	5.5	37.5	0.2	1.6	0.1	1.9	0.5	137.9	33.8	5.8	3.0	4.2	4.2	15.1	0.2	0.3	5.0	0.5	1.0	1.3	1.0	10.4	0.3	2.4	11.8	12.5	0.4	6.1	0.8	1.2	36.3	10.5	1.2	0.0	3.7	3.8	7.4	0.0	9.5	3.6	0.3	0.0	10.5	0.7	0.4	0.0	3.6	129.6	18.8	0.0	3.6	3.7	104.4	9.2	0.1	0.3	0.5	0.9	1.9	0.2	0.4
LRRC7	"densin-180, KIAA1365"	ENSG00000033122	"Leucine rich repeat containing 7"		1	69567922-70151945	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	9	"brain: 20.2"	"Group enriched"	"Detected in many"	20	"Excitatory neurons: 1132.4;Inhibitory neurons: 996.9;Oligodendrocyte precursor cells: 1038.0;Oligodendrocytes: 408.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 6.9;basal ganglia: 17.0;cerebral cortex: 20.2;hippocampal formation: 17.7;thalamus: 11.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HaCaT: 12.6;HEL: 44.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA005625			Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA005625: AB_1853340"	"unprognostic (2.81e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.64e-6)"	"unprognostic (1.31e-2)"	"unprognostic (1.74e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.08e-3)"	0.1	0.2	6.9	0.1	17.0	0.2	0.0	0.0	20.2	0.2	0.0	0.4	0.1	0.2	0.1	0.2	0.0	1.0	1.4	17.7	1.7	0.8	0.2	0.0	0.1	0.0	2.2	0.1	0.8	0.1	0.0	0.2	0.0	0.3	0.6	1.5	0.0	0.1	1.0	0.2	0.2	0.2	0.0	0.0	0.2	1.6	11.4	0.0	2.2	0.0	0.0	0.1	0.1	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.4	4.4	0.0	0.0	12.6	0.3	0.0	0.0	0.0	0.6	44.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	4.7	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.1	0.0	0.0	0.0	0.0	6.9	17.0	0.0	20.2	17.7	1.7	0.0	2.2	0.0	0.0	11.4	2.9	0.8	0.0	0.0	41.4	2.5	0.8	0.6	0.4	1.8	44.4	0.3	0.3	6.2	2.8	0.2	0.0	2.1	0.4	2.4	0.0	0.0	0.0	29.4	0.5	1.4	1.2	0.0	3.2	1132.4	0.0	0.5	1.8	0.0	1.4	0.0	0.6	2.9	6.5	0.3	6.7	996.9	0.0	0.0	2.8	3.6	6.3	0.6	0.5	5.4	17.8	1.7	1.0	2.1	1038.0	408.2	0.0	0.0	3.0	1.3	0.9	0.0	1.6	0.1	8.3	0.0	1.4	1.5	9.2	3.0	0.5	1.3	0.1	2.3	0.1	0.0	0.1
LRRC75A	"C17orf76, FAM211A, FLJ35696"	ENSG00000181350	"Leucine rich repeat containing 75A"	Q8NAA5	17	16441577-16492193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 62.1;SK-MEL-30: 21.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028528, HPA065840"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA028528: AB_10600755, HPA065840: "	"unprognostic (1.09e-1)"	"unprognostic (5.60e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.85e-5)"	"unprognostic (3.93e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (7.74e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (7.46e-5)"	"unprognostic (8.36e-2)"	"unprognostic (4.28e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.06e-1)"	5.5	21.5	6.8	6.4	5.0	16.1	0.5	1.8	7.7	1.3	0.1	20.2	47.4	4.0	0.2	2.1	1.3	3.1	2.4	6.8	6.5	2.0	0.6	4.6	5.6	4.1	6.7	4.4	7.0	4.7	3.1	3.4	5.1	1.9	9.0	2.3	1.3	1.1	2.9	2.2	44.0	2.3	3.4	21.5	7.4	10.6	5.1	0.5	4.9	0.6	1.6	1.5	0.5	5.3	8.9	6.3	7.6	6.0	0.2	0.2	1.3	2.4	0.4	1.8	1.5	7.9	2.6	0.6	6.6	0.2	3.7	3.7	0.2	0.0	0.0	3.4	6.5	62.1	3.9	0.0	0.3	1.5	7.3	0.0	0.0	0.4	0.0	3.2	2.3	9.4	3.9	1.7	0.1	12.8	15.3	6.7	1.7	20.3	0.7	5.8	5.5	0.8	0.4	1.8	16.6	4.6	0.6	1.8	21.7	3.3	1.4	1.4	0.0	2.2	10.5	6.7	11.9	12.2	2.6	2.0	0.8	5.1	7.0	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.7	0.3	0.4	1.0	0.0	0.0	0.4	6.8	5.0	1.8	7.7	6.8	6.5	4.1	6.7	5.1	3.4	5.1	5.3	40.5	41.7	69.7	10.7	21.6	0.0	9.6	0.0	2.2	9.1	24.9	13.3	0.7	14.3	19.8	1.8	6.2	16.1	24.8	52.5	19.6	3.9	7.1	30.0	61.0	14.7	24.7	9.7	5.3	7.1	20.4	30.5	2.0	58.7	29.7	25.0	11.0	10.0	12.0	3.3	3.6	52.2	0.0	13.9	0.0	8.0	16.4	22.9	0.0	1.0	7.7	21.3	2.1	4.0	4.2	6.2	36.0	11.3	12.0	8.7	65.4	19.4	8.7	18.2	13.1	22.9	19.4	8.0	6.5	1.1	0.0	16.7	18.6	66.3	66.0	7.5
LRTM1	HT017	ENSG00000144771	"Leucine rich repeats and transmembrane domains 1"	Q9HBL6	3	54918231-54967088	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"retina: 78.9;skeletal muscle: 25.8"	"Cell type enriched"	"Detected in some"	12	"Bipolar cells: 389.8"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEL: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 56: Bipolar cells - Visual perception"								"unprognostic (2.28e-1)"	"unprognostic (1.58e-2)"								"unprognostic (9.56e-2)"	"unprognostic (2.16e-1)"		"unprognostic (1.87e-3)"	0.1	0.0	2.7	0.0	4.0	0.0	0.5	0.8	3.7	0.2	3.2	0.3	0.0	0.0	0.2	4.0	0.1	0.0	0.1	2.5	3.9	0.0	0.3	0.2	0.1	1.1	1.6	0.0	0.1	0.1	0.0	0.5	1.4	1.1	0.1	78.9	1.0	0.5	25.8	0.0	0.2	0.0	0.5	6.6	0.1	0.5	1.4	0.1	0.3	2.5	0.1	0.1	0.0	3.3	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.4	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.0	0.4	0.1	0.2	0.0	1.1	0.3	0.2	0.0	0.0	0.2	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.5	0.0	0.1	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.1	2.7	4.0	0.8	3.7	2.5	3.9	1.1	1.6	1.4	0.5	1.4	3.3	0.2	0.0	0.0	5.9	0.0	0.4	0.6	0.1	0.0	389.8	0.0	0.0	0.5	0.0	0.0	1.8	16.7	9.3	0.0	0.1	0.0	0.0	3.0	0.1	0.2	1.0	0.0	0.0	27.1	0.4	1.3	1.2	0.0	0.3	0.0	0.2	0.0	0.0	0.7	1.7	10.9	0.0	0.0	0.0	0.6	0.7	5.9	0.1	0.0	1.9	0.1	17.2	0.0	4.0	0.5	2.0	0.0	4.5	0.0	0.6	0.0	0.0	0.0	30.8	0.0	3.2	1.6	3.1	3.7	0.0	0.4	22.2	0.1	0.5	0.0	0.4
LRTM2		ENSG00000166159	"Leucine rich repeats and transmembrane domains 2"	Q8N967	12	1820267-1836753	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 11.8"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 7.9;Excitatory neurons: 10.2;Horizontal cells: 11.8;Inhibitory neurons: 7.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEL: 4.3;SCLC-21H: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA055094, HPA062745"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA055094: AB_2682693, HPA062745: "	"unprognostic (1.84e-3)"			"unprognostic (4.83e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"		"unprognostic (5.49e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.24e-1)"		"unprognostic (6.20e-4)"	"unprognostic (2.21e-1)"	"unprognostic (8.02e-2)"		0.0	0.0	2.9	0.0	11.4	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	3.6	0.0	0.0	0.0	0.0	0.6	4.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	11.4	0.0	3.8	3.9	3.6	0.6	4.8	0.5	0.2	11.8	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	7.8	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0
LY6G6D	"C6orf23, G6D, Ly6-D, MEGT1, NG25"	ENSG00000244355	"Lymphocyte antigen 6 family member G6D"	O95868	6	31715356-31717804	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skin 1: 24.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	22	"colorectal cancer: 18.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEL: 1.7"	"Region enhanced"	"Detected in many"		"cerebellum: 6.1"					HPA054412	Uncertain				"Intracellular and membrane"	NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 36: HEL - Hemostasis"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA054412: AB_2682480"			"unprognostic (5.48e-2)"		"unprognostic (1.25e-1)"					"unprognostic (2.81e-2)"		"unprognostic (2.13e-1)"						0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	3.9	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.1	0.1	0.0	0.0	1.4	0.0	24.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0
LY6G6E	"C6orf22, G6e"	ENSG00000255552	"Lymphocyte antigen 6 family member G6E"		6	31711771-31714065	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"bone marrow: 1.4;skin 1: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	114	"HEL: 23.7"									HPA056234			Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA				"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"		Nucleoplasm		"HPA056234: AB_2732601"			"unprognostic (1.77e-1)"							"unprognostic (1.58e-2)"				"unprognostic (2.25e-1)"		"unprognostic (6.88e-2)"		0.1	0.0	0.2	0.0	0.2	1.4	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.8	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.4	0.1	0.1	0.2	0.1	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LY6G6F	"C6orf21, G6f, LY6G6D, NG32"	ENSG00000204424	"Lymphocyte antigen 6 family member G6F"	Q5SQ64	6	31706866-31710679	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.7;lymphoid tissue: 1.2;skin 1: 1.3"	"Cell type enriched"	"Detected in some"	9	"Macrophages: 9.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.6"	"Cell line enriched"	"Detected in single"	379	"HEL: 37.8"	"Low region specificity"	"Detected in many"							HPA008053	Uncertain					NA	NA		380000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA008053: AB_1840160"			"unprognostic (3.77e-1)"							"unprognostic (7.01e-2)"						"unprognostic (2.66e-3)"		0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	2.6	0.0	0.0	0.5	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	9.1	0.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MAGI1	"AIP3, BAIAP1, BAP1, MAGI-1, TNRC19, WWP3"	ENSG00000151276	"Membrane associated guanylate kinase, WW and PDZ domain containing 1"	Q96QZ7	3	65353525-66038834	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 497.7;Inhibitory neurons: 809.8;Oligodendrocyte precursor cells: 368.4;Oligodendrocytes: 532.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 36.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031851, HPA031853, HPA077002"	Supported		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Cell Junctions"	Nucleoplasm	"HPA031851: AB_10599289, HPA031853: AB_10602095, HPA077002: "	"unprognostic (5.00e-2)"	"unprognostic (9.84e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.46e-3)"	"unprognostic (8.59e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.05e-3)"	"prognostic favorable (4.55e-8)"	"unprognostic (3.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-2)"	"unprognostic (8.03e-2)"	11.3	5.0	3.7	1.3	4.8	0.0	12.5	6.3	5.9	5.5	3.9	9.7	5.0	6.2	2.0	8.0	5.8	5.3	9.0	4.7	5.3	10.2	13.4	8.8	1.1	3.7	3.8	2.7	12.6	5.9	7.7	5.3	2.6	7.1	4.2	7.0	11.6	4.9	3.8	12.5	6.4	3.1	2.7	11.9	14.7	10.3	4.1	2.0	13.4	4.1	1.8	5.4	7.2	4.9	4.1	2.2	12.3	1.3	2.4	1.7	5.5	7.0	5.9	2.6	4.0	15.1	3.5	0.0	1.0	8.3	2.1	1.2	3.4	2.4	4.1	0.0	1.9	36.1	4.3	10.2	1.5	0.0	1.1	2.7	2.0	8.9	1.8	6.8	6.0	4.7	15.6	0.0	2.8	3.1	0.0	0.0	16.6	12.2	2.1	0.0	3.5	0.9	3.1	13.5	3.9	10.8	2.7	3.3	0.1	8.0	6.4	0.0	1.6	8.2	6.0	2.1	2.9	0.0	0.0	0.0	4.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	4.8	6.3	5.9	4.7	5.3	3.7	3.8	2.6	2.7	4.1	4.9	102.8	76.9	29.8	204.7	1.3	22.3	17.7	7.9	26.2	98.3	46.5	37.5	35.6	102.9	22.5	23.9	75.0	20.2	0.5	51.0	3.9	44.3	179.1	35.8	35.5	55.5	36.5	2.7	497.7	31.8	2.4	9.6	47.4	50.8	1.3	78.4	82.5	60.9	4.8	232.2	809.8	40.3	12.2	5.0	3.6	27.0	6.5	1.8	5.4	170.5	0.6	15.2	0.0	368.4	532.1	40.3	25.4	8.6	0.2	14.7	33.2	12.2	40.3	26.4	32.9	7.0	17.5	44.7	12.3	12.7	18.8	5.1	2.7	27.1	26.3	11.9
MAN2A2	"HsT19662, MANA2X"	ENSG00000196547	"Mannosidase alpha class 2A member 2"	P49641	15	90902218-90922584	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 92.6;Rod photoreceptor cells: 74.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.8;neutrophil: 7.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 100.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077930			Approved	"Cytoplasmic bodies"		NA	NA		43000000	"Cluster 38: Basophils - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Cytoplasmic bodies"		"HPA077930: AB_2732363"	"unprognostic (5.17e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (8.95e-4)"	"unprognostic (7.55e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.33e-2)"	24.8	18.3	29.7	12.8	53.6	78.2	22.9	43.4	38.9	12.3	12.7	18.2	13.3	11.0	9.4	9.2	14.7	9.6	41.7	29.8	36.6	15.1	34.5	22.9	14.1	51.9	47.4	15.8	44.3	13.4	25.0	11.4	53.3	14.3	8.9	74.9	28.1	12.9	61.0	16.8	20.9	7.7	34.7	35.1	24.4	15.4	49.0	12.3	21.9	44.0	9.9	13.3	10.6	85.1	14.4	15.4	9.6	22.3	27.7	7.0	20.2	11.3	9.6	11.9	8.6	13.2	9.6	2.1	24.6	12.0	9.2	16.0	11.0	6.5	6.0	35.2	29.5	100.7	23.8	8.8	8.4	16.4	55.4	5.4	10.9	13.1	9.7	20.2	13.4	26.8	41.7	11.7	4.7	20.4	8.8	30.9	3.2	22.3	5.0	12.5	10.1	13.8	12.1	35.1	25.1	15.6	15.0	24.2	20.3	9.2	11.5	42.5	11.9	8.5	9.3	10.4	12.8	19.6	62.3	5.2	9.8	21.0	14.5	8.8	1.2	0.5	1.0	0.8	0.7	0.8	0.4	0.6	0.2	0.9	0.3	0.3	7.9	0.1	2.9	1.6	1.1	1.4	29.7	53.6	43.4	38.9	29.8	36.6	51.9	47.4	53.3	34.7	49.0	85.1	22.3	12.8	22.6	20.2	5.5	6.0	3.4	2.8	4.0	26.4	9.9	8.8	14.7	12.8	7.7	9.2	27.1	10.0	10.6	12.2	0.0	5.0	9.1	6.6	9.6	9.5	4.2	19.1	27.3	6.5	2.3	7.5	13.3	12.9	15.8	7.1	7.1	22.5	6.0	25.2	26.6	6.4	2.0	13.9	14.1	7.1	6.8	17.9	30.2	11.2	11.7	17.4	3.1	29.7	92.6	3.8	4.3	4.9	6.9	5.3	8.7	2.9	4.5	74.5	13.1	12.0	11.4	12.4	9.6	5.2	4.7	7.5	10.2	1.6	9.3	3.6
MAST4	KIAA0303	ENSG00000069020	"Microtubule associated serine/threonine kinase family member 4"	O15021	5	66596361-67169595	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 519.7;Basal prostatic cells: 507.3;Excitatory neurons: 636.6;Inhibitory neurons: 489.6;Suprabasal keratinocytes: 399.2;Urothelial cells: 676.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 27.7"	"Immune cell enhanced"	"Detected in many"		"basophil: 15.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 33.2;HDLM-2: 43.2;HEL: 35.5;RT4: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000544	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA000544: AB_1079315"	"unprognostic (1.77e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.83e-2)"	"prognostic favorable (5.18e-5)"	"unprognostic (9.01e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.79e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.08e-2)"	14.9	11.0	4.6	4.5	5.2	1.9	11.1	0.9	27.7	12.1	0.0	6.0	5.1	10.0	5.0	27.0	9.4	8.0	29.5	4.2	5.4	12.0	8.4	11.0	4.4	5.0	5.5	16.4	4.6	15.3	4.6	8.8	1.2	7.6	4.1	4.7	11.5	6.6	11.2	14.8	4.5	9.3	1.1	5.0	7.0	10.0	3.3	16.8	6.5	7.2	10.1	16.0	21.2	11.4	14.6	7.8	3.8	0.2	12.4	10.9	9.0	3.2	4.9	1.1	1.0	7.3	3.9	1.0	6.5	2.7	2.9	12.8	11.8	33.2	1.3	43.2	3.8	35.5	4.7	3.1	0.9	0.1	11.9	18.4	17.8	7.1	14.2	13.3	26.2	3.2	3.5	3.9	8.9	12.6	5.1	0.2	2.5	1.2	6.3	1.1	3.3	0.7	3.1	42.9	5.5	4.4	4.3	1.7	0.2	2.7	2.8	0.2	25.2	3.0	4.1	4.6	5.4	9.9	4.8	0.2	7.7	0.1	2.4	15.2	0.3	0.8	0.9	0.4	2.5	2.9	4.0	1.0	0.4	2.5	4.2	1.8	3.5	2.3	0.9	1.0	6.9	1.3	4.6	5.2	0.9	27.7	4.2	5.4	5.0	5.5	1.2	1.1	3.3	11.4	130.2	32.1	53.3	519.7	11.4	368.6	507.3	127.9	114.9	15.9	79.3	38.1	139.1	27.1	78.7	18.4	2.1	40.7	4.9	24.4	37.2	59.0	129.2	35.8	5.3	111.8	32.2	5.5	636.6	115.8	50.0	33.2	28.5	55.3	93.8	19.4	70.6	42.2	5.1	8.4	489.6	18.1	40.7	6.9	33.7	127.4	41.3	9.8	48.0	78.7	2.1	55.2	4.1	165.9	108.4	70.8	27.2	32.7	13.5	355.5	14.8	93.9	57.2	4.5	39.5	15.9	31.1	14.8	9.2	211.7	399.2	137.2	21.0	14.7	16.1	676.4
MED12L	"KIAA1635, TNRC11L, TRALP, TRALPUSH"	ENSG00000144893	"Mediator complex subunit 12L"	Q86YW9	3	151085697-151437072	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	"Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"choroid plexus: 24.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 383.3;Excitatory neurons: 302.4;Inhibitory neurons: 120.7;Oligodendrocyte precursor cells: 225.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.3;plasmacytoid DC: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 18.5;HEL: 20.9;JURKAT: 13.0;MOLT-4: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036807	Enhanced		Approved	Nucleoli		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli		"HPA036807: AB_10670242"	"unprognostic (1.01e-2)"	"unprognostic (5.82e-2)"	"unprognostic (5.12e-2)"	"unprognostic (8.14e-4)"	"unprognostic (2.03e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.36e-3)"	"unprognostic (3.84e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.92e-2)"	0.7	1.5	0.7	0.4	2.6	4.3	0.2	0.3	5.6	1.0	24.1	0.2	1.0	0.4	1.9	0.1	0.3	0.5	0.2	2.4	0.7	0.1	0.0	0.2	1.0	0.2	0.9	0.2	0.1	0.2	1.7	1.2	0.0	0.6	0.0	3.0	0.3	0.3	0.3	0.1	0.4	0.3	0.0	0.4	0.2	4.5	3.6	0.5	0.4	0.0	1.0	0.3	0.4	0.6	0.9	0.4	2.9	0.2	0.1	0.1	18.5	0.0	0.3	0.7	0.8	1.0	0.3	0.0	0.2	0.1	2.1	0.1	3.8	0.3	0.8	0.0	1.8	20.9	0.1	0.1	0.0	0.7	7.1	0.0	0.1	0.1	0.1	0.1	0.0	13.0	0.0	3.1	0.0	3.1	9.9	0.0	3.4	0.1	0.7	0.1	1.1	0.5	0.3	3.0	4.9	0.7	0.4	0.2	0.0	5.2	1.0	0.1	0.0	0.0	2.2	0.0	1.5	5.9	0.0	7.3	0.2	1.8	1.1	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.7	2.6	0.3	5.6	2.4	0.7	0.2	0.9	0.0	0.0	3.6	0.6	0.1	0.0	0.0	383.3	1.0	1.1	1.1	0.3	2.8	11.1	0.5	0.4	1.2	0.0	1.3	1.8	4.2	18.6	0.4	0.2	0.0	0.1	13.2	1.1	0.4	0.4	0.0	13.0	302.4	0.6	1.5	0.9	0.0	0.3	0.0	0.2	0.4	0.2	1.9	33.7	120.7	0.0	0.0	1.6	1.1	7.3	0.9	1.7	0.0	52.5	1.3	26.2	0.0	225.7	9.6	0.2	0.0	0.4	1.3	1.1	0.0	0.5	0.9	1.9	0.0	0.3	0.5	8.2	4.3	0.4	0.1	27.0	0.2	1.1	0.0	0.4
MEF2C		ENSG00000081189	"Myocyte enhancer factor 2C"	Q06413	5	88717117-88904257	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 555.4;tongue: 246.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 471.5;Excitatory neurons: 735.7;Inhibitory neurons: 759.5;Microglial cells: 730.7"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"amygdala: 29.7;basal ganglia: 58.6;cerebral cortex: 75.3;hippocampal formation: 55.7"	"Group enriched"	"Detected in many"	4	"classical monocyte: 72.0;intermediate monocyte: 82.6;memory B-cell: 141.6;myeloid DC: 95.2;naive B-cell: 187.9;non-classical monocyte: 71.5;plasmacytoid DC: 100.3"	"Group enriched"	"Detected in many"	5	"B-cells: 187.9;dendritic cells: 100.3;monocytes: 82.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 103.6;HEL: 229.3;Karpas-707: 121.6;REH: 261.8;WM-115: 145.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 70.0;cerebral cortex: 253.1;hippocampal formation: 220.0;olfactory bulb: 66.8"	"HPA005533, CAB068196, CAB068197"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Vesicles"		"CAB068196: AB_2665646, CAB068197: AB_2665645, HPA005533: AB_1079352"	"unprognostic (2.74e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.78e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (7.18e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.42e-2)"	28.9	26.8	29.7	39.2	58.6	11.1	17.5	0.0	75.3	18.8	0.0	15.9	6.9	25.9	7.3	13.6	17.3	28.5	35.2	55.7	0.0	10.4	10.5	21.3	62.9	0.0	0.0	34.9	5.6	9.3	6.3	45.5	0.0	20.0	15.4	34.2	9.0	17.7	555.4	4.9	11.2	31.5	0.0	43.8	12.7	9.4	0.0	12.8	21.7	246.8	77.7	21.3	7.6	11.0	1.6	0.0	7.1	0.0	7.7	4.6	0.2	2.2	4.5	0.3	1.0	0.2	1.0	103.6	0.6	12.0	2.5	3.1	9.6	9.1	0.2	31.7	12.5	229.3	12.3	0.0	2.8	10.4	0.6	21.6	0.0	0.3	0.0	1.4	35.1	0.0	12.3	121.6	9.0	0.0	0.3	0.1	2.2	0.1	8.4	261.8	63.1	50.5	0.0	1.2	0.0	8.3	0.0	0.7	29.5	3.9	0.3	58.0	40.4	5.6	1.0	0.6	5.4	92.0	11.5	62.0	1.5	70.1	145.2	0.6	72.0	0.2	0.2	82.6	0.1	141.6	0.2	0.1	95.2	187.9	0.2	0.2	24.3	16.7	71.5	100.3	0.5	34.4	29.7	58.6	0.0	75.3	55.7	0.0	0.0	0.0	0.0	0.0	0.0	11.0	367.4	32.1	52.0	117.5	471.5	10.7	4.2	0.0	7.4	22.6	5.2	26.5	86.4	10.0	21.7	1.8	214.8	0.8	138.6	9.2	27.4	0.8	11.0	0.8	13.4	197.5	1.2	59.1	735.7	12.7	1.2	26.8	2.0	1.0	5.1	107.5	283.4	3.4	171.1	5.0	759.5	1.5	0.0	205.8	127.5	8.6	29.8	205.1	67.6	730.7	202.7	61.8	8.2	119.6	18.7	0.4	3.0	71.8	314.7	2.1	0.2	0.8	3.7	202.9	335.2	72.7	257.6	4.0	29.5	2.5	8.4	1.6	12.2	58.6	6.3	2.3
MFSD2B		ENSG00000205639	"Major facilitator superfamily domain containing 2B"	A6NFX1	2	24010081-24063321	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"bone marrow: 11.8"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 25.1;Erythroid cells: 65.2;Prostatic glandular cells: 41.0;Urothelial cells: 30.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 2.9"	"Group enriched"	"Detected in some"	14	"HEL: 8.3;K-562: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA044145	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA044145: AB_2678833"	"unprognostic (5.67e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.84e-1)"	"unprognostic (5.35e-5)"	"unprognostic (2.82e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.42e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.90e-2)"	"unprognostic (6.87e-6)"	"unprognostic (7.76e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.72e-1)"	0.0	0.0	0.2	0.0	0.4	11.8	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	3.6	0.0	0.4	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	1.3	0.2	0.4	0.5	0.3	0.1	0.3	0.2	0.1	0.1	0.0	0.3	0.2	0.1	0.0	1.3	0.3	1.6	10.1	25.1	0.7	0.0	0.9	0.3	0.3	4.6	1.5	0.5	0.0	4.2	6.9	0.2	0.9	3.9	5.0	0.6	0.1	0.3	1.7	1.2	65.2	0.3	1.8	4.4	1.6	0.0	0.3	5.1	0.3	0.4	0.0	3.1	0.0	0.5	2.9	2.0	1.4	5.9	0.8	0.0	4.5	0.0	1.0	0.6	0.1	0.0	0.0	0.3	10.6	2.3	0.0	0.2	41.0	3.1	0.2	0.0	1.5	0.0	1.1	0.7	0.9	2.1	0.0	11.2	7.5	1.1	0.0	5.5	30.3
MKNK1	MNK1	ENSG00000079277	"MAPK interacting serine/threonine kinase 1"	Q9BUB5	1	46557407-46616843	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 128.6"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 142.8;Microglial cells: 100.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB027355, CAB037310, HPA071293"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 36: HEL - Hemostasis"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"CAB027355: AB_2266303, CAB037310: AB_1854049, HPA071293: AB_2686382"	"unprognostic (4.05e-3)"	"prognostic favorable (7.05e-4)"	"unprognostic (5.28e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.38e-2)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (3.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (1.51e-5)"	"unprognostic (7.02e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.67e-1)"	"unprognostic (5.67e-3)"	30.6	21.8	15.5	23.5	14.4	30.3	23.1	19.0	18.0	22.8	17.0	27.4	15.6	18.5	12.0	23.5	21.4	16.1	22.3	15.1	14.6	17.5	21.8	31.5	17.0	14.2	13.3	19.0	128.6	12.0	18.4	22.1	14.4	19.4	17.7	3.9	16.7	8.5	23.9	18.0	24.9	18.4	13.7	48.1	23.1	12.4	16.6	22.6	16.2	23.9	13.8	20.1	20.7	16.5	34.1	21.7	13.5	15.7	12.0	17.9	18.0	16.7	16.4	20.7	27.1	26.4	13.5	23.1	20.2	17.8	23.0	38.5	23.8	27.5	23.1	37.7	21.4	47.8	28.3	21.7	17.3	25.4	34.8	22.0	17.7	25.2	13.4	10.8	24.1	26.2	24.7	16.6	12.2	21.5	18.3	21.8	9.9	19.6	24.8	16.7	30.5	22.1	20.2	35.2	10.4	9.0	32.3	27.9	25.6	26.5	21.5	28.6	18.5	7.6	1.4	22.2	19.9	12.6	23.7	21.2	14.6	31.9	13.4	9.7	26.3	36.1	15.3	25.7	44.7	9.9	12.9	14.2	13.1	11.6	9.2	13.9	69.7	11.2	20.6	9.7	10.6	14.5	15.5	14.4	19.0	18.0	15.1	14.6	14.2	13.3	14.4	13.7	16.6	16.5	20.3	12.8	21.5	41.4	15.3	13.9	17.8	15.2	9.1	19.4	17.8	12.3	19.2	15.7	17.8	22.0	2.1	21.6	23.7	27.9	7.9	18.9	15.5	12.5	12.8	18.3	16.8	21.9	42.2	37.1	34.2	20.5	11.7	13.3	12.0	22.8	18.2	22.7	142.8	18.5	52.7	12.0	4.1	84.5	61.0	23.8	21.5	49.9	10.6	100.2	26.7	5.2	21.6	21.6	8.5	32.3	17.7	36.5	13.3	19.5	27.8	15.7	11.1	5.0	6.6	31.2	15.0	15.3	17.2	22.6	11.1	18.5	25.2	35.1	15.0	29.6
MLLT3	"AF-9, AF9, YEATS3"	ENSG00000171843	"MLLT3 super elongation complex subunit"	P42568	9	20341669-20622499	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Astrocytes: 144.6;Excitatory neurons: 284.0;Inhibitory neurons: 288.4;Intestinal goblet cells: 112.3;Microglial cells: 114.3;Oligodendrocyte precursor cells: 254.3;Oligodendrocytes: 216.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"NK-cells: 5.1;T-cells: 16.3"	"Cell line enriched"	"Detected in many"	5	"HEL: 316.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001824	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Cytosol	"HPA001824: AB_1079394"	"unprognostic (3.31e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.57e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (1.85e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.68e-1)"	6.7	15.4	11.6	10.0	16.0	37.3	12.7	9.7	16.4	11.7	2.6	28.8	8.1	12.6	10.6	8.8	12.8	13.9	8.9	17.4	10.9	12.3	2.4	12.6	11.3	6.4	7.8	11.9	4.8	10.1	9.8	11.9	6.6	12.7	37.8	8.2	25.3	12.8	11.1	7.0	15.7	12.3	6.4	6.9	20.1	4.2	9.1	24.3	27.2	11.1	8.3	10.6	6.3	12.0	8.7	24.4	8.4	9.6	19.8	11.7	5.4	22.3	37.8	9.6	11.5	22.8	8.2	36.1	11.9	10.6	3.2	4.4	8.5	38.0	9.2	68.0	23.6	316.4	68.3	12.3	13.8	4.9	20.1	9.4	15.4	3.8	25.3	34.7	9.8	13.8	0.4	42.5	21.7	6.8	24.9	18.6	5.1	50.8	6.8	0.0	15.4	8.8	50.0	13.4	27.2	11.0	18.1	10.2	10.1	8.4	9.3	11.9	6.5	0.0	5.6	6.0	8.3	18.4	18.7	13.1	0.4	10.6	4.8	2.3	0.4	0.6	4.5	0.3	4.3	0.6	8.6	6.5	0.9	1.4	16.3	10.3	0.1	5.1	0.4	0.6	10.8	3.6	11.6	16.0	9.7	16.4	17.4	10.9	6.4	7.8	6.6	6.4	9.1	12.0	20.0	28.9	30.0	144.6	8.0	8.3	15.9	18.7	21.1	7.8	21.2	12.3	13.5	18.6	32.5	22.0	33.3	0.9	17.3	23.5	13.7	29.2	3.0	10.3	17.5	13.7	33.0	28.4	284.0	8.2	6.1	18.0	23.0	19.5	12.0	8.7	11.4	2.2	2.4	5.0	288.4	112.3	16.2	1.9	6.5	7.4	13.7	7.1	23.2	114.3	2.7	31.9	17.5	254.3	216.6	27.3	23.6	9.4	18.2	14.5	13.8	9.0	11.7	2.2	0.0	25.2	21.6	1.0	10.5	14.2	8.4	1.6	33.3	9.8	27.0	15.7
MOB1B	"MOB4A, MOBKL1A"	ENSG00000173542	"MOB kinase activator 1B"	Q7L9L4	4	70902326-71022449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 71.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047088, HPA071690"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA047088: AB_2679927, HPA071690: AB_2686432"	"unprognostic (1.05e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (2.94e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-3)"	7.3	7.5	9.4	9.6	12.0	30.0	8.4	5.4	13.0	7.5	19.4	5.8	4.8	7.8	5.0	7.5	8.9	6.9	8.5	19.1	13.5	22.5	6.5	9.6	11.3	9.7	11.3	7.8	8.6	12.5	4.0	8.8	10.0	9.6	6.3	4.9	8.5	5.4	6.1	8.8	5.4	7.7	12.9	8.8	8.1	6.0	8.1	20.0	11.0	6.3	10.3	6.9	5.3	15.8	8.2	6.6	24.2	19.9	12.9	16.2	20.2	24.2	13.2	13.3	11.5	8.8	15.3	45.6	11.5	21.6	9.1	5.7	15.2	20.3	31.9	25.1	5.5	71.5	7.4	6.8	12.9	15.6	13.8	13.5	10.9	14.9	12.0	14.8	15.9	23.4	45.0	14.5	21.3	8.9	49.2	9.7	8.0	5.3	8.5	15.6	23.5	6.1	22.1	14.1	8.4	16.5	10.6	4.7	32.9	12.9	10.9	10.0	19.3	36.6	18.9	16.8	10.0	9.2	3.4	19.1	12.8	11.5	17.2	0.3	1.2	1.1	0.5	0.6	0.4	0.1	0.2	0.2	1.7	0.2	0.3	0.2	0.1	0.2	0.4	2.1	0.6	0.5	9.4	12.0	5.4	13.0	19.1	13.5	9.7	11.3	10.0	12.9	8.1	15.8	11.1	25.6	19.1	42.4	8.9	17.8	6.0	6.1	18.8	3.3	13.7	8.8	17.4	5.7	10.2	44.1	18.8	5.6	31.5	2.6	9.8	5.4	0.8	27.2	16.0	12.8	37.8	99.1	38.4	4.6	5.6	12.1	7.1	25.6	10.8	24.5	9.7	7.1	11.2	6.7	36.5	8.9	4.1	29.2	39.7	1.6	4.4	33.5	10.6	65.6	45.6	6.0	8.2	41.7	12.1	9.4	2.1	8.6	6.9	11.5	1.4	17.1	16.9	4.5	26.3	8.7	23.0	6.4	9.0	15.1	17.0	5.7	10.3	23.4	6.6	9.4
MOB3C	"MOB1E, MOBKL2C"	ENSG00000142961	"MOB kinase activator 3C"	Q70IA8	1	46607715-46616884	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057744			Uncertain	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Intermediate filaments, Cytosol"		"HPA057744: "	"unprognostic (1.76e-3)"	"prognostic favorable (3.16e-5)"	"unprognostic (1.32e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (7.22e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.97e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.61e-3)"	21.2	11.3	11.9	9.4	12.9	5.8	14.2	16.4	11.8	13.3	10.7	15.4	10.3	9.9	10.8	17.5	13.2	11.1	16.6	10.6	15.9	14.3	10.2	16.9	10.1	13.8	12.7	15.6	38.2	11.2	14.1	13.8	13.6	16.6	10.4	1.8	14.2	13.2	24.6	7.8	13.7	11.1	12.7	19.3	14.6	5.7	12.6	9.2	13.1	49.4	10.5	20.8	14.8	11.5	10.6	4.5	2.0	6.1	19.7	15.2	0.9	5.8	14.7	10.3	10.0	1.6	7.3	0.9	6.2	9.9	14.9	14.7	2.2	7.5	5.4	15.7	0.3	24.6	6.1	1.5	10.2	2.1	8.9	12.5	11.3	9.8	2.7	13.7	6.8	2.5	3.8	6.0	4.3	4.4	1.0	3.3	0.7	6.5	12.7	2.8	6.7	4.6	5.7	18.7	0.8	2.5	9.0	6.3	7.4	2.4	3.8	8.2	5.1	5.1	3.6	8.7	5.2	5.6	1.3	0.7	7.7	3.6	4.3	3.0	11.5	22.9	15.8	12.7	27.6	9.3	15.4	15.9	7.9	11.2	13.4	13.6	8.1	22.9	8.4	9.8	11.1	16.8	11.9	12.9	16.4	11.8	10.6	15.9	13.8	12.7	13.6	12.7	12.6	11.5	12.0	6.4	6.9	3.6	4.9	11.1	10.2	5.6	12.5	2.9	6.3	4.8	4.9	5.7	4.6	7.3	0.0	1.9	5.1	7.0	5.9	3.2	7.7	2.0	4.3	7.7	8.4	7.8	0.5	6.3	0.9	9.1	3.1	2.3	5.7	7.7	8.2	3.3	13.1	5.0	0.8	8.9	2.0	8.4	14.9	0.9	6.2	23.9	3.6	5.6	5.9	1.8	4.1	3.5	1.3	3.9	2.7	6.8	5.4	14.5	6.8	4.0	5.4	0.8	6.6	13.7	8.1	0.2	0.4	8.0	6.5	1.4	8.1	6.9	5.7	18.5
MPIG6B	"C6orf25, G6b, G6b-B, NG31"	ENSG00000204420	"Megakaryocyte and platelet inhibitory receptor G6b"	O95866	6	31718594-31726714	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Heparin-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 4.8;skin 1: 8.3"	"Cell type enriched"	"Detected in single"	14	"granulocytes: 10.1"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	14	"HEL: 6.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA054404, HPA073017"			Approved	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		330000	"Cluster 15: NK-cells - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"	"Golgi apparatus"	"Nucleoplasm, Endoplasmic reticulum, Plasma membrane, Cytosol"	"HPA054404: , HPA073017: AB_2686566"	"unprognostic (1.45e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.71e-2)"	0.5	0.0	0.0	0.1	0.0	1.1	0.4	0.1	0.2	1.0	0.1	0.3	0.1	0.4	0.0	1.6	0.5	0.2	0.8	0.1	0.1	0.1	0.3	3.5	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.6	0.0	0.2	8.3	0.4	0.0	0.0	4.8	0.3	2.3	0.1	0.0	0.5	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.8	0.0	2.2	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
MPL	"CD110, THPOR, TPOR"	ENSG00000117400	"MPL proto-oncogene, thrombopoietin receptor"	P40238	1	43337818-43354466	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"Erythroid cells: 3.0;Excitatory neurons: 2.0;Oligodendrocytes: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.4"	"Cell line enriched"	"Detected in some"	57	"HEL: 77.4"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.5"	"Low region specificity"	"Detected in many"			HPA007619			Supported	"Nuclear membrane,Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Nuclear membrane"	"HPA007619: AB_1854080"	"unprognostic (2.74e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.95e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.94e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.19e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.03e-4)"	"unprognostic (1.42e-1)"	0.6	0.4	0.8	0.2	1.7	1.8	0.4	0.8	1.3	0.3	0.1	0.3	0.3	0.7	1.2	0.5	0.8	0.3	1.0	0.6	1.2	0.4	0.4	0.6	0.2	1.2	1.0	2.9	0.8	0.4	0.0	0.3	1.1	0.9	0.4	1.5	0.4	0.7	0.6	0.5	0.2	0.7	0.7	0.4	0.5	1.2	1.1	0.1	0.9	0.3	0.1	0.2	0.0	2.8	0.4	0.7	0.1	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.7	1.3	0.1	0.3	0.1	0.0	0.6	0.0	0.2	0.0	0.4	0.1	77.4	1.2	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.5	0.1	0.1	0.2	0.0	0.2	0.7	0.6	0.4	0.2	0.6	0.1	0.2	0.2	0.3	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.9	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.2	1.4	0.1	0.1	0.3	0.1	1.8	0.8	1.7	0.8	1.3	0.6	1.2	1.2	1.0	1.1	0.7	1.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MS4A2	"APY, FCER1B, IGER, MS4A1"	ENSG00000149534	"Membrane spanning 4-domains A2"	Q01362	11	60088261-60098467	"FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 12.6"	"Cell type enriched"	"Detected in some"	20	"granulocytes: 967.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	908	"basophil: 275.5"	"Lineage enriched"	"Detected in single"	1467	"granulocytes: 275.5"	"Cell line enhanced"	"Detected in some"		"HEL: 2.7;THP-1: 1.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"spinal cord: 15.3"	HPA059967	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"			"HPA059967: AB_2684183"	"unprognostic (7.28e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.50e-4)"	"unprognostic (4.97e-2)"	"unprognostic (4.47e-1)"	"unprognostic (2.40e-6)"	"unprognostic (1.88e-2)"	"unprognostic (6.21e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.63e-3)"	"unprognostic (6.49e-3)"	"unprognostic (9.95e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.74e-1)"	2.6	0.2	0.3	2.4	0.3	0.9	2.7	0.5	0.5	6.3	0.6	4.9	5.5	4.2	3.7	4.8	0.9	8.2	0.6	0.3	0.3	0.5	0.4	12.6	1.1	0.4	0.3	0.1	0.5	0.3	0.1	0.3	0.4	3.0	5.4	0.0	1.8	2.4	2.9	2.5	6.7	4.1	0.3	0.2	5.3	1.0	0.3	1.2	0.1	1.2	1.8	3.8	2.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	275.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.4	0.3	0.3	0.5	0.5	0.3	0.3	0.4	0.3	0.4	0.3	0.3	0.5	0.1	0.0	30.9	0.0	0.3	0.0	0.9	0.0	0.0	0.3	0.1	0.1	0.5	0.0	6.8	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.4	0.1	0.1	0.3	0.0	46.7	0.1	0.0	0.1	1.1	0.0	0.1	967.4	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.0	0.0	0.7	0.4	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.0	12.2	0.0	0.0	0.2
MTSS1	"KIAA0429, MIM, MIMA, MIMB"	ENSG00000170873	"MTSS I-BAR domain containing 1"	O43312	8	124550784-124728473	"Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 208.2;Oligodendrocyte precursor cells: 360.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 168.3"	"Group enriched"	"Detected in all"	5	"B-cells: 50.3;monocytes: 168.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 81.4;HDLM-2: 98.7;HEL: 337.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019613, HPA064003, HPA075540"	Approved	Supported	Approved	"Plasma membrane,Cytosol"		NA	NA		140000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"		"HPA019613: , HPA064003: , HPA075540: AB_2686756"	"unprognostic (1.70e-1)"	"unprognostic (4.13e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.87e-2)"	"unprognostic (7.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (2.11e-7)"	"unprognostic (6.74e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.92e-3)"	24.5	36.2	16.8	13.2	23.2	12.5	14.0	46.1	23.4	12.5	22.3	11.0	6.4	8.4	9.9	45.2	12.5	9.2	17.1	16.3	27.7	24.2	72.9	16.5	16.0	27.5	20.6	10.4	28.5	3.7	11.0	35.7	25.3	10.1	9.1	15.0	13.9	6.3	32.3	30.8	7.9	9.6	20.5	34.5	12.0	22.3	26.4	18.4	6.0	24.4	17.2	15.5	24.3	39.5	3.6	1.1	51.6	1.0	81.4	41.7	0.1	2.1	14.2	1.1	0.5	4.8	0.4	1.6	4.9	0.2	0.4	0.8	0.4	29.2	1.1	98.7	1.2	337.8	0.9	27.0	18.4	0.0	34.5	66.4	65.4	15.9	41.0	2.1	31.5	0.3	0.5	0.3	5.6	2.7	0.8	4.0	1.8	54.8	0.4	0.4	0.1	0.5	11.6	11.3	36.3	2.8	7.9	6.3	26.6	2.5	1.3	1.1	16.7	2.7	1.0	0.2	0.7	0.5	0.3	5.4	29.1	0.4	10.7	3.1	13.1	0.1	22.7	88.1	2.6	44.9	4.8	8.7	11.8	50.3	2.2	6.8	2.2	2.2	168.3	0.2	0.5	29.2	16.8	23.2	46.1	23.4	16.3	27.7	27.5	20.6	25.3	20.5	26.4	39.5	33.0	0.0	26.9	15.7	92.0	35.8	81.4	41.2	9.6	0.0	8.0	19.9	34.9	22.8	30.9	66.2	0.0	36.0	51.4	10.7	21.5	17.6	54.2	25.5	0.9	32.2	44.2	17.2	40.4	5.2	2.3	30.5	26.5	9.7	46.3	0.9	70.3	78.1	74.2	0.0	208.2	17.1	61.1	167.1	116.2	62.1	3.7	96.7	26.6	114.3	90.2	0.0	78.2	360.4	178.4	32.6	15.9	4.5	12.6	71.9	1.2	19.9	42.0	0.0	39.5	25.2	17.3	2.5	10.7	86.1	63.4	94.4	22.7	1.8	15.8	59.2
MTURN	"C7orf41, Ells1, FLJ25903"	ENSG00000180354	"Maturin, neural progenitor differentiation regulator homolog"	Q8N3F0	7	30134986-30162762	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	14	"brain: 1933.2;choroid plexus: 740.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 156.5"	"Cancer enhanced"	"Detected in all"		"glioma: 29.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 8.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 8.2;NK-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 52.9;HEL: 96.2;SCLC-21H: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029507	Enhanced		Approved	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"HPA029507: AB_10601149"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.70e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-3)"	"unprognostic (9.80e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.11e-3)"	"unprognostic (8.11e-3)"	"prognostic favorable (7.64e-13)"	"unprognostic (9.50e-2)"	"unprognostic (7.64e-2)"	"unprognostic (4.64e-1)"	"unprognostic (3.26e-1)"	88.4	10.8	1190.3	9.7	1373.7	23.3	41.6	1103.3	1933.2	25.7	740.3	35.8	5.4	19.4	95.3	19.5	21.1	10.4	25.0	946.3	1044.1	50.3	4.1	20.9	5.4	1359.2	1275.8	33.4	12.9	15.7	17.4	7.5	1312.7	19.2	10.0	41.0	35.2	23.8	36.6	23.2	13.8	17.0	1311.0	8.3	26.4	10.9	1260.6	7.5	14.7	59.8	5.4	32.1	20.0	1483.6	12.5	2.1	7.1	7.6	52.9	35.9	6.4	6.0	7.0	2.0	2.8	1.0	5.0	0.7	4.8	13.3	11.0	2.4	16.4	23.6	6.4	5.4	13.2	96.2	16.1	6.7	4.1	4.8	30.8	17.9	10.8	6.2	10.9	8.6	3.2	13.1	6.4	5.0	13.8	4.8	5.6	2.3	4.9	11.6	7.5	0.5	16.3	21.4	24.1	5.1	68.7	18.2	3.8	19.1	19.4	6.6	13.5	7.1	15.5	7.8	8.5	16.6	8.5	8.3	12.7	1.1	10.4	10.3	4.0	8.2	0.3	3.6	0.3	0.2	0.1	0.5	0.2	0.1	0.4	0.3	0.1	0.3	2.2	2.1	0.0	1.0	0.7	1.4	1190.3	1373.7	1103.3	1933.2	946.3	1044.1	1359.2	1275.8	1312.7	1311.0	1260.6	1483.6	38.9	16.0	20.0	18.6	5.6	37.5	17.8	6.6	13.1	0.0	48.3	40.8	27.6	17.2	10.2	44.1	0.0	2.6	32.1	3.2	156.5	8.3	14.1	46.6	16.9	18.9	54.1	35.1	55.9	8.6	7.3	24.6	7.7	52.6	6.3	16.6	26.0	5.0	5.3	0.0	34.7	9.1	0.0	23.4	16.8	32.5	17.1	29.3	55.2	37.5	12.1	0.0	6.2	16.6	77.1	10.4	5.9	12.4	4.9	26.6	0.4	11.2	26.6	0.0	6.6	17.8	30.2	2.0	7.3	11.4	36.8	2.2	7.4	5.9	6.0	23.0
MYL4	"ALC1, AMLC, GT1, PRO1957"	ENSG00000198336	"Myosin light chain 4"	P12829	17	47200446-47223679	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Atrial fibrillation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	47	"heart muscle: 6347.0"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 2426.3"	"Cancer enriched"	"Detected in some"	5	"thyroid cancer: 11.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	9	"plasmacytoid DC: 1.8"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 1.8"	"Cell line enriched"	"Detected in some"	4	"HEL: 552.8"	"Group enriched"	"Detected in all"	6	"amygdala: 25.8;cerebral cortex: 88.4;hippocampal formation: 25.2;white matter: 50.9"	"Not detected"	"Not detected"			"HPA046859, HPA051884, HPA063034"	Enhanced		Approved	"Plasma membrane"		NA	NA		3100000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane"		"HPA046859: AB_2679842, HPA051884: AB_2681651, HPA063034: AB_2684927"	"unprognostic (2.43e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.12e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.00e-6)"	"unprognostic (1.92e-4)"	"unprognostic (2.54e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.50e-1)"	2.1	0.5	0.2	0.4	0.3	134.6	2.7	0.2	0.4	0.4	0.4	0.8	0.8	0.8	0.0	0.6	0.5	1.0	6347.0	0.3	0.4	1.3	1.4	9.4	0.9	0.3	0.3	0.8	8.6	0.3	0.5	9.1	0.4	1.1	0.3	42.2	3.0	0.2	3.5	1.2	1.3	0.8	0.2	3.1	3.4	15.5	0.3	2.4	11.0	6.4	0.4	0.9	0.8	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.9	0.3	0.0	0.2	0.0	0.9	0.1	1.6	0.9	0.0	0.4	0.0	0.1	0.0	0.0	3.0	0.2	552.8	0.1	0.0	0.0	0.0	0.3	21.2	0.0	0.3	0.1	0.0	1.0	1.4	133.3	0.3	0.2	0.0	10.0	0.1	0.3	0.0	0.4	0.3	12.9	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	24.3	0.0	0.2	4.5	0.0	0.3	0.1	0.0	0.3	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.2	0.3	0.2	0.4	0.3	0.4	0.3	0.3	0.4	0.2	0.3	0.4	3.2	3.2	0.0	0.0	0.7	0.8	0.0	0.0	0.0	5.5	0.0	0.0	2426.3	0.0	0.0	0.0	64.6	0.5	2.7	0.1	0.0	0.1	23.3	0.1	0.0	23.2	0.0	412.8	0.1	0.0	3.9	150.7	1.5	0.1	0.0	0.3	1.8	0.5	1.9	1.7	0.0	0.8	0.0	0.6	0.6	54.6	3.4	34.0	12.4	0.0	1.5	7.9	4.1	0.0	0.1	0.1	0.0	1.5	0.8	0.0	10.9	0.2	0.0	24.4	0.0	0.6	36.5	9.9	0.5	0.0	0.9	1.4	0.3	0.2	1.0	0.0
MYLK3	"caMLCK, MLCK"	ENSG00000140795	"Myosin light chain kinase 3"	Q32MK0	16	46702282-46790407	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 103.4;skeletal muscle: 46.5;tongue: 72.6"	"Group enriched"	"Detected in some"	12	"Cardiomyocytes: 169.0;Endometrial ciliated cells: 44.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 12.9;HEL: 40.2;K-562: 6.5;SK-BR-3: 7.9"	"Group enriched"	"Detected in some"	7	"cerebral cortex: 9.6;hippocampal formation: 5.1"	"Region enriched"	"Detected in single"	5	"hippocampal formation: 3.5"	HPA073447	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Vesicles	"HPA073447: AB_2732225"	"unprognostic (6.01e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.94e-3)"	"unprognostic (2.60e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.97e-1)"	0.0	0.1	1.9	0.1	1.7	0.3	0.1	1.1	2.3	0.4	1.7	0.0	0.1	0.3	0.8	4.3	1.7	0.2	103.4	2.5	2.8	1.1	0.1	0.4	0.2	9.8	12.2	0.3	0.1	0.0	0.4	0.5	8.2	2.2	0.1	0.2	2.1	0.1	46.5	0.1	0.1	0.2	5.9	0.1	0.1	6.0	1.9	0.1	0.1	72.6	0.1	0.0	0.0	3.0	0.0	0.1	0.1	0.1	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.8	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.2	2.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	6.5	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.4	0.0	7.9	0.2	3.5	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.3	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	1.9	1.7	1.1	2.3	2.5	2.8	9.8	12.2	8.2	5.9	1.9	3.0	0.2	0.0	3.3	0.7	0.5	0.0	0.7	0.0	0.0	0.9	1.3	0.0	169.0	0.0	3.7	0.0	2.1	2.0	0.2	0.0	0.0	0.0	8.1	44.8	7.1	1.7	0.0	0.0	0.9	0.2	0.5	6.7	0.0	2.2	1.3	1.6	0.7	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.0	7.2	0.6	0.8	0.0	0.0	0.2	0.8	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.8	0.0	0.2	8.7	1.3	0.0	4.9	2.7	1.0	0.7	0.0	0.0	0.3	0.8	0.7	0.0	0.8
MYLK4	SgK085	ENSG00000145949	"Myosin light chain kinase family member 4"	Q86YV6	6	2663629-2750922	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"skeletal muscle: 30.1;tongue: 72.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 7.8;Inhibitory neurons: 7.2;Microglial cells: 4.7;Oligodendrocyte precursor cells: 8.0;Proximal tubular cells: 4.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HEL: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA015860	Uncertain		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	"Nucleoli, Vesicles"	"HPA015860: AB_2147922"	"unprognostic (1.75e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.63e-2)"	1.2	0.5	0.6	0.3	0.6	0.8	1.0	0.6	0.9	0.6	0.7	0.4	0.3	0.6	0.7	1.3	0.5	0.4	1.4	0.7	0.7	3.0	0.5	1.2	0.4	0.4	0.5	0.4	0.9	0.9	1.3	0.6	0.4	0.7	0.3	0.8	2.4	0.6	30.1	1.4	0.6	0.3	0.4	0.6	0.6	0.4	0.6	0.3	0.8	72.1	0.7	0.6	0.8	0.6	0.1	0.1	0.3	0.6	0.5	0.6	0.3	0.4	0.8	0.2	0.2	0.3	0.6	0.6	0.9	0.4	0.1	1.0	0.1	0.2	0.3	0.1	0.3	7.2	0.4	0.0	0.2	0.2	0.3	0.8	0.3	0.0	0.6	0.3	0.3	0.1	0.0	0.0	0.1	0.3	0.0	0.8	0.1	0.2	0.0	0.5	0.0	0.0	0.4	0.1	0.5	0.3	0.1	0.1	0.3	0.5	0.2	0.5	0.4	0.2	0.0	0.1	0.2	0.2	0.1	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	0.9	0.7	0.7	0.4	0.5	0.4	0.4	0.6	0.6	0.5	3.2	1.1	1.6	0.5	0.1	0.1	0.5	0.6	1.0	0.6	0.3	1.9	1.5	1.0	0.0	0.0	0.3	0.1	0.2	0.0	0.3	0.4	0.1	0.7	0.6	1.2	0.0	7.8	0.2	0.0	0.5	0.0	0.2	0.0	0.6	1.1	0.2	0.3	1.7	7.2	0.0	0.0	0.8	1.2	0.2	0.3	0.4	0.0	4.7	1.1	0.3	0.0	8.0	2.9	0.0	0.0	1.5	0.0	0.2	0.1	4.5	0.3	0.3	0.0	0.8	0.3	0.0	0.3	0.3	0.9	0.3	0.2	0.4	0.3	0.2
MYO3B		ENSG00000071909	"Myosin IIIB"	Q8WXR4	2	170178145-170655171	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 14.1;kidney: 5.3;parathyroid gland: 8.8;retina: 5.8"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 85.5;Early spermatids: 34.2;Inhibitory neurons: 18.3;Late spermatids: 29.6;Rod photoreceptor cells: 51.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HDLM-2: 11.2;HEL: 8.8;RT4: 11.7"	"Region enriched"	"Detected in some"	5	"basal ganglia: 5.2"	"Not detected"	"Not detected"			HPA045483	Approved					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA045483: AB_2679344"	"unprognostic (1.65e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.61e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.12e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.25e-5)"	"unprognostic (2.34e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.07e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	14.1	0.4	0.6	0.1	0.0	0.0	0.3	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	8.8	0.3	0.0	0.0	0.0	0.0	5.8	0.1	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.4	1.3	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	11.2	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	1.1	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.3	0.3	0.6	0.5	0.3	0.0	3.1	0.2	0.3	0.7	0.0	0.5	3.7	85.5	0.0	0.6	0.1	13.7	0.3	34.2	5.3	0.4	0.3	1.8	0.0	1.8	0.0	0.0	0.8	0.0	1.7	0.0	0.1	0.0	0.2	0.0	0.0	18.3	0.6	0.0	0.3	1.1	29.6	0.3	0.2	0.0	1.9	0.0	3.0	0.0	5.5	2.9	0.1	0.0	0.4	0.0	0.2	0.0	0.2	0.2	51.0	0.0	1.7	0.5	1.5	0.8	0.3	0.4	0.1	0.3	0.3	0.0	0.1
MYOCOS		ENSG00000283683	"Myocilin opposite strand"	A0A1B0GUC4	1	171600621-171638799	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"cervix: 5.4;epididymis: 3.4;fallopian tube: 3.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Endometrial ciliated cells: 14.7;Glandular and luminal cells: 4.3;Proximal tubular cells: 5.4"					"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HEL: 27.6"					"Not detected"	"Not detected"									NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 49: Ciliated cells - Cilium organization"																					0.0	0.0	0.6	0.1	0.6	0.4	0.1	1.1	0.7	5.4	0.5	0.1	0.2	1.2	3.4	0.2	3.0	0.3	0.1	0.6	0.5	1.0	0.2	0.2	0.3	0.4	0.4	0.2	0.6	0.0	0.0	0.3	0.4	0.2	0.2	0.7	0.1	0.7	0.4	0.2	0.2	0.1	0.3	0.1	0.3	1.1	0.5	0.0	0.8	0.0	0.2	0.3	0.0	0.6	0.0	0.5	0.4	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.3	0.1	3.3	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	27.6	0.5	0.5	0.1	0.1	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.8	0.5	0.1	0.2	0.0	0.1	0.1	0.5	0.1	0.0	0.0	0.1	0.9	1.8	0.2	0.0	0.0	0.0	0.1	0.3	0.3	0.1	0.0	0.1	0.0	0.2	0.1	0.7	0.1	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.6	0.6	1.1	0.7	0.6	0.5	0.4	0.4	0.4	0.3	0.5	0.6	0.1	3.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.7	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0
MYZAP	"GCOM1, Gup, Gup1, MYOZAP"	ENSG00000263155	"Myocardial zonula adherens protein"	P0CAP1	15	57591904-57685364	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"heart muscle: 588.9"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 481.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 3.4;naive CD4 T-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 137.3;hTERT-HME1: 24.0;HUVEC TERT2: 28.3;OE19: 47.5;RT4: 25.1;TIME: 33.1"									HPA039827	Approved					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA039827: AB_10673364"	"unprognostic (1.30e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.26e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.10e-3)"	"unprognostic (5.19e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.77e-2)"	65.3	54.7	2.0	2.6	2.4	4.0	22.3	6.3	1.8	17.3	1.3	18.1	16.8	29.4	1.8	41.4	4.7	4.8	588.9	1.8	2.5	5.7	2.4	31.8	6.0	6.7	2.8	5.1	35.1	0.6	1.7	56.6	7.7	19.8	11.8	1.3	18.3	38.2	11.6	9.6	15.4	17.2	1.6	12.4	23.4	2.5	3.5	1.4	3.7	15.5	8.6	84.1	26.9	1.7	6.0	1.7	0.0	10.5	2.3	0.1	3.2	0.9	8.6	1.4	1.7	7.3	4.1	0.1	0.7	0.0	8.9	2.6	0.0	4.4	1.7	0.0	0.2	137.3	1.7	0.1	0.4	0.0	0.1	0.0	3.1	0.3	24.0	0.1	28.3	0.2	1.9	0.0	0.7	2.3	0.0	0.1	0.1	47.5	2.4	0.0	11.4	0.3	0.0	25.1	0.0	4.1	0.6	5.9	0.0	1.2	7.9	0.1	33.1	0.1	2.6	0.4	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.4	0.0	0.0	3.4	2.0	0.0	0.5	0.0	0.8	0.0	0.2	2.4	2.0	2.4	6.3	1.8	1.8	2.5	6.7	2.8	7.7	1.6	3.5	1.7	22.9	9.6	0.6	0.0	0.3	0.0	10.2	0.0	0.0	0.3	3.0	1.0	481.4	5.7	0.6	25.8	0.0	4.4	0.0	26.9	7.9	32.5	0.1	1.1	3.0	15.1	1.8	1.3	0.0	18.9	2.4	9.8	7.1	3.5	0.0	65.1	4.6	0.2	1.4	0.0	0.0	7.9	0.0	7.9	0.0	0.7	4.7	8.7	0.0	0.0	3.4	0.6	0.0	0.0	0.0	21.5	24.9	17.0	0.0	11.0	18.1	0.3	0.7	0.2	0.0	0.2	8.1	0.0	1.6	0.0	0.0	1.2	0.2	13.2	6.6	22.4
NCAPD3	"CAP-D3, FLJ42888, hCAP-D3, hcp-6, hHCP-6, KIAA0056"	ENSG00000151503	"Non-SMC condensin II complex subunit D3"	P42695	11	134150113-134225454	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"prostate: 58.5"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	8	"prostate cancer: 50.8"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040286			Supported	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 72: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA040286: AB_2676918"	"unprognostic (4.27e-2)"	"unprognostic (6.05e-2)"	"unprognostic (7.78e-3)"	"unprognostic (8.22e-3)"	"unprognostic (2.79e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.32e-2)"	"unprognostic (4.75e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.48e-1)"	4.7	5.5	1.9	3.1	2.0	10.0	4.9	4.0	3.8	4.2	2.3	4.4	3.5	4.0	3.3	7.1	3.8	2.6	5.0	3.1	1.6	3.6	8.8	4.9	4.2	2.0	1.1	3.4	4.5	1.9	7.0	3.1	1.1	58.5	1.5	4.5	5.7	0.9	3.7	9.0	5.4	1.3	0.9	6.2	5.1	9.5	1.6	3.1	6.0	0.9	1.7	3.7	5.2	3.0	5.5	1.9	12.3	25.3	1.8	1.3	10.6	11.5	1.9	3.5	4.0	5.6	3.4	6.1	11.1	3.5	9.8	6.1	3.5	5.2	4.4	9.2	21.7	26.6	5.1	8.5	2.3	13.1	15.4	1.7	1.1	5.1	2.0	3.6	2.6	11.6	7.1	4.7	4.2	6.0	10.9	15.1	8.6	5.5	13.8	2.9	13.7	8.5	4.1	3.2	22.1	13.4	9.1	5.9	1.7	10.0	9.7	6.9	1.7	11.8	5.7	11.8	9.9	4.5	4.5	5.5	8.3	16.4	15.2	1.6	3.3	1.6	5.7	2.7	2.2	2.3	3.7	3.8	2.5	5.2	5.5	5.8	1.6	1.7	2.2	8.0	6.5	1.9	1.9	2.0	4.0	3.8	3.1	1.6	2.0	1.1	1.1	0.9	1.6	3.0	7.7	3.2	8.1	8.5	12.1	9.2	4.4	6.0	8.0	20.2	9.9	8.6	6.7	2.8	7.0	12.9	10.4	13.0	13.2	5.4	0.0	2.7	7.2	7.8	12.8	5.6	7.8	32.8	19.7	2.6	9.9	7.5	7.7	9.0	2.5	19.6	5.7	9.7	8.8	11.8	16.7	7.2	10.2	6.4	8.7	10.4	4.7	10.9	1.8	15.0	17.1	9.0	17.5	11.1	16.0	2.8	1.6	4.1	22.9	8.8	3.2	3.6	4.9	20.9	0.0	9.5	9.2	21.5	14.4	10.7	9.1	4.5	14.2	11.3	11.6	3.4
NDUFV3	CI-10k	ENSG00000160194	"NADH:ubiquinone oxidoreductase subunit V3"	P56181	21	42879644-42913304	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 88.0"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 770.8;Early spermatids: 502.9;Late spermatids: 1712.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019791, HPA020463, HPA030427, CAB034142"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 36: HEL - Hemostasis"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"CAB034142: AB_2298212, HPA019791: AB_1854357, HPA020463: AB_1854358, HPA030427: AB_10603024"	"unprognostic (1.62e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.56e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.94e-1)"	20.5	18.1	9.2	3.2	9.3	6.8	17.5	9.5	8.9	16.6	7.5	24.2	5.1	19.1	7.9	18.9	17.3	2.4	47.2	7.6	8.0	18.0	26.9	13.7	3.1	9.5	9.7	19.1	24.0	7.5	16.6	3.0	9.2	16.3	4.1	7.7	17.3	4.0	88.0	19.0	16.1	3.6	8.4	17.0	19.7	20.9	9.2	2.5	14.9	21.1	3.2	18.4	15.9	10.1	3.3	4.9	9.1	8.1	7.9	5.0	10.4	6.6	4.2	5.2	3.4	10.6	6.2	4.9	4.2	4.1	11.7	5.4	8.8	8.1	3.5	2.8	7.4	20.1	8.7	9.0	9.4	6.0	7.8	8.0	8.2	6.9	12.0	4.2	6.1	5.6	13.5	7.3	5.6	10.5	3.7	6.2	10.2	15.7	6.9	4.6	5.3	12.3	9.5	7.5	5.8	4.7	9.0	10.3	4.8	4.4	10.2	4.6	8.9	3.2	3.0	4.4	4.8	12.1	7.1	3.5	5.7	7.7	4.6	3.1	5.7	3.8	2.8	7.1	2.4	2.9	2.4	2.2	5.0	3.5	2.9	2.8	3.3	4.4	6.6	4.4	2.7	2.8	9.2	9.3	9.5	8.9	7.6	8.0	9.5	9.7	9.2	8.4	9.2	10.1	42.8	54.5	46.7	14.4	36.5	19.9	53.7	97.7	24.5	81.2	64.9	65.7	770.8	92.9	58.6	90.1	68.8	57.5	32.5	89.3	230.9	86.5	502.9	84.5	64.9	48.1	78.3	112.4	19.4	101.5	59.5	57.2	55.5	56.9	31.6	45.5	68.2	334.5	114.4	57.2	22.1	114.8	87.5	88.3	38.1	1712.0	66.5	62.3	37.4	17.8	86.4	88.7	49.4	15.6	19.5	98.6	80.9	62.4	39.0	109.3	176.4	372.6	85.9	104.7	72.3	54.0	66.1	243.5	77.1	50.0	23.4	89.9	29.9	83.8	95.4	65.3
NEPRO	"C3orf17, DKFZP434F2021, NET17"	ENSG00000163608	"Nucleolus and neural progenitor protein"	Q6NW34	3	113002444-113019861	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069654			Supported	Nucleoplasm,Nucleoli		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA069654: AB_2686164"	"unprognostic (8.45e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (2.29e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.29e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.28e-2)"	6.7	6.7	4.7	7.0	5.4	10.6	8.8	6.9	6.5	6.5	6.3	7.0	7.1	8.4	10.3	6.0	6.5	7.4	8.4	5.2	4.9	6.3	5.9	6.4	12.3	5.8	5.3	8.1	8.2	6.9	6.6	6.7	5.6	6.6	5.4	11.7	6.9	6.1	18.7	10.8	7.0	5.8	5.1	8.8	8.3	11.3	5.3	9.4	11.5	7.7	7.8	6.7	5.3	7.9	13.6	10.9	17.3	13.0	5.5	10.1	9.2	12.6	8.1	6.9	4.7	10.1	8.5	17.6	6.6	4.3	9.6	13.7	12.7	5.8	9.4	3.5	8.0	27.3	10.0	7.5	10.0	17.4	9.4	15.7	10.0	5.5	14.2	18.8	6.1	17.2	9.5	13.5	5.2	8.6	15.1	10.3	18.1	12.0	14.0	12.1	13.7	9.3	7.8	11.2	11.9	17.3	7.3	9.1	21.4	12.7	10.4	14.7	12.4	9.4	9.3	3.6	9.1	13.3	11.2	20.6	15.2	13.6	7.0	1.9	1.3	1.6	2.2	1.6	2.3	1.8	2.6	1.9	1.8	1.4	3.2	3.2	0.8	4.3	0.7	1.3	1.2	1.4	4.7	5.4	6.9	6.5	5.2	4.9	5.8	5.3	5.6	5.1	5.3	7.9	16.3	9.6	12.8	0.0	7.6	0.0	0.0	0.0	0.0	0.0	17.4	16.9	0.0	0.0	10.5	18.4	0.0	18.4	23.4	0.0	17.6	14.1	0.0	11.9	20.7	6.3	0.0	0.0	0.0	12.6	15.5	9.3	0.0	16.1	17.7	24.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	9.3	0.0	0.0	0.0	0.0	14.4	0.0	0.0	4.5	0.0	0.0	14.8	8.7	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	20.4	9.1	33.9	0.0	0.0
NFE2	NF-E2	ENSG00000123405	"Nuclear factor, erythroid 2"	Q16621	12	54292111-54301015	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 112.5;lymphoid tissue: 45.3"	"Cell type enriched"	"Detected in some"	5	"Erythroid cells: 265.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"basophil: 1489.2;neutrophil: 810.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 1489.2"	"Group enriched"	"Detected in some"	5	"HEL: 376.9;K-562: 168.1;NB-4: 118.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001914	Enhanced		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Actin filaments"		"HPA001914: AB_1079475"	"unprognostic (2.68e-4)"	"unprognostic (2.93e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.55e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.90e-6)"	"unprognostic (1.81e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.46e-2)"	3.8	0.3	0.5	6.2	0.7	112.5	0.6	0.5	1.0	1.4	1.4	0.4	0.5	0.3	0.1	0.8	2.4	1.2	1.9	0.5	0.5	1.4	2.6	13.0	0.3	0.7	0.6	0.2	0.7	1.1	0.9	4.0	0.7	0.5	0.2	0.0	0.5	0.1	1.3	4.8	0.6	1.9	0.5	45.3	0.8	1.2	0.6	1.4	1.4	3.7	0.1	2.3	0.5	0.6	0.3	0.3	0.0	0.0	0.0	0.5	1.4	1.1	6.9	0.7	0.9	5.5	10.0	0.1	0.9	0.9	0.4	0.3	0.0	0.0	0.3	0.0	0.1	376.9	0.9	9.1	0.0	5.8	48.5	0.5	0.1	0.3	0.2	4.4	0.0	0.1	168.1	0.1	0.0	0.1	15.3	118.8	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	2.6	0.2	0.6	1.8	1.0	18.9	0.3	0.2	0.4	1.1	0.1	0.0	0.0	0.1	0.4	23.4	0.0	1489.2	241.7	232.3	0.6	66.7	1.0	0.3	0.8	0.5	156.7	0.5	1.0	0.7	810.6	1.1	42.0	2.7	0.2	160.2	0.5	0.7	0.5	1.0	0.5	0.5	0.7	0.6	0.7	0.5	0.6	0.6	0.0	0.0	3.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	1.5	0.1	0.0	0.0	0.2	1.3	0.0	0.0	0.1	5.9	0.1	0.0	0.0	0.0	265.6	0.0	0.0	0.5	0.4	0.0	0.1	3.8	0.1	0.4	0.2	1.0	0.0	0.0	0.0	0.0	22.8	0.2	19.0	0.0	44.3	1.8	0.0	33.9	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.3	1.3	0.0	0.3	1.2	1.1	0.0	0.1	0.1
NFRKB	"DKFZp547B2013, INO80G"	ENSG00000170322	"Nuclear factor related to kappaB binding protein"	Q6P4R8	11	129863636-129895590	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007082, HPA007128"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA007082: AB_1079481, HPA007128: AB_1079482"	"unprognostic (1.22e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.41e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (6.36e-3)"	"unprognostic (1.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.31e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.15e-2)"	"unprognostic (6.57e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.93e-2)"	9.8	9.0	7.2	10.8	9.9	22.7	11.0	9.7	7.3	15.0	9.1	11.8	13.1	15.6	17.5	13.2	17.9	9.9	7.5	8.3	6.5	10.6	11.8	10.8	14.5	4.9	5.5	20.6	13.9	10.5	11.7	13.1	5.5	12.4	10.1	9.8	14.3	13.3	15.4	21.9	12.4	13.5	4.5	11.2	11.2	20.3	7.2	15.0	20.0	9.7	13.4	12.6	13.8	6.7	17.9	16.8	37.4	20.3	15.6	15.4	23.5	12.2	11.0	14.2	13.9	52.6	30.1	42.6	32.5	9.4	20.8	44.8	36.5	23.8	13.2	16.9	31.9	84.2	32.8	22.2	11.4	21.7	27.3	9.9	25.9	23.3	24.3	16.3	24.9	28.1	49.9	31.5	14.4	16.2	18.6	37.1	19.1	26.2	39.1	27.2	16.3	19.6	17.7	55.6	19.0	20.0	27.4	26.7	7.3	27.5	62.3	19.9	19.7	21.1	20.6	15.6	15.4	10.0	13.3	39.0	8.8	41.9	18.5	6.6	5.1	6.3	6.0	5.8	6.3	3.3	6.1	5.1	5.1	3.9	5.0	4.2	6.0	2.4	5.2	4.5	4.4	4.5	7.2	9.9	9.7	7.3	8.3	6.5	4.9	5.5	5.5	4.5	7.2	6.7	6.2	9.6	15.0	17.0	10.0	29.3	16.8	17.5	18.8	10.2	12.1	10.0	7.6	20.0	17.0	7.3	10.4	19.2	7.8	9.5	7.9	11.9	14.8	12.9	14.4	9.5	8.5	9.4	13.1	10.0	15.6	9.7	6.1	17.8	10.8	14.1	8.9	10.9	10.4	8.4	10.7	9.7	8.2	7.7	6.2	7.1	14.6	8.4	14.2	9.4	12.4	9.7	12.3	12.1	7.7	10.9	8.0	10.5	10.5	15.4	15.6	8.1	12.9	11.1	32.9	10.8	14.2	43.0	49.0	10.7	35.2	23.3	13.1	9.4	12.2	17.9
NLRC5	"CLR16.1, FLJ21709, NOD27"	ENSG00000140853	"NLR family CARD domain containing 5"	Q86WI3	16	56989485-57083531	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.6;lymphoid tissue: 32.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 35.8;Distal enterocytes: 43.2;Gastric mucus-secreting cells: 41.8;NK-cells: 39.1;T-cells: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 94.2;NB-4: 51.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA060405, HPA074724"			Supported	Centrosome,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	Centrosome	"HPA060405: AB_2684277, HPA074724: "	"unprognostic (9.66e-2)"	"prognostic favorable (9.69e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.12e-1)"	"unprognostic (9.27e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.30e-4)"	"unprognostic (2.69e-1)"	"unprognostic (3.46e-1)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (2.99e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.75e-3)"	5.8	3.6	2.4	24.1	2.9	34.6	2.9	2.1	2.6	2.7	1.2	8.5	6.0	4.2	1.5	5.5	2.7	8.4	4.1	1.8	2.5	2.4	2.6	11.3	28.9	7.4	3.1	2.8	2.6	3.0	4.8	2.7	5.5	2.9	6.8	0.7	8.6	2.5	3.1	13.6	8.8	6.0	3.3	32.8	9.2	1.2	4.1	10.6	2.8	4.8	17.3	7.0	2.7	3.7	11.3	2.1	0.3	0.8	0.7	3.6	0.1	6.1	9.4	19.1	18.4	0.0	19.0	22.9	4.5	10.0	7.5	7.3	2.4	0.6	2.1	1.0	0.7	94.2	21.8	2.3	6.5	3.3	5.4	7.0	0.2	15.6	1.7	6.1	7.5	3.2	0.1	4.5	4.0	0.4	5.2	51.8	0.1	0.3	2.0	24.5	6.9	9.4	2.1	0.9	0.7	0.8	12.4	1.1	2.6	0.0	1.3	12.3	9.7	9.1	3.2	33.7	5.1	9.0	5.0	23.9	16.3	6.9	1.7	7.2	3.8	12.6	5.8	1.9	3.5	4.6	3.4	5.7	1.5	2.7	2.1	2.3	8.5	2.3	2.3	1.1	4.1	3.0	2.4	2.9	2.1	2.6	1.8	2.5	7.4	3.1	5.5	3.3	4.1	3.7	29.8	0.0	11.2	6.2	28.0	6.8	0.9	1.1	2.2	0.9	3.1	2.8	5.3	0.0	3.6	5.5	0.0	0.1	35.8	43.2	0.0	5.6	0.5	5.1	8.5	16.9	8.4	4.8	0.5	8.4	0.2	3.4	41.8	16.7	9.5	2.2	7.9	5.5	4.5	0.0	0.8	20.7	4.1	16.2	5.4	0.5	0.9	14.2	0.0	26.2	17.8	0.2	39.1	1.5	4.5	9.4	14.1	0.4	14.7	2.3	3.0	0.9	2.5	1.3	0.0	3.7	6.4	0.1	0.1	3.3	9.9	0.1	42.2	7.8	15.9	3.5
NOS1AP	"CAPON, KIAA0464"	ENSG00000198929	"Nitric oxide synthase 1 adaptor protein"	O75052	1	162069691-162370475	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 22.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 204.3;Excitatory neurons: 142.3;Horizontal cells: 67.3;Inhibitory neurons: 107.6;Oligodendrocyte precursor cells: 79.9;Oligodendrocytes: 82.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.9;HaCaT: 3.1;HEL: 4.6"	"Low region specificity"	"Detected in all"							"CAB018582, HPA030066, HPA055561"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"		"CAB018582: AB_2251417, HPA030066: AB_2673294, HPA055561: AB_2682851"	"unprognostic (7.04e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.15e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.08e-3)"	0.4	2.8	16.3	0.1	20.1	1.8	1.2	8.0	16.2	0.6	0.0	1.3	0.6	0.5	0.2	0.7	0.6	0.6	0.8	22.2	2.4	0.9	3.1	0.4	0.0	3.0	2.1	0.2	0.9	0.5	0.8	0.4	0.4	0.7	1.1	3.6	1.5	1.4	0.2	1.1	0.7	0.4	0.0	0.0	1.4	1.8	5.5	0.1	0.1	0.2	0.2	0.6	0.4	21.5	3.9	0.0	1.8	1.1	0.0	0.0	0.2	0.3	0.4	0.5	0.4	0.9	1.0	0.0	2.2	0.1	0.6	3.1	0.6	0.1	0.1	0.1	1.7	4.6	0.6	1.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.5	1.0	0.6	0.4	0.0	0.1	2.1	0.3	0.0	1.3	0.6	1.5	0.0	0.7	0.1	0.9	1.4	1.4	0.9	0.8	0.1	0.6	0.5	1.1	0.2	0.4	0.0	0.4	0.0	0.6	2.2	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.3	20.1	8.0	16.2	22.2	2.4	3.0	2.1	0.4	0.0	5.5	21.5	4.4	0.0	0.5	5.9	0.4	2.9	6.1	0.7	0.6	11.6	14.1	21.5	2.3	2.8	1.5	22.0	204.3	0.2	0.4	7.9	9.8	1.0	36.8	4.5	3.5	3.6	6.7	2.7	142.3	1.2	0.3	1.3	9.7	7.9	0.0	8.0	3.3	21.2	0.1	67.3	107.6	10.2	0.0	0.8	0.4	12.4	4.4	0.2	0.0	43.1	0.0	13.4	1.0	79.9	82.9	0.7	5.3	7.2	0.1	6.8	3.9	0.6	1.7	3.8	6.6	0.9	1.1	2.0	2.2	2.3	2.0	0.5	0.5	1.9	5.3	7.8
NPY1R	NPYR	ENSG00000164128	"Neuropeptide Y receptor Y1"	P25929	4	163323962-163344832	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 119.6"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 32.8;Excitatory neurons: 39.8;Hepatic stellate cells: 160.6;Sertoli cells: 46.0;Smooth muscle cells: 34.1"	"Cancer enriched"	"Detected in many"	13	"breast cancer: 65.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"HEL: 128.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"prognostic favorable (7.68e-5)"	"unprognostic (9.14e-3)"	"unprognostic (1.55e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.29e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.92e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.21e-1)"	30.5	31.0	10.4	2.9	13.1	0.0	32.4	0.0	13.7	7.8	0.0	5.8	1.0	7.3	10.2	1.8	8.4	4.5	4.8	9.1	19.7	32.3	14.7	2.1	17.3	0.3	0.8	2.8	28.7	3.6	3.0	5.2	0.4	2.5	4.5	4.4	21.4	8.3	2.9	9.8	1.5	5.7	5.7	119.6	1.8	4.1	2.2	1.1	7.9	2.6	0.9	1.8	4.9	9.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.0	0.0	7.0	0.0	0.0	0.0	0.0	128.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.9	0.0	0.1	0.4	0.0	0.0	1.2	0.0	4.6	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.1	0.0	0.0	0.4	3.0	0.0	0.0	0.1	1.2	0.0	0.6	0.1	0.0	0.0	1.4	0.0	4.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	10.4	13.1	0.0	13.7	9.1	19.7	0.3	0.8	0.4	5.7	2.2	9.0	2.1	0.0	0.5	1.3	0.7	2.8	0.7	0.0	3.4	11.6	19.2	3.3	0.9	1.5	0.0	0.0	2.1	0.0	0.0	3.4	13.7	12.5	5.0	0.0	0.4	10.8	32.8	0.0	39.8	0.0	0.0	5.1	0.0	0.1	0.0	3.7	160.6	0.9	0.1	0.0	18.8	1.6	0.0	7.2	0.9	2.4	11.5	0.1	5.4	4.7	0.0	1.1	0.0	2.0	1.4	0.1	15.9	0.4	0.0	0.5	0.1	0.1	0.0	2.1	46.0	1.1	34.1	0.5	0.6	0.1	1.7	0.0	0.6	0.5	2.1	0.3
NR5A1	"AD4BP, ELP, FTZ1, FTZF1, hSF-1, SF-1, SF1"	ENSG00000136931	"Nuclear receptor subfamily 5 group A member 1"	Q13285	9	124481236-124507420	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 188.3;lymphoid tissue: 142.8"	"Group enriched"	"Detected in some"	8	"Granulosa cells: 47.9;Theca cells: 180.1"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 1.7;ovarian cancer: 2.4;testis cancer: 2.6"	"Region enriched"	"Detected in some"	9	"thalamus: 18.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 82.9;Hep G2: 59.2;K-562: 20.6"	"Region enriched"	"Detected in single"	52	"hypothalamus: 5.2"	"Region enriched"	"Detected in single"	8	"hypothalamus: 1.2"	HPA079181			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA079181: "	"unprognostic (1.66e-1)"	"unprognostic (3.08e-1)"	"unprognostic (6.13e-5)"	"unprognostic (2.32e-7)"	"unprognostic (3.95e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.14e-2)"			"unprognostic (4.75e-3)"	"unprognostic (1.14e-1)"		"unprognostic (1.49e-2)"	0.1	188.3	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	2.0	0.0	0.1	0.0	0.1	0.0	0.0	35.8	0.0	0.0	21.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	142.8	0.1	14.1	18.3	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	82.9	0.0	59.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.2	2.0	0.0	0.0	0.3	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	47.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	11.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	1.4	0.3	0.2	0.0	0.0	0.0	0.0	180.1	0.0	0.0
NRGN	RC3	ENSG00000154146	Neurogranin	Q92686	11	124739942-124747210	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"brain: 1158.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 245.6;Macrophages: 214.7;Smooth muscle cells: 60.5"	"Cancer enhanced"	"Detected in all"		"glioma: 39.8"	"Region enhanced"	"Detected in many"		"cerebral cortex: 1158.0"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"dendritic cells: 1.8;granulocytes: 2.5;monocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"HEL: 154.7;PC-3: 122.8"	"Group enriched"	"Detected in all"	9	"amygdala: 785.5;basal ganglia: 687.3;cerebral cortex: 1219.9;hippocampal formation: 641.9;white matter: 422.3"	"Group enriched"	"Detected in all"	6	"basal ganglia: 2940.0;cerebral cortex: 4703.6;hippocampal formation: 2490.2"	"CAB006908, HPA038171"	Enhanced					NA	NA		5300000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"			"CAB006908: , HPA038171: AB_2675878"	"unprognostic (1.37e-1)"	"unprognostic (8.24e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.49e-2)"	"unprognostic (5.33e-3)"	"unprognostic (1.02e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.72e-3)"	"unprognostic (4.14e-3)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (8.29e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.03e-2)"	13.8	4.4	119.9	7.8	563.0	36.3	9.1	0.0	1158.0	9.6	0.0	6.1	1.9	10.5	2.7	4.4	12.4	5.2	19.7	282.2	0.0	29.6	6.5	55.2	3.5	0.0	0.0	9.5	2.7	0.4	11.6	5.8	0.0	6.3	1.5	1.1	3.4	2.5	3.7	4.1	6.3	4.9	0.0	55.8	4.8	7.0	0.0	1.5	11.8	4.3	1.6	8.0	7.8	627.0	13.5	11.2	44.8	51.2	0.6	0.2	1.5	6.4	3.8	5.7	3.5	7.7	20.3	38.1	22.4	1.4	14.5	4.2	8.8	15.4	2.4	6.4	24.9	154.7	4.9	4.5	0.2	3.8	47.4	0.3	0.0	4.7	1.1	4.4	29.4	13.2	8.7	15.0	4.7	51.3	0.2	2.1	16.1	7.7	122.8	21.6	21.5	3.6	3.2	9.0	8.2	16.3	8.6	27.8	1.8	8.7	25.7	41.3	31.2	21.8	16.0	9.1	16.8	3.6	0.6	0.3	15.2	39.9	27.5	1.7	3.6	0.9	0.1	2.1	0.2	0.2	0.2	0.0	1.8	0.4	0.2	0.2	2.5	0.1	1.3	0.5	0.0	6.8	119.9	563.0	0.0	1158.0	282.2	0.0	0.0	0.0	0.0	0.0	0.0	627.0	12.5	0.0	41.9	35.9	4.3	3.6	0.9	0.6	0.6	5.3	2.1	2.7	2.3	1.5	0.1	0.0	0.0	1.6	4.7	2.2	3.9	0.9	3.1	1.7	1.4	20.8	6.0	5.5	245.6	0.2	2.7	3.8	1.5	1.5	1.3	0.9	15.7	1.0	13.0	0.0	14.4	1.7	0.0	43.4	15.2	7.2	0.6	214.7	5.4	42.2	45.4	0.1	25.7	29.7	33.4	0.3	0.3	0.7	3.4	0.6	0.3	0.1	0.2	1.8	19.7	1.6	60.5	3.6	6.5	1.3	1.4	0.1	4.6	0.8	2.2	1.6
OR11G2		ENSG00000196832	"Olfactory receptor family 11 subfamily G member 2"	Q8NGC1	14	20190894-20201075	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 4.8;Club cells: 3.1;granulocytes: 6.3;Respiratory ciliated cells: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 2.2"	"Cell line enriched"	"Detected in single"	15	"HEL: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 50: Neutrophils - Cellular senescence"		"Cluster 36: HEL - Hemostasis"	"Cluster 11: Alveolar cells - Smell perception"																					0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	4.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	3.1	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	6.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0
OR2T8	OR2T8P	ENSG00000177462	"Olfactory receptor family 2 subfamily T member 8"	A6NH00	1	247920252-247923152	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 4.9;Inhibitory neurons: 1.3;Microglial cells: 1.0;Oligodendrocyte precursor cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"GAMG: 1.1"															NA	NA					"Cluster 36: HEL - Hemostasis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (7.26e-2)"									"unprognostic (4.16e-1)"		"unprognostic (2.88e-1)"			"unprognostic (1.06e-1)"	"unprognostic (2.83e-2)"		0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.3	0.2	0.3	0.3	0.1	0.4	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
OR2W3	"OR2W3P, OR2W8P, OST718"	ENSG00000238243	"Olfactory receptor family 2 subfamily W member 3"	Q7Z3T1	1	247895587-247896531	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	6	"bone marrow: 13.0;brain: 6.1;thyroid gland: 6.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 13.5;K-562: 4.1;PC-3: 13.2;U-2 OS: 8.4;U-937: 6.3;WM-115: 9.4"					"Not detected"	"Not detected"			HPA045594	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"				"HPA045594: AB_10960280"	"unprognostic (9.44e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.57e-5)"	"unprognostic (1.98e-1)"	"unprognostic (5.11e-2)"		"unprognostic (2.79e-6)"	"unprognostic (2.71e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.71e-3)"	"unprognostic (9.05e-3)"	"unprognostic (9.34e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.48e-1)"	0.3	0.6	1.1	0.4	1.1	13.0	0.2	0.0	1.5	0.1	0.0	0.7	0.1	0.1	0.1	0.1	0.8	0.1	0.1	1.2	4.3	0.1	0.1	0.5	0.1	3.0	3.1	0.0	0.3	0.0	0.2	1.3	3.9	0.5	0.6	0.3	0.1	0.2	0.0	0.4	0.2	0.5	0.8	1.0	0.2	1.2	6.1	0.1	6.3	0.9	0.0	0.1	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	3.9	0.0	0.0	0.0	0.3	13.5	0.0	0.0	0.0	1.7	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.3	4.1	0.0	0.0	0.0	0.1	0.1	0.5	0.0	13.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.0	0.0	8.4	0.0	0.0	1.4	0.0	0.0	0.0	6.3	9.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.1	1.1	0.0	1.5	1.2	4.3	3.0	3.1	3.9	0.8	6.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR4N5		ENSG00000184394	"Olfactory receptor family 4 subfamily N member 5"	Q8IXE1	14	20138820-20145471	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	60	"HEL: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA					"Cluster 36: HEL - Hemostasis"																						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR7D2	"FLJ38149, HTPCRH03, OR19-4"	ENSG00000188000	"Olfactory receptor family 7 subfamily D member 2"	Q96RA2	19	9178979-9188818	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"Early spermatids: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEL: 1.7"					"Low region specificity"	"Detected in all"									NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (5.00e-4)"	"unprognostic (2.03e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.40e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.92e-4)"	0.2	0.2	0.5	0.3	0.4	0.7	0.1	1.1	1.0	0.2	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.5	0.4	0.1	0.1	0.1	0.6	0.3	0.1	0.1	0.2	0.0	0.2	0.1	0.3	0.2	0.1	0.6	0.2	0.4	0.3	0.5	0.2	0.2	0.0	0.5	0.3	1.1	0.4	0.1	0.2	0.1	0.3	0.2	0.1	1.0	0.1	0.1	0.2	0.7	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.3	0.0	0.2	0.3	0.0	0.1	0.0	0.2	0.1	1.7	0.3	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.5	0.7	0.0	0.1	0.3	0.4	0.1	0.0	0.1	0.3	0.3	0.0	0.0	0.5	0.2	0.1	0.1	0.2	0.0	0.3	0.2	0.0	0.0	0.2	0.2	0.1	0.1	0.3	0.2	0.2	0.1	0.1	0.0	0.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.6	0.2	0.1	0.2	0.0	0.0	0.5	0.4	1.1	1.0	0.5	0.4	0.3	0.1	0.3	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	7.2	0.1	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.5	0.2	0.1	0.0	0.0	0.0	0.4	0.1	0.2	0.2	0.0	0.0	0.3	0.1	0.0	0.2	0.3
OSBPL8	"MST120, MSTP120, ORP8, OSBP10"	ENSG00000091039	"Oxysterol binding protein like 8"	Q9BZF1	12	76351797-76559809	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001309	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Vesicles, Cytosol"		"HPA001309: AB_1079530"	"unprognostic (2.55e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.84e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (9.79e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.19e-3)"	24.2	13.5	18.1	24.3	43.3	32.5	21.1	9.7	22.5	22.6	12.3	11.2	9.3	22.3	7.7	24.4	10.5	18.4	14.0	15.3	13.7	36.4	19.2	19.6	30.9	11.7	13.4	17.4	14.0	13.0	5.6	18.2	14.0	14.9	11.7	14.2	13.5	12.7	10.7	28.7	13.0	18.9	9.1	26.7	16.0	16.6	13.1	33.7	14.3	11.5	32.0	19.1	10.2	16.6	36.5	22.8	49.7	35.5	67.5	94.8	31.6	54.7	76.3	34.2	31.1	33.2	14.6	50.8	30.4	65.3	21.5	14.9	37.2	31.6	51.3	43.6	33.3	136.0	21.0	19.8	41.7	87.2	53.1	50.4	58.7	51.2	63.3	61.8	30.0	29.1	95.0	22.7	57.3	25.0	58.8	41.4	24.3	13.2	22.6	30.4	67.7	29.3	26.4	30.3	27.2	28.4	46.7	16.6	34.0	38.9	13.0	52.4	70.6	55.0	27.5	57.5	29.7	22.7	38.4	54.6	21.0	47.9	32.8	134.8	50.8	74.1	29.2	37.4	27.9	45.3	31.2	24.6	46.9	40.8	27.9	23.2	195.7	36.0	44.5	54.9	41.1	31.8	18.1	43.3	9.7	22.5	15.3	13.7	11.7	13.4	14.0	9.1	13.1	16.6	63.5	57.7	58.3	54.5	87.8	116.2	65.7	39.6	114.9	49.7	68.4	55.5	42.5	25.8	36.1	51.5	89.6	34.8	111.3	13.6	60.7	53.9	47.4	29.0	102.6	68.7	9.5	63.5	246.3	55.2	28.7	98.0	28.5	44.1	254.8	36.3	52.1	45.9	77.1	42.1	248.6	25.8	40.7	98.0	127.0	22.1	65.9	142.0	35.6	79.6	149.3	50.2	125.7	113.6	92.9	104.0	28.3	82.8	56.8	54.6	23.9	180.2	37.4	37.3	46.0	79.3	83.1	66.2	129.9	89.9	124.5	48.2	105.3	58.4	20.0	62.4
P2RY1	"P2Y1, SARCC"	ENSG00000169860	"Purinergic receptor P2Y1"	P47900	3	152835131-152841439	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 25.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 23.3;Cholangiocytes: 21.5;Distal enterocytes: 25.4;Kupffer cells: 21.1;Squamous epithelial cells: 45.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 6.0;non-classical monocyte: 2.6"	"Group enriched"	"Detected in many"	9	"granulocytes: 6.0;monocytes: 2.6"	"Cell line enriched"	"Detected in many"	5	"HEL: 45.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA015577	Enhanced					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA015577: AB_1854882"	"unprognostic (3.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.76e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.14e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (2.04e-7)"	"unprognostic (1.36e-1)"	"unprognostic (8.98e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.20e-2)"	1.6	1.4	6.2	2.3	14.2	5.7	1.4	3.1	6.4	4.5	1.0	9.1	3.2	6.5	0.5	19.2	2.1	2.0	2.9	5.9	6.7	0.8	1.5	7.0	0.8	3.3	4.2	8.8	3.3	0.3	1.6	25.4	8.4	7.7	6.7	9.0	3.2	2.2	7.7	8.9	6.1	4.5	4.9	2.2	0.9	1.1	8.2	1.6	1.3	3.4	2.7	2.4	8.0	4.1	0.0	0.7	7.0	0.0	1.1	0.1	0.0	0.0	0.1	0.2	0.6	9.0	0.1	0.0	0.7	0.0	1.1	1.5	3.9	1.3	0.3	0.0	3.4	45.9	0.1	0.0	0.0	5.4	4.0	0.5	8.7	0.0	0.4	3.5	0.0	1.5	1.4	0.0	0.0	0.1	0.8	0.1	6.4	0.0	5.5	0.0	0.2	1.3	0.0	3.1	1.1	0.0	0.0	0.0	0.9	1.6	0.0	2.4	0.0	0.7	1.8	0.0	3.9	0.0	0.0	0.0	4.5	0.0	5.2	6.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.6	0.5	0.0	0.1	6.2	14.2	3.1	6.4	5.9	6.7	3.3	4.2	8.4	4.9	8.2	4.1	1.0	0.0	0.5	12.7	0.8	1.9	6.7	3.3	15.9	23.3	0.5	0.1	7.1	21.5	1.0	0.0	0.0	0.2	1.6	25.4	0.0	1.3	0.2	1.9	12.0	7.1	0.0	10.8	0.0	0.0	0.3	5.6	0.0	2.7	10.1	0.1	11.7	0.3	7.4	0.0	0.2	8.9	0.0	21.1	0.3	0.8	14.9	15.9	0.0	1.0	1.8	19.1	0.0	0.0	0.6	0.9	12.3	6.0	0.0	6.3	13.4	0.2	0.2	1.5	0.0	1.2	1.0	0.4	2.2	45.4	2.0	0.1	0.5	3.5	8.3	4.9
PARD3B	"ALS2CR19, PAR3beta, Par3L"	ENSG00000116117	"Par-3 family cell polarity regulator beta"	Q8TEW8	2	204545475-205620162	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 490.7;Microglial cells: 183.6;Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 104.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.8;BJ hTERT+: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035283	Approved		Supported	"Cell Junctions"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cell Junctions"		"HPA035283: AB_10671102"	"unprognostic (6.18e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (2.67e-10)"	"unprognostic (1.74e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.09e-2)"	9.1	2.8	6.0	1.7	7.3	0.0	5.5	5.3	5.3	4.9	9.3	12.6	3.6	5.1	3.7	4.0	6.5	4.5	4.0	4.6	9.2	6.9	3.4	5.4	2.1	9.3	12.2	7.3	4.9	9.2	1.9	4.4	8.3	4.8	5.5	2.5	3.0	5.2	2.7	4.5	4.2	5.2	8.4	3.1	4.5	3.8	8.0	1.4	5.6	3.6	2.5	5.9	4.0	7.4	2.5	2.1	6.3	2.3	17.8	8.9	3.4	3.8	12.5	3.5	3.8	6.2	1.7	0.0	4.3	7.8	2.8	0.3	0.8	1.0	3.6	0.2	2.9	8.8	5.2	0.0	1.8	0.0	0.5	3.4	1.7	1.2	5.2	5.3	5.2	0.8	0.2	0.1	4.5	1.0	0.0	0.0	0.8	0.9	0.5	0.0	2.7	2.1	3.7	2.5	0.7	2.0	2.0	1.9	1.7	6.2	3.1	0.0	10.9	2.7	1.7	5.5	1.8	0.0	0.0	0.0	2.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	7.3	5.3	5.3	4.6	9.2	9.3	12.2	8.3	8.4	8.0	7.4	9.5	9.6	8.6	490.7	0.5	11.0	3.3	2.4	6.8	0.5	5.6	5.8	10.8	15.7	14.5	29.5	0.0	3.2	0.2	12.4	0.0	8.7	76.6	8.5	4.0	6.8	6.0	0.8	5.6	2.4	0.2	16.2	11.7	7.4	1.3	14.1	8.2	4.5	0.5	5.0	50.8	9.2	2.0	1.0	4.3	26.0	31.1	0.6	7.2	183.6	0.1	9.7	0.0	159.3	104.2	6.5	15.9	57.9	1.4	5.0	9.4	4.8	17.0	0.3	19.7	23.5	9.6	1.4	2.9	3.5	4.7	1.1	1.0	2.3	8.0	5.3
PARP15	"ARTD7, FLJ40597, pART7"	ENSG00000173200	"Poly(ADP-ribose) polymerase family member 15"	Q460N3	3	122577628-122639047	"Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 23.1;intestine: 42.1;lymphoid tissue: 67.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 19.2;B-cells: 88.4;dendritic cells: 38.6;granulocytes: 19.6;NK-cells: 21.6;Plasma cells: 18.6;T-cells: 31.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 7.6;JURKAT: 5.1;REH: 3.5;THP-1: 3.7;TIME: 8.9"					"Low region specificity"	"Detected in single"			HPA035757			Approved	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 57: B-cells - Immune response"	Mitochondria		"HPA035757: AB_10669656"	"unprognostic (8.19e-3)"	"unprognostic (2.88e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.01e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.63e-2)"	"unprognostic (9.24e-7)"	"unprognostic (9.03e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.22e-2)"	3.7	1.2	3.1	25.7	2.7	23.1	1.8	4.2	3.8	1.7	1.2	3.8	2.6	1.9	1.3	2.0	2.0	4.4	1.7	2.1	1.2	1.7	3.2	9.0	44.4	1.8	2.3	0.7	0.8	0.2	0.7	2.5	1.7	1.8	4.8	2.2	2.2	1.1	6.0	1.2	42.1	1.9	0.7	67.2	4.1	2.5	2.0	8.3	3.0	1.9	50.3	4.5	1.6	3.6	0.3	0.2	0.3	0.3	0.1	0.2	0.3	0.2	0.1	0.0	0.0	0.2	0.7	0.3	0.4	0.1	0.2	0.3	0.0	0.0	0.0	0.7	0.1	7.6	0.5	0.3	0.1	0.5	0.3	1.5	0.1	0.3	0.1	0.2	1.7	5.1	0.2	1.3	0.0	0.3	2.3	0.4	0.4	0.1	0.1	3.5	0.2	0.3	0.0	0.6	0.5	0.3	0.1	0.1	0.1	0.3	0.5	3.7	8.9	0.2	0.6	0.3	0.2	0.6	0.4	1.6	0.4	0.2	0.1	1.8	0.2	0.1	7.2	0.3	5.8	9.4	4.4	5.4	0.8	9.3	3.8	4.8	0.5	3.9	0.7	1.0	4.2	2.2	3.1	2.7	4.2	3.8	2.1	1.2	1.8	2.3	1.7	0.7	2.0	3.6	0.8	19.2	15.9	0.0	88.4	0.5	0.0	0.0	0.0	0.0	0.6	0.6	0.7	0.0	2.1	0.0	0.0	0.1	38.6	0.1	0.0	0.0	0.2	0.3	0.1	1.2	0.0	7.4	0.1	0.0	0.1	2.7	2.6	0.3	19.6	0.0	2.2	0.6	8.3	0.0	0.2	0.0	0.0	5.1	1.4	0.2	0.0	6.4	1.8	6.5	4.7	0.0	21.6	0.0	0.1	0.1	0.0	0.0	18.6	0.0	0.0	0.1	10.5	0.0	0.0	0.7	0.4	0.1	1.6	0.4	0.0	0.3	31.1	0.0	0.0	0.0
PCNT	"KEN, KIAA0402, PCN, PCNT2, PCNTB, SCKL4"	ENSG00000160299	Pericentrin	O95613	21	46324141-46445769	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 239.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"dendritic cells: 4.6;granulocytes: 6.0;T-cells: 8.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016820, HPA019887, HPA032101"	Uncertain		Supported	"Centriolar satellite,Centrosome,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 37: Myocytes - Muscle contraction"	Centrosome	"Centriolar satellite, Cytosol"	"HPA016820: AB_1855079, HPA019887: AB_1855080, HPA032101: AB_2674151"	"unprognostic (9.07e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.95e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.86e-2)"	9.7	11.1	7.6	5.9	10.5	17.7	8.9	4.2	11.9	8.6	5.3	10.7	4.1	8.2	4.3	11.7	8.5	3.6	28.3	6.0	5.4	7.7	10.9	8.2	8.2	9.0	3.9	9.6	7.8	4.3	20.3	3.5	9.5	8.2	4.3	4.6	9.7	4.2	239.2	12.3	10.1	4.4	2.6	11.5	9.5	25.6	4.7	12.5	8.4	52.0	5.5	9.6	9.2	7.4	15.4	11.6	18.0	11.1	8.9	8.8	11.3	11.6	8.0	11.3	10.0	14.2	9.7	15.2	7.3	13.4	15.3	10.8	14.6	9.9	7.8	44.9	20.4	40.2	24.1	11.3	3.1	20.6	16.1	4.8	7.5	15.2	7.6	5.5	8.8	15.8	20.9	22.4	15.8	25.4	20.6	21.3	18.0	13.9	8.0	25.3	7.2	13.5	8.7	16.3	22.1	9.8	25.4	15.7	8.0	4.4	14.8	16.0	12.1	20.4	10.2	11.7	18.9	19.3	17.2	16.4	12.6	19.9	11.1	6.0	0.6	1.2	1.5	0.5	4.6	0.3	0.7	4.8	2.0	0.1	0.5	8.8	0.4	0.4	1.0	4.6	0.8	2.0	7.6	10.5	4.2	11.9	6.0	5.4	9.0	3.9	9.5	2.6	4.7	7.4	10.5	28.9	32.0	19.9	8.6	8.3	5.7	7.0	13.6	15.0	8.9	8.6	35.7	10.0	15.3	0.0	6.2	6.4	36.7	14.0	0.0	7.1	20.4	17.0	19.9	10.1	15.6	36.2	38.1	7.6	7.4	13.1	25.0	17.8	16.4	25.4	7.1	9.0	23.3	23.5	39.0	11.2	4.1	6.9	5.5	25.6	12.8	12.7	0.0	17.8	14.7	6.8	25.7	10.6	21.9	5.7	5.7	12.0	31.4	4.2	5.7	4.1	13.0	11.1	26.3	61.3	14.2	40.5	39.8	25.0	7.1	6.4	18.8	15.1	10.4	5.1
PCYT1B	"CCT-beta, CTB"	ENSG00000102230	"Phosphate cytidylyltransferase 1, choline, beta"	Q9Y5K3	X	24558087-24672677	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.2;retina: 12.1;testis: 13.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 23.5;Early spermatids: 29.1;Late spermatids: 90.1;Muller glia cells: 30.1;Oligodendrocyte precursor cells: 23.6;Oligodendrocytes: 41.9"	"Cancer enhanced"	"Detected in some"		"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 10.3;CACO-2: 22.2;HEL: 25.7;Hep G2: 10.2;NTERA-2: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006367	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA006367: AB_1079585"	"unprognostic (4.49e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.88e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.65e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.63e-6)"	"unprognostic (2.62e-4)"	"unprognostic (4.56e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.96e-4)"	0.1	0.8	12.1	0.2	12.2	0.8	0.1	10.6	12.8	0.7	7.5	1.2	0.3	1.6	0.6	0.8	2.2	0.4	2.9	13.2	9.8	0.2	0.0	0.7	0.0	9.5	10.2	1.4	1.5	0.0	1.3	1.3	9.8	0.8	0.2	12.1	0.1	2.4	0.0	0.1	0.6	2.5	8.6	0.2	0.2	13.4	11.4	0.5	0.0	0.0	0.0	0.3	0.3	12.9	0.0	0.0	10.3	0.1	0.0	0.0	0.1	0.0	0.9	0.3	0.1	22.2	0.0	0.0	5.2	0.0	0.0	1.0	4.2	0.0	0.0	0.0	0.1	25.7	0.0	10.2	0.1	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	3.9	0.5	11.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	7.2	5.8	0.0	0.0	0.5	7.1	0.1	0.0	0.0	0.0	0.3	0.0	0.5	0.2	0.0	0.0	4.4	0.7	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.2	12.1	12.2	10.6	12.8	13.2	9.8	9.5	10.2	9.8	8.6	11.4	12.9	0.0	0.0	0.0	23.5	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.5	1.6	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.8	29.1	10.7	0.2	0.1	1.8	1.3	5.6	0.0	0.0	0.4	0.0	0.2	4.5	5.8	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	90.1	0.3	0.9	0.0	3.7	0.3	30.1	0.0	23.6	41.9	0.2	0.0	2.6	0.1	0.1	0.0	0.5	6.4	1.6	0.0	0.0	1.0	1.8	0.5	0.0	0.0	0.0	0.0	0.8	0.0	0.1
PDZD8	"bA129M16.2, FLJ34427, PDZK8"	ENSG00000165650	"PDZ domain containing 8"	Q8NEN9	10	117277274-117375440	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 73.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 208.7;Late spermatids: 477.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 124.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015716, HPA051610"	Uncertain		Approved	"Nucleoli fibrillar center,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center"	"Plasma membrane"	"HPA015716: AB_1855162, HPA051610: AB_2681549"	"unprognostic (1.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.65e-3)"	"unprognostic (2.75e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.90e-2)"	"unprognostic (5.37e-3)"	"unprognostic (7.60e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.01e-2)"	7.1	7.0	8.9	4.7	12.1	73.0	4.7	15.7	8.6	7.9	17.9	9.3	14.0	9.1	14.1	10.8	6.8	9.7	5.1	8.1	11.8	13.1	15.8	6.0	3.2	11.9	13.8	8.9	14.1	28.3	4.2	5.4	12.2	6.4	11.2	14.1	12.9	10.6	4.9	5.5	10.6	6.9	11.3	3.7	10.4	13.2	12.5	5.8	6.8	5.8	3.6	6.6	5.8	13.2	12.6	21.1	7.6	14.7	12.8	11.4	4.3	11.9	10.2	5.2	4.2	10.7	16.4	14.7	10.5	18.1	6.0	18.4	13.4	12.6	10.3	9.4	11.8	124.3	8.6	10.6	9.4	52.4	11.2	11.2	14.7	9.5	27.9	19.3	9.3	12.1	11.5	15.0	13.0	5.1	10.2	6.7	6.0	6.6	18.8	8.2	29.2	6.4	15.5	9.0	6.0	9.6	12.6	5.4	9.7	6.9	3.7	7.6	15.1	8.6	9.4	15.8	20.5	8.0	7.2	10.5	10.8	23.6	7.7	1.4	0.5	2.6	0.9	0.5	0.9	0.3	0.7	0.7	0.7	0.4	0.5	0.7	2.3	1.2	0.9	0.5	0.3	0.2	8.9	12.1	15.7	8.6	8.1	11.8	11.9	13.8	12.2	11.3	12.5	13.2	22.1	12.8	30.7	32.3	13.7	29.7	24.4	10.3	24.5	31.9	16.4	17.0	19.8	40.0	21.0	18.4	22.9	9.8	36.1	26.9	9.8	31.9	208.7	78.3	46.7	24.0	33.7	82.0	49.2	81.9	7.2	27.3	48.4	111.2	44.2	14.6	18.9	58.6	7.5	32.0	61.0	38.8	10.2	16.0	31.8	477.6	23.6	25.2	23.2	30.0	15.5	29.0	23.7	51.8	56.4	57.6	23.1	28.6	28.1	41.1	27.0	26.5	28.5	45.0	26.3	46.3	24.5	25.8	29.1	36.3	32.4	6.7	28.4	90.8	50.2	44.6
PF4	"CXCL4, SCYB4"	ENSG00000163737	"Platelet factor 4"	P02776	4	73980811-73982027	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Cytokine, Heparin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 66.5;lymphoid tissue: 31.5"	"Cell type enriched"	"Detected in some"	23	"Macrophages: 1360.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.4"	"Region enriched"	"Detected in single"	5	"cerebral cortex: 2.2"	"Group enriched"	"Detected in many"	12	"basophil: 85.2;neutrophil: 43.0"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 85.2"	"Cell line enriched"	"Detected in some"	10	"HEL: 29.8"									"CAB026008, HPA052485"	Enhanced				"Secreted to blood"	NA	NA	7700000		"Cluster 34: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"			"CAB026008: , HPA052485: AB_2681847"		"unprognostic (4.14e-4)"	"unprognostic (1.00e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-4)"	"unprognostic (7.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.84e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.54e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.77e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.81e-2)"	0.8	0.2	0.1	0.7	0.3	66.5	0.3	0.1	2.2	0.1	0.7	1.0	0.0	0.1	0.0	0.1	0.3	0.7	0.9	0.1	0.1	0.6	2.2	10.5	0.3	0.3	0.2	0.1	0.3	0.0	0.3	3.0	0.3	0.1	0.8	0.0	0.4	0.1	1.0	0.0	0.2	0.1	0.4	31.5	0.9	0.1	0.2	0.0	0.6	2.5	0.0	0.1	0.1	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	29.8	0.0	0.0	1.5	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.2	3.8	1.4	0.8	1.2	0.8	0.0	0.2	0.0	1.5	0.7	0.7	0.3	43.0	0.1	3.9	5.4	0.6	148.4	0.1	0.3	0.1	2.2	0.1	0.1	0.3	0.2	0.3	0.4	0.2	0.3	0.7	0.0	0.0	0.0	10.8	0.0	0.2	0.4	0.0	0.0	0.1	0.3	0.0	2.8	1.5	1.8	0.0	0.0	4.1	5.3	0.0	6.0	0.0	0.0	0.0	7.1	13.3	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.0	0.0	24.7	0.2	0.3	0.0	0.0	1.8	0.0	9.5	0.0	0.1	0.0	1360.7	0.0	0.0	59.0	0.0	57.7	0.0	0.0	7.6	0.7	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	1.1	0.2	0.0	0.4	0.0	0.0	0.3	5.8	0.0	7.4	0.2
PHF20	"C20orf104, dJ1121G12.1, TDRD20A"	ENSG00000025293	"PHD finger protein 20"	Q9BVI0	20	35771974-35950370	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 452.5;Late spermatids: 661.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029619, HPA029620, HPA029621"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA029619: AB_10600090, HPA029620: AB_10601110, HPA029621: AB_10602201"	"unprognostic (1.21e-3)"	"unprognostic (7.30e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.01e-2)"	12.9	8.2	10.4	12.0	11.5	11.8	12.5	15.4	13.0	10.8	9.4	10.9	6.0	11.8	7.3	11.9	9.2	10.8	11.5	11.2	10.4	7.8	8.2	10.0	14.2	11.6	11.1	13.2	6.8	12.1	5.4	11.7	11.1	10.3	8.4	14.4	9.5	10.8	32.3	8.1	7.8	11.6	9.5	14.7	8.2	11.8	11.8	14.7	10.2	17.6	13.9	10.5	8.5	14.7	18.1	14.2	24.4	36.0	17.3	19.7	22.5	20.2	19.1	19.8	17.2	41.4	13.1	30.1	17.9	27.1	24.4	10.7	22.6	28.2	24.1	13.7	9.6	55.8	26.3	15.6	17.3	27.2	20.8	15.6	38.8	21.0	32.2	23.5	22.1	21.0	23.3	18.8	23.1	10.8	27.6	15.9	12.0	11.9	17.5	20.0	35.9	17.9	15.9	12.4	21.9	17.9	36.0	41.0	18.4	21.8	32.6	20.0	31.1	43.7	9.9	23.0	21.0	17.2	22.0	21.5	32.2	19.5	22.9	17.3	11.2	33.1	12.4	11.5	13.6	15.0	12.5	14.6	10.6	11.1	14.0	14.7	25.9	16.0	16.9	9.9	7.2	9.0	10.4	11.5	15.4	13.0	11.2	10.4	11.6	11.1	11.1	9.5	11.8	14.7	51.2	38.5	41.8	28.4	131.1	34.8	76.6	52.5	31.3	77.4	49.8	53.5	62.2	31.5	43.5	38.6	98.0	106.7	191.0	16.3	37.2	29.8	452.5	39.8	41.6	46.3	36.0	37.6	49.7	19.9	52.5	53.6	23.0	34.7	142.4	41.2	47.2	18.2	54.5	114.4	49.5	27.9	30.5	62.7	84.3	661.6	35.8	87.1	39.2	62.8	62.6	50.0	105.0	34.2	55.2	24.1	26.5	53.4	76.9	60.0	14.0	24.8	50.2	80.7	19.7	65.5	50.6	60.4	47.0	29.8	28.3	22.3	127.8	30.1	28.8	55.4
PLCXD1	FLJ11323	ENSG00000182378	"Phosphatidylinositol specific phospholipase C X domain containing 1"	Q9NUJ7	X	276322-303356	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 34.7;Distal enterocytes: 34.2;Gastric mucus-secreting cells: 33.1;Paneth cells: 40.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 110.4;HEL: 172.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA007721	Approved		Approved	Cytosol		NA	Yes			"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA007721: AB_1079630"	"unprognostic (2.73e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.57e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (3.80e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (1.47e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.80e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.11e-3)"	"prognostic unfavorable (7.82e-14)"	"unprognostic (6.01e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.78e-1)"	14.7	4.1	4.6	9.4	8.8	32.9	9.7	13.0	19.2	10.0	0.0	8.2	8.6	5.6	1.4	17.5	9.1	8.8	5.6	4.4	0.0	5.7	10.1	7.4	17.3	3.4	1.5	12.8	7.5	3.2	7.7	7.8	4.4	7.5	5.7	6.0	11.4	3.7	8.4	18.7	12.5	2.7	0.5	17.5	26.9	6.7	4.0	8.9	10.4	2.7	9.0	6.1	9.7	13.4	28.4	110.4	25.7	38.8	5.0	3.9	20.4	24.4	2.9	12.8	12.4	40.6	29.1	34.8	17.9	10.7	19.0	8.5	6.3	15.9	6.7	21.2	46.2	172.6	36.1	59.7	15.6	17.4	63.1	20.1	1.9	47.0	4.9	8.6	9.7	57.2	44.0	18.7	9.2	8.2	52.3	24.2	57.8	7.1	19.2	29.1	13.3	53.9	3.9	12.9	25.9	15.0	24.6	14.4	21.1	17.5	27.6	22.0	7.2	17.1	28.2	18.5	26.9	6.3	17.9	86.4	11.0	44.4	18.2	3.7	2.7	5.4	1.9	6.0	2.7	1.6	1.4	2.4	2.0	5.6	1.8	1.9	3.3	1.2	9.0	2.1	3.2	2.3	4.6	8.8	13.0	19.2	4.4	0.0	3.4	1.5	4.4	0.5	4.0	13.4	15.8	9.6	34.7	5.5	4.1	6.9	13.6	3.9	2.2	7.4	4.7	3.6	6.5	10.0	2.8	0.0	2.1	10.1	4.9	34.2	0.0	6.3	0.9	1.6	3.4	6.1	3.0	9.9	5.3	1.8	11.3	6.1	33.1	3.2	3.8	32.1	4.6	6.9	5.5	8.4	6.1	11.2	0.0	7.3	9.8	0.9	2.5	11.9	0.0	5.6	3.7	2.3	9.2	0.5	5.7	18.8	40.9	3.8	2.7	5.3	3.0	1.7	1.3	7.1	13.1	6.5	7.9	8.4	15.9	4.2	8.7	27.0	3.8	2.8	9.4	8.0
PPBP	"b-TG1, Beta-TG, CTAP3, CTAPIII, CXCL7, LA-PF4, LDGF, MDGF, NAP-2, NAP-2-L1, PBP, SCYB7, TGB, TGB1, THBGB1"	ENSG00000163736	"Pro-platelet basic protein"	P02775	4	73986439-73988190	"Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Cytokine, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 98.7;lymphoid tissue: 53.6"	"Cell type enriched"	"Detected in some"	18	"Macrophages: 1497.3"	"Cancer enriched"	"Detected in many"	7	"colorectal cancer: 86.8"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	13	"basophil: 394.2;neutrophil: 132.3"	"Lineage enriched"	"Detected in all"	20	"granulocytes: 394.2"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.0;HEL: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008354, CAB017624"	Supported				"Secreted to blood"	NA	NA	24500000	2900000000	"Cluster 34: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"			"CAB017624: AB_1127132, HPA008354: AB_1847353"	"unprognostic (2.13e-1)"	"prognostic unfavorable (6.17e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.98e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.59e-2)"	1.3	0.5	0.3	0.5	0.4	98.7	0.6	0.3	2.2	0.1	1.0	0.1	0.0	0.1	0.0	0.2	0.8	0.8	1.3	0.2	0.3	0.9	2.9	19.4	0.0	0.5	0.4	0.1	0.1	0.0	0.4	5.2	0.8	0.1	0.0	0.0	0.6	0.0	1.4	0.1	0.0	0.1	0.8	53.6	0.2	0.0	0.7	0.1	1.0	4.2	0.0	8.4	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	394.2	13.0	9.3	2.0	5.3	2.9	1.5	1.2	0.6	8.0	2.3	4.1	1.0	132.3	1.9	5.0	20.1	2.1	1791.5	0.3	0.4	0.3	2.2	0.2	0.3	0.5	0.4	0.8	0.8	0.7	0.4	0.3	3.2	1.1	0.0	10.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.5	4.0	1.8	0.0	0.0	9.3	0.1	0.0	4.7	0.0	0.0	0.0	12.3	0.0	2.7	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	36.8	1.1	0.1	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.0	1497.3	0.0	0.0	80.8	0.0	75.2	0.0	0.0	7.0	0.0	0.0	0.1	0.0	0.0	0.3	1.7	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.1	7.8	0.0	0.0	0.0
PPDPFL	C8orf22	ENSG00000168333	"Pancreatic progenitor cell differentiation and proliferation factor like"	Q8WWR9	8	49054311-49076093	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 948.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"glioma: 0.7;renal cancer: 2.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"HEL: 1.3"									HPA060329	Uncertain					NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 50: Fibroblasts - ECM organization"			"HPA060329: AB_2684255"					"unprognostic (6.33e-2)"							"unprognostic (2.72e-1)"	"prognostic unfavorable (2.06e-10)"					2.6	0.1	0.2	0.0	0.6	0.0	1.1	0.6	0.5	0.0	0.2	0.2	0.0	0.0	0.0	2.4	0.1	0.0	1.6	0.3	1.4	0.0	0.1	0.1	0.0	1.0	0.2	0.1	0.1	0.0	0.3	0.0	1.1	2.3	0.0	0.3	9.8	0.2	948.1	1.7	0.2	0.0	0.5	0.0	0.1	0.2	0.4	0.0	0.3	112.8	0.0	0.3	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.6	0.5	0.3	1.4	1.0	0.2	1.1	0.5	0.4	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPP1R9A	"FLJ20068, KIAA1222, Neurabin-I"	ENSG00000158528	"Protein phosphatase 1 regulatory subunit 9A"	Q9ULJ8	7	94907202-95296415	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 294.1;Excitatory neurons: 262.8;Inhibitory neurons: 201.5;Oligodendrocyte precursor cells: 593.1;Oligodendrocytes: 308.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"basophil: 6.8;NK-cell: 10.3"	"Group enriched"	"Detected in many"	9	"granulocytes: 6.8;NK-cells: 10.3"	"Cell line enhanced"	"Detected in many"		"HAP1: 12.2;RH-30: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027726, HPA075591"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"		"HPA027726: AB_1855653, HPA075591: AB_2732296"	"unprognostic (1.05e-1)"	"unprognostic (6.59e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (7.17e-4)"	"unprognostic (2.26e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (8.63e-6)"	"unprognostic (2.74e-1)"	"unprognostic (4.85e-2)"	"unprognostic (8.47e-2)"	"unprognostic (8.79e-3)"	1.7	7.0	13.0	0.9	20.1	0.2	4.9	6.0	14.5	2.7	0.3	8.2	1.7	3.0	4.9	1.6	5.7	2.4	5.2	14.4	7.5	4.7	0.4	3.7	0.3	5.9	6.9	3.3	8.8	6.7	4.6	2.5	8.0	2.3	3.8	18.5	9.6	2.8	4.9	0.5	2.2	2.2	6.6	1.8	4.9	6.7	10.2	0.5	6.6	4.9	0.3	2.6	0.5	13.9	0.0	11.0	6.6	7.6	0.0	0.0	5.3	0.5	0.1	1.0	0.8	6.1	3.7	0.0	9.0	0.5	0.6	0.0	12.2	0.0	1.2	0.0	4.5	11.4	4.5	7.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.8	4.8	0.1	0.0	5.5	4.9	1.8	0.0	11.8	0.0	10.7	9.2	7.3	7.4	0.0	0.9	1.4	4.0	2.1	0.0	0.0	0.1	4.4	0.1	4.0	7.3	11.5	0.0	0.2	0.0	0.9	6.8	0.0	0.4	0.0	0.0	0.2	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	10.3	0.1	0.3	0.0	0.1	13.0	20.1	6.0	14.5	14.4	7.5	5.9	6.9	8.0	6.6	10.2	13.9	4.5	41.7	66.6	294.1	2.4	0.4	0.9	0.0	0.6	58.2	24.4	12.2	127.7	18.6	16.5	47.8	56.3	21.6	3.3	15.7	3.9	25.1	17.9	40.3	4.5	6.8	38.9	2.5	262.8	7.0	3.1	9.4	21.4	57.1	5.7	39.5	7.9	1.5	1.7	1.7	201.5	15.0	4.1	0.6	0.3	15.3	2.5	0.8	7.2	41.2	0.0	46.9	3.1	593.1	308.4	6.6	14.4	0.7	2.7	4.8	1.8	9.6	20.6	88.9	0.0	118.4	9.2	25.1	12.6	0.5	0.9	33.1	1.7	22.9	15.7	2.6
PPP3R1	"CALNB1, CNB, CNB1"	ENSG00000221823	"Protein phosphatase 3 regulatory subunit B, alpha"	P63098	2	68178857-68256237	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 189.9"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005610, HPA047157"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		42000	"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	Cytosol	"CAB005610: AB_325975, HPA047157: AB_2679960"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (9.08e-6)"	"unprognostic (5.90e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (3.59e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.70e-5)"	"unprognostic (5.24e-3)"	"unprognostic (5.35e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-1)"	53.7	37.7	56.1	32.4	92.9	73.6	27.1	38.0	127.3	27.3	0.0	27.6	25.7	31.0	26.1	30.0	23.3	28.0	20.6	99.0	24.2	21.4	58.2	27.7	40.2	23.5	18.4	24.9	20.7	17.0	18.3	36.6	24.9	26.3	27.8	189.9	24.9	30.1	88.8	33.6	23.9	35.3	14.4	34.2	24.8	20.6	30.0	42.6	23.8	31.0	40.5	32.9	28.6	64.5	61.5	51.7	69.7	48.4	47.4	54.3	70.5	86.3	75.9	98.8	86.8	75.9	55.4	85.7	28.7	61.4	69.5	41.8	74.4	64.8	120.0	59.4	52.9	284.0	38.3	71.1	93.1	111.9	92.2	55.1	57.6	76.9	78.0	55.9	67.2	72.2	67.8	96.8	73.2	53.8	96.1	99.4	81.9	52.0	44.4	69.1	90.6	139.9	61.7	66.1	91.4	64.2	50.4	72.3	65.9	45.0	33.9	51.8	69.5	84.6	76.5	64.2	75.1	53.8	62.6	124.7	61.3	115.2	54.0	1.5	0.5	1.3	0.2	0.3	0.5	0.2	0.3	0.1	0.5	0.3	0.3	0.5	2.7	0.3	0.6	0.7	0.3	0.4	56.1	92.9	38.0	127.3	99.0	24.2	23.5	18.4	24.9	14.4	30.0	64.5	37.0	9.6	12.7	81.6	40.4	74.8	11.6	7.0	72.8	22.2	21.0	13.1	17.9	10.0	7.7	16.5	52.1	11.7	34.0	20.5	11.7	7.1	20.0	19.9	23.0	34.0	15.1	52.8	151.2	8.7	17.2	24.2	18.8	29.1	19.7	11.2	15.4	19.2	24.7	11.8	93.1	15.6	4.1	40.0	105.1	7.7	9.9	54.7	35.6	105.9	21.2	27.8	18.6	72.9	77.5	12.9	10.6	8.6	39.2	17.3	12.6	20.1	5.8	92.7	13.1	14.4	29.8	2.9	6.1	64.0	70.5	12.0	39.9	14.2	13.2	21.3
PRKDC	"DNA-PKC, DNA-PKcs, DNAPK, DNAPKc, DNPK1, HYRC, HYRC1, p350, p460, XRCC7"	ENSG00000253729	"Protein kinase, DNA-activated, catalytic subunit"	P78527	8	47773111-47960178	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, Ribosome biogenesis"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005167, HPA035174"	Supported		Enhanced	Nucleoplasm		NA	NA		250000	"Cluster 6: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 36: HEL - Hemostasis"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"CAB005167: AB_2172845, HPA035174: AB_2674504"	"unprognostic (3.14e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (8.95e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.70e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.76e-3)"	"unprognostic (7.77e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.15e-2)"	17.3	16.8	8.6	14.1	10.7	19.2	16.1	9.8	11.9	18.2	10.8	16.2	7.0	20.1	8.0	24.0	18.3	7.4	16.7	10.6	9.3	14.8	14.0	14.8	17.9	10.4	10.0	19.8	18.0	14.0	16.3	10.9	9.8	13.5	11.6	23.8	16.0	9.2	26.4	19.8	17.2	12.1	10.6	18.8	16.6	18.3	9.6	27.8	13.4	15.0	17.1	18.7	17.5	14.3	123.5	103.4	98.4	93.9	59.9	63.0	41.6	51.2	49.9	70.3	68.9	68.0	39.6	117.1	43.1	63.3	52.3	68.5	131.3	70.2	109.3	26.3	81.8	230.2	92.1	83.7	25.8	88.6	46.0	45.9	22.5	111.3	115.3	27.1	73.4	79.5	156.6	48.0	78.8	57.7	125.8	72.3	108.6	85.6	31.2	60.8	77.3	41.2	35.5	104.4	49.2	62.5	158.1	50.6	51.1	60.2	72.6	60.1	86.2	91.5	78.0	73.0	104.2	41.3	56.7	162.8	51.7	97.9	75.6	11.4	8.1	4.1	8.7	6.8	11.0	13.1	10.8	9.2	6.5	16.7	11.2	10.3	7.7	12.8	13.7	15.3	8.3	2.9	8.6	10.7	9.8	11.9	10.6	9.3	10.4	10.0	9.8	10.6	9.6	14.3	73.4	38.5	36.1	56.8	67.9	38.4	48.3	59.7	77.4	103.4	63.1	64.0	82.1	22.8	44.1	42.3	125.1	61.1	81.9	17.5	17.6	41.9	29.0	66.0	166.5	59.7	25.8	147.6	85.5	36.0	60.6	73.2	55.0	72.6	45.6	105.1	32.5	41.2	35.9	104.3	77.1	31.2	38.7	45.5	20.1	15.5	56.8	54.6	19.6	61.8	63.6	73.1	57.7	82.0	76.0	34.9	16.6	69.6	69.3	57.1	13.2	23.5	50.1	111.6	52.6	91.2	69.3	100.7	106.3	85.3	40.6	33.0	71.0	143.2	55.2	36.4
PRKG2	"cGKII, PKG2, PRKGR2"	ENSG00000138669	"Protein kinase cGMP-dependent 2"	Q13237	4	81087370-81215117	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 13.1;prostate: 9.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 35.3;Excitatory neurons: 32.6;Inhibitory neurons: 66.1;Oligodendrocyte precursor cells: 106.6;Proximal enterocytes: 19.7;Smooth muscle cells: 29.8"	"Group enriched"	"Detected in some"	4	"melanoma: 4.1;prostate cancer: 2.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.0;ASC TERT1: 3.8;HEL: 21.2;hTCEpi: 4.0;SCLC-21H: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007386, CAB018739"	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 10: Non-specific - Unknown function"			"CAB018739: AB_2284387, HPA007386: AB_1079678"	"unprognostic (6.14e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.01e-4)"	"unprognostic (4.33e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.06e-1)"	1.0	0.2	2.1	0.2	1.5	0.5	1.5	0.5	1.7	1.0	0.0	2.4	9.6	0.4	0.3	2.8	0.3	0.2	4.3	1.5	1.6	0.5	0.0	3.3	0.2	3.5	2.7	0.0	1.4	0.0	2.2	0.0	3.8	9.6	2.8	0.3	0.3	3.4	0.0	1.2	13.1	0.5	2.2	0.0	0.9	0.9	6.0	1.0	0.9	0.0	0.4	0.5	0.6	1.0	0.1	0.3	0.1	0.0	5.0	3.8	0.0	0.3	0.0	0.0	0.0	0.4	2.4	0.0	0.2	0.9	0.0	0.1	0.3	1.5	0.0	0.4	0.0	21.2	0.6	0.1	0.0	0.0	0.0	0.5	4.0	0.0	0.0	1.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.1	0.9	0.6	0.4	0.0	0.0	0.1	0.0	0.9	6.3	0.0	0.0	0.2	0.0	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.1	1.5	0.5	1.7	1.5	1.6	3.5	2.7	3.8	2.2	6.0	1.0	0.3	35.3	2.6	1.0	0.3	0.0	0.9	0.1	1.2	0.0	0.3	0.1	4.9	0.0	2.0	0.0	0.0	0.0	0.1	5.5	0.0	0.2	10.3	0.3	0.6	0.1	0.0	8.0	32.6	0.0	0.1	2.5	0.0	0.1	1.3	0.1	0.0	0.0	0.1	0.0	66.1	1.7	0.0	0.0	0.0	2.2	0.0	0.1	0.0	12.2	0.1	0.0	0.0	106.6	1.1	0.9	9.2	0.0	0.5	0.8	19.7	0.2	0.8	0.0	0.0	0.1	29.8	0.0	1.3	0.8	0.1	0.0	0.4	0.0	0.7	0.3
PRKN	"AR-JP, PARK2, parkin, PDJ"	ENSG00000185345	"Parkin RBR E3 ubiquitin protein ligase"	O60260	6	161347417-162727775	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 28.3;tongue: 15.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 4.8;Distal tubular cells: 19.6;Proximal tubular cells: 6.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.3"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.0;HEL: 4.1;HSkMC: 1.7;Karpas-707: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016257, HPA036012"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"	Cytosol	"CAB016257: AB_628104, HPA036012: AB_2732471"	"unprognostic (9.23e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.85e-2)"	"unprognostic (5.85e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-3)"	"unprognostic (8.16e-2)"	"prognostic favorable (6.75e-12)"	"unprognostic (9.93e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.50e-1)"	3.4	3.3	4.1	0.1	3.6	0.3	1.9	0.4	5.7	1.3	0.6	2.7	1.2	1.6	1.2	3.2	1.2	1.5	9.1	4.6	1.8	5.2	1.2	1.0	0.5	1.0	1.9	2.8	1.2	2.3	1.8	0.4	1.6	1.2	0.6	1.5	1.3	1.4	28.3	2.0	1.0	1.2	1.0	1.0	1.9	5.3	1.9	0.5	1.3	15.9	0.3	2.5	1.0	2.4	0.0	0.0	0.3	2.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.5	4.1	0.1	0.6	0.3	0.0	0.0	1.7	0.0	0.0	0.2	0.3	0.0	0.2	0.2	2.2	0.0	0.2	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.7	0.0	0.0	0.5	1.0	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.7	1.7	0.3	2.2	0.8	0.1	1.3	0.6	0.8	0.9	0.7	1.6	1.8	1.8	0.5	0.6	0.4	0.0	0.1	0.8	4.1	3.6	0.4	5.7	4.6	1.8	1.0	1.9	1.6	1.0	1.9	2.4	2.3	9.6	4.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.1	1.5	0.0	0.0	1.8	1.8	0.0	0.5	0.4	0.0	19.6	1.1	0.0	3.4	1.8	0.7	0.0	0.0	0.0	2.2	0.1	1.8	0.0	3.2	2.5	3.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	6.8	1.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.4	3.7	0.0	0.0
PSIP1	"DFS70, LEDGF, p52, p75, PSIP2"	ENSG00000164985	"PC4 and SFRS1 interacting protein 1"	O75475	9	15464066-15510995	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 279.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 860.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013718, HPA019697"	Enhanced		Enhanced	Nucleoplasm		NA	NA		24000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"CAB013718: , HPA019697: AB_1852779"	"unprognostic (8.54e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.89e-3)"	"unprognostic (5.10e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.49e-3)"	"unprognostic (5.49e-2)"	"unprognostic (6.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.39e-1)"	32.9	40.9	67.8	46.9	72.1	62.0	27.4	83.9	89.1	45.8	52.6	40.8	23.1	57.5	36.0	26.2	42.9	30.8	34.4	71.5	79.2	32.6	22.3	32.8	80.7	65.2	66.4	86.0	17.1	30.3	52.2	39.5	64.4	36.3	30.9	154.4	19.1	41.0	38.6	26.0	34.4	43.2	65.1	54.7	28.5	81.6	68.1	129.7	37.1	29.5	69.3	31.2	32.3	72.2	117.5	76.5	254.7	187.4	54.0	65.2	56.7	138.3	98.1	121.7	143.6	32.1	59.5	248.1	31.4	73.5	68.2	32.0	160.1	75.0	174.9	164.8	96.6	860.4	194.9	60.8	65.1	101.7	91.7	54.8	21.0	102.1	74.4	121.0	108.0	115.2	144.4	134.1	80.2	42.8	211.5	250.9	395.2	2.7	117.2	194.7	138.8	50.7	68.3	40.5	161.1	176.7	123.7	54.0	67.1	157.5	54.5	134.9	76.7	88.0	88.6	66.7	133.2	57.1	85.3	221.8	70.2	100.8	51.6	13.7	2.6	5.4	6.1	2.0	7.7	11.0	12.5	8.8	3.0	17.5	18.7	11.6	8.4	9.5	5.7	3.1	12.9	2.4	67.8	72.1	83.9	89.1	71.5	79.2	65.2	66.4	64.4	65.1	68.1	72.2	93.7	54.5	31.9	27.4	98.1	31.9	49.1	8.1	48.9	231.0	22.0	35.6	57.8	31.5	23.1	47.8	66.7	122.7	82.1	24.7	62.6	9.5	95.5	92.9	62.5	84.8	38.1	160.1	73.4	8.5	76.2	74.8	23.0	35.1	15.2	104.2	65.3	18.0	32.1	138.0	76.9	34.1	2.0	36.5	45.9	58.5	125.9	45.8	40.9	20.6	47.9	162.2	83.4	49.8	67.6	3.6	20.6	134.3	60.4	19.6	14.1	54.5	42.1	279.1	124.9	85.2	89.8	217.9	243.8	34.5	21.2	41.3	111.6	68.6	45.8	20.3
PSKH2		ENSG00000147613	"Protein serine kinase H2"	Q96QS6	8	86047109-86088621	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"retina: 2.4"	"Cell type enhanced"	"Detected in single"		"Rod photoreceptor cells: 2.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"HEL: 9.4"									"HPA015095, HPA056839"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA015095: AB_1855815, HPA056839: "															"unprognostic (1.77e-2)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
PSMG1	"c21-LRP, DSCR2, LRPC21, PAC1"	ENSG00000183527	"Proteasome assembly chaperone 1"	O95456	21	39174769-39183488	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.3"	"Group enriched"	"Detected in all"	4	"Early spermatids: 673.8;Spermatocytes: 544.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA057193, HPA070225"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA057193: AB_2683363, HPA070225: AB_2686236"	"unprognostic (1.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.10e-1)"	"unprognostic (9.38e-2)"	"unprognostic (5.06e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (2.84e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.17e-3)"	7.5	9.8	4.0	9.1	4.0	17.3	6.8	2.7	5.5	7.3	2.5	10.5	8.9	7.8	4.8	11.8	6.4	5.4	8.3	4.6	3.8	9.7	15.9	5.7	8.9	2.2	2.4	7.2	10.8	5.1	8.0	7.7	3.2	5.5	9.9	4.9	7.3	3.2	13.8	7.1	8.2	5.1	2.1	6.3	7.1	40.3	3.7	6.3	10.8	5.6	6.2	7.8	7.4	4.0	104.0	34.7	23.5	32.9	12.3	15.1	65.0	55.3	25.9	44.8	28.2	66.6	26.9	113.7	28.9	17.1	38.1	28.5	40.3	30.3	30.2	48.9	61.6	209.6	52.4	83.6	21.9	101.0	40.4	18.9	24.6	46.2	46.5	9.8	24.9	47.0	160.4	61.9	27.2	58.2	63.0	54.7	82.2	38.9	53.5	99.6	29.8	115.8	19.1	30.4	77.6	22.7	70.4	39.1	57.4	4.0	36.6	51.4	26.7	50.1	16.8	66.7	79.9	46.4	79.3	96.8	42.0	170.4	38.6	10.6	6.8	3.9	10.5	9.0	12.3	12.0	14.7	12.4	12.2	10.6	11.5	10.3	0.6	7.5	9.1	11.3	13.7	7.9	4.0	4.0	2.7	5.5	4.6	3.8	2.2	2.4	3.2	2.1	3.7	4.0	23.7	6.4	17.6	5.2	17.8	136.0	44.1	68.6	43.9	14.2	31.3	39.0	24.8	22.8	39.9	20.2	4.2	108.9	12.6	14.7	66.5	50.8	673.8	20.8	36.5	26.3	29.9	63.3	7.5	49.7	118.6	31.8	18.8	21.6	36.1	26.2	18.9	32.7	59.5	8.4	8.0	45.7	69.2	17.7	35.5	88.4	31.7	25.0	46.2	3.7	24.4	18.0	12.3	3.5	5.9	32.4	20.0	33.1	31.7	41.5	30.6	89.4	20.8	19.7	26.3	29.5	31.3	544.1	98.7	51.7	97.7	54.5	20.1	54.7	56.9	27.9
PTGER1	EP1	ENSG00000160951	"Prostaglandin E receptor 1"	P34995	19	14472466-14475354	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	5	"kidney: 30.9"	"Cell type enriched"	"Detected in some"	70	"Collecting duct cells: 198.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 2.4;NB-4: 1.3;PC-3: 3.2;SH-SY5Y: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (3.44e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.50e-4)"	"unprognostic (8.69e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.74e-8)"	"unprognostic (1.19e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.27e-3)"	"unprognostic (4.88e-2)"	0.9	1.4	0.4	0.5	0.7	0.0	0.4	0.3	2.2	1.2	0.9	0.5	0.3	0.5	0.0	0.8	1.0	0.0	0.1	0.3	1.0	30.9	0.3	2.4	0.0	0.4	0.3	0.1	0.3	0.1	1.4	0.0	0.5	0.7	0.0	0.0	0.3	0.0	0.1	0.1	1.4	0.4	0.1	6.5	3.0	0.2	0.5	0.0	0.5	0.0	0.0	1.1	0.6	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.1	0.0	3.2	0.3	0.0	0.1	0.0	0.0	0.2	1.8	0.0	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.7	0.3	2.2	0.3	1.0	0.4	0.3	0.5	0.1	0.5	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.3	0.9	2.8	0.0	198.6	0.0	0.1	1.3	0.3	0.0	0.1	0.1	1.5	0.4	0.2	0.0	0.0	0.0	0.0	0.2	2.5	1.1	1.4	0.0	0.4	0.4	0.5	0.3	0.0	0.1	0.2	0.0	0.3	0.0	0.5	0.3	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.6	1.8	0.0	0.0	0.0	0.8	0.0	0.8	0.1	0.1	0.0	0.4	2.5	0.3	0.9	0.3	0.0	0.0	0.6	0.8	0.2	0.4
PTGIR	IP	ENSG00000160013	"Prostaglandin I2 receptor"	P43119	19	46620468-46625089	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 55.5"	"Group enriched"	"Detected in some"	5	"Langerhans cells: 177.2;monocytes: 160.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"classical monocyte: 28.2;intermediate monocyte: 65.3;myeloid DC: 20.9;non-classical monocyte: 38.7"	"Group enriched"	"Detected in many"	11	"dendritic cells: 20.9;monocytes: 65.3"	"Cell line enhanced"	"Detected in some"		"BJ: 10.8;BJ hTERT+: 12.2;fHDF/TERT166: 15.4;HDLM-2: 7.6;HEL: 28.3;HHSteC: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 3: Monocytes - Immune response regulation"				"unprognostic (3.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.49e-3)"	"unprognostic (4.22e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.45e-2)"	"unprognostic (4.47e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (2.09e-8)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (1.16e-1)"	"unprognostic (5.66e-2)"	13.7	6.8	0.5	6.0	0.4	3.4	5.2	0.4	0.9	6.0	0.4	4.8	2.0	4.6	0.3	2.1	4.5	2.9	27.3	0.6	0.4	26.1	9.2	55.5	3.5	0.6	0.5	2.4	5.7	0.6	1.9	4.4	0.5	2.6	1.0	0.0	4.1	0.9	2.8	4.3	5.8	2.9	0.6	10.8	6.7	0.3	0.5	1.5	16.6	0.8	2.6	6.0	5.2	0.5	0.0	0.0	0.0	0.0	0.2	5.5	0.0	10.8	12.2	1.5	4.3	0.0	0.0	0.0	0.9	15.4	0.1	0.0	0.0	0.0	0.9	7.6	0.0	28.3	0.0	0.0	7.2	0.0	0.0	1.7	0.0	3.9	0.2	0.0	3.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.5	1.4	1.7	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.7	0.7	0.0	28.2	0.0	0.0	65.3	0.4	1.5	0.3	0.0	20.9	0.7	3.3	0.1	1.1	0.0	38.7	2.0	3.9	17.6	0.5	0.4	0.4	0.9	0.6	0.4	0.6	0.5	0.5	0.6	0.5	0.5	1.5	0.0	0.6	0.3	3.7	4.2	0.8	0.4	0.0	0.4	0.2	0.5	0.9	0.0	0.1	1.8	0.0	0.1	2.7	0.2	0.0	0.3	0.2	0.1	1.5	2.3	0.0	0.4	0.7	0.4	0.1	10.3	0.5	0.1	3.8	0.1	4.2	0.2	2.6	0.0	0.6	0.0	0.0	7.9	177.2	0.0	2.1	23.7	7.2	0.0	160.9	0.1	1.0	0.5	0.3	0.4	0.0	0.0	0.1	0.8	0.0	0.2	0.7	0.8	6.6	1.1	30.9	0.1	0.4	0.0	4.4	0.3	2.0	0.1	0.0	0.7
PTH2R	PTHR2	ENSG00000144407	"Parathyroid hormone 2 receptor"	P49190	2	208359714-208854503	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 16.5"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 12.5;Distal tubular cells: 7.9;Excitatory neurons: 15.9;Proximal tubular cells: 16.1;Rod photoreceptor cells: 26.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"EFO-21: 10.7;HEL: 16.0;HL-60: 4.0;SH-SY5Y: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA010655	Approved					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA010655: AB_2668333"	"unprognostic (4.76e-3)"	"unprognostic (1.39e-3)"	"unprognostic (1.64e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.77e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.54e-3)"	"unprognostic (6.87e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.37e-2)"	1.2	0.3	2.2	0.1	1.1	4.2	0.9	0.0	3.1	0.0	0.1	0.0	0.0	0.7	2.1	0.0	0.0	0.0	0.0	2.4	2.0	0.2	0.6	0.1	0.1	0.3	0.6	0.0	0.6	0.0	0.3	1.2	0.2	0.5	0.0	16.5	3.6	0.5	0.0	0.1	0.0	0.5	0.1	0.1	0.0	0.5	4.5	0.0	0.0	0.0	0.1	0.0	0.0	1.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	2.2	1.1	0.0	3.1	2.4	2.0	0.3	0.6	0.2	0.1	4.5	1.5	0.1	0.0	0.0	0.3	0.6	0.0	0.0	0.1	0.0	1.1	1.8	3.2	0.2	0.0	0.1	5.5	12.5	0.5	0.9	0.0	7.9	0.1	0.6	0.2	0.5	0.1	1.8	4.2	15.9	0.0	0.1	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	1.0	0.1	2.5	2.1	2.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	26.5	0.0	0.0	0.4	0.6	0.4	0.0	0.0	0.1	0.1	0.3	0.0	0.0
PUM3	"HA-8, hPUF-A, KIAA0020, PEN, Puf-A, PUF6, XTP5"	ENSG00000080608	"Pumilio RNA binding family member 3"	Q15397	9	2720469-2844095	"Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 338.4;HEL: 327.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002353	Approved		Supported	Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 36: HEL - Hemostasis"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoli		"HPA002353: AB_1852266"	"unprognostic (1.39e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (4.89e-5)"	"unprognostic (2.02e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (2.44e-3)"	"unprognostic (8.44e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.11e-2)"	"unprognostic (8.43e-2)"	19.5	16.7	6.2	22.3	5.9	19.0	24.7	8.1	5.6	13.8	4.9	15.8	12.8	14.7	9.8	24.8	13.5	11.7	12.0	5.5	5.7	21.8	15.2	15.4	23.2	5.0	4.7	18.3	14.8	12.2	10.1	18.0	5.3	12.5	18.7	7.4	16.8	10.6	11.1	16.6	11.7	13.6	4.2	14.7	13.2	15.4	5.2	17.1	11.9	9.4	22.0	30.7	16.0	6.7	78.9	56.7	47.0	48.2	38.6	40.8	53.5	71.7	37.6	72.3	67.3	43.6	36.0	86.4	16.1	49.5	43.2	38.8	85.8	62.0	93.5	338.4	30.7	327.8	59.3	52.9	51.0	146.2	58.7	33.3	26.8	58.8	83.5	33.0	54.3	55.6	35.0	38.1	63.8	36.0	74.6	119.9	120.4	59.9	25.1	86.7	36.8	37.3	48.8	52.7	48.4	46.4	43.2	39.8	40.3	52.0	25.2	78.4	52.1	48.6	40.2	46.8	97.1	17.7	31.0	120.5	36.8	52.4	36.1	7.7	13.7	4.1	18.8	19.9	26.3	23.4	19.3	18.9	18.5	22.4	21.2	20.7	1.9	25.2	17.1	20.8	15.7	11.8	6.2	5.9	8.1	5.6	5.5	5.7	5.0	4.7	5.3	4.2	5.2	6.7	27.7	48.1	41.4	0.0	35.8	0.0	59.6	0.0	62.6	28.0	27.5	26.7	0.0	14.3	41.5	23.9	10.4	34.7	25.5	1.9	46.9	41.2	4.8	36.7	79.1	28.3	8.5	23.8	0.0	26.5	45.4	30.9	35.2	54.9	17.7	39.8	20.0	22.1	21.6	26.9	0.0	9.2	0.0	15.8	0.0	4.9	47.2	20.6	0.0	0.0	29.4	14.2	25.7	0.0	0.0	29.1	8.0	23.0	29.2	57.7	7.6	108.3	32.1	24.0	0.0	50.2	26.8	43.7	45.3	54.3	0.0	35.0	26.5	44.5	12.7	38.2
RAB6B		ENSG00000154917	"RAB6B, member RAS oncogene family"	Q9NRW1	3	133824235-133895882	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 138.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 30.8;Erythroid cells: 79.2;Excitatory neurons: 60.5;Horizontal cells: 67.3;Inhibitory neurons: 54.1"	"Cancer enhanced"	"Detected in all"		"glioma: 18.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	4	"MAIT T-cell: 7.3"	"Lineage enriched"	"Detected in single"	47	"T-cells: 7.3"	"Cell line enriched"	"Detected in many"	4	"HEL: 226.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017713, HPA059131"	Uncertain		Approved	"Golgi apparatus"		NA	NA		2200000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Golgi apparatus"		"CAB017713: , HPA059131: AB_2683916"	"unprognostic (2.87e-2)"	"unprognostic (6.33e-3)"	"unprognostic (4.53e-3)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (3.61e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.73e-4)"	"unprognostic (3.12e-2)"	"unprognostic (4.26e-2)"	"unprognostic (4.80e-2)"	"prognostic favorable (3.97e-6)"	"unprognostic (9.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.10e-2)"	"unprognostic (9.53e-2)"	"unprognostic (6.05e-3)"	6.8	11.1	45.7	2.8	72.6	12.0	4.4	0.4	138.0	2.9	0.0	6.8	2.4	3.0	2.1	4.2	16.2	3.2	20.8	71.8	31.3	7.1	0.9	3.1	3.3	74.6	43.1	2.1	4.4	24.9	12.0	1.7	55.7	2.7	2.1	29.4	10.1	5.9	2.7	1.5	2.9	8.4	3.7	5.9	5.5	4.0	21.5	1.4	5.2	2.8	2.0	1.6	2.2	63.1	0.1	3.0	5.8	14.9	10.1	10.3	0.5	3.0	6.3	7.2	0.8	1.6	1.5	0.2	6.3	2.4	21.2	0.4	13.8	0.4	3.6	0.2	8.6	226.6	3.5	0.5	1.2	1.4	8.5	3.1	2.9	1.1	0.2	0.1	2.9	8.3	53.4	0.6	1.1	5.5	0.7	21.3	18.0	10.8	2.2	0.2	0.4	2.3	4.0	1.3	47.2	10.1	4.4	4.2	26.7	22.5	16.8	9.7	3.7	6.5	15.5	3.2	5.4	5.6	1.5	0.5	0.7	0.5	5.6	0.0	0.0	0.0	0.6	0.0	7.3	0.1	0.1	1.7	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.8	45.7	72.6	0.4	138.0	71.8	31.3	74.6	43.1	55.7	3.7	21.5	63.1	2.0	0.0	0.0	25.8	0.2	1.3	2.2	0.5	0.6	10.5	2.0	2.3	30.8	1.5	2.8	1.8	2.1	0.3	0.6	2.2	3.9	3.6	0.1	2.3	0.9	3.5	0.0	79.2	60.5	1.3	0.7	3.7	2.0	1.3	0.0	12.4	7.9	0.1	0.2	67.3	54.1	0.2	0.0	0.6	1.1	0.2	1.8	0.4	1.8	16.9	0.1	10.2	0.0	17.1	9.6	2.5	1.1	6.8	0.1	2.0	0.0	1.5	9.3	21.3	0.0	4.1	13.8	0.9	12.7	0.8	1.4	0.3	1.1	2.2	0.0	0.6
RANBP6		ENSG00000137040	"RAN binding protein 6"	O60518	9	6011025-6015625	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043748, HPA052684"	Approved		Supported	Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA043748: AB_10796796, HPA052684: AB_2681913"	"unprognostic (1.47e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.89e-2)"	"prognostic favorable (1.34e-7)"	"unprognostic (2.42e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.61e-1)"	8.6	11.4	8.3	12.9	8.8	31.0	11.4	11.5	12.4	7.7	18.4	7.1	7.5	8.8	7.0	7.9	7.3	7.6	12.4	9.3	10.8	13.4	15.2	8.4	17.0	11.2	9.7	9.6	7.8	13.6	5.0	8.9	11.9	9.7	7.1	21.6	8.6	8.5	16.3	9.9	8.6	10.3	9.2	13.1	11.1	5.9	10.0	19.6	12.0	16.1	16.2	8.7	5.6	10.3	25.1	13.6	27.2	23.4	23.6	18.6	14.6	30.9	21.9	26.8	21.6	7.5	7.7	33.5	8.4	24.7	13.1	14.0	24.2	28.2	29.7	80.1	13.9	88.3	53.0	15.6	13.9	34.2	17.9	20.2	15.2	16.5	16.3	21.1	31.3	30.1	6.9	27.3	25.8	8.4	24.3	54.8	12.3	9.0	11.0	25.6	16.7	15.7	28.1	17.6	13.2	19.9	14.7	11.0	8.7	22.3	17.7	23.0	37.6	25.1	14.9	12.4	29.4	16.3	27.8	31.5	14.4	19.8	9.3	5.1	4.5	3.7	2.6	6.3	2.5	2.5	3.8	2.8	2.7	1.9	4.4	4.2	1.3	2.8	5.2	3.1	5.2	2.9	8.3	8.8	11.5	12.4	9.3	10.8	11.2	9.7	11.9	9.2	10.0	10.3	11.3	9.6	8.1	8.8	11.5	10.3	6.6	10.1	13.1	18.0	8.1	5.6	24.4	8.6	16.3	11.0	2.1	8.8	12.0	4.1	7.9	8.6	1.6	12.2	16.5	13.1	9.5	8.6	15.9	10.9	4.1	8.3	16.8	17.7	10.8	10.1	10.0	13.7	4.4	11.8	19.0	3.2	2.0	10.5	6.0	1.2	6.5	7.2	1.8	8.4	7.2	15.9	9.2	3.0	20.5	7.5	3.8	6.8	11.8	5.7	1.8	12.5	8.7	23.1	0.0	11.6	10.2	10.1	9.3	9.8	9.5	6.6	13.3	12.7	4.8	7.3
RAP1B	"DKFZp586H0723, K-REV, RAL1B"	ENSG00000127314	"RAP1B, member of RAS oncogene family"	P61224	12	68610855-68671901	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (1.20e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.15e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (8.08e-4)"	"unprognostic (1.08e-1)"	"unprognostic (8.86e-2)"	"unprognostic (7.86e-2)"	"unprognostic (3.22e-1)"	156.1	107.5	48.2	166.5	53.4	277.9	118.2	55.8	64.2	89.8	62.5	126.4	84.2	120.2	69.7	86.3	78.7	129.7	67.9	49.5	60.0	107.3	141.1	134.9	211.8	58.3	53.5	69.3	78.8	74.1	52.0	133.0	59.7	85.1	111.5	57.6	70.0	135.9	49.5	73.5	121.0	146.4	52.4	153.3	104.4	89.6	55.6	162.5	89.1	57.3	181.1	198.1	83.8	66.2	199.9	133.1	153.2	131.2	317.6	253.1	140.2	414.9	252.1	269.5	203.5	178.9	130.2	280.0	232.8	580.5	124.2	113.4	146.5	202.9	379.8	496.2	125.7	725.2	156.7	120.9	370.8	282.0	407.1	254.8	203.3	289.5	346.0	218.6	298.7	232.1	261.2	445.6	272.0	127.9	265.4	361.7	173.9	86.8	191.3	235.8	181.9	211.1	204.9	488.3	59.6	93.3	209.1	124.8	206.1	174.7	160.3	327.2	330.4	243.0	108.9	275.6	229.9	227.1	452.4	342.3	224.7	191.8	212.3	399.1	215.4	205.7	340.1	407.0	221.2	154.1	206.1	297.6	196.2	140.3	222.2	303.4	149.8	469.5	464.3	99.0	186.2	820.8	48.2	53.4	55.8	64.2	49.5	60.0	58.3	53.5	59.7	52.4	55.6	66.2	210.9	80.1	79.9	41.1	166.2	294.4	72.4	150.9	70.6	14.0	73.3	61.0	14.7	37.1	108.9	80.9	22.9	35.5	373.9	176.1	109.5	157.9	99.6	78.5	154.3	132.4	189.5	104.7	45.0	130.8	75.2	123.4	52.0	119.6	147.8	60.5	85.3	32.7	78.5	33.7	46.8	93.5	95.6	111.3	437.6	44.6	38.8	273.1	188.5	105.9	257.3	28.6	362.5	45.8	67.8	186.0	215.6	36.5	228.4	61.4	72.3	182.2	104.0	23.3	6.6	40.3	204.8	46.3	50.2	78.9	297.8	154.5	256.9	123.2	92.2	92.4
RBM11		ENSG00000185272	"RNA binding motif protein 11"	P57052	21	14216130-14228372	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"epididymis: 45.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 15.6;Excitatory neurons: 13.0;Inhibitory neurons: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"HEL: 1.4;REH: 1.0;SuSa: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA045885			Supported	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA045885: AB_10963937"	"unprognostic (1.95e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.44e-4)"	"unprognostic (2.18e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.92e-4)"	"unprognostic (5.74e-2)"	"unprognostic (1.16e-4)"	"unprognostic (3.45e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.69e-1)"	"unprognostic (9.24e-3)"	0.2	0.7	2.4	0.3	2.1	0.5	0.4	1.8	2.9	0.3	1.5	0.3	0.2	0.7	45.2	0.6	0.9	0.2	0.6	2.2	2.2	1.2	0.0	0.3	0.3	2.2	2.4	2.0	0.3	1.2	1.6	0.1	2.5	0.5	0.1	2.4	0.4	1.1	0.0	0.1	0.3	0.4	2.2	0.4	0.3	1.5	2.3	0.6	1.1	0.0	0.2	0.4	0.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.3	0.0	0.9	0.0	0.0	1.0	0.0	0.0	0.2	0.4	0.1	0.0	0.1	0.9	0.0	1.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.1	1.8	2.9	2.2	2.2	2.2	2.4	2.5	2.2	2.3	2.5	0.3	3.2	2.7	2.0	2.9	1.8	6.5	0.7	1.8	7.0	2.8	3.7	0.1	0.0	0.8	1.8	0.0	2.3	1.5	0.2	15.6	2.5	9.3	0.7	0.7	0.8	7.7	0.8	13.0	1.2	0.8	1.5	2.6	0.6	2.5	1.3	0.0	0.0	0.8	5.0	14.7	0.9	2.0	0.0	0.4	5.2	0.6	0.3	0.0	0.0	0.8	9.4	2.1	4.0	6.3	0.8	0.4	0.7	0.3	5.1	0.0	0.8	0.8	4.4	0.0	2.1	2.4	7.2	9.8	2.8	1.1	1.2	1.6	1.8	0.4	5.6
RCL1	"RNAC, RPCL1"	ENSG00000120158	"RNA terminal phosphate cyclase like 1"	Q9Y2P8	9	4792944-4885917	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 245.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 74.1;Hepatocytes: 183.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"HDLM-2: 145.5;HEL: 375.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071308			Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA071308: AB_2686384"	"prognostic favorable (5.48e-4)"	"unprognostic (7.60e-3)"	"unprognostic (7.55e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (8.02e-4)"	"unprognostic (3.55e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.59e-2)"	"prognostic favorable (2.40e-7)"	"unprognostic (1.01e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.66e-2)"	37.2	13.4	5.8	9.0	7.8	44.3	21.7	6.5	7.3	9.4	8.2	7.5	4.1	8.3	9.9	10.4	10.6	6.3	6.6	5.9	8.0	12.3	245.8	13.1	15.0	8.4	7.9	17.6	64.6	8.7	7.0	13.8	8.8	7.0	7.5	3.8	6.8	7.1	14.4	21.1	8.0	7.7	8.3	9.2	10.4	13.8	8.1	9.7	8.2	8.6	12.5	12.5	10.6	10.2	23.3	27.6	10.3	16.5	15.0	10.1	27.3	10.8	12.0	19.9	16.8	13.9	13.4	45.2	7.4	9.7	22.1	14.4	48.0	32.5	22.8	145.5	24.2	375.0	33.5	28.1	21.5	34.1	28.9	22.4	18.2	19.0	28.7	11.2	19.7	32.4	38.9	28.0	12.0	30.4	27.8	57.8	35.7	27.7	11.0	34.2	13.8	24.2	24.3	25.9	29.6	24.3	13.6	20.0	15.8	20.4	18.9	39.8	13.9	11.6	13.3	16.6	34.0	11.5	35.3	48.1	21.3	20.8	8.1	16.2	1.6	4.3	5.7	2.5	7.0	8.7	6.5	7.7	4.3	11.5	8.7	9.0	0.6	12.1	1.3	7.4	5.9	3.7	5.8	7.8	6.5	7.3	5.9	8.0	8.4	7.9	8.8	8.3	8.1	10.2	10.9	6.4	6.8	18.9	14.7	25.5	21.8	11.9	25.0	5.4	9.3	8.0	10.6	11.5	7.8	3.7	0.0	39.8	8.5	3.0	25.4	12.4	74.1	8.3	8.8	12.1	3.0	68.4	14.1	11.5	16.6	11.9	8.6	5.7	14.5	16.7	16.1	183.4	17.7	5.0	15.9	6.4	6.1	11.3	6.2	39.7	23.0	7.6	3.6	36.5	9.7	9.2	5.2	18.1	34.3	10.6	3.7	37.6	14.3	18.1	3.2	13.7	14.0	7.0	13.1	19.1	10.2	18.2	18.4	18.6	21.2	35.4	8.9	12.1	8.9	16.6
RGPD8	"RanBP2alpha, RANBP2L1"	ENSG00000169629	"RANBP2 like and GRIP domain containing 8"	O14715	2	112368369-112434488	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 15.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Early spermatids: 24.3;Excitatory neurons: 9.8;Late spermatids: 10.1;Microglial cells: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 16.2;hTEC/SVTERT24-B: 13.4"									"HPA045704, HPA049497, HPA051675, HPA067564"	Uncertain		Uncertain	"Nuclear membrane,Vesicles"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane, Vesicles"		"HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (1.37e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.15e-3)"	"unprognostic (3.17e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.05e-2)"	4.3	1.8	2.7	2.8	3.6	10.6	4.5	8.6	7.6	2.8	4.5	2.1	1.6	3.1	5.4	1.4	2.2	2.9	1.8	3.7	3.5	2.4	5.1	3.3	2.4	2.2	2.4	3.2	3.0	2.2	2.6	3.3	1.9	2.6	2.3	7.9	2.5	2.9	1.7	3.8	2.1	2.6	1.1	3.0	1.7	15.6	2.6	3.2	2.4	2.2	3.0	2.6	1.6	5.5	6.1	2.6	4.3	2.6	1.6	3.6	0.1	2.4	1.9	2.3	1.5	5.3	0.4	0.0	1.7	4.0	2.0	2.9	12.3	1.7	2.4	8.7	4.0	16.2	4.5	4.1	2.2	0.1	0.2	0.6	2.2	13.4	3.4	5.7	1.9	2.8	8.4	0.4	3.6	2.5	8.7	2.1	3.0	0.9	3.7	0.0	0.5	0.1	1.3	2.5	2.7	0.5	8.1	0.1	1.7	3.0	1.2	6.8	8.9	1.3	1.8	6.9	4.4	0.0	0.0	0.0	0.5	2.9	0.3	1.3	0.4	0.4	1.0	0.3	1.4	0.5	0.7	0.9	0.4	0.6	1.0	0.6	0.3	0.5	0.8	0.7	0.4	0.3	2.7	3.6	8.6	7.6	3.7	3.5	2.2	2.4	1.9	1.1	2.6	5.5	1.0	9.6	3.6	1.6	2.8	0.4	0.4	0.2	5.2	0.8	0.3	0.3	8.0	1.5	1.9	0.0	2.1	0.2	0.7	0.1	0.0	0.5	24.3	0.6	0.5	1.5	0.0	2.5	9.8	1.1	0.1	2.2	2.6	0.6	5.1	0.6	0.7	0.2	0.4	0.0	7.0	0.4	0.0	0.6	0.8	10.1	0.3	2.0	0.0	9.4	2.3	0.4	0.0	7.5	5.2	0.9	0.0	0.0	2.4	0.0	0.0	0.1	6.7	0.7	0.0	0.9	0.9	6.8	2.7	2.7	0.0	0.4	3.1	0.0	0.0	0.3
RGS9BP	"FLJ45744, PERRS, R9AP"	ENSG00000186326	"Regulator of G protein signaling 9 binding protein"	Q6ZS82	19	32675848-32678300	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"choroid plexus: 28.9;retina: 17.4;skeletal muscle: 9.0"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 29.0;Cone photoreceptor cells: 56.3;Rod photoreceptor cells: 75.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 6.3;HMC-1: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049791	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"		"HPA049791: AB_2680884"	"unprognostic (2.82e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.20e-7)"	"unprognostic (1.49e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.71e-2)"	"unprognostic (6.74e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.29e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.34e-2)"	0.0	0.1	0.8	0.0	0.7	0.0	0.0	0.8	0.8	0.0	28.9	0.1	0.0	0.0	0.1	0.4	0.0	0.0	1.3	3.3	0.9	0.3	0.0	0.3	0.0	1.1	1.4	0.0	0.0	0.2	0.2	0.0	0.9	0.2	0.0	17.4	0.1	0.1	9.0	0.1	0.0	0.0	0.5	0.0	0.1	0.4	1.5	0.1	0.0	3.2	0.0	0.4	0.0	0.7	0.1	0.1	0.0	0.5	0.3	0.1	0.3	0.0	0.3	0.2	0.1	0.0	0.1	0.1	0.3	0.0	0.3	0.0	1.0	0.0	0.0	0.2	0.1	6.3	0.1	0.0	0.1	0.1	1.6	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.4	0.8	0.1	0.2	0.0	1.0	0.0	0.0	1.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.6	0.3	0.0	0.2	0.3	0.1	0.1	0.3	0.4	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.8	0.8	3.3	0.9	1.1	1.4	0.9	0.5	1.5	0.7	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	29.0	0.4	0.4	4.6	0.0	0.0	1.8	56.3	0.3	0.6	0.5	0.0	0.0	5.1	0.2	0.1	0.7	0.0	0.8	0.0	0.0	0.2	0.2	0.0	0.4	0.0	1.8	0.7	0.0	0.2	1.7	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.1	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.4	0.9	0.0	75.4	0.0	0.4	0.2	0.5	0.4	0.0	0.0	0.0	0.1	1.1	0.4	0.0
RHCE	"CD240CE, RH"	ENSG00000188672	"Rh blood group CcEe antigens"	P18577	1	25362249-25430192	"Blood group antigen proteins, CD markers, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"bone marrow: 48.5"	"Cell type enriched"	"Detected in some"	67	"Erythroid cells: 511.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HEL: 81.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Plasma membrane"		"HPA060951: , HPA077385: "	"unprognostic (1.37e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.91e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.61e-2)"	"unprognostic (5.77e-5)"	"unprognostic (1.38e-1)"	"unprognostic (3.94e-2)"	"unprognostic (7.15e-3)"	"unprognostic (1.63e-1)"	0.3	0.6	1.5	0.1	1.9	48.5	0.3	1.6	3.3	0.3	1.2	0.2	0.2	0.2	4.2	0.6	1.0	0.3	1.2	1.5	1.4	0.4	1.7	0.4	0.5	1.9	1.6	0.5	1.2	0.1	3.4	1.1	1.9	1.0	0.3	2.2	5.5	0.2	1.5	0.6	0.1	0.0	1.5	1.1	0.4	2.2	1.6	0.8	0.6	0.9	0.3	0.1	0.5	2.2	0.2	0.1	0.2	0.5	0.9	0.6	0.1	0.3	0.3	0.4	0.1	0.1	1.5	0.7	1.1	1.0	0.1	0.3	0.0	0.2	0.2	0.4	0.1	81.3	0.0	0.0	1.1	0.0	0.6	1.9	1.5	0.6	0.5	0.0	0.0	0.6	17.5	0.4	0.5	0.8	0.0	0.6	1.7	0.7	0.5	0.2	0.2	2.6	0.0	0.0	0.7	0.8	0.3	0.3	1.0	0.8	0.5	0.0	0.1	0.2	0.0	0.9	0.0	5.1	1.4	1.0	2.9	0.9	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.5	1.9	1.6	3.3	1.5	1.4	1.9	1.6	1.9	1.5	1.6	2.2	0.8	0.0	0.0	5.5	0.8	0.5	0.5	0.3	0.6	4.2	1.1	2.5	0.7	1.5	0.2	0.0	0.0	0.8	1.2	0.5	0.0	0.3	1.1	1.2	0.7	0.4	0.0	511.8	2.9	0.2	0.7	0.4	3.6	0.8	4.5	0.6	0.0	0.7	0.2	6.7	2.3	0.0	0.0	0.6	0.4	0.5	0.6	1.7	0.0	0.0	0.0	4.7	1.0	2.0	2.7	0.5	0.0	0.7	3.0	0.3	0.1	0.0	0.9	2.4	6.6	0.5	0.5	3.0	7.6	0.6	1.4	0.8	0.8	0.7	0.3	0.7
RHD	"CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI"	ENSG00000187010	"Rh blood group D antigen"	Q02161	1	25272393-25330445	"Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"bone marrow: 15.8"	"Cell type enriched"	"Detected in some"	21	"Erythroid cells: 153.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.3"	"Group enriched"	"Detected in some"	7	"HEL: 43.0;K-562: 13.0"									"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Plasma membrane"		"HPA060951: , HPA077385: "	"unprognostic (4.75e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.93e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.92e-3)"	0.1	0.4	0.4	0.5	1.0	15.8	0.1	1.4	0.7	0.3	0.1	0.1	0.3	0.4	0.1	0.3	0.2	0.4	0.3	0.4	0.1	0.1	0.1	0.2	0.7	0.3	0.1	0.5	0.4	0.0	0.2	0.3	0.2	0.3	0.1	1.9	2.4	0.0	3.8	2.0	0.3	0.0	0.0	0.6	0.2	0.5	0.5	0.1	0.3	0.0	0.1	0.1	0.1	1.2	0.2	0.0	0.3	0.3	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.1	0.3	0.6	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.7	0.2	43.0	1.0	0.2	0.0	0.3	0.4	0.0	0.1	0.1	0.1	0.2	0.1	0.2	13.0	0.9	0.1	0.2	0.2	0.3	4.0	0.0	0.2	0.3	0.2	0.1	0.0	0.1	0.6	0.4	0.1	0.2	0.1	0.1	0.2	0.6	0.4	0.7	0.2	0.5	0.2	0.4	0.2	0.2	0.6	0.2	0.2	4.3	0.9	2.0	0.6	0.4	0.7	1.0	0.8	0.5	0.1	1.3	0.9	0.8	6.3	1.0	0.6	0.4	0.7	0.6	0.4	1.0	1.4	0.7	0.4	0.1	0.3	0.1	0.2	0.0	0.5	1.2	0.2	0.0	0.5	1.0	0.6	0.1	0.2	0.0	0.0	0.3	0.1	0.1	1.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.1	0.3	1.0	0.0	153.0	5.2	0.2	0.0	0.2	0.0	0.3	0.0	0.2	0.4	0.0	0.1	0.0	4.3	0.0	0.0	0.3	0.3	0.0	0.0	3.0	0.0	3.7	0.0	0.4	0.0	7.1	6.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	1.2	0.4	0.1	0.6	0.0	0.0	0.0	0.7	0.2	0.0	0.1
RIC1	"bA207C16.1, KIAA1432"	ENSG00000107036	"RIC1 homolog, RAB6A GEF complex partner 1"	Q4ADV7	9	5629025-5776557	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 62.3;Excitatory neurons: 84.5;Inhibitory neurons: 79.6;Microglial cells: 98.4;Oligodendrocyte precursor cells: 69.9;Oligodendrocytes: 70.6;Plasma cells: 80.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 73.3;HEL: 91.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051578	Supported					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 57: B-cells - Immune response"			"HPA051578: AB_2681541"	"unprognostic (1.78e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.51e-2)"	"unprognostic (8.87e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.87e-2)"	"unprognostic (7.16e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.77e-2)"	11.8	7.2	3.2	12.7	7.3	13.2	9.8	10.2	5.2	11.6	11.1	8.4	10.0	11.6	8.7	11.4	8.8	11.4	6.9	4.2	5.6	7.5	9.9	10.1	17.3	7.3	5.5	10.3	10.5	8.9	4.9	14.3	7.4	8.2	9.4	7.4	11.3	10.5	17.6	13.5	9.3	13.3	4.3	11.8	7.9	11.6	6.3	14.8	11.3	15.7	16.5	11.0	10.0	10.1	18.5	10.7	18.3	12.6	20.8	24.1	15.3	26.1	24.0	17.6	22.8	9.8	3.9	41.8	3.1	27.1	7.0	8.8	13.9	14.4	24.4	73.3	9.2	91.5	23.3	10.6	17.2	14.4	15.7	22.7	9.7	12.1	18.7	20.1	21.2	13.0	5.5	48.5	14.7	4.6	11.9	26.0	9.2	7.0	5.3	22.8	12.0	16.9	9.2	7.1	5.0	12.4	14.2	8.8	7.3	29.1	7.9	24.1	20.5	14.2	17.7	8.0	12.4	13.4	18.0	51.8	5.8	5.5	4.9	0.3	0.6	0.5	0.3	1.0	0.4	0.7	0.4	0.5	0.5	0.2	0.2	0.3	0.3	1.0	0.5	0.7	0.5	0.5	3.2	7.3	10.2	5.2	4.2	5.6	7.3	5.5	7.4	4.3	6.3	10.1	11.7	9.6	4.8	62.3	45.9	0.0	5.8	0.0	42.1	7.1	6.9	5.5	4.4	10.0	0.0	0.0	4.2	7.4	12.1	5.6	1.9	3.9	9.6	8.1	12.8	8.7	3.6	17.9	84.5	5.4	4.6	13.5	25.0	10.1	5.1	7.6	9.7	10.7	7.8	21.9	79.6	2.7	0.0	25.7	0.0	9.5	8.7	19.8	0.0	98.4	20.8	2.5	7.2	69.9	70.6	5.6	2.7	6.4	80.1	6.1	7.0	3.3	0.7	5.9	13.1	10.1	11.1	8.0	4.1	32.0	0.0	7.3	15.3	6.4	2.8	8.1
RILP	FLJ31193	ENSG00000167705	"Rab interacting lysosomal protein"	Q96NA2	17	1646145-1649866	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 60.5;skeletal muscle: 48.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 101.4;Proximal enterocytes: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 3.5;eosinophil: 1.0;intermediate monocyte: 1.2;myeloid DC: 2.4;neutrophil: 3.3;plasmacytoid DC: 1.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;granulocytes: 3.3;monocytes: 3.5"	"Cell line enhanced"	"Detected in many"		"HEL: 40.6;HMC-1: 19.5;K-562: 15.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"									NA	NA		18000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"prognostic favorable (7.97e-4)"	"unprognostic (7.93e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.84e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.93e-1)"	"prognostic favorable (8.51e-5)"	"unprognostic (2.26e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (7.12e-4)"	17.4	18.0	3.4	0.8	3.3	8.1	15.6	3.2	5.1	5.0	10.7	15.5	10.5	5.9	0.6	5.4	6.9	1.1	60.5	3.1	3.3	15.3	29.1	13.1	1.0	3.7	3.4	3.2	10.4	1.8	4.5	0.8	3.4	6.0	1.4	0.4	11.5	1.2	48.1	6.3	13.0	0.9	2.9	15.1	13.5	3.2	3.8	0.3	29.6	8.3	0.4	11.3	5.1	3.2	2.3	1.6	0.2	1.7	1.1	2.7	7.7	1.5	1.0	1.6	0.9	3.6	0.5	0.4	5.2	1.2	0.5	5.5	0.2	0.2	0.3	0.2	3.6	40.6	0.5	4.6	1.7	0.3	19.5	2.2	0.7	0.4	0.0	0.8	1.4	0.3	15.8	0.4	0.5	2.2	1.4	3.1	0.4	0.4	8.1	5.8	0.0	1.1	0.0	1.3	0.1	0.6	0.8	1.0	2.0	0.2	1.0	0.3	7.8	0.5	1.0	1.9	1.5	0.3	0.5	0.0	3.0	1.8	0.3	0.3	3.5	1.0	0.1	1.2	0.1	0.3	0.2	0.1	2.4	0.0	0.2	0.0	3.3	0.5	0.2	1.3	0.1	0.7	3.4	3.3	3.2	5.1	3.1	3.3	3.7	3.4	3.4	2.9	3.8	3.2	42.6	19.2	17.7	3.3	3.2	8.8	13.3	7.5	2.8	1.6	11.1	13.1	59.9	17.2	8.9	7.3	0.0	15.8	12.1	101.4	50.9	29.2	0.1	3.2	5.1	21.9	3.0	65.9	3.1	25.4	9.4	12.9	24.5	5.1	0.0	2.1	26.0	30.6	57.1	3.3	2.4	27.6	8.2	35.2	34.3	2.6	6.8	34.1	14.2	5.6	28.1	9.9	5.2	2.0	1.3	20.2	59.7	8.2	10.3	8.4	84.9	20.8	3.1	1.3	13.1	8.3	9.2	0.6	12.2	7.4	8.2	34.6	5.2	9.4	28.7	21.0
RIPOR3	"C20orf175, C20orf176, dJ530I15.2, dJ530I15.3, FAM65C"	ENSG00000042062	"RIPOR family member 3"	Q96MK2	20	50586108-50691542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Collecting duct cells: 3.7;Endometrial stromal cells: 6.5;Fibroblasts: 3.8;monocytes: 2.0;Proximal tubular cells: 3.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 36.0;ASC TERT1: 16.7;HEL: 55.9;HSkMC: 33.0;K-562: 33.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA051823, HPA054759"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA051823: AB_2681626, HPA054759: AB_2682596"	"unprognostic (7.23e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (1.66e-5)"	"unprognostic (4.96e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.98e-1)"	"unprognostic (9.21e-3)"	"unprognostic (1.67e-2)"	"unprognostic (4.58e-2)"	19.4	13.3	2.7	3.4	3.0	22.4	11.7	2.7	3.5	38.5	5.1	8.5	2.5	18.2	1.0	5.3	27.7	3.2	16.6	2.7	2.6	28.9	14.1	5.3	4.7	3.0	2.9	8.3	3.0	0.8	9.1	1.9	2.9	6.0	1.5	0.1	6.9	0.6	7.8	5.5	11.3	4.4	2.6	7.5	5.8	6.1	2.8	4.7	7.5	3.8	1.3	8.2	16.6	2.6	0.0	0.0	0.9	0.0	36.0	16.7	0.1	0.0	11.6	0.0	0.2	0.3	0.1	0.1	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	55.9	0.0	0.2	4.3	0.0	0.0	33.0	0.0	1.0	0.0	0.0	0.0	0.0	33.2	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	1.9	0.0	3.2	0.0	0.0	5.3	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.3	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	2.7	3.0	2.7	3.5	2.7	2.6	3.0	2.9	2.9	2.6	2.8	2.6	1.1	3.2	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.6	3.7	0.0	0.6	0.4	0.0	0.0	0.5	0.0	0.8	6.5	0.2	0.0	0.0	0.0	0.4	0.4	3.8	0.0	1.6	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.9	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.5	0.1	0.0	0.0
RLN1	H1	ENSG00000107018	"Relaxin 1"	P04808	9	5334930-5339876	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	71	"prostate: 23.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 2.8;Enteroendocrine cells: 4.8;Prostatic glandular cells: 10.6;Spermatocytes: 2.4;Spermatogonia: 3.1"	"Cancer enriched"	"Detected in some"	106	"prostate cancer: 67.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEL: 1.2"														"Secreted to blood"	NA	NA				"Cluster 51: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 35: Glandular cells - Unknown function"				"unprognostic (7.12e-6)"	"unprognostic (2.32e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.04e-1)"		"unprognostic (4.32e-2)"	"unprognostic (3.44e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.08e-4)"	"unprognostic (8.15e-2)"	"unprognostic (2.89e-4)"	"unprognostic (8.82e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.53e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.9	0.2	0.0	0.5	1.0	0.8	0.2	2.8	0.1	0.0	0.0	0.7	0.3	0.0	0.0	0.6	1.6	0.7	0.2	0.1	4.8	1.7	0.0	0.5	0.4	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.4	10.6	0.0	0.4	1.0	0.8	0.0	0.2	0.1	2.4	3.1	0.0	0.1	1.1	1.6	0.1	0.2	0.3
RLN2	"bA12D24.1.1, bA12D24.1.2, H2, RLXH2"	ENSG00000107014	"Relaxin 2"	P04090	9	5299864-5304716	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 5.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 13.0;Muller glia cells: 9.6;Spermatocytes: 17.3;Syncytiotrophoblasts: 13.5"	"Group enriched"	"Detected in some"	5	"breast cancer: 2.0;prostate cancer: 6.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	26	"gdT-cell: 1.4;MAIT T-cell: 4.2;memory B-cell: 1.9;memory CD4 T-cell: 2.8;memory CD8 T-cell: 2.3;naive B-cell: 1.4;naive CD4 T-cell: 4.0;naive CD8 T-cell: 3.0;NK-cell: 3.5;T-reg: 1.3"	"Group enriched"	"Detected in many"	33	"B-cells: 1.9;NK-cells: 3.5;T-cells: 4.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.6;HEL: 21.9;T-47d: 6.1;U-266/84: 10.2"														"Secreted to blood"	NA	NA	24400	10000	"Cluster 22: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"				"unprognostic (1.63e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.03e-2)"	"unprognostic (9.99e-2)"		"unprognostic (1.48e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.50e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.74e-6)"	"unprognostic (2.36e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.88e-2)"	"unprognostic (8.41e-4)"	0.4	0.0	0.4	1.4	0.5	0.3	2.3	0.6	0.7	0.4	0.5	0.5	0.0	0.5	0.3	0.3	5.2	0.2	0.5	0.4	0.5	1.9	0.0	0.7	2.8	0.6	0.5	0.1	0.5	4.2	2.9	0.6	0.6	3.9	0.4	2.9	0.3	0.6	0.0	0.4	0.5	0.2	0.5	0.9	0.5	2.8	0.5	2.7	0.8	0.2	2.3	0.2	0.1	0.5	3.0	0.4	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.5	1.0	0.3	1.6	5.6	0.4	0.0	0.0	0.9	0.0	2.8	0.7	4.4	2.0	21.9	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.5	0.0	0.0	0.2	0.1	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.0	0.6	2.7	3.0	0.0	0.6	0.1	0.2	6.1	0.1	0.2	0.0	0.5	0.0	0.1	1.3	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	4.2	1.9	2.8	2.3	0.0	1.4	4.0	3.0	0.0	3.5	0.0	0.0	1.3	0.8	0.4	0.5	0.6	0.7	0.4	0.5	0.6	0.5	0.6	0.5	0.5	0.5	0.8	3.2	0.6	0.3	2.6	0.5	2.3	1.5	1.2	1.5	3.8	3.0	1.9	1.5	1.2	1.8	0.0	6.3	1.3	0.1	7.9	2.8	13.0	3.3	0.3	0.8	3.6	1.7	0.4	1.5	2.3	0.4	0.5	0.3	0.0	0.6	0.0	0.0	0.6	3.3	0.9	1.7	2.0	0.0	0.0	5.3	0.6	0.1	0.0	1.0	0.8	9.6	4.1	0.0	0.9	0.8	0.2	0.4	0.5	1.0	0.1	1.4	5.0	1.7	0.0	0.6	0.4	17.3	5.1	1.4	1.3	13.5	3.4	0.0	1.5	0.5
ROBO2	KIAA1568	ENSG00000185008	"Roundabout guidance receptor 2"	Q9HCK4	3	75906695-77649964	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.7;retina: 15.4"	"Group enriched"	"Detected in many"	24	"Excitatory neurons: 3438.7;Inhibitory neurons: 4706.0"	"Cancer enhanced"	"Detected in many"		"glioma: 3.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 29.8;HEL: 83.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013371, HPA013975"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	NA		1900000		"Cluster 58: Brain - Synaptic function"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nucleoplasm, Centriolar satellite"	"HPA013371: AB_1856391, HPA013975: "	"unprognostic (1.14e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.25e-3)"	"unprognostic (1.82e-2)"	"unprognostic (5.93e-3)"	"unprognostic (3.87e-1)"	"unprognostic (2.83e-3)"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.65e-3)"	0.7	2.4	10.1	0.5	13.6	0.0	0.6	0.0	14.2	2.4	0.0	0.8	0.5	2.1	0.4	4.8	0.1	2.3	0.6	10.4	1.7	1.8	1.2	10.0	1.5	14.8	13.1	7.0	1.6	2.8	1.5	5.2	14.3	1.2	0.4	15.4	1.6	5.7	0.1	2.3	0.7	1.4	16.7	2.9	0.7	3.7	4.9	9.3	0.1	0.4	2.2	1.2	1.7	8.1	0.0	0.0	2.2	0.0	7.5	8.1	0.1	0.3	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	9.8	83.9	1.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.5	0.0	5.1	9.1	0.0	0.0	1.1	5.1	12.2	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.5	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	13.6	0.0	14.2	10.4	1.7	14.8	13.1	14.3	16.7	4.9	8.1	0.7	0.0	0.5	164.6	0.0	1.8	2.0	0.4	19.4	30.8	0.2	1.0	2.4	1.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.2	1.0	1.7	1.1	0.0	0.0	3438.7	0.0	0.1	10.6	0.0	3.2	0.0	2.3	3.3	0.7	0.1	52.2	4706.0	3.0	0.0	0.0	2.8	3.4	3.1	0.1	0.0	54.4	0.0	2.0	0.0	63.3	52.4	0.2	0.0	6.0	0.0	0.8	0.3	0.1	0.1	5.6	0.0	0.1	0.9	2.9	1.1	15.7	1.1	0.1	0.2	40.5	0.5	0.2
RPUSD4	FLJ14494	ENSG00000165526	"RNA pseudouridine synthase D4"	Q96CM3	11	126202096-126211692	"Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 135.5;tongue: 75.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039689	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	Nucleoplasm	"HPA039689: AB_10673537"	"unprognostic (2.02e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (6.14e-4)"	"unprognostic (3.16e-3)"	"unprognostic (2.90e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.32e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.44e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.47e-2)"	14.8	12.7	10.2	9.8	10.4	10.6	14.0	10.5	11.2	13.8	10.7	12.1	10.4	12.6	7.7	15.1	12.9	8.1	27.2	10.5	10.4	11.8	20.5	9.4	13.8	10.2	10.2	18.3	26.8	7.8	8.8	6.8	10.5	11.5	10.1	6.1	14.4	7.0	135.5	17.1	12.1	9.2	10.6	14.4	20.0	8.8	10.5	13.2	10.1	75.2	15.5	12.4	13.4	10.5	15.6	14.0	17.0	19.7	24.5	34.3	12.5	16.2	22.7	16.6	15.1	46.4	27.3	35.7	16.8	14.1	23.7	25.1	40.3	25.8	17.3	32.4	23.9	84.1	15.0	40.5	18.3	42.5	17.1	29.8	35.0	18.4	22.9	24.8	33.4	28.8	51.8	25.1	20.2	13.5	26.6	46.3	18.4	49.3	29.1	31.0	25.2	33.3	25.7	19.8	29.3	20.5	21.5	29.7	16.7	17.0	46.2	21.9	20.9	18.6	13.3	15.4	19.9	10.1	12.4	30.7	8.8	47.2	19.7	1.6	12.7	1.4	15.9	11.7	19.6	14.4	18.0	14.3	16.3	14.5	20.4	16.8	0.9	14.3	14.0	7.0	18.1	13.3	10.2	10.4	10.5	11.2	10.5	10.4	10.2	10.2	10.5	10.6	10.5	10.5	10.0	3.2	8.4	6.8	15.3	27.5	20.4	13.2	17.1	9.9	13.1	9.1	35.4	12.8	7.4	7.3	8.4	14.0	12.3	7.2	9.8	12.3	1.8	6.7	7.1	11.9	15.5	6.7	7.0	19.6	17.1	10.2	10.7	7.4	5.7	15.2	13.6	11.3	13.3	11.8	8.4	10.7	2.0	15.9	8.7	2.3	9.6	8.6	10.6	8.4	21.0	5.3	14.4	6.6	7.8	13.5	7.4	8.6	12.4	17.4	15.6	14.5	7.0	8.2	6.6	15.6	9.9	10.3	16.7	13.2	24.0	13.3	13.1	18.3	18.8	14.7
RSU1	"FLJ31034, RSP-1"	ENSG00000148484	"Ras suppressor protein 1"	Q15404	10	16590611-16817463	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025927	Uncertain		Approved	Vesicles		NA	NA		33000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"HPA025927: AB_10610420"	"unprognostic (7.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.89e-1)"	"unprognostic (9.56e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.30e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (9.32e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.53e-2)"	35.6	14.2	8.8	22.0	8.9	27.9	25.4	8.8	10.1	21.2	10.1	27.8	12.0	30.3	19.9	27.7	19.2	19.7	25.1	8.7	10.1	19.4	16.7	27.7	22.3	10.5	9.4	21.8	21.2	14.1	3.9	23.2	9.8	17.9	23.8	9.9	14.5	27.0	15.8	15.9	13.7	41.8	8.6	20.4	15.6	5.5	10.4	18.1	18.7	13.8	22.3	24.0	18.0	9.6	27.3	18.6	15.0	88.5	78.4	80.3	18.3	66.3	28.2	45.1	48.6	17.3	25.0	27.0	10.5	91.2	24.1	23.9	18.3	34.7	48.3	40.6	14.6	85.2	11.1	16.7	34.5	13.1	47.8	40.0	36.0	43.3	13.7	40.9	47.8	27.8	14.0	18.2	61.6	17.6	30.5	23.5	15.7	39.6	10.5	19.6	20.3	18.4	44.0	10.0	5.9	11.6	33.1	21.6	33.6	26.8	7.6	34.4	58.8	38.4	13.3	48.5	34.6	15.9	20.6	23.3	51.0	37.1	16.9	33.0	20.9	22.8	24.7	26.0	28.0	16.6	28.1	26.7	34.7	17.9	20.5	25.8	14.6	31.3	25.5	25.9	36.0	48.5	8.8	8.9	8.8	10.1	8.7	10.1	10.5	9.4	9.8	8.6	10.4	9.6	111.1	35.3	24.5	26.4	29.9	36.7	30.3	74.0	12.0	1.7	22.5	36.2	41.2	27.1	48.3	42.3	2.1	131.9	41.6	57.0	68.4	72.1	80.5	20.7	47.2	69.6	7.2	74.7	52.8	119.2	83.0	52.8	28.5	24.8	34.2	20.5	64.2	32.7	121.7	3.3	34.7	19.0	52.9	61.1	80.7	163.3	39.4	106.2	60.5	52.5	92.3	5.8	66.9	45.8	51.7	81.2	16.8	68.4	36.7	17.4	14.9	58.3	48.8	17.9	65.7	32.4	136.1	3.9	22.6	34.1	42.8	96.2	46.8	35.9	27.2	24.9
RUNX1T1	"AML1T1, CBFA2T1, CDR, ETO, MTG8, ZMYND2"	ENSG00000079102	"RUNX1 partner transcriptional co-repressor 1"	Q06455	8	91954967-92103286	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 93.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 142.1;Excitatory neurons: 196.9;Hepatic stellate cells: 124.2;Inhibitory neurons: 326.3;Oligodendrocyte precursor cells: 262.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	7	"cerebellum: 93.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 19.6;fHDF/TERT166: 16.5;HEL: 35.9;HSkMC: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049852, HPA070951"	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA049852: AB_2680914, HPA070951: AB_2686326"	"unprognostic (2.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.37e-4)"	"unprognostic (2.29e-4)"	"unprognostic (5.56e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.70e-4)"	"unprognostic (8.98e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.80e-3)"	7.0	2.8	9.4	2.1	13.2	0.2	5.1	93.1	8.7	8.4	0.0	6.5	1.2	7.4	3.6	2.5	4.7	5.0	8.2	13.1	2.3	1.4	0.6	3.8	1.3	1.4	12.8	4.7	1.0	1.0	3.0	5.8	4.6	2.5	2.4	5.2	3.1	2.4	3.9	2.4	2.5	6.5	4.2	1.9	2.7	3.6	3.6	0.5	3.7	4.8	1.1	3.8	3.9	1.2	0.0	0.0	0.4	1.9	5.0	7.2	0.0	7.6	11.6	5.0	7.6	0.0	0.0	19.6	0.0	16.5	0.0	0.0	4.0	0.5	3.3	0.0	3.2	35.9	0.0	0.0	1.9	0.0	0.0	13.6	0.0	8.4	0.4	0.0	10.8	0.0	0.1	0.0	1.3	0.0	0.0	0.0	2.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	11.1	6.0	0.0	0.0	0.0	7.8	0.0	0.0	1.2	0.4	0.0	0.9	0.0	3.8	0.0	6.3	0.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	13.2	93.1	8.7	13.1	2.3	1.4	12.8	4.6	4.2	3.6	1.2	44.9	0.0	1.1	90.8	0.1	6.2	0.2	0.0	0.6	142.1	1.2	5.1	46.0	0.0	0.6	0.0	16.7	1.1	0.5	0.2	1.9	0.0	2.6	1.1	65.8	64.3	47.7	2.7	196.9	0.2	0.3	77.7	0.5	1.1	1.3	2.1	124.2	1.5	1.9	35.3	326.3	0.6	0.0	4.1	9.4	7.5	96.3	1.2	10.6	103.0	0.0	3.9	0.0	262.4	17.3	0.2	0.0	98.9	0.0	0.3	0.0	0.1	0.0	7.2	65.7	24.4	43.1	3.3	16.8	0.9	4.8	1.1	1.1	20.7	0.0	0.1
SELP	"CD62, CD62P, GMP140, GRMP, PADGEM, PSEL"	ENSG00000174175	"Selectin P"	P16109	1	169588849-169630193	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 14.7;Endothelial cells: 51.8;Hepatic stellate cells: 33.9;Macrophages: 10.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 8.3;T-reg: 8.8"	"Group enriched"	"Detected in many"	7	"granulocytes: 8.3;T-cells: 8.8"	"Group enriched"	"Detected in some"	38	"EFO-21: 36.0;HEL: 34.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002145, HPA002655, HPA005990"	Enhanced					NA	NA		520000000	"Cluster 35: T-regs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB002145: AB_563984, HPA002655: AB_1078480, HPA005990: AB_1078479"	"unprognostic (3.37e-2)"	"unprognostic (2.98e-4)"	"unprognostic (4.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.26e-2)"	"prognostic favorable (3.12e-4)"	"unprognostic (5.30e-4)"	"unprognostic (4.14e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.93e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.24e-3)"	"unprognostic (1.74e-2)"	"unprognostic (7.85e-3)"	"unprognostic (1.66e-1)"	11.3	2.3	0.2	11.9	0.6	2.2	10.6	0.0	0.6	8.9	3.7	3.3	5.1	6.4	4.1	5.1	6.7	9.5	6.7	0.3	0.0	5.6	2.5	12.6	7.0	0.2	0.2	1.8	1.2	3.1	2.2	6.3	0.2	6.1	4.1	0.0	2.7	5.7	1.0	3.6	4.8	14.2	0.1	1.0	2.8	0.7	0.7	2.6	4.0	1.8	12.6	14.4	4.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.3	0.4	0.6	0.0	0.2	0.0	1.1	0.5	0.2	0.0	0.1	0.2	0.1	2.1	0.3	0.0	0.1	8.8	7.8	0.2	0.6	0.0	0.6	0.3	0.0	0.2	0.2	0.2	0.1	0.7	0.2	14.7	0.0	3.6	0.3	0.4	3.7	0.1	0.0	0.6	0.0	0.2	0.1	1.9	1.5	0.0	1.8	0.0	2.6	0.1	0.0	0.0	0.0	2.0	0.1	0.1	51.8	0.0	5.2	0.5	0.2	0.0	1.5	0.0	0.0	0.0	0.0	33.9	0.4	0.2	0.0	0.2	0.0	0.0	1.5	3.6	0.1	0.3	10.1	3.6	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.1	0.1	3.4	4.1	0.5	0.0	0.0	0.3
SIGLEC11		ENSG00000161640	"Sialic acid binding Ig like lectin 11"	Q96RL6	19	49948985-49961172	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 23.1;ovary: 65.5"	"Group enriched"	"Detected in some"	7	"Granulosa cells: 196.9;Theca cells: 192.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.4;non-classical monocyte: 1.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.4;monocytes: 1.3"	"Cell line enriched"	"Detected in single"	16	"HEL: 10.1"									"HPA052132, HPA060278"	Approved		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA052132: , HPA060278: AB_2684240"	"unprognostic (1.07e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.93e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.79e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.95e-3)"	"unprognostic (5.38e-2)"	1.1	7.3	0.5	1.8	0.8	0.4	0.4	0.4	0.7	0.3	0.6	0.5	0.8	0.3	0.2	0.1	0.9	0.3	0.4	0.6	0.6	0.4	1.7	1.7	0.6	1.4	1.0	65.5	2.7	0.1	0.2	1.8	1.3	0.2	0.4	0.2	0.3	0.2	0.2	0.2	1.0	1.2	0.8	23.1	4.7	1.5	1.6	0.1	0.2	0.1	0.0	0.6	0.2	1.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	10.1	0.1	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.3	1.4	0.0	1.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.2	1.3	0.1	0.0	0.1	0.5	0.8	0.4	0.7	0.6	0.6	1.4	1.0	1.3	0.8	1.6	1.4	0.1	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	19.6	0.0	0.6	0.2	0.3	1.0	0.0	0.0	0.0	1.1	0.1	4.3	0.0	0.3	0.0	196.9	5.3	0.6	7.9	0.0	0.0	0.0	0.0	26.8	0.2	0.1	0.0	6.1	0.0	5.6	1.3	0.0	0.0	0.0	0.0	2.7	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.2	7.5	1.7	0.7	0.0	0.1	0.1	0.2	192.3	0.0	0.0
SIK3	"FLJ12240, KIAA0999, L19, QSK"	ENSG00000160584	"SIK family kinase 3"	Q9Y2K2	11	116843402-117098437	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 375.5;Excitatory neurons: 384.4;Inhibitory neurons: 399.6;Oligodendrocyte precursor cells: 457.9;Oligodendrocytes: 1679.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045245, HPA048161"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA045245: AB_2679270, HPA048161: AB_2680293"	"unprognostic (3.19e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.78e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.12e-5)"	"unprognostic (1.82e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-2)"	10.1	7.2	19.3	11.4	36.6	12.7	9.2	15.0	34.3	9.6	0.0	11.7	8.5	12.6	7.2	10.4	12.4	9.8	12.8	19.7	19.4	10.3	13.8	9.7	9.9	22.0	23.1	16.5	15.4	17.7	10.0	12.1	22.5	8.2	8.8	19.1	9.8	11.3	19.5	7.5	8.7	14.1	11.5	11.8	9.7	21.4	36.1	12.3	17.1	14.4	10.4	10.1	7.5	41.1	11.8	8.9	13.9	14.7	11.7	12.6	22.2	8.8	15.7	6.8	7.6	21.8	13.3	13.9	14.0	16.3	15.0	18.1	11.6	12.7	9.4	38.5	7.4	31.2	9.7	13.6	10.9	11.2	11.8	13.9	7.2	14.5	23.3	8.7	9.2	9.0	15.2	10.1	9.4	4.0	10.2	12.1	7.7	8.0	6.6	12.9	8.0	11.1	9.3	2.2	13.5	10.8	23.7	10.3	4.4	10.5	6.8	11.8	10.6	8.3	10.4	14.0	8.9	7.1	5.6	17.5	7.7	18.2	11.4	2.0	0.4	0.0	0.3	0.5	0.5	0.1	0.3	0.1	0.6	1.0	0.0	0.0	0.9	0.6	1.5	0.0	0.0	0.2	19.3	36.6	15.0	34.3	19.7	19.4	22.0	23.1	22.5	11.5	36.1	41.1	25.8	9.6	22.1	375.5	34.9	26.5	26.0	6.8	7.4	42.6	26.1	21.5	22.2	10.0	12.4	5.5	112.6	8.7	47.3	12.5	5.9	7.6	89.2	64.4	27.9	20.4	17.3	12.4	384.4	7.3	2.8	22.1	12.8	71.5	17.2	37.4	17.2	26.3	7.7	47.1	399.6	11.1	6.1	21.7	45.1	214.9	10.2	31.4	16.0	161.1	25.6	36.3	12.3	457.9	1679.9	9.2	8.2	14.3	28.1	22.0	9.7	6.9	20.5	63.9	0.0	35.0	23.2	18.0	14.8	7.4	24.3	29.7	44.2	14.8	11.4	30.0
SIPA1	SPA1	ENSG00000213445	"Signal-induced proliferation-associated 1"	Q96FS4	11	65638101-65650918	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 95.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 82.5;NK-cells: 88.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020833, HPA039867"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoli	"Nucleoplasm, Golgi apparatus, Plasma membrane"	"CAB020833: , HPA039867: AB_2676716"	"unprognostic (6.10e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.42e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (3.52e-6)"	"unprognostic (1.60e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-1)"	21.6	17.2	16.4	48.7	15.5	53.8	16.2	14.1	16.8	20.6	10.3	24.0	12.5	20.9	3.4	14.3	19.5	16.0	25.7	15.8	13.2	17.0	15.0	37.0	60.7	22.3	16.0	13.1	8.4	3.5	7.5	19.4	19.5	17.1	6.0	0.9	14.1	10.0	10.0	8.1	37.8	12.0	19.5	95.6	15.9	4.7	24.5	21.3	14.9	6.4	32.5	18.8	15.3	21.0	1.6	13.3	9.1	20.1	5.4	11.1	21.7	14.9	12.7	11.7	11.3	3.9	14.5	21.3	33.2	7.6	0.4	7.8	3.4	5.1	3.9	22.7	8.1	52.6	20.7	7.4	9.6	21.5	21.5	11.4	2.3	16.2	2.1	11.5	34.4	21.8	30.3	9.2	5.8	5.8	8.6	36.1	6.4	5.4	12.3	38.8	5.1	19.3	4.4	0.8	3.4	20.9	7.5	12.6	31.7	8.5	9.6	32.5	49.2	14.2	28.7	15.2	3.0	14.1	12.2	48.4	19.5	33.0	42.0	3.2	3.3	9.3	5.8	3.9	4.1	4.1	2.8	3.7	2.3	4.7	2.0	3.1	11.1	4.7	4.8	2.1	3.0	3.0	16.4	15.5	14.1	16.8	15.8	13.2	22.3	16.0	19.5	19.5	24.5	21.0	22.5	6.4	5.2	7.5	59.0	6.8	24.7	23.2	17.6	2.1	24.8	26.5	7.2	21.5	19.2	23.9	0.0	10.1	82.5	16.5	37.2	19.8	3.0	8.3	6.8	26.8	21.0	31.6	0.1	14.5	19.6	12.2	11.2	14.9	7.0	37.1	42.8	22.0	38.4	5.0	0.2	12.8	30.5	44.4	11.4	9.8	8.1	40.2	10.6	14.0	23.7	7.6	88.6	0.5	4.0	27.2	12.7	13.2	29.6	29.0	39.0	20.7	6.0	1.8	13.1	7.4	20.9	0.8	13.8	14.4	11.1	13.5	50.4	30.9	14.3	31.9
SLA2	"C20orf156, FLJ21992, SLAP-2"	ENSG00000101082	"Src like adaptor 2"	Q9H6Q3	20	36612318-36646196	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.5;lymphoid tissue: 18.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 97.0;Macrophages: 21.8;NK-cells: 44.3;Plasma cells: 25.8;T-cells: 59.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"gdT-cell: 28.8;MAIT T-cell: 24.1;memory CD4 T-cell: 23.8;memory CD8 T-cell: 27.1;naive CD4 T-cell: 21.8;naive CD8 T-cell: 30.5;NK-cell: 39.2;plasmacytoid DC: 48.5;T-reg: 33.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 48.5;NK-cells: 39.2;T-cells: 33.4"	"Group enriched"	"Detected in some"	7	"HEL: 91.2;JURKAT: 51.8"	"Not detected"	"Not detected"							"HPA053746, HPA058217"			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA053746: AB_2682246, HPA058217: AB_2683641"	"unprognostic (4.16e-3)"	"prognostic favorable (7.36e-4)"	"unprognostic (4.52e-4)"	"unprognostic (2.30e-6)"	"unprognostic (3.37e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.77e-8)"	"unprognostic (8.48e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.45e-3)"	1.3	0.6	0.4	5.7	0.6	12.5	0.8	1.6	0.7	0.8	0.3	1.7	2.7	1.0	0.5	0.7	0.9	2.4	0.7	0.4	0.2	0.5	1.5	4.1	10.4	0.7	0.4	0.4	0.4	0.1	0.4	0.6	0.8	0.7	1.7	0.5	1.4	0.5	0.6	0.7	3.1	0.5	0.3	8.0	2.6	0.5	0.6	18.3	0.7	0.2	9.0	2.2	0.6	1.1	0.0	0.2	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	91.2	0.6	3.4	0.0	2.5	0.3	0.1	0.1	0.0	0.0	0.0	0.1	51.8	0.1	0.2	0.0	0.2	10.9	7.6	0.1	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	2.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.1	7.6	0.1	3.0	0.4	3.8	28.8	0.7	24.1	0.4	23.8	27.1	0.4	0.3	21.8	30.5	4.8	39.2	0.1	48.5	33.4	26.5	0.4	0.6	1.6	0.7	0.4	0.2	0.7	0.4	0.8	0.3	0.6	1.1	0.6	0.0	3.9	0.0	1.6	0.4	0.1	0.0	0.0	0.3	0.5	0.3	0.3	0.0	0.7	0.0	0.0	0.1	97.0	0.6	0.0	0.2	1.1	0.4	0.4	0.4	0.0	8.2	2.2	0.0	0.2	0.5	4.1	0.6	1.3	0.0	0.7	0.1	0.2	0.0	1.7	0.0	0.0	1.6	0.4	0.0	0.3	21.8	0.0	1.9	1.2	0.4	44.3	1.5	1.4	0.3	0.1	0.0	25.8	0.1	0.0	0.1	0.0	0.9	0.0	0.3	0.4	0.0	0.2	0.2	0.1	0.1	59.2	0.0	0.2	0.3
SLAMF9	"CD2F-10, CD84-H1, SF2001"	ENSG00000162723	"SLAM family member 9"	Q96A28	1	159951492-159954237	"Predicted membrane proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Langerhans cells: 53.9;Late spermatids: 38.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	8	"myeloid DC: 2.1"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 2.1"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 3.7;HEL: 5.1;PC-3: 2.0;SK-MEL-30: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035153	Uncertain					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"		"Cluster 36: HEL - Hemostasis"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA035153: AB_10670586"	"unprognostic (1.05e-1)"	"unprognostic (1.54e-5)"	"unprognostic (6.12e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.54e-4)"	"unprognostic (5.27e-4)"	"unprognostic (5.47e-2)"	"unprognostic (6.17e-5)"	"unprognostic (8.97e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-1)"	0.5	0.0	0.0	0.4	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.7	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	2.0	0.5	0.4	0.8	0.0	0.7	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.5	1.5	0.4	9.4	0.0	0.0	1.0	0.3	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	9.7	0.1	0.0	0.2	0.0	0.4	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	2.8	6.8	0.0	0.0	0.0	0.0	1.3	53.9	38.5	0.3	7.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.9	0.0	0.1	0.3	0.0	0.0	0.2	0.2	0.4	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.7
SLC25A37	"HT015, MFRN, MFRN1, MSCP"	ENSG00000147454	"Solute carrier family 25 member 37"	Q9NYZ2	8	23528956-23575463	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 138.4"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 707.8;Erythroid cells: 4197.2;Late spermatids: 1087.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	19	"neutrophil: 57.7"	"Lineage enriched"	"Detected in all"	19	"granulocytes: 57.7"	"Cell line enhanced"	"Detected in all"		"HEL: 118.7;hTERT-RPE1: 65.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045680	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria	Cytosol	"HPA045680: AB_10963693"	"unprognostic (6.15e-3)"	"unprognostic (7.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (4.37e-6)"	"unprognostic (8.27e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	14.5	41.9	13.5	16.5	16.9	138.4	17.9	13.4	21.0	26.8	15.2	11.4	50.6	9.8	6.0	9.9	17.2	6.7	15.3	13.4	14.0	20.1	25.2	26.4	6.0	15.0	14.1	23.0	29.5	10.9	15.0	8.0	15.4	35.5	5.7	10.3	36.7	7.5	16.2	10.1	21.8	5.7	13.0	46.1	11.1	6.8	15.0	2.8	14.6	12.7	5.0	13.4	20.4	14.6	9.6	10.3	10.7	9.9	13.7	16.8	15.7	7.4	9.6	5.3	5.9	10.4	19.9	15.3	8.7	6.3	34.5	12.0	9.9	20.0	7.2	2.3	4.9	118.7	19.4	3.7	11.5	6.7	4.4	14.5	19.2	11.6	11.5	65.9	8.4	12.3	26.3	7.5	8.5	4.2	8.1	28.1	5.4	11.6	7.5	8.3	5.3	6.0	16.4	5.2	3.2	4.6	10.1	15.2	7.6	10.0	4.4	10.3	13.3	25.6	3.8	15.3	14.5	5.9	2.4	9.4	24.1	16.1	16.5	1.4	3.0	2.7	1.1	1.1	0.9	2.3	0.6	0.5	2.8	1.5	2.1	1.2	57.7	1.3	1.5	0.6	1.3	1.4	13.5	16.9	13.4	21.0	13.4	14.0	15.0	14.1	15.4	13.0	15.0	14.6	43.5	38.5	61.7	36.6	45.5	93.3	125.2	95.8	28.5	35.6	120.0	49.1	35.6	61.5	75.8	77.3	68.8	44.6	19.1	78.4	15.6	93.8	707.8	33.1	68.6	94.5	20.4	4197.2	44.0	226.4	76.4	95.4	43.8	50.0	36.8	49.7	151.3	38.8	41.7	6.7	37.3	44.7	36.7	59.0	141.2	1087.9	52.5	86.8	69.4	73.1	45.5	30.5	10.3	16.1	21.9	176.9	47.7	37.2	24.0	347.1	189.0	34.1	42.5	59.7	19.7	55.9	52.3	24.6	42.3	23.3	53.8	18.3	32.4	86.7	70.3	137.6
SLC34A1	"NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2"	ENSG00000131183	"Solute carrier family 34 member 1"	Q06495	5	177379235-177398848	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"kidney: 155.4"	"Cell type enriched"	"Detected in some"	14	"Proximal tubular cells: 143.2"	"Cancer enriched"	"Detected in single"	12	"renal cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HEL: 2.4;U-937: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051255, HPA077175"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles, Plasma membrane"	"Nucleoplasm, Mitotic spindle, Cytosol"	"HPA051255: AB_2681409, HPA077175: "	"unprognostic (1.17e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.49e-2)"		"unprognostic (1.56e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-2)"	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	7.3	0.0	0.0	0.2	0.0	9.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	143.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.1
SLC37A1		ENSG00000160190	"Solute carrier family 37 member 1"	P57057	21	42496008-42581440	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 45.8"	"Group enriched"	"Detected in many"	5	"Early spermatids: 308.6;Late spermatids: 319.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 125.4;MCF7: 50.1;OE19: 54.0;SK-BR-3: 42.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030418, CAB034154"	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 34: Spermatids - Unknown function"			"CAB034154: AB_2190373, HPA030418: AB_10601602"	"unprognostic (1.44e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (9.22e-5)"	"unprognostic (1.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.99e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.08e-2)"	"unprognostic (7.94e-2)"	"prognostic favorable (3.43e-5)"	"unprognostic (1.61e-2)"	4.2	8.9	7.2	10.3	6.0	12.5	9.1	5.8	6.4	5.4	1.8	23.9	45.8	3.3	6.3	13.7	9.6	13.5	4.4	5.5	6.5	6.0	5.7	11.7	9.8	5.7	4.7	3.9	6.5	3.7	17.9	5.4	5.4	15.1	19.5	6.4	19.3	5.1	9.5	6.6	39.2	3.4	4.7	9.2	24.0	8.3	5.6	7.1	12.3	3.4	9.3	12.5	8.6	4.1	13.7	5.3	1.4	2.5	0.1	0.2	11.5	0.5	0.0	0.5	0.3	3.3	27.0	9.6	13.7	0.0	8.2	5.4	2.7	6.9	0.0	4.5	6.6	125.4	4.6	0.2	3.2	2.7	11.9	0.7	4.0	0.1	0.3	0.0	4.0	10.8	2.5	12.9	0.0	50.1	9.7	7.0	9.3	54.0	3.1	9.9	0.0	0.3	11.2	25.8	14.1	1.7	8.0	42.4	3.5	1.3	16.1	14.0	7.1	0.0	2.5	0.1	0.0	24.7	16.4	9.2	0.0	20.6	1.4	5.4	4.9	37.1	7.5	13.2	9.5	11.1	5.2	6.7	7.0	7.4	4.3	6.1	5.7	6.9	17.0	19.8	3.0	6.8	7.2	6.0	5.8	6.4	5.5	6.5	5.7	4.7	5.4	4.7	5.6	4.1	6.7	19.2	27.7	11.8	17.7	2.2	8.5	9.9	0.6	3.0	36.6	7.0	4.1	17.2	17.6	12.9	6.2	7.1	20.9	59.5	0.0	26.1	308.6	34.1	3.6	5.2	30.1	11.0	18.6	30.9	6.0	3.1	52.5	18.9	1.3	3.2	3.9	5.5	8.8	3.3	16.0	39.6	14.2	9.1	3.0	319.3	7.2	12.3	7.2	18.7	15.2	36.6	1.0	6.0	1.5	33.8	56.2	2.6	17.2	27.0	61.9	2.2	32.9	4.1	0.0	2.2	5.4	51.7	5.4	4.7	1.6	8.6	10.6	2.7	37.9	20.8
SLC40A1	"FPN1, HFE4, IREG1, MTP1, SLC11A3"	ENSG00000138449	"Solute carrier family 40 member 1"	Q9NP59	2	189560590-189583758	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 489.8;Kupffer cells: 1340.2;Syncytiotrophoblasts: 2463.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 326.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 509.0;CACO-2: 123.1;HEL: 430.0;HMC-1: 110.5;T-47d: 207.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065634	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA065634: AB_2685524"	"unprognostic (1.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.22e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.44e-2)"	"prognostic favorable (8.55e-5)"	"unprognostic (4.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.11e-2)"	59.6	333.5	9.3	52.6	11.9	45.8	97.7	9.6	9.8	156.3	10.4	124.7	289.3	95.4	61.6	30.5	214.2	148.7	52.6	7.2	12.0	79.9	251.5	122.9	172.6	15.6	15.7	317.2	53.2	91.8	19.0	250.1	12.8	39.5	130.8	29.5	58.7	53.1	64.2	12.2	127.9	69.3	15.5	368.1	96.8	33.2	13.9	62.6	68.0	60.3	59.1	53.1	21.8	11.3	0.0	7.4	0.6	0.0	509.0	3.3	25.4	0.2	6.6	1.9	3.1	123.1	0.4	0.2	1.0	0.2	1.4	0.4	2.4	0.3	1.6	0.3	1.7	430.0	1.7	45.8	1.9	1.5	110.5	35.9	0.2	1.2	0.0	11.7	13.0	16.4	44.6	1.1	6.3	0.0	18.2	28.8	1.5	92.7	1.7	0.2	5.0	2.5	5.3	18.1	1.0	5.4	0.8	35.4	0.0	39.5	207.6	6.2	0.3	0.8	11.7	0.5	0.1	1.1	0.2	0.3	0.1	0.2	0.1	129.8	101.5	172.1	2.2	23.7	3.2	0.2	54.4	4.9	115.6	0.7	80.2	17.8	326.2	4.6	2.6	18.8	5.3	105.8	9.3	11.9	9.6	9.8	7.2	12.0	15.6	15.7	12.8	15.5	13.9	11.3	44.2	125.0	40.3	3.6	12.0	9.2	51.3	10.5	19.9	4.8	83.8	30.0	48.0	138.7	31.6	33.1	4.2	489.8	5.7	328.9	49.0	54.7	10.5	39.6	38.2	39.8	18.6	253.7	0.3	71.8	20.3	81.9	76.5	129.5	9.5	12.8	245.9	259.7	86.4	6.7	6.8	60.8	6.1	1340.2	26.8	9.2	121.2	172.7	8.8	34.7	41.7	17.5	2.1	14.6	0.2	71.5	86.2	58.6	4.1	26.2	163.0	150.0	34.4	48.4	65.7	13.7	49.1	7.4	3.9	12.5	8.1	2463.5	11.9	84.8	48.9	27.7
SLC6A19		ENSG00000174358	"Solute carrier family 6 member 19"	Q695T7	5	1201595-1225111	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	35	"intestine: 142.4;kidney: 88.7"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 561.5"	"Group enriched"	"Detected in many"	4	"renal cancer: 7.9;stomach cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 14.3;HEL: 18.3;OE19: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037415, HPA043207"	Enhanced					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 45: Enterocytes - Digestion"			"HPA037415: AB_10672346, HPA043207: AB_2678363"			"unprognostic (1.26e-1)"				"unprognostic (1.01e-3)"				"unprognostic (6.04e-2)"	"unprognostic (3.64e-1)"	"prognostic favorable (4.14e-6)"	"unprognostic (1.37e-1)"	"unprognostic (7.36e-2)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	139.7	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	88.7	0.9	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	5.6	0.0	0.0	0.0	0.0	0.0	142.4	0.3	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.4	0.0	5.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	64.3	0.6	1.8	0.0	0.0	0.0	104.4	1.9	0.1	0.1	0.0	0.0	0.1	4.8	2.7	0.0	0.0	14.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	0.0	561.5	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	8.7	0.0
SLFN14		ENSG00000236320	"Schlafen family member 14"	P0C7P3	17	35543985-35560819	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"bone marrow: 3.9"	"Group enriched"	"Detected in some"	41	"Erythroid cells: 16.8;Macrophages: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HEL: 18.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA022994, HPA023065"	Uncertain					NA	NA				"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA022994: AB_10670035, HPA023065: AB_2671055"	"unprognostic (4.27e-3)"	"unprognostic (4.72e-4)"		"unprognostic (1.21e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.79e-1)"	"unprognostic (7.59e-8)"	"unprognostic (1.21e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.13e-3)"	0.0	0.0	0.1	0.3	0.1	3.9	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.4	0.0	0.0	0.6	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	18.7	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.8	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SMIM1	Vel	ENSG00000235169	"Small integral membrane protein 1 (Vel blood group)"	B2RUZ4	1	3772749-3775982	"Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 40.3;testis: 42.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 84.1;Erythroid cells: 404.4;Granulosa cells: 81.5;Proximal tubular cells: 247.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"eosinophil: 48.5"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 48.5"	"Group enriched"	"Detected in many"	4	"HEL: 68.0;Hep G2: 32.5;K-562: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA069088	Enhanced					NA	NA		340000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA069088: AB_2686080"	"unprognostic (9.50e-3)"	"unprognostic (7.19e-4)"	"unprognostic (5.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.50e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.31e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.91e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.32e-2)"	2.6	2.7	1.8	0.4	2.6	32.1	3.2	3.8	3.0	5.8	6.2	2.9	0.7	2.8	1.1	1.4	3.4	1.3	40.3	1.4	3.9	16.9	13.1	3.7	1.0	8.7	5.3	8.7	9.4	4.3	16.0	2.1	9.0	6.9	0.1	0.4	17.3	5.5	1.1	2.1	2.1	0.2	5.5	4.0	6.6	42.2	3.6	0.4	9.3	0.2	0.5	3.4	3.6	6.2	0.3	1.4	1.4	3.0	0.0	0.0	5.0	0.9	1.2	0.0	0.0	3.5	3.9	0.1	6.3	0.0	0.2	1.3	0.4	1.5	0.0	6.1	3.6	68.0	0.0	32.5	2.4	0.0	1.2	2.1	0.8	0.3	0.5	2.9	0.0	0.3	33.9	1.2	0.0	7.8	0.0	2.1	0.3	3.4	6.0	0.0	0.0	9.9	3.8	1.0	1.6	6.3	0.2	6.8	4.8	0.5	7.0	3.7	0.4	0.0	0.8	0.0	0.0	2.8	0.8	0.2	0.0	0.0	0.2	4.4	2.0	48.5	1.1	1.0	0.4	2.5	1.6	0.6	0.6	3.7	4.0	1.9	3.2	0.2	0.4	0.6	1.2	2.2	1.8	2.6	3.8	3.0	1.4	3.9	8.7	5.3	9.0	5.5	3.6	6.2	1.1	6.4	20.1	0.7	5.9	1.7	13.1	4.4	10.2	0.4	31.1	35.9	57.0	8.6	8.1	16.5	0.0	23.4	1.4	1.6	84.1	17.2	10.8	3.7	1.2	3.9	5.4	404.4	0.1	14.5	18.8	10.1	6.6	3.5	1.3	81.5	3.9	50.2	10.4	1.7	0.1	3.9	8.2	8.9	1.0	27.8	9.9	8.5	42.7	0.0	4.3	47.0	2.1	0.0	1.6	13.7	1.7	9.8	11.1	10.2	1.9	247.9	2.2	1.5	0.0	3.6	4.3	8.7	20.4	1.7	1.1	6.7	4.6	3.0	4.3	9.1
SPTLC2	"hLCB2a, KIAA0526, LCB2, LCB2A"	ENSG00000100596	"Serine palmitoyltransferase long chain base subunit 2"	O15270	14	77505997-77616637	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"	"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 164.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 36: HEL - Hemostasis"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (3.16e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.09e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (6.69e-8)"	"unprognostic (1.29e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.32e-1)"	17.6	12.2	14.6	12.6	26.7	33.7	18.3	24.0	19.4	15.2	9.9	18.5	14.5	10.5	7.6	22.8	14.2	11.8	6.7	15.3	18.1	17.6	7.7	13.1	12.0	30.7	21.5	10.4	5.7	10.7	6.2	20.4	31.5	8.4	19.8	14.2	13.7	8.8	3.9	12.2	17.4	11.6	25.3	19.6	20.4	5.0	21.7	10.3	10.9	6.1	13.3	15.0	10.8	52.7	28.9	18.5	14.1	15.5	14.3	17.8	23.7	41.7	30.8	28.2	29.3	23.7	62.3	28.8	10.4	42.7	14.5	34.7	38.1	23.7	42.5	12.6	11.0	82.5	13.4	14.3	12.1	8.4	25.8	11.7	11.4	18.4	20.4	16.3	40.6	19.4	16.2	13.5	16.2	24.9	22.2	28.7	9.2	45.4	16.8	23.5	14.3	10.0	32.9	63.4	13.6	17.1	15.0	50.3	15.8	24.7	61.8	15.3	25.9	25.7	18.2	9.6	9.7	7.6	13.4	19.1	17.3	29.4	14.8	18.3	31.3	27.1	6.1	24.2	5.7	6.7	5.1	6.8	31.2	7.9	3.5	5.8	19.1	17.7	31.8	11.1	6.0	13.4	14.6	26.7	24.0	19.4	15.3	18.1	30.7	21.5	31.5	25.3	21.7	52.7	125.1	28.9	27.3	24.8	27.3	32.4	28.3	27.0	15.4	15.7	24.3	18.4	8.9	15.7	30.7	47.8	35.5	11.9	28.3	37.6	1.9	24.0	1.6	44.1	36.0	53.1	13.2	51.3	31.2	16.1	12.3	18.9	43.3	36.0	51.3	37.2	68.2	7.2	25.1	5.0	29.5	39.3	20.3	75.9	19.8	1.7	14.6	66.2	19.6	83.4	51.3	8.8	32.0	59.3	164.0	35.0	30.4	15.8	11.0	27.0	28.4	8.8	33.5	20.0	32.9	10.5	25.5	7.3	19.0	37.7	29.1	6.6	23.3	14.6	33.0	60.0
SRSF4	"SFRS4, SRP75"	ENSG00000116350	"Serine and arginine rich splicing factor 4"	Q08170	1	29147743-29181900	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050975	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 22: Epithelial cell types - Mixed function"	"Nuclear speckles"		"HPA050975: AB_2681296"	"unprognostic (3.26e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (4.26e-4)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (6.25e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.60e-2)"	84.7	61.1	43.4	46.8	45.4	77.5	78.2	47.6	46.6	82.3	44.1	86.7	49.6	79.7	38.6	73.5	71.7	36.4	61.9	43.0	46.9	62.9	95.8	83.5	57.4	44.8	43.7	88.2	61.6	38.7	56.0	57.6	45.6	72.0	35.6	51.8	62.5	39.6	94.1	76.2	73.1	40.6	43.0	81.9	66.7	44.5	45.0	63.2	73.7	51.7	43.4	77.7	76.6	46.1	108.2	63.5	117.0	42.8	83.9	63.0	72.5	87.6	65.5	103.3	88.0	58.6	64.9	122.2	79.9	74.5	66.9	99.0	99.7	81.4	104.5	148.6	118.9	185.7	95.6	92.9	87.2	127.8	114.0	51.1	101.1	87.7	111.8	83.9	86.6	70.2	154.8	95.7	71.1	54.1	162.2	110.4	125.2	64.4	60.0	150.6	126.9	83.3	71.1	110.0	71.3	81.4	107.4	61.5	105.8	103.4	41.0	76.3	84.2	82.9	66.1	91.0	146.4	88.0	70.6	134.5	79.4	161.0	91.9	72.7	45.7	102.2	64.6	55.1	63.3	49.0	59.7	70.5	55.8	53.1	51.0	55.0	89.6	48.4	62.3	43.2	78.9	51.1	43.4	45.4	47.6	46.6	43.0	46.9	44.8	43.7	45.6	43.0	45.0	46.1	142.3	80.1	129.8	23.8	94.2	99.8	179.6	65.0	91.0	70.2	50.2	42.9	51.1	45.8	92.8	51.5	85.5	132.7	100.0	68.4	54.8	64.9	8.2	85.4	98.4	131.0	39.0	114.3	20.1	47.2	124.6	87.8	76.5	99.4	91.7	76.2	101.0	75.9	68.8	57.2	21.1	72.7	59.0	69.8	79.0	11.6	85.7	83.4	55.2	14.0	88.6	74.8	92.7	19.6	19.6	56.3	78.8	89.1	121.4	172.3	83.1	58.3	91.7	108.3	72.3	99.5	97.4	64.7	51.9	95.9	103.3	142.8	105.1	75.9	78.7	210.4
STAM	STAM1	ENSG00000136738	"Signal transducing adaptor molecule"	Q92783	10	17644151-17716824	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"T-reg: 76.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034399, HPA043882"	Supported		Supported	Vesicles		NA	NA		82000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles		"CAB034399: AB_2197486, HPA043882: AB_2678713"	"unprognostic (1.09e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (3.44e-6)"	"unprognostic (1.39e-1)"	"unprognostic (8.53e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.37e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.02e-1)"	10.8	13.3	7.7	6.9	9.7	53.1	8.9	14.0	11.8	10.7	3.4	8.0	8.2	9.0	5.8	12.2	7.8	9.1	18.0	9.2	8.7	10.2	6.9	10.9	7.5	9.8	9.5	11.4	10.4	10.3	7.4	8.5	9.8	8.7	7.7	11.2	8.5	6.1	24.5	10.0	7.3	8.5	9.6	6.8	11.4	8.1	9.1	13.1	10.8	10.1	7.5	10.9	9.0	14.7	34.8	19.8	30.8	14.2	30.1	21.9	10.3	45.1	19.8	41.0	33.1	25.9	31.7	9.1	7.2	33.9	31.7	18.2	27.6	21.1	35.0	10.9	12.7	86.3	15.3	43.1	31.8	6.5	43.7	22.7	27.0	33.6	28.3	26.6	19.8	56.3	30.1	10.5	43.8	10.4	35.7	5.6	14.7	19.7	10.2	18.0	29.0	11.9	17.5	11.2	13.0	19.2	24.6	16.7	34.6	24.1	27.5	9.4	26.6	23.9	24.5	42.7	21.1	6.6	11.5	15.6	25.6	9.6	15.6	47.5	7.5	12.5	5.9	8.2	5.6	5.4	12.8	6.2	9.6	3.1	8.8	7.1	5.9	17.3	7.5	5.5	76.5	6.4	7.7	9.7	14.0	11.8	9.2	8.7	9.8	9.5	9.8	9.6	9.1	14.7	13.2	12.8	23.4	15.7	14.1	22.9	5.3	16.2	23.9	19.7	9.4	8.9	30.0	5.7	14.0	16.5	10.4	10.2	24.3	6.4	5.9	15.1	3.5	16.3	22.3	11.0	11.4	56.8	31.7	13.4	10.5	23.5	15.8	25.9	31.6	13.0	10.4	7.8	15.5	10.1	36.9	7.8	2.0	10.4	16.3	3.5	9.6	15.6	19.6	39.4	8.4	13.7	10.3	31.7	59.4	29.9	8.0	6.0	20.8	10.1	5.7	15.6	14.0	14.5	26.3	22.3	12.6	22.1	14.6	21.8	21.0	24.6	27.6	18.4	8.1	8.5
STK19	"D6S60, G11, RP1"	ENSG00000204344	"Serine/threonine kinase 19"	P49842	6	31971091-31982821	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in all"	4	"Proximal tubular cells: 348.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.4;HEL: 1.5;HL-60: 1.6;REH: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031511, HPA068559"	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 72: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA031511: AB_2673915, HPA068559: AB_2686004"	"unprognostic (1.65e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (3.95e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.10e-1)"	1.5	3.6	0.1	0.2	0.1	0.0	1.3	0.4	0.9	2.1	0.0	2.5	0.0	1.4	0.3	1.9	1.0	0.1	1.2	0.0	0.0	1.5	2.2	1.3	0.0	0.0	0.0	1.1	1.1	0.2	1.4	0.4	0.1	2.1	0.0	0.2	0.9	0.1	1.3	2.5	0.7	0.0	0.0	1.2	1.3	1.5	0.1	0.1	1.2	0.0	0.1	2.0	1.5	0.4	0.0	0.1	0.0	0.4	1.1	0.7	0.0	0.3	0.1	0.2	0.4	0.0	0.7	0.6	0.3	0.5	0.0	0.6	0.0	0.2	0.3	1.4	0.4	1.5	0.3	0.0	0.5	1.6	0.0	0.6	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	1.1	0.4	0.0	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.9	0.0	0.7	0.2	0.0	0.0	1.1	0.0	0.1	0.3	0.2	0.6	0.2	0.0	0.8	0.2	0.3	0.1	0.1	0.3	0.4	0.4	0.0	0.1	0.1	0.1	0.4	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	21.2	9.6	21.5	13.7	16.4	13.0	14.0	23.0	13.6	11.8	26.6	27.6	8.1	18.6	24.6	22.0	20.9	37.2	22.4	13.8	39.2	26.3	85.8	27.8	31.8	20.6	19.3	4.6	8.7	28.3	20.0	23.3	19.4	20.7	9.5	20.1	14.3	21.1	19.3	10.1	8.0	17.3	18.3	8.8	10.0	76.0	20.2	18.3	17.8	11.2	12.5	30.2	13.4	4.5	6.5	23.6	16.4	18.4	11.9	13.2	15.0	348.9	41.8	21.9	32.9	19.6	21.1	39.5	21.0	17.9	18.2	49.7	19.8	45.1	13.1	11.8
STON2	"STN2, STNB2"	ENSG00000140022	"Stonin 2"	Q8WXE9	14	81260656-81436465	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 79.8"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 253.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"intermediate monocyte: 1.2"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"HEL: 113.4;HMC-1: 60.9;Karpas-707: 58.3;RT4: 46.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003086	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Cytosol"		"HPA003086: AB_2302748"	"unprognostic (5.28e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (2.50e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.30e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.44e-1)"	3.4	0.8	65.6	1.2	64.8	5.5	9.6	31.2	44.7	4.6	14.1	4.4	4.0	1.2	5.1	14.3	10.7	5.9	3.0	60.1	79.8	14.3	3.0	5.0	1.0	36.5	68.3	2.8	0.9	0.3	10.0	2.5	39.5	2.1	5.0	10.2	5.6	2.7	13.2	8.0	4.3	1.7	27.0	16.3	5.7	3.3	60.9	2.5	10.8	17.4	2.9	6.3	9.5	53.7	4.7	3.1	12.1	0.2	0.0	0.1	13.4	0.0	0.1	0.0	0.3	10.0	4.2	0.0	5.5	0.0	3.4	30.6	16.5	39.8	0.0	0.8	5.5	113.4	19.9	4.2	0.0	0.0	60.9	1.7	33.5	0.0	11.0	0.0	0.0	6.1	40.2	58.3	1.2	6.8	5.4	0.0	11.9	11.5	2.4	0.1	17.6	3.4	8.4	46.0	28.1	1.7	13.7	0.6	0.0	9.9	1.7	0.3	0.3	2.4	8.8	9.7	2.6	6.0	11.9	0.1	8.4	0.4	2.6	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.1	65.6	64.8	31.2	44.7	60.1	79.8	36.5	68.3	39.5	27.0	60.9	53.7	6.3	3.2	0.5	253.4	0.1	13.6	13.2	20.5	30.7	0.6	11.8	8.1	1.1	2.8	6.8	18.4	12.5	1.4	0.1	4.8	7.9	0.6	0.4	56.0	1.2	5.0	0.0	12.2	0.9	0.5	0.4	8.3	7.1	16.1	0.0	12.5	4.2	0.9	3.4	3.3	4.4	3.2	14.2	18.0	6.1	1.6	10.2	13.5	1.8	23.4	2.3	23.9	0.0	12.1	15.2	3.2	2.7	8.6	1.0	6.8	4.6	20.6	5.8	6.1	0.0	36.1	3.2	1.0	5.9	24.3	8.8	15.5	0.9	6.3	2.7	33.2
STUM	"C1orf95, DKFZp761P211"	ENSG00000203685	"Stum, mechanosensory transduction mediator homolog"	Q69YW2	1	226548764-226609230	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"brain: 234.8"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 9.8;Endometrial stromal cells: 3.8;Fibroblasts: 1.5;Glandular and luminal cells: 1.6;Smooth muscle cells: 2.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"medulla oblongata: 234.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HEL: 29.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 70.3;basal ganglia: 76.6;cerebral cortex: 75.5;hippocampal formation: 74.0;thalamus: 21.3"	HPA074381			Approved	Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA074381: AB_2732253"	"unprognostic (3.23e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.07e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.62e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (6.40e-4)"	"unprognostic (1.14e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.79e-3)"	3.7	1.0	45.5	1.2	40.0	0.0	2.8	0.0	43.7	3.1	0.0	15.7	1.6	3.2	1.3	5.7	3.1	0.8	2.2	38.8	17.6	5.5	0.1	0.5	0.2	234.8	30.0	2.5	0.9	0.9	7.4	0.4	101.9	4.0	2.1	1.4	1.0	1.2	3.6	4.2	2.7	5.8	9.4	1.0	2.3	1.4	49.5	0.5	0.7	1.3	0.3	6.8	3.5	5.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	4.9	0.4	29.9	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.4	0.3	0.0	4.4	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.5	40.0	0.0	43.7	38.8	17.6	234.8	30.0	101.9	9.4	49.5	5.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.8	0.0	0.0	1.0	3.8	0.2	0.0	0.0	0.0	0.2	0.5	1.5	0.0	1.6	0.0	0.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0
SUPT20H	"bA421P11.4, C13orf19, FAM48A, P38IP, SPT20"	ENSG00000102710	"SPT20 homolog, SAGA complex component"	Q8NEM7	13	37009312-37059713	"Predicted intracellular proteins"	"Autophagy, Gastrulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 56.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 145.7;Spermatocytes: 316.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038906, HPA038907"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli fibrillar center"		"HPA038906: AB_10673482, HPA038907: AB_10697401"	"unprognostic (4.04e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.81e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.46e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.21e-3)"	10.1	9.1	8.8	12.3	9.9	19.2	10.0	11.3	12.7	13.7	11.0	15.4	7.6	13.4	8.8	10.4	15.2	10.6	12.1	9.0	9.9	10.2	6.5	11.8	13.9	10.2	9.7	13.0	7.5	9.9	9.8	13.6	9.8	11.4	11.3	11.0	8.9	12.5	14.6	9.4	10.6	16.1	9.4	13.4	9.9	56.3	9.7	23.7	9.2	11.4	15.9	13.6	10.6	11.3	13.8	16.7	52.0	29.5	19.2	26.1	21.7	36.4	22.6	40.8	29.4	28.0	26.3	27.3	14.7	29.4	45.3	23.4	32.6	37.7	54.2	38.1	29.5	82.9	11.7	30.6	36.9	33.9	35.4	19.9	23.1	37.0	63.2	24.9	49.3	36.7	27.5	6.9	47.9	20.5	47.6	23.7	32.7	31.9	18.8	38.2	36.3	5.9	30.6	21.5	9.7	26.1	23.4	20.9	26.0	41.3	15.1	29.8	29.8	16.5	14.4	19.4	31.1	11.5	12.3	26.8	18.8	19.9	31.7	18.9	16.1	22.6	18.9	21.1	16.7	12.9	18.0	17.0	15.3	14.1	20.6	19.7	28.1	19.3	20.4	11.9	21.7	15.2	8.8	9.9	11.3	12.7	9.0	9.9	10.2	9.7	9.8	9.4	9.7	11.3	25.9	22.4	29.6	34.9	29.0	13.5	16.1	18.8	19.4	36.0	20.3	22.6	16.4	14.3	28.1	31.3	35.5	32.4	26.4	13.1	21.5	24.7	145.7	48.5	35.6	21.4	31.2	33.9	41.8	14.5	31.0	23.3	25.0	25.3	45.5	60.2	23.2	9.8	19.6	21.9	47.7	20.4	26.4	18.2	16.8	29.4	34.2	22.6	7.2	54.4	33.2	17.3	37.0	45.2	60.1	21.6	14.9	33.4	25.4	19.6	17.9	17.6	40.5	34.4	32.9	20.1	27.8	316.0	74.2	23.3	9.9	26.4	34.5	69.4	19.9	15.7
TAL1	"bHLHa17, SCL, TCL5"	ENSG00000162367	"TAL bHLH transcription factor 1, erythroid differentiation factor"	P17542	1	47216290-47232220	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 29.4"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 151.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 153.7;HMC-1: 70.6;HUVEC TERT2: 31.2;JURKAT: 60.0;K-562: 48.9;MOLT-4: 26.3;TIME: 34.4"	"Region enriched"	"Detected in many"	5	"midbrain: 14.3"	"Low region specificity"	"Detected in many"			"CAB017805, HPA047866, HPA073983"	Approved		Enhanced	Nucleoplasm		Yes	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"CAB017805: , HPA047866: AB_2680192, HPA073983: AB_2732246"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.68e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-2)"	7.5	2.5	4.9	1.0	4.5	29.4	6.3	4.7	4.4	2.9	3.0	2.1	0.8	2.9	0.6	1.8	3.5	2.3	5.9	4.6	4.6	4.4	1.5	13.0	1.4	6.5	7.1	1.2	0.9	0.9	1.7	6.9	6.8	2.1	1.3	0.2	1.1	0.8	2.1	1.7	3.1	2.7	6.9	7.1	1.8	0.9	6.4	0.4	5.4	2.5	0.7	2.4	2.5	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.2	0.1	153.7	0.0	0.0	0.0	0.0	70.6	0.0	0.0	0.0	0.0	0.0	31.2	60.0	48.9	0.1	0.0	0.0	26.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.1	34.4	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.5	4.9	4.5	4.7	4.4	4.6	4.6	6.5	7.1	6.8	6.9	6.4	6.8	23.9	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.1	0.1	3.7	1.5	1.3	1.8	0.0	0.1	0.0	0.0	0.0	0.1	5.3	0.0	0.1	18.1	0.0	151.5	0.0	0.0	0.3	0.6	0.0	0.0	36.8	0.0	26.7	0.1	10.6	0.0	0.1	0.0	0.0	1.6	1.5	18.2	0.0	4.8	1.8	29.0	0.8	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.4	1.3	0.4	0.1	1.0	0.0	2.0	0.0	0.0	0.0
TBCEL-TECTA		ENSG00000285509	"TBCEL-TECTA readthrough"		11	121024125-121113108	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in single"		"brain: 1.1"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEL: 1.3"									"HPA038593, HPA038594"	Uncertain		Uncertain	Cytosol		NA	NA					"Cluster 36: HEL - Hemostasis"		Cytosol		"HPA038593: AB_10669647, HPA038594: AB_2676103"																		0.1	0.0	0.4	0.1	0.6	0.0	0.1	0.3	0.6	0.2	0.5	0.1	0.1	0.2	0.0	0.1	0.0	0.2	0.2	0.4	1.1	0.3	0.1	0.2	0.0	0.7	0.6	0.2	0.6	0.4		0.2	0.7	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.5	1.1	0.1	0.0	0.0	0.0	0.1		0.6	0.1	0.2	0.5	0.1	0.0	0.1	0.0	0.6	0.7	0.7	0.1	0.3	0.4	0.2	0.2	0.2	0.3	0.0	0.2	0.1	0.7	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.3	0.0	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.8	0.2	0.0	0.2	0.7	0.9	0.2	0.0	0.0	0.7	0.4	0.0	0.0	0.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.3	0.6	0.4	1.1	0.7	0.6	0.7	0.3	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TCTEX1D1	FLJ40873	ENSG00000152760	"Tctex1 domain containing 1"	Q8N7M0	1	66752459-66779047	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 8.9;liver: 7.1"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 55.7;granulocytes: 25.9;Inhibitory neurons: 21.6;Respiratory ciliated cells: 104.2"	"Cancer enriched"	"Detected in single"	10	"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HEL: 14.6;HUVEC TERT2: 13.4;THP-1: 16.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA028420	Uncertain					NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA028420: AB_10603995"	"unprognostic (3.54e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.72e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.53e-6)"	"unprognostic (9.28e-4)"	"unprognostic (2.78e-2)"	"unprognostic (6.13e-3)"	"unprognostic (3.65e-2)"	1.1	0.3	2.5	0.4	2.2	4.4	1.0	2.8	2.2	1.1	6.6	0.8	0.2	0.4	0.1	0.3	8.9	0.3	3.0	2.3	2.7	3.3	7.1	2.5	0.0	6.3	5.5	0.0	0.2	0.0	0.7	5.7	5.0	0.6	0.3	0.9	0.5	0.6	0.7	0.5	0.5	0.4	4.6	0.2	0.4	0.0	3.5	0.1	0.5	0.2	0.1	0.7	0.7	4.9	0.0	0.0	0.2	0.0	0.2	2.3	0.0	0.3	0.7	0.3	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.5	0.0	0.0	13.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.2	2.8	2.2	2.3	2.7	6.3	5.5	5.0	4.6	3.5	4.9	7.5	0.0	3.2	2.9	0.3	1.3	0.0	4.5	0.0	0.3	0.1	0.0	0.6	0.0	11.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.3	55.7	0.5	12.5	0.0	0.8	13.2	0.0	0.0	0.5	0.0	0.5	25.9	0.0	0.7	3.5	2.7	0.0	21.6	0.0	0.0	0.6	0.8	0.1	0.0	3.0	0.0	1.9	0.3	6.1	0.0	0.5	0.5	0.0	0.0	0.4	1.2	0.5	0.0	0.0	104.2	0.6	0.0	0.4	1.3	0.0	0.1	0.0	0.6	0.0	3.1	0.1	0.0	0.1
TEX15	CT42	ENSG00000133863	"Testis expressed 15, meiosis and synapsis associated"	Q9BXT5	8	30831544-30913008	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, DNA damage, DNA repair, Meiosis, RNA-mediated gene silencing, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"endometrium 1: 6.7;smooth muscle: 5.3;testis: 12.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 24.2;Early spermatids: 114.3;Late spermatids: 49.7;Spermatocytes: 95.4;Spermatogonia: 98.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 8.4;HEL: 19.3;K-562: 5.5;OE19: 4.2;SCLC-21H: 4.1"	"Region enhanced"	"Detected in single"		"olfactory bulb: 2.2"	"Low region specificity"	"Detected in many"			HPA036800	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 36: HEL - Hemostasis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA036800: AB_10671714"	"unprognostic (3.10e-1)"	"unprognostic (2.56e-1)"		"unprognostic (3.30e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-2)"		"unprognostic (2.15e-3)"	"unprognostic (2.80e-3)"	"unprognostic (4.52e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.61e-5)"	"unprognostic (8.88e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.92e-1)"	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.2	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.3	0.2	0.2	0.4	12.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.9	0.0	8.4	1.1	0.0	1.2	3.1	19.3	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	5.5	0.0	0.0	0.1	0.1	0.1	3.7	4.2	0.3	0.0	0.0	0.0	0.0	0.0	4.1	1.3	0.0	0.0	3.6	0.2	0.2	1.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.1	0.4	0.7	0.3	0.3	0.6	0.7	0.2	0.4	0.2	0.1	0.0	0.0	24.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.3	0.1	1.3	0.5	0.0	0.0	5.7	0.0	0.0	1.2	0.0	0.0	0.0	1.7	2.5	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	49.7	1.2	0.1	0.0	1.0	0.0	1.3	0.0	0.5	0.4	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.1	13.1	0.0	0.1	95.4	98.5	0.0	0.0	0.1	0.0	4.4	0.0	0.0
TFRC	"CD71, p90, TFR1"	ENSG00000072274	"Transferrin receptor"	P02786	3	196027183-196082096	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 254.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 556.4;Syncytiotrophoblasts: 502.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 860.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000153, HPA028598"	Enhanced		Supported	Endosomes,Lysosomes	"Secreted to blood"	NA	NA	1310000000	38000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Endosomes, Lysosomes"		"CAB000153: AB_2533029, HPA028598: AB_10601599"	"unprognostic (2.95e-2)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.88e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (6.92e-2)"	"unprognostic (3.30e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.63e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (2.62e-2)"	44.6	28.7	21.6	63.4	18.3	254.5	20.2	18.5	32.3	31.3	15.7	77.2	35.9	23.8	11.1	36.0	25.9	24.9	31.0	21.9	19.0	26.4	27.8	78.0	23.0	24.2	19.9	93.9	15.9	44.8	13.1	103.2	26.3	13.2	55.6	47.3	15.7	13.4	76.2	21.8	32.1	31.5	20.8	15.5	21.4	21.6	25.3	22.0	20.1	68.7	28.1	68.5	17.4	20.7	175.3	155.0	69.8	142.1	151.7	87.3	438.7	242.5	183.7	168.1	276.3	384.6	156.6	178.5	446.3	91.0	363.5	261.8	243.3	81.1	204.2	860.4	82.4	677.4	120.2	179.2	119.4	561.8	130.4	99.1	78.6	144.5	129.0	47.8	56.9	95.6	287.3	164.1	132.8	161.7	185.8	116.8	214.9	228.6	314.0	97.3	103.9	214.1	148.3	435.3	159.3	65.9	234.4	613.9	55.2	115.9	595.0	115.8	72.5	198.4	159.7	175.3	369.7	46.3	387.8	276.7	232.3	149.2	122.3	0.0	1.6	2.2	2.2	7.3	1.4	5.1	2.4	1.5	3.5	3.1	2.1	1.7	0.2	1.9	13.2	7.1	6.4	2.1	21.6	18.3	18.5	32.3	21.9	19.0	24.2	19.9	26.3	20.8	25.3	20.7	25.4	44.8	32.1	43.1	46.6	60.3	37.2	33.6	21.1	53.1	37.1	34.9	103.0	41.5	38.8	20.2	148.0	122.5	53.2	156.6	0.0	49.4	3.5	35.3	20.3	23.6	56.1	556.4	24.7	41.8	25.3	32.4	77.5	56.1	23.4	40.2	8.6	93.2	73.4	13.5	28.3	67.8	22.4	37.1	77.6	5.3	11.5	161.7	17.8	44.0	49.4	22.0	9.2	11.6	8.2	52.0	50.8	8.6	42.1	25.6	48.3	13.1	32.1	44.4	26.3	36.3	29.3	23.8	18.2	51.3	35.8	502.7	42.6	16.6	103.5	23.7
TGM5	"TGMX, TGX"	ENSG00000104055	"Transglutaminase 5"	O43548	15	43232590-43266928	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 12.0;skin 1: 39.3"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 2.6;Club cells: 4.3;Early spermatids: 3.2;Late spermatids: 4.0;Suprabasal keratinocytes: 6.7;Urothelial cells: 12.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HEL: 16.6"	"Region enriched"	"Detected in single"	12	"cerebellum: 2.6"	"Low region specificity"	"Detected in many"									NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 36: HEL - Hemostasis"	"Cluster 22: Epithelial cell types - Mixed function"				"unprognostic (3.17e-2)"	"unprognostic (1.03e-2)"		"unprognostic (5.92e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.24e-2)"		"unprognostic (1.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.44e-15)"	"unprognostic (1.94e-1)"	"unprognostic (3.14e-1)"	"unprognostic (7.22e-3)"	"unprognostic (5.71e-2)"	0.8	0.0	0.0	0.0	0.0	0.2	1.7	0.2	0.0	3.9	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.2	1.0	0.0	0.0	4.3	1.2	0.3	39.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	2.3	0.5	7.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.3	0.0	0.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.2	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	2.6	1.5	0.0	0.0	1.0	0.5	0.2	0.0	4.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.2	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	4.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.2	0.8	6.7	1.9	0.0	0.0	0.0	12.1
TIAM1		ENSG00000156299	"TIAM Rac1 associated GEF 1"	Q13009	21	31118416-31559977	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 207.9"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 327.3;Microglial cells: 133.0;Oligodendrocyte precursor cells: 120.6;Oligodendrocytes: 124.6;Suprabasal keratinocytes: 143.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 15.1"	"Region enriched"	"Detected in all"	4	"cerebellum: 207.9"	"Group enriched"	"Detected in many"	5	"classical monocyte: 17.4;intermediate monocyte: 15.3;memory CD4 T-cell: 12.5;myeloid DC: 9.6;naive CD4 T-cell: 16.2;NK-cell: 11.3;non-classical monocyte: 22.0;T-reg: 27.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 34.5;HEL: 34.7;HMC-1: 29.1;RT4: 35.5;SCLC-21H: 32.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 245.9"	"CAB010416, HPA034853"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cell Junctions"	"Nuclear membrane, Cytokinetic bridge, Cytosol"	"CAB010416: AB_2240410, HPA034853: "	"unprognostic (9.59e-2)"	"unprognostic (7.44e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.70e-3)"	"unprognostic (7.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-1)"	7.2	12.7	40.3	6.6	35.2	2.8	5.4	207.9	49.2	17.8	12.5	5.1	1.7	9.9	3.2	39.7	11.0	4.6	5.5	51.8	26.5	5.5	7.9	5.8	11.1	26.7	33.4	3.3	2.2	0.3	12.9	4.3	36.1	9.0	3.1	8.6	5.6	3.3	0.9	27.2	5.0	11.1	27.5	5.2	2.4	10.5	37.3	18.7	1.9	0.8	11.1	12.1	18.5	28.6	2.9	1.0	21.7	1.3	0.4	4.9	34.5	0.0	0.0	2.7	0.9	0.2	3.9	7.6	1.5	0.5	4.0	5.1	2.5	4.4	4.3	0.6	12.0	34.7	0.7	0.2	0.5	0.0	29.1	2.2	1.5	14.7	5.9	2.6	0.0	11.3	0.0	10.9	11.1	14.7	5.4	0.2	7.1	5.3	9.4	7.0	6.8	0.0	3.3	35.5	32.6	8.1	1.5	11.4	1.3	7.5	4.7	0.1	0.2	3.1	12.5	0.0	1.5	12.3	9.9	6.6	7.2	2.6	24.2	1.5	17.4	0.0	0.5	15.3	3.1	0.1	12.5	2.4	9.6	0.0	16.2	1.0	1.0	11.3	22.0	0.5	27.8	5.9	40.3	35.2	207.9	49.2	51.8	26.5	26.7	33.4	36.1	27.5	37.3	28.6	3.7	3.2	2.3	21.2	1.7	83.7	65.6	3.0	22.8	8.9	4.9	1.9	1.1	1.5	11.8	0.0	2.1	10.1	8.0	1.3	0.0	1.8	11.7	25.2	2.2	31.4	5.4	2.7	43.9	0.7	29.7	11.4	2.0	28.4	24.1	2.0	35.0	5.5	8.1	74.0	327.3	0.4	10.2	22.9	73.4	11.3	34.5	26.3	10.6	133.0	37.3	35.2	4.1	120.6	124.6	1.8	11.6	58.3	3.2	30.8	0.0	0.5	1.2	4.6	6.6	0.9	2.1	1.3	9.8	60.2	143.3	10.7	16.3	82.6	1.2	106.7
TMA16	"C4orf43, FLJ11184"	ENSG00000198498	"Translation machinery associated 16 homolog"	Q96EY4	4	163494442-163520539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 165.6;Late spermatids: 179.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041571, HPA052688"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA041571: AB_10794381, HPA052688: AB_2681916"	"unprognostic (6.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.92e-3)"	"prognostic unfavorable (2.70e-5)"	"prognostic unfavorable (4.40e-4)"	"unprognostic (2.30e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-2)"	16.4	11.9	4.4	17.9	4.6	12.5	18.0	5.4	6.7	10.8	5.1	13.0	11.0	15.8	6.9	14.3	11.4	9.9	9.2	4.4	5.1	12.1	13.5	8.9	22.0	4.8	4.7	16.8	14.8	9.5	5.3	14.0	5.0	11.8	11.8	5.7	14.4	9.9	9.6	14.4	10.1	13.0	4.9	16.1	12.8	26.7	4.5	19.1	11.6	7.6	20.0	13.9	10.8	6.2	49.1	24.1	43.0	37.3	20.1	32.6	41.3	56.3	29.8	34.2	28.5	23.4	65.4	108.1	22.7	34.0	27.0	25.2	54.6	43.0	43.0	58.1	42.6	154.3	23.3	41.3	39.6	120.2	46.7	22.6	40.0	27.1	36.4	29.5	34.5	39.4	55.1	79.9	39.7	47.2	74.9	68.4	45.6	28.4	43.0	67.7	38.3	68.9	26.2	23.8	22.5	35.2	36.8	46.3	43.4	25.7	30.3	51.3	59.3	23.5	46.0	22.9	61.2	55.8	75.8	124.7	47.3	64.0	72.3	11.7	37.0	3.5	18.4	58.8	26.1	55.6	32.4	23.5	42.3	51.7	29.8	26.1	1.3	35.3	48.4	74.8	31.3	19.4	4.4	4.6	5.4	6.7	4.4	5.1	4.8	4.7	5.0	4.9	4.5	6.2	25.7	22.4	31.2	3.3	51.2	32.9	36.3	52.0	29.6	15.4	42.9	40.5	37.6	47.1	31.7	33.1	4.2	53.8	25.6	16.4	64.6	53.2	165.6	19.0	61.4	30.0	30.5	28.8	8.8	71.0	92.3	37.9	15.3	17.9	29.1	41.6	36.0	55.6	36.4	15.2	7.3	37.5	20.3	43.3	23.4	179.2	55.6	25.4	26.6	6.5	44.4	15.8	16.5	11.6	11.0	54.9	30.6	32.0	30.0	57.8	11.9	71.7	19.0	14.3	39.5	30.4	33.7	103.9	42.1	28.5	39.6	30.5	24.1	43.7	44.0	28.9
TMEM69	"C1orf154, FLJ21029"	ENSG00000159596	"Transmembrane protein 69"	Q5SWH9	1	45688181-45694436	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026993	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA026993: AB_10601824"	"prognostic favorable (2.24e-4)"	"unprognostic (2.47e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (3.66e-8)"	"unprognostic (4.05e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.17e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.41e-3)"	"unprognostic (3.65e-2)"	17.4	19.5	12.0	17.2	12.4	9.4	21.0	13.2	14.4	14.6	15.6	19.0	22.7	15.6	26.7	21.5	17.1	15.8	31.8	12.4	12.9	16.3	19.4	12.1	26.9	12.6	13.0	23.5	14.0	31.9	5.9	19.7	13.0	19.1	22.9	16.6	21.2	15.4	23.9	21.2	17.0	13.9	12.4	16.2	15.2	13.3	13.0	21.2	21.1	25.4	27.7	26.0	8.7	13.3	50.1	13.2	33.9	25.9	25.1	32.6	81.6	31.6	37.1	52.5	50.7	34.2	24.8	59.8	20.4	30.9	38.1	64.9	26.5	77.2	56.3	40.1	31.6	126.2	30.6	38.2	45.3	59.6	58.2	38.8	75.5	50.7	32.6	34.3	44.7	57.8	75.5	37.4	32.4	17.9	32.9	41.3	77.8	30.0	33.4	51.1	29.2	59.9	56.7	57.2	36.8	34.6	32.8	88.8	56.2	61.2	47.0	59.1	32.5	23.9	40.0	49.8	38.9	29.9	41.6	44.8	32.5	43.0	36.5	12.2	25.0	10.2	9.0	25.8	11.7	16.6	12.8	10.5	22.1	15.5	14.5	11.4	9.6	9.2	34.6	12.5	12.8	13.6	12.0	12.4	13.2	14.4	12.4	12.9	12.6	13.0	13.0	12.4	13.0	13.3	10.8	0.0	14.9	9.8	22.4	20.1	22.8	49.2	37.5	11.0	19.1	21.7	9.1	12.8	26.8	18.4	0.0	61.4	7.7	16.7	43.0	22.7	1.9	13.4	12.6	14.3	24.0	32.4	9.1	17.8	36.1	17.1	35.7	11.6	6.3	12.1	14.6	14.4	37.7	6.7	9.7	21.3	34.6	38.9	11.9	4.4	18.6	21.8	17.8	2.8	23.9	14.5	14.4	9.5	14.6	14.8	16.1	12.8	16.3	22.7	31.0	39.0	18.8	9.8	13.1	10.8	13.0	21.7	16.9	53.5	26.0	59.7	13.7	16.3	25.0	22.4
TOP1		ENSG00000198900	"DNA topoisomerase I"	P11387	20	41028822-41124487	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 801.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009058, HPA019039"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	Yes		7600	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB009058: AB_2303554, HPA019039: AB_1858187"	"unprognostic (1.46e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (5.86e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.74e-3)"	"unprognostic (6.51e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.70e-2)"	"unprognostic (5.14e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	37.9	36.7	17.4	49.9	18.6	74.9	27.9	21.8	25.1	26.9	25.3	36.9	42.6	27.9	34.4	36.7	22.4	37.2	19.1	18.0	18.9	39.0	47.5	40.0	59.9	18.5	18.4	24.3	28.6	26.7	22.4	50.2	18.1	31.8	37.3	25.5	26.7	24.2	21.3	26.5	42.6	23.9	18.7	38.5	36.5	18.9	18.8	58.9	37.6	20.2	60.6	42.7	28.8	19.2	105.2	71.7	131.4	108.2	52.2	61.8	129.8	92.6	81.0	105.0	94.8	190.5	127.6	296.4	96.4	48.5	112.3	98.9	159.1	147.2	153.0	64.9	81.6	378.6	54.9	139.0	135.4	165.1	124.0	69.8	76.4	102.4	166.8	94.0	111.5	98.1	167.8	98.7	120.9	233.2	235.3	119.7	106.3	104.1	131.6	197.7	123.1	157.7	121.4	95.2	108.6	75.4	145.4	88.3	95.0	94.2	98.6	146.4	109.9	84.7	71.3	78.8	100.9	62.7	75.6	338.3	113.7	91.1	82.0	12.6	9.9	16.8	6.6	10.3	8.3	10.5	7.3	7.0	9.5	10.1	7.7	6.9	19.1	6.3	13.2	18.8	9.0	5.4	17.4	18.6	21.8	25.1	18.0	18.9	18.5	18.4	18.1	18.7	18.8	19.2	116.9	118.6	201.5	66.0	117.6	245.9	338.0	90.3	153.7	98.2	90.5	75.7	49.7	78.6	170.3	99.3	60.5	192.1	137.1	194.1	74.3	94.4	10.0	151.3	167.4	115.1	91.8	486.5	86.9	65.8	175.4	121.4	84.1	259.2	78.6	119.1	67.1	131.7	99.2	72.3	77.4	126.9	69.2	101.2	109.1	12.8	59.7	151.6	72.9	74.9	95.4	88.0	78.2	87.4	90.7	119.2	169.8	69.6	234.1	162.3	94.1	136.2	68.3	87.0	85.5	135.5	130.8	116.8	54.6	129.4	214.2	801.5	111.5	123.7	117.8	237.7
TOPORS	"LUN, RP31, TP53BPL"	ENSG00000197579	"TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase"	Q9NS56	9	32540544-32552586	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, Ubl conjugation pathway"	Transferase	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 169.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 67.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 67.6"	"Cell line enhanced"	"Detected in all"		"HEL: 90.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060640, HPA065661"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA060640: AB_2684334, HPA065661: AB_2685527"	"unprognostic (1.75e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.94e-2)"	"prognostic favorable (7.07e-4)"	"unprognostic (2.70e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (6.64e-6)"	"unprognostic (1.22e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.92e-1)"	9.8	9.8	5.4	8.4	6.3	25.2	12.4	10.5	8.5	10.3	7.3	9.2	8.3	11.4	10.0	9.9	7.6	8.7	6.8	5.4	6.6	13.2	16.2	9.3	9.3	6.1	6.1	15.3	8.6	14.0	6.9	10.0	6.2	11.2	9.3	11.5	7.6	9.3	7.2	9.6	8.8	11.2	5.9	10.5	8.9	14.8	6.6	14.5	14.1	10.4	10.1	10.3	7.2	8.3	16.6	15.1	20.4	17.9	24.4	21.8	12.9	20.7	19.5	16.9	19.5	9.5	8.3	26.8	11.7	20.8	14.8	10.9	24.2	23.5	23.6	22.5	13.3	90.8	25.2	11.9	15.1	26.1	24.0	17.9	25.8	24.4	17.1	20.9	20.8	20.1	16.1	13.6	27.9	8.9	23.5	47.6	27.2	12.3	15.2	23.9	18.1	12.2	22.5	17.2	10.1	16.1	20.7	11.2	13.8	22.9	11.3	14.7	22.0	18.4	18.6	9.6	15.5	9.5	16.2	28.5	17.0	14.8	8.4	38.8	10.0	21.3	9.6	9.8	10.3	9.4	10.4	11.4	10.2	10.8	13.9	13.8	67.6	15.0	13.6	8.2	13.5	7.3	5.4	6.3	10.5	8.5	5.4	6.6	6.1	6.1	6.2	5.9	6.6	8.3	69.2	54.5	32.0	10.7	49.1	47.2	45.3	33.7	61.5	46.8	32.7	28.6	18.4	25.8	37.0	25.8	37.5	31.9	63.4	26.3	19.6	25.1	169.9	36.2	38.1	48.8	45.9	66.5	14.5	18.4	16.9	42.0	25.0	45.5	41.8	43.6	26.4	24.3	17.7	55.5	15.5	22.9	44.7	19.1	35.3	21.8	33.2	31.8	19.6	7.5	30.4	43.5	36.0	13.0	22.4	21.1	24.3	32.7	39.5	39.0	24.3	22.7	22.3	42.0	19.7	54.0	48.2	54.4	53.7	39.0	47.6	50.8	55.4	43.1	24.0	49.8
TREML1	"dJ238O23.3, TLT1"	ENSG00000161911	"Triggering receptor expressed on myeloid cells like 1"	Q86YW5	6	41149342-41154337	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.7;brain: 4.5;lymphoid tissue: 7.3"	"Group enriched"	"Detected in some"	7	"Macrophages: 75.6;monocytes: 28.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"basophil: 92.4"	"Lineage enriched"	"Detected in many"	49	"granulocytes: 92.4"	"Cell line enriched"	"Detected in single"	170	"HEL: 66.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016700, HPA017860"	Enhanced		Uncertain	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		43000000	"Cluster 34: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Nuclear speckles, Cytosol"	"Golgi apparatus, Plasma membrane"	"HPA016700: AB_1858262, HPA017860: AB_1858261"	"unprognostic (6.70e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.53e-5)"	"unprognostic (1.10e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.11e-4)"	"unprognostic (1.36e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.41e-2)"	0.9	1.0	1.7	2.7	2.1	8.7	0.5	2.2	4.5	0.3	1.3	0.3	0.0	0.1	0.4	0.1	0.4	0.9	0.3	1.9	2.5	0.2	0.3	2.1	5.4	3.3	2.4	0.1	0.4	0.2	0.4	0.5	2.8	0.2	0.9	0.2	0.4	0.3	0.1	0.3	0.4	0.2	2.5	7.3	0.2	0.1	3.6	4.1	0.3	0.5	4.8	0.4	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	66.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.4	1.7	2.8	0.2	1.8	0.4	0.2	0.1	0.0	0.7	0.3	0.5	0.0	10.7	0.0	0.3	0.9	0.0	110.6	1.7	2.1	2.2	4.5	1.9	2.5	3.3	2.4	2.8	2.5	3.6	3.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	3.9	0.0	3.9	0.0	0.0	0.0	0.0	1.6	2.7	0.0	0.0	75.6	0.0	6.5	28.3	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0
TREML2	"C6orf76, dJ238O23.1, FLJ13693, TLT2"	ENSG00000112195	"Triggering receptor expressed on myeloid cells like 2"	Q5T2D2	6	41189749-41201149	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 14.4;lymphoid tissue: 9.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 5.3;Early spermatids: 19.1;Late spermatids: 37.3;Syncytiotrophoblasts: 8.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 23.3;neutrophil: 33.3"	"Group enriched"	"Detected in many"	15	"B-cells: 23.3;dendritic cells: 9.3;granulocytes: 33.3"	"Cell line enhanced"	"Detected in some"		"HEL: 27.9;HL-60: 6.9;JURKAT: 7.9;SuSa: 4.5;U-698: 8.0;U-937: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA		3400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (3.76e-3)"	"unprognostic (2.39e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.22e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.40e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.54e-2)"	"unprognostic (6.23e-2)"	"unprognostic (6.71e-2)"	1.7	0.0	0.1	6.4	0.1	14.4	0.1	0.2	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.3	0.5	0.1	0.1	0.5	0.0	0.1	0.7	9.5	0.1	0.1	0.0	0.2	0.4	0.0	3.0	0.2	0.0	0.3	0.1	0.3	0.0	0.8	0.1	1.1	0.3	0.0	6.6	0.3	3.7	0.1	6.9	0.1	0.8	7.5	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.1	0.4	0.0	0.0	1.5	2.2	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	5.2	0.0	2.6	0.6	13.4	0.4	1.2	0.5	6.0	1.0	0.2	2.2	23.3	1.3	0.4	33.3	0.7	1.4	9.3	0.7	2.0	0.1	0.1	0.2	0.3	0.1	0.5	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	1.1	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.4	37.3	0.0	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	8.8	0.2	0.0	0.0	0.0
TREML4	TLT4	ENSG00000188056	"Triggering receptor expressed on myeloid cells like 4"	Q6UXN2	6	41228339-41238882	"Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"choroid plexus: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"eosinophil: 4.5;neutrophil: 8.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.1"	"Cell line enriched"	"Detected in single"	6	"HEL: 1.1"	"Not detected"	"Not detected"							HPA065044	Uncertain		Approved	"Plasma membrane"	"Secreted - unknown location"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"HPA065044: AB_2685411"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.58e-2)"		"unprognostic (2.07e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.03e-1)"		"unprognostic (5.50e-2)"	"unprognostic (9.50e-3)"		"unprognostic (1.18e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.21e-2)"	0.0	0.0	0.0	0.3	0.2	0.7	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	4.5	0.0	0.4	0.0	0.1	0.0	0.0	0.5	0.9	0.0	0.0	8.1	0.0	0.4	0.7	0.0	0.4	0.0	0.2	0.0	0.4	0.1	0.2	0.2	0.1	0.1	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIB1	"C8FW, GIG2, TRB1"	ENSG00000173334	"Tribbles pseudokinase 1"	Q96RU8	8	125430358-125438403	"Enzymes, Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 365.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 242.7;Distal enterocytes: 281.6;Endometrial stromal cells: 240.1;Plasma cells: 283.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 9.9;neutrophil: 4.7;non-classical monocyte: 3.5;T-reg: 2.8"	"Group enriched"	"Detected in many"	12	"granulocytes: 9.9;monocytes: 3.5;T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"HEL: 193.9;U-266/70: 114.2;U-266/84: 123.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063982			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"HPA063982: AB_2685165"	"unprognostic (1.90e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.34e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.81e-3)"	"unprognostic (9.36e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.08e-2)"	82.5	25.5	7.5	40.9	9.0	365.5	28.0	12.1	16.2	35.9	7.0	45.1	20.4	25.5	13.6	33.5	15.7	80.2	18.3	8.2	10.1	23.9	139.6	53.7	17.2	9.0	8.4	4.1	43.0	78.9	12.0	28.9	8.7	45.4	51.9	16.3	19.2	7.1	44.0	20.4	32.0	43.2	7.5	22.3	38.0	6.9	11.9	36.0	107.5	19.2	18.0	99.1	5.4	7.6	14.7	16.4	2.2	4.6	4.6	8.8	25.4	9.4	13.2	6.8	2.3	22.1	18.9	26.5	8.5	6.9	40.6	11.0	7.0	9.1	5.8	11.8	34.3	193.9	7.3	43.6	11.6	98.3	17.0	8.5	13.5	27.8	62.8	33.0	20.0	0.3	17.5	81.6	0.9	15.8	9.2	15.3	15.8	35.1	31.6	18.5	3.3	29.2	54.6	55.1	13.7	5.0	22.9	24.6	93.1	14.0	6.4	4.6	10.4	7.3	9.5	7.3	11.7	114.2	123.2	36.6	13.1	0.7	17.7	0.0	0.7	9.9	0.0	1.1	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	4.7	0.0	3.5	0.3	2.8	0.1	7.5	9.0	12.1	16.2	8.2	10.1	9.0	8.4	8.7	7.5	11.9	7.6	69.6	134.6	168.5	13.7	19.8	100.1	242.7	68.6	77.4	25.5	100.8	71.9	16.6	31.5	67.9	16.5	0.0	12.3	2.8	281.6	11.7	45.3	0.4	96.6	240.1	62.0	112.0	5.3	2.1	24.7	19.1	54.6	58.6	222.5	29.9	0.5	8.2	131.7	35.3	21.9	0.7	129.6	32.6	72.0	59.7	1.7	0.3	85.9	56.9	4.7	27.5	20.1	0.0	4.5	0.2	45.5	130.9	0.4	283.6	139.0	117.4	24.9	39.7	3.8	0.0	36.6	45.1	0.3	2.2	88.2	64.2	30.6	14.8	1.5	106.9	128.7
TRIM10	"HERF1, RFB30, RNF9"	ENSG00000204613	"Tripartite motif containing 10"	Q9UDY6	6	30151943-30161211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 7.8;kidney: 2.0;liver: 2.9"	"Cell type enriched"	"Detected in some"	21	"Erythroid cells: 126.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"HEL: 22.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"hippocampal formation: 3.4"	HPA043325	Uncertain					NA	NA				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA043325: AB_2678428"		"unprognostic (2.98e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.99e-2)"		"unprognostic (2.13e-1)"	"unprognostic (2.98e-1)"	"unprognostic (9.53e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.64e-2)"		"unprognostic (1.74e-3)"	"unprognostic (1.46e-2)"	"unprognostic (4.37e-2)"		"unprognostic (1.22e-2)"	0.0	0.0	0.0	0.1	0.0	7.8	0.0	0.0	0.0	0.1	0.0	1.6	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.0	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	126.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	1.9	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	5.9	0.0	0.0	0.0	3.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.0
TRIM15	"RNF93, ZNF178, ZNFB7"	ENSG00000204610	"Tripartite motif containing 15"	Q9C019	6	30163206-30172693	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 17.1;kidney: 6.0;liver: 14.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 139.1;Intestinal goblet cells: 41.5;Paneth cells: 332.0;Proximal enterocytes: 80.0"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 14.4;liver cancer: 5.6;pancreatic cancer: 7.7;renal cancer: 4.4;stomach cancer: 8.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"HEL: 16.5;Hep G2: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047527			Approved	"Centriolar satellite,Cytosol"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Centriolar satellite"	"HPA047527: "	"unprognostic (2.61e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.71e-1)"		"unprognostic (5.36e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.57e-4)"	"unprognostic (5.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.00e-2)"		"unprognostic (2.16e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.41e-1)"	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	13.8	17.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	6.0	14.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.7	12.2	0.3	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.1	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	11.5	0.0	0.0	0.0	0.0	0.0	139.1	1.9	1.8	0.0	0.0	0.1	0.0	0.0	2.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	41.5	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	332.0	0.0	0.0	0.0	80.0	21.5	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.5	0.0	29.1	0.0
TRIM40	RNF35	ENSG00000204614	"Tripartite motif containing 40"	Q6P9F5	6	30136124-30148735	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 3.0;liver: 1.6;testis: 1.4"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 20.1;Paneth cells: 24.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.7;stomach cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"HEL: 1.1"	"Region enriched"	"Detected in single"	18	"thalamus: 3.1"	"Low region specificity"	"Detected in many"			HPA043818	Uncertain		Approved	Cytosol		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA043818: AB_10963090"		"unprognostic (2.88e-1)"	"unprognostic (5.20e-2)"			"unprognostic (4.11e-1)"	"unprognostic (1.13e-1)"				"unprognostic (1.77e-1)"			"unprognostic (4.84e-2)"				0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	24.7	0.0	0.0	0.0	3.8	0.5	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0
TRIM58	BIA2	ENSG00000162722	"Tripartite motif containing 58"	Q8NG06	1	247857187-247880138	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 32.2;thyroid gland: 15.2"	"Cell type enriched"	"Detected in many"	23	"Erythroid cells: 456.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 2.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 18.3;HEL: 40.7;K-562: 21.8;PC-3: 37.0;U-2 OS: 29.0;WM-115: 42.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA023637	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA023637: AB_1858309"	"unprognostic (3.85e-1)"	"unprognostic (5.24e-3)"	"unprognostic (7.00e-2)"	"unprognostic (6.52e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.14e-5)"	"unprognostic (3.59e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.57e-2)"	0.5	0.6	0.7	0.6	0.5	32.2	0.5	0.1	1.0	0.4	0.0	1.1	0.1	0.2	0.1	0.1	1.3	0.3	0.2	0.6	2.9	0.2	0.2	1.3	0.2	3.2	4.1	0.0	0.2	0.1	0.2	5.8	4.3	1.5	0.9	0.6	0.3	0.2	0.2	0.9	0.3	0.6	1.3	2.4	0.4	2.7	3.1	0.3	15.2	1.6	0.1	0.2	0.2	0.9	0.0	0.0	0.0	0.0	0.7	2.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.4	1.7	18.3	0.0	0.0	0.0	1.3	40.7	0.0	0.0	0.0	5.5	2.4	0.0	0.0	0.2	0.0	0.0	0.0	1.4	21.8	0.1	0.0	0.0	0.2	0.3	2.7	0.0	37.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.2	4.7	0.0	0.0	29.0	0.0	0.0	6.3	0.0	0.0	0.0	13.0	42.1	0.7	0.1	0.3	0.0	0.1	0.0	0.8	0.0	0.0	0.2	0.2	0.0	0.0	0.6	0.3	0.1	0.1	0.0	0.6	0.7	0.5	0.1	1.0	0.6	2.9	3.2	4.1	4.3	1.3	3.1	0.9	0.6	3.2	3.0	0.3	1.7	1.0	1.4	0.0	0.6	3.4	1.1	0.3	0.5	0.0	5.6	1.8	12.5	3.3	0.4	0.8	0.0	0.1	4.3	2.5	0.7	1.7	1.2	456.4	3.7	0.0	4.6	3.0	0.0	2.1	8.2	0.4	1.8	0.1	2.4	0.0	1.8	0.4	0.0	3.2	1.4	1.2	0.9	19.4	1.8	0.0	1.0	2.7	2.1	0.5	0.3	0.2	0.7	0.7	0.3	4.0	0.0	0.2	3.7	3.7	0.0	0.9	0.7	2.8	9.7	0.1	0.9	4.9	1.7	0.3	0.8	0.8
TSC22D1	"MGC17597, TGFB1I4, TSC22"	ENSG00000102804	"TSC22 domain family member 1"	Q15714	13	44432143-44577147	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1231.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 44.7"	"Group enriched"	"Detected in all"	5	"dendritic cells: 17.9;granulocytes: 44.7;NK-cells: 16.7"	"Cell line enhanced"	"Detected in many"		"HEL: 247.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077414			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Nuclear bodies"		"HPA077414: AB_2686839"	"unprognostic (6.61e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.00e-1)"	"unprognostic (6.40e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.78e-3)"	"unprognostic (6.30e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (4.24e-2)"	"unprognostic (9.08e-2)"	"prognostic favorable (4.54e-4)"	"unprognostic (8.14e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.83e-2)"	"unprognostic (4.48e-2)"	125.9	88.8	261.8	58.9	276.9	16.5	143.1	223.1	295.7	162.3	283.4	133.0	64.9	159.4	138.5	107.6	152.0	115.6	128.2	272.4	252.1	172.1	86.9	120.3	38.6	248.0	270.8	180.1	35.4	114.1	110.3	88.0	253.9	181.5	109.1	73.7	76.1	84.7	190.8	67.6	118.2	147.6	237.8	26.7	115.0	61.8	268.6	168.6	88.3	125.7	41.4	138.1	87.3	245.4	21.7	67.7	62.1	24.6	36.3	45.7	75.5	22.4	93.9	23.1	25.8	77.1	74.9	35.4	48.6	47.9	52.6	53.8	25.1	191.2	33.4	6.5	22.2	247.3	116.9	23.4	36.1	12.8	30.1	65.0	80.2	65.6	162.0	184.8	55.6	18.6	6.9	0.2	45.5	21.0	44.9	10.3	45.3	148.8	61.6	31.1	11.6	10.6	47.7	35.5	33.5	45.3	64.3	61.8	18.6	65.1	30.8	19.5	49.6	26.4	25.8	59.1	34.9	0.6	6.6	10.2	70.0	10.6	65.7	44.7	1.9	5.8	4.6	1.9	4.4	1.3	1.4	2.1	1.8	2.0	1.5	2.2	8.6	16.7	5.1	17.9	3.4	50.0	261.8	276.9	223.1	295.7	272.4	252.1	248.0	270.8	253.9	237.8	268.6	245.4	739.9	118.6	368.2	77.7	21.4	441.9	415.0	905.0	870.2	147.8	464.9	296.5	279.9	97.2	425.3	435.9	114.7	584.7	34.9	660.8	369.8	190.8	851.5	186.0	105.0	643.0	225.0	118.9	302.4	157.0	177.2	234.3	211.0	313.8	314.2	108.2	88.9	74.5	106.5	127.9	261.0	254.0	526.9	21.1	153.3	1231.0	91.6	218.4	402.0	148.0	16.2	246.2	26.8	207.1	103.8	229.5	339.6	136.5	17.2	550.9	212.0	155.1	265.8	149.9	447.0	268.2	500.9	80.9	34.6	178.2	610.0	1170.1	65.0	80.6	273.6	445.8
TTC39B	"C9orf52, FLJ33868"	ENSG00000155158	"Tetratricopeptide repeat domain 39B"	Q5VTQ0	9	15163622-15307360	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 64.4;Paneth cells: 65.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 2.0;gdT-cell: 2.9;MAIT T-cell: 3.9;memory CD4 T-cell: 4.0;memory CD8 T-cell: 4.6;naive CD4 T-cell: 4.7;naive CD8 T-cell: 2.9;NK-cell: 6.3;T-reg: 3.8"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.0;NK-cells: 6.3;T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"HEL: 40.9;RT4: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063162			Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA063162: AB_2684952"	"unprognostic (1.64e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.47e-2)"	"unprognostic (7.89e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.12e-2)"	"prognostic favorable (9.64e-6)"	"unprognostic (5.99e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.89e-2)"	"prognostic favorable (4.08e-7)"	"unprognostic (3.31e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.48e-1)"	1.9	2.6	2.9	4.0	2.5	1.5	4.8	10.8	7.0	4.3	1.8	6.7	5.7	3.5	1.9	8.8	3.3	6.9	1.3	1.5	4.6	9.0	5.4	4.6	6.1	7.0	2.9	2.9	3.9	1.9	3.9	1.2	7.2	2.3	5.6	2.9	3.0	1.9	1.8	9.6	5.6	4.2	2.5	3.8	5.5	5.7	4.7	3.4	2.6	1.3	6.0	3.6	4.7	2.9	3.9	0.8	1.2	5.6	5.3	9.9	1.2	5.0	9.1	3.9	9.3	0.8	1.6	0.0	0.6	6.3	4.6	3.4	0.9	6.2	3.3	4.5	0.8	40.9	1.7	7.3	8.8	0.0	0.8	9.7	4.7	8.1	9.0	2.8	5.6	3.3	0.1	9.1	10.0	1.3	2.2	0.2	1.6	12.3	1.2	0.4	3.0	1.9	8.3	23.0	2.9	0.5	1.2	2.9	0.9	1.8	12.7	2.5	4.2	2.2	1.8	3.1	1.4	0.1	0.1	0.0	2.1	0.5	1.1	2.0	0.7	0.9	2.9	0.5	3.9	0.2	4.0	4.6	0.4	0.6	4.7	2.9	0.4	6.3	0.7	0.1	3.8	2.5	2.9	2.5	10.8	7.0	1.5	4.6	7.0	2.9	7.2	2.5	4.7	2.9	7.5	12.8	19.8	10.4	7.0	17.3	7.8	19.1	10.8	25.5	9.0	4.4	4.1	10.0	15.8	7.3	0.0	3.2	18.0	40.6	17.6	6.6	43.2	11.8	10.1	7.4	12.7	0.4	44.0	21.8	1.1	10.0	22.4	7.7	29.1	3.6	7.5	11.6	4.1	13.5	64.4	16.1	24.4	3.1	9.2	33.2	7.2	16.7	7.2	12.2	2.9	14.9	11.3	24.6	2.3	10.5	65.0	12.8	5.5	11.5	30.3	35.5	25.3	4.3	0.0	9.4	12.4	4.7	3.0	8.6	21.5	4.1	22.3	6.8	17.3	14.4
TUBAL3	FLJ21665	ENSG00000178462	"Tubulin alpha like 3"	A6NHL2	10	5393101-5404828	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 28.3"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 19.8;Proximal enterocytes: 19.7"	"Cancer enriched"	"Detected in some"	4	"colorectal cancer: 3.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEL: 13.3;JURKAT: 7.7;K-562: 4.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA045900, HPA063394"	Uncertain					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 45: Enterocytes - Digestion"			"HPA045900: AB_10961130, HPA063394: AB_2685003"	"unprognostic (2.63e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.13e-2)"		"unprognostic (3.02e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.44e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.35e-4)"	"unprognostic (7.93e-4)"	0.1	0.0	0.4	0.5	0.3	0.1	0.4	0.4	0.6	0.1	1.4	11.9	24.3	0.0	0.0	0.3	0.2	0.1	0.7	0.3	0.4	5.8	0.0	0.2	0.1	0.8	0.5	0.0	0.0	0.0	0.0	0.1	0.9	0.1	10.8	0.0	0.8	0.0	0.1	0.3	28.3	0.3	0.6	0.0	0.2	1.0	0.8	0.3	0.0	1.4	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.7	0.0	1.2	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	13.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.7	4.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.6	0.3	0.4	0.8	0.5	0.9	0.6	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	19.8	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.9	0.0	0.0	0.0	19.7	4.4	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.1	0.0	1.4	0.1
TUBB1	dJ543J19.4	ENSG00000101162	"Tubulin beta 1 class VI"	Q9H4B7	20	59019429-59026654	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.5;lymphoid tissue: 4.3"	"Cell type enriched"	"Detected in some"	10	"Macrophages: 191.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	17	"basophil: 63.5;neutrophil: 26.0"	"Lineage enriched"	"Detected in many"	24	"granulocytes: 63.5"	"Cell line enriched"	"Detected in some"	19	"HEL: 29.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004286, HPA043640, HPA046280"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA		87000000	"Cluster 34: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB004286: AB_2288090, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (3.76e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.10e-4)"	"unprognostic (1.02e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.51e-4)"	"unprognostic (1.90e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.80e-5)"	"unprognostic (3.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.00e-1)"	0.2	0.2	0.2	0.3	0.2	8.5	0.1	0.5	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.3	2.4	0.2	0.3	0.2	0.1	0.1	0.0	0.3	1.1	0.2	0.0	0.0	0.2	0.1	0.0	0.4	0.1	0.2	0.0	0.1	4.3	0.1	0.9	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.3	0.1	0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.2	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	29.5	0.8	1.5	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.4	0.0	0.0	0.1	0.3	0.3	0.0	0.1	0.4	0.2	0.1	0.3	0.0	0.3	0.3	0.2	0.2	0.6	0.1	0.1	0.1	0.2	0.0	0.2	0.2	0.3	0.1	0.2	0.3	0.2	0.1	0.2	0.4	63.5	2.4	1.9	0.5	0.6	0.4	0.9	0.2	0.0	1.1	0.5	0.4	0.0	26.0	0.2	0.3	2.6	0.5	281.6	0.2	0.2	0.5	0.5	0.1	0.2	0.3	0.2	0.2	0.1	0.2	0.3	0.1	0.0	1.1	0.3	1.4	0.0	0.0	0.0	0.0	1.7	0.1	0.1	0.1	0.0	0.6	0.0	4.2	0.0	3.1	0.0	0.0	0.0	16.0	0.3	0.2	1.5	0.0	19.0	0.2	0.0	0.1	0.1	0.0	0.7	1.3	0.0	3.6	0.2	0.3	0.0	0.2	0.0	0.0	2.8	0.0	5.9	0.3	191.2	0.0	0.0	13.8	0.2	13.4	0.0	0.1	0.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	1.9	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	1.0	0.1	0.1	0.1
TUSC1	"CCDC89B, TSG-9"	ENSG00000198680	"Tumor suppressor candidate 1"	Q2TAM9	9	25676389-25678440	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 164.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051426	Approved		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA051426: AB_2681481"	"unprognostic (9.84e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-3)"	"unprognostic (9.41e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.72e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.85e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.21e-2)"	16.1	10.6	8.5	2.8	8.5	1.7	14.8	7.0	9.3	13.6	9.5	14.3	5.3	18.3	6.2	9.1	15.9	2.8	12.2	8.7	8.9	13.1	10.9	9.8	1.6	9.6	10.5	13.2	9.8	5.6	9.0	3.8	8.2	11.7	3.7	2.8	10.8	6.1	8.3	13.1	9.1	5.5	9.0	6.8	11.5	21.8	8.6	3.2	11.9	4.7	2.0	12.7	10.7	10.4	10.0	2.1	2.1	0.0	7.0	5.8	0.1	7.5	0.0	2.8	3.4	0.1	3.5	0.0	2.2	8.9	7.6	0.0	5.3	9.4	1.7	0.0	10.3	38.6	11.2	0.0	3.4	0.0	0.0	7.1	13.0	3.1	7.3	0.0	3.1	0.0	0.0	0.1	3.3	5.0	0.0	0.1	1.8	8.0	9.5	0.0	1.4	0.1	3.9	4.6	0.7	16.8	9.3	7.6	8.2	4.1	6.7	10.8	6.6	0.0	13.6	0.1	0.0	0.0	0.0	0.0	8.8	2.6	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	8.5	8.5	7.0	9.3	8.7	8.9	9.6	10.5	8.2	9.0	8.6	10.4	46.5	12.8	6.4	2.3	2.1	60.8	46.1	14.7	47.3	24.8	45.4	55.0	12.2	20.0	5.9	16.5	4.2	29.5	2.4	14.8	66.5	7.9	85.7	11.0	26.6	24.4	13.1	4.8	7.3	12.4	13.8	33.0	7.1	17.2	0.0	15.7	22.9	18.5	9.7	21.9	7.6	11.8	10.2	4.8	13.0	16.2	30.7	5.2	28.4	3.7	1.2	42.9	0.0	4.0	9.3	8.1	9.5	21.8	0.5	45.5	8.1	23.1	3.5	14.3	32.9	52.8	36.9	164.0	12.8	16.8	37.8	29.0	1.3	16.3	14.3	19.8
U2AF1	"RN, RNU2AF1, U2AF35, U2AFBP"	ENSG00000160201	"U2 small nuclear RNA auxiliary factor 1"	Q01081	21	43092956-43107570	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 492.9;Basal respiratory cells: 406.9;Ionocytes: 266.5;Langerhans cells: 374.7;Suprabasal keratinocytes: 433.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 607.7"	"Low region specificity"	"Detected in all"							"HPA044833, HPA052083"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 36: HEL - Hemostasis"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA044833: AB_10960990, HPA052083: AB_2681720"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.06e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.29e-4)"	"unprognostic (4.81e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.14e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-2)"	62.9	47.6	36.8	31.1	39.9	85.9	58.7	39.8	46.9	57.6	38.0	79.3	25.8	68.9	27.8	64.3	60.8	18.7	43.0	37.7	41.1	42.8	48.0	57.3	45.2	39.3	40.2	69.3	41.8	32.7	60.1	34.6	38.5	48.0	26.8	28.9	49.1	40.8	74.9	47.5	57.2	35.8	38.3	65.4	58.2	54.4	38.8	61.8	62.6	24.8	55.9	60.7	50.7	40.8	101.1	27.7	250.5	71.3	28.7	38.8	248.1	88.2	82.4	105.4	115.3	486.0	59.8	20.8	35.1	54.3	125.6	33.0	161.1	36.3	104.9	114.6	134.0	607.7	61.2	117.9	77.0	264.0	115.2	45.5	90.6	177.1	100.6	43.5	62.8	238.0	105.8	113.4	97.2	324.4	271.1	358.1	287.6	123.4	108.3	485.1	166.9	211.9	99.8	15.4	125.9	77.6	212.6	98.6	147.6	36.5	125.5	147.5	12.1	79.2	59.6	82.0	236.3	191.4	178.3	48.8	80.3	333.6	118.6	211.9	141.0	153.1	101.2	140.4	106.7	140.2	112.7	95.5	150.4	134.2	112.9	109.1	213.1	93.1	196.9	240.7	149.3	188.7	36.8	39.9	39.8	46.9	37.7	41.1	39.3	40.2	38.5	38.3	38.8	40.8	9.5	19.2	18.1	3.9	37.8	492.9	32.5	406.9	86.6	23.9	5.7	2.8	5.0	17.2	153.5	1.8	43.8	19.5	15.3	16.5	1.9	5.2	3.1	4.2	4.4	51.7	18.2	45.0	5.2	6.0	20.7	51.8	44.4	4.2	28.4	3.8	31.8	16.2	23.2	18.5	4.6	17.0	266.5	33.0	374.7	4.1	18.3	30.6	202.7	4.7	19.3	13.0	27.8	3.0	6.2	4.8	17.0	22.6	60.3	31.1	43.2	3.1	107.6	60.7	6.6	39.1	110.7	16.4	18.9	79.8	433.6	23.8	46.6	1.3	20.2	39.1
UBR3	"DKFZp434P117, FLJ37422, KIAA2024, ZNF650"	ENSG00000144357	"Ubiquitin protein ligase E3 component n-recognin 3"	Q6ZT12	2	169827454-170084131	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 71.2;tongue: 87.1"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 162.6;Excitatory neurons: 305.1;Inhibitory neurons: 302.0;Oligodendrocyte precursor cells: 232.2;Oligodendrocytes: 288.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035390	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli"		"HPA035390: AB_10670699"	"unprognostic (1.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.18e-1)"	14.2	12.4	4.4	7.7	5.8	7.4	9.2	5.9	8.5	10.9	2.8	8.8	8.1	10.1	6.9	12.8	8.4	9.3	29.4	8.0	3.3	15.2	21.0	8.8	7.2	2.4	2.7	10.2	11.9	21.5	2.1	8.7	3.3	13.1	8.5	21.2	11.5	10.3	71.2	9.2	7.5	11.1	3.2	8.8	9.3	9.7	3.4	9.5	17.9	87.1	7.3	11.0	2.3	8.4	14.8	12.4	12.9	17.1	25.0	19.7	10.8	26.1	15.0	14.7	11.8	19.1	9.1	16.7	22.2	20.5	12.0	19.0	15.5	13.2	18.2	17.4	13.4	61.1	12.6	20.3	12.4	20.4	18.9	11.9	12.1	19.3	12.9	11.7	14.8	8.3	32.4	17.6	25.6	14.0	13.3	10.0	10.1	14.9	10.2	12.6	21.1	17.8	10.5	20.5	25.1	13.7	18.4	16.7	10.6	10.2	10.9	11.4	18.9	22.1	9.0	17.5	16.7	14.2	11.9	15.1	18.2	11.8	12.5	0.0	0.6	0.5	0.9	0.6	1.3	0.6	0.5	0.8	0.9	0.3	0.9	1.2	0.6	0.8	0.5	0.7	1.0	0.4	4.4	5.8	5.9	8.5	8.0	3.3	2.4	2.7	3.3	3.2	3.4	8.4	19.0	44.8	26.9	162.6	16.3	25.9	12.4	14.8	20.5	46.3	15.8	8.9	109.7	17.2	20.0	12.9	81.3	19.7	22.9	17.1	3.9	8.7	7.6	16.8	21.9	26.4	16.7	24.4	305.1	11.0	8.4	22.2	23.4	22.0	16.5	22.7	30.4	39.0	10.2	63.9	302.0	11.3	22.4	20.9	18.7	10.2	25.7	18.7	16.0	110.5	18.7	61.7	14.4	232.2	288.0	10.7	15.0	19.2	21.3	20.9	15.3	10.0	13.4	51.5	26.3	29.0	21.8	12.4	8.6	22.9	29.0	23.0	18.1	17.3	13.2	17.2
UPF2	"DKFZP434D222, KIAA1408, RENT2, smg-3"	ENSG00000151461	"UPF2 regulator of nonsense mediated mRNA decay"	Q9HAU5	10	11920022-12043170	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067008			Supported	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"	Cytosol	"Cytoplasmic bodies"	"HPA067008: AB_2685762"	"unprognostic (1.99e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (5.48e-2)"	"unprognostic (5.68e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.01e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.48e-2)"	12.8	8.1	12.4	14.1	13.7	21.0	12.7	15.8	15.1	12.0	12.5	16.2	10.0	14.9	10.7	10.9	11.0	8.9	10.6	12.5	13.6	10.9	16.7	10.4	18.9	11.8	12.2	16.2	13.7	14.8	7.9	14.1	11.6	13.5	12.9	14.8	11.1	12.2	22.0	12.9	11.4	12.1	11.9	14.8	11.3	19.5	12.7	21.5	12.8	21.4	17.7	13.4	11.8	13.2	35.9	22.3	18.8	23.5	14.0	17.9	21.2	27.5	12.7	19.2	23.0	21.2	28.6	51.4	9.1	23.0	15.8	29.4	27.2	24.9	27.4	32.5	15.7	61.6	18.2	19.4	15.8	28.1	39.8	13.5	19.0	24.3	16.4	18.2	23.8	27.1	37.1	25.7	22.2	17.7	34.8	16.4	18.0	27.1	11.8	30.4	22.5	25.3	18.2	14.2	12.1	13.0	21.6	23.1	23.8	18.7	27.9	37.1	25.5	15.0	31.4	31.1	21.1	23.4	19.8	41.4	24.0	26.9	12.1	13.7	4.2	10.2	4.3	4.2	4.2	10.7	4.9	4.5	3.0	10.6	5.4	4.5	29.5	5.4	2.9	11.5	3.8	1.8	12.4	13.7	15.8	15.1	12.5	13.6	11.8	12.2	11.6	11.9	12.7	13.2	74.8	25.6	34.6	32.0	133.3	71.9	35.0	46.9	64.3	66.3	53.8	38.6	69.6	52.9	39.4	49.7	102.2	47.0	79.6	97.7	39.2	47.7	70.1	99.3	86.2	62.6	66.3	108.4	36.1	44.8	51.7	48.2	58.1	88.7	58.9	71.8	64.2	89.5	41.1	52.2	31.6	90.2	48.8	71.4	125.3	116.9	86.3	56.0	53.4	31.9	89.0	45.5	98.9	37.2	45.4	53.7	78.9	59.0	121.2	38.7	70.6	34.1	41.5	97.2	98.6	54.3	60.1	182.9	149.8	47.3	81.8	56.5	73.6	35.9	65.5	36.3
UROS		ENSG00000188690	"Uroporphyrinogen III synthase"	P10746	10	125784980-125823258	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 231.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044038	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		69000	"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	Cytosol	"HPA044038: AB_10966692"	"unprognostic (8.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.93e-1)"	27.9	41.3	54.1	13.4	55.3	67.5	26.9	40.6	64.5	15.9	33.0	29.9	20.9	21.4	56.9	24.9	19.3	15.6	73.2	56.3	45.8	40.7	59.7	20.5	18.8	41.6	48.1	22.5	32.9	30.0	29.9	11.3	43.5	27.4	16.5	26.2	29.6	19.1	83.8	23.0	24.2	18.1	40.2	28.0	29.6	31.2	51.8	18.6	32.5	80.0	19.1	27.3	17.0	47.8	45.5	56.3	29.8	74.9	38.5	42.2	51.9	51.4	94.5	39.0	34.6	22.9	54.0	58.4	24.7	72.9	24.3	23.5	18.5	43.1	31.3	78.1	39.9	125.3	27.9	40.1	67.3	50.7	29.7	59.3	20.7	25.8	66.0	47.5	34.4	48.5	24.4	54.1	63.5	65.2	51.2	72.8	37.7	31.8	54.0	33.1	34.1	37.3	53.9	28.2	26.2	46.8	51.6	41.8	80.7	30.8	40.4	59.1	33.8	52.3	19.6	38.1	48.2	50.7	36.8	40.6	75.6	23.1	26.3	4.9	31.9	4.6	30.1	33.1	33.9	30.1	29.3	38.6	53.5	37.5	38.1	29.6	2.1	53.6	31.9	25.3	29.8	38.1	54.1	55.3	40.6	64.5	56.3	45.8	41.6	48.1	43.5	40.2	51.8	47.8	19.0	19.2	23.1	20.5	34.3	9.3	12.0	31.8	9.6	49.3	36.2	39.5	70.5	40.0	28.6	36.8	45.9	60.8	36.3	19.1	101.8	59.7	57.0	11.2	25.5	22.2	14.5	231.5	23.9	59.6	47.4	33.3	23.9	16.9	11.4	112.3	28.2	53.4	79.3	47.1	25.2	25.6	40.7	47.8	20.8	123.7	35.8	31.6	62.2	9.4	58.7	77.0	69.0	13.6	29.6	42.7	15.8	40.6	46.9	27.3	52.9	142.6	20.4	42.3	6.6	22.8	36.7	55.7	100.9	28.5	12.8	20.0	37.8	55.0	38.8	21.3
USP33	"KIAA1097, VDU1"	ENSG00000077254	"Ubiquitin specific peptidase 33"	Q8TEY7	1	77695987-77759852	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 159.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005719	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Golgi apparatus"		"HPA005719: AB_10601708"	"unprognostic (2.31e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.59e-1)"	"unprognostic (5.36e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-2)"	40.7	31.2	31.5	24.6	40.4	34.5	34.3	52.0	49.7	24.2	37.3	24.3	25.4	28.0	26.8	21.6	22.5	26.3	21.7	35.4	31.8	31.1	25.4	26.2	28.1	28.6	24.9	29.3	19.5	35.0	20.9	28.0	30.8	28.8	25.2	49.1	25.2	22.9	18.0	24.3	26.9	24.1	22.3	26.0	24.4	25.4	28.6	27.1	30.4	20.7	26.0	22.9	20.0	55.5	42.4	18.8	64.1	44.2	90.0	78.3	54.8	45.3	42.9	54.0	60.1	25.4	35.5	31.4	41.2	44.3	88.2	32.1	47.4	31.1	65.7	28.8	36.6	111.1	44.6	22.2	56.0	37.8	26.8	58.3	23.9	52.4	37.9	51.9	48.7	28.0	43.9	26.3	41.2	16.1	34.9	38.0	62.2	32.6	37.2	33.0	67.7	22.2	51.0	41.1	53.8	41.2	31.9	41.5	64.2	54.3	23.1	41.2	41.2	49.4	34.4	50.1	43.2	21.0	28.4	30.4	37.3	44.5	25.4	67.3	22.5	31.8	21.0	22.6	21.7	20.5	20.6	21.7	17.5	22.3	24.5	21.9	30.5	19.2	30.1	18.4	20.7	16.7	31.5	40.4	52.0	49.7	35.4	31.8	28.6	24.9	30.8	22.3	28.6	55.5	40.2	44.8	40.9	66.3	35.1	17.2	18.8	21.2	32.5	56.7	25.7	22.1	39.9	22.8	25.5	35.0	58.4	25.1	48.8	35.9	9.8	20.8	4.3	54.8	37.8	31.8	35.5	50.9	149.3	15.4	19.0	39.6	43.3	54.6	23.4	43.1	28.2	23.1	19.0	62.2	159.0	28.6	22.4	30.8	20.7	5.5	35.8	35.1	23.2	75.9	38.7	31.4	37.0	98.0	138.5	19.6	27.8	32.0	42.4	22.9	33.2	25.6	37.3	44.5	19.7	34.9	35.6	39.8	30.1	28.4	16.3	11.9	41.0	39.2	24.8	21.8
WBP4	"FBP21, MGC117310"	ENSG00000120688	"WW domain binding protein 4"	O75554	13	41061509-41084006	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038965, HPA058738"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA038965: AB_10672836, HPA058738: AB_2683803"	"unprognostic (2.56e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.71e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.52e-2)"	"unprognostic (7.65e-3)"	"prognostic favorable (2.89e-4)"	"unprognostic (2.52e-1)"	17.5	16.0	16.1	9.8	16.8	15.6	13.4	16.5	23.9	12.0	13.2	13.2	11.2	18.5	16.0	11.2	11.1	9.3	23.1	16.1	18.1	12.3	16.3	10.4	11.8	16.3	16.6	13.2	8.7	12.4	8.2	11.5	16.4	14.0	9.1	16.5	8.1	14.7	41.0	11.3	11.5	14.8	15.7	9.8	9.3	12.2	16.5	14.7	11.2	29.8	11.6	11.3	11.0	18.6	15.0	9.8	26.7	17.3	17.1	25.9	16.2	33.3	23.4	25.9	19.7	15.5	15.7	21.4	13.0	23.6	31.2	20.6	10.2	16.7	33.0	22.3	14.3	30.2	10.0	16.0	26.3	19.1	18.8	21.3	25.0	18.8	26.5	21.1	22.0	20.3	16.4	9.1	27.5	12.6	27.3	20.6	16.3	23.2	8.0	25.3	16.5	8.4	23.6	14.6	6.1	14.7	10.6	11.3	16.1	21.5	9.4	29.3	19.3	16.0	14.7	22.2	19.5	6.0	7.0	14.7	19.7	13.7	22.2	19.2	13.0	12.4	10.6	12.0	9.7	14.2	13.6	11.5	11.0	12.6	14.4	14.3	27.3	12.5	21.8	18.5	14.4	6.1	16.1	16.8	16.5	23.9	16.1	18.1	16.3	16.6	16.4	15.7	16.5	18.6	42.4	51.3	29.3	21.2	23.9	54.4	60.3	54.8	33.0	46.8	33.5	37.5	110.0	40.0	32.5	25.8	33.3	55.6	23.0	32.3	76.3	52.3	11.9	32.9	58.4	46.9	37.8	111.7	17.0	42.0	61.1	52.2	15.8	44.5	45.7	27.5	38.2	63.1	40.9	45.4	16.6	28.1	18.3	26.7	47.1	9.7	47.8	33.0	32.0	10.3	60.4	63.8	28.8	17.1	33.3	50.3	33.2	52.6	16.8	60.9	33.8	70.6	23.6	49.2	26.3	55.3	66.7	87.5	103.9	29.7	44.9	49.9	22.3	31.9	27.6	40.9
YTHDF3	FLJ31657	ENSG00000185728	"YTH N6-methyladenosine RNA binding protein 3"	Q7Z739	8	63168553-63212786	"Predicted intracellular proteins"	"Host-virus interaction"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 36: HEL - Hemostasis"	"Cluster 44: Endometrium - Transcription"				"unprognostic (1.06e-2)"	"unprognostic (9.89e-3)"	"unprognostic (6.65e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.87e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.11e-1)"	24.8	22.9	8.4	20.6	10.5	91.5	22.1	12.8	14.4	24.0	13.0	24.3	21.7	24.6	21.3	21.4	18.7	22.4	28.7	10.3	10.4	24.7	41.0	20.5	21.1	9.0	9.2	23.5	22.6	24.2	8.7	29.7	9.8	22.9	24.1	15.2	22.1	19.9	34.3	15.9	21.6	29.0	9.4	22.0	18.9	22.5	11.7	25.0	23.2	36.1	21.1	23.3	13.2	10.7	37.6	50.4	47.9	36.3	62.5	53.9	32.2	67.2	56.7	42.5	49.1	42.9	37.5	40.5	14.0	66.5	47.6	35.0	64.1	45.3	61.7	32.7	29.9	74.7	36.5	30.4	57.1	21.9	35.0	71.0	35.0	45.1	63.5	44.4	35.9	24.6	43.9	35.6	66.7	26.9	40.1	22.6	65.8	50.4	36.8	30.5	36.1	19.9	42.7	66.4	19.4	34.8	48.0	42.5	51.0	40.7	57.0	27.2	65.2	38.4	36.4	34.2	36.4	42.6	40.6	56.2	38.9	29.4	47.5	40.3	29.1	30.7	14.2	32.9	15.8	11.7	14.1	17.0	29.0	13.8	17.0	16.3	36.5	18.4	47.2	8.6	16.5	18.1	8.4	10.5	12.8	14.4	10.3	10.4	9.0	9.2	9.8	9.4	11.7	10.7	33.0	32.1	51.1	41.8	28.2	38.7	22.2	19.1	26.2	15.4	34.1	24.5	49.9	28.6	26.5	20.2	6.2	20.2	34.1	51.0	7.9	15.7	8.0	39.2	72.4	28.2	40.7	14.5	49.8	16.7	27.1	33.5	30.1	77.4	22.8	24.9	28.9	69.3	31.1	20.2	47.2	31.8	10.2	62.1	61.5	12.0	23.9	54.4	17.8	54.4	32.4	15.4	15.5	60.3	61.9	21.3	30.6	26.4	22.9	32.8	27.9	29.7	31.2	13.4	13.1	26.4	31.5	15.1	19.3	37.9	31.4	26.4	28.8	25.5	28.5	35.8
ZBTB11	"ZNF-U69274, ZNF913"	ENSG00000066422	"Zinc finger and BTB domain containing 11"	O95625	3	101648889-101677132	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015328, HPA024138"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA015328: AB_1858938, HPA024138: AB_1858939"	"unprognostic (3.25e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (2.86e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.77e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.09e-1)"	7.3	7.2	6.1	10.6	7.0	38.0	10.0	11.8	10.3	8.2	5.9	6.7	8.3	9.8	7.2	7.6	6.8	7.4	5.6	6.9	5.9	7.3	9.6	8.2	13.5	5.6	6.0	10.4	9.6	9.9	5.5	9.2	6.2	8.1	7.6	12.4	9.2	6.7	9.1	12.4	7.2	7.1	6.6	13.1	7.8	10.5	6.3	13.7	8.4	10.0	12.7	8.6	6.8	10.0	14.8	16.5	10.7	14.0	16.7	16.3	18.7	14.4	14.2	13.0	14.3	15.0	10.0	18.1	11.4	11.0	11.6	18.0	16.3	16.4	23.3	18.8	11.3	40.1	15.8	14.1	12.8	28.8	14.2	13.1	20.8	12.1	27.8	11.6	13.0	20.6	23.7	21.2	14.1	18.4	25.5	12.8	10.1	15.7	24.0	20.6	16.7	22.1	12.2	17.4	31.0	11.4	18.7	15.0	19.1	6.5	19.1	15.3	14.7	19.6	14.2	8.2	14.5	24.2	21.7	33.4	12.2	18.6	13.9	6.7	3.7	4.2	3.6	4.6	4.7	2.9	3.1	4.0	4.6	3.8	3.5	3.0	2.4	3.0	7.3	2.7	3.8	2.8	6.1	7.0	11.8	10.3	6.9	5.9	5.6	6.0	6.2	6.6	6.3	10.0	19.0	32.1	20.8	12.7	28.2	46.4	20.0	8.4	51.8	14.2	21.4	17.4	12.1	10.0	19.3	1.8	33.3	10.2	40.3	14.0	0.0	6.6	3.2	44.7	50.4	20.1	20.2	12.4	32.7	5.5	7.5	19.4	15.8	70.2	8.8	13.7	13.2	10.3	7.9	21.9	28.2	14.5	14.2	23.0	24.4	3.9	8.4	25.9	19.6	12.2	20.3	12.0	21.6	15.1	27.6	7.6	4.4	14.3	32.6	18.3	8.2	6.2	20.1	22.8	6.6	25.0	19.1	25.5	21.8	50.0	49.0	16.8	34.1	14.3	14.2	24.1
ZDHHC21	"DHHC21, DNZ1, HSPC097"	ENSG00000175893	"Zinc finger DHHC-type palmitoyltransferase 21"	Q8IVQ6	9	14611071-14693432	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 219.4;Inhibitory neurons: 201.6;Oligodendrocyte precursor cells: 268.9;Oligodendrocytes: 158.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 29.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065254	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus, Cytosol"		"HPA065254: AB_2685446"	"unprognostic (2.95e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.37e-2)"	"unprognostic (9.79e-3)"	"unprognostic (3.97e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.87e-2)"	"prognostic favorable (9.28e-6)"	3.7	5.7	4.7	4.6	5.8	2.5	6.2	12.7	6.7	6.2	2.2	4.7	6.8	4.9	6.1	8.5	4.5	3.5	5.1	6.0	4.5	4.9	2.6	5.2	6.6	3.4	3.3	5.2	4.7	4.8	6.5	4.2	3.7	5.2	5.2	10.6	4.6	3.7	4.5	8.7	7.2	4.1	3.4	5.5	4.3	4.1	3.5	2.6	6.1	3.4	6.1	4.2	6.7	4.7	7.1	3.6	6.9	4.6	1.1	1.2	5.3	8.9	2.7	3.1	3.5	1.8	3.3	7.0	2.1	6.2	3.9	4.5	4.8	2.9	4.4	14.1	3.7	29.9	8.3	3.5	3.6	5.3	9.5	2.3	6.6	3.6	2.3	5.7	18.4	2.8	2.5	0.8	5.5	3.9	1.2	5.1	4.8	3.0	6.7	0.0	3.3	3.5	9.6	7.8	4.2	11.3	4.1	5.0	2.8	5.3	6.3	8.6	13.2	2.2	3.3	2.2	8.3	2.8	5.6	0.0	4.6	0.3	2.3	0.2	0.1	0.0	0.4	0.3	0.4	2.0	0.4	0.4	0.0	1.4	0.3	0.4	0.0	1.1	0.2	0.5	0.6	0.2	4.7	5.8	12.7	6.7	6.0	4.5	3.4	3.3	3.7	3.4	3.5	4.7	18.0	22.4	24.1	132.9	46.6	9.6	9.3	8.1	13.1	45.1	23.0	14.1	23.2	24.3	18.2	44.1	43.8	8.8	27.7	31.9	5.9	16.0	5.3	18.1	23.5	18.4	15.6	7.2	219.4	17.9	7.1	14.0	26.5	24.6	10.8	36.7	32.9	10.1	11.1	37.0	201.6	14.6	10.2	15.5	8.2	7.7	19.3	11.8	1.8	107.7	17.7	65.7	41.2	268.9	158.2	35.9	14.1	31.2	20.8	12.4	46.7	11.3	12.7	49.4	6.6	19.7	15.3	22.3	26.6	24.4	20.0	7.7	14.4	10.5	13.9	16.1
ZNF175	OTK18	ENSG00000105497	"Zinc finger protein 175"	Q9Y473	19	51571283-51592510	"Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 50.6;RT4: 45.4;TIME: 45.7"					"Low region specificity"	"Detected in all"			"HPA002717, HPA074615"	Uncertain		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoli	Cytosol	"HPA002717: AB_1080681, HPA074615: "	"unprognostic (9.41e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.50e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.33e-3)"	"unprognostic (9.94e-2)"	"unprognostic (6.33e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (3.50e-3)"	3.1	3.9	4.6	4.3	5.0	3.5	5.4	11.2	6.2	3.9	6.7	3.9	5.5	5.9	5.2	3.1	4.7	3.1	4.4	3.9	4.8	4.4	3.1	4.9	6.0	4.7	4.4	8.9	3.3	10.0	6.2	8.0	4.5	4.0	3.8	11.3	6.0	4.9	4.6	3.6	4.3	5.1	3.9	6.0	4.5	10.3	5.9	5.2	6.9	3.6	6.1	3.8	3.2	6.7	3.6	6.3	6.2	6.6	6.5	9.0	0.1	8.1	10.3	7.4	8.9	6.4	5.5	6.6	4.6	8.2	4.6	5.9	6.8	5.6	13.2	0.0	10.0	50.6	10.5	2.2	5.7	8.5	31.1	3.5	5.1	15.1	7.3	37.2	12.1	6.3	17.3	6.7	8.1	0.0	9.2	6.3	3.5	4.4	6.4	0.0	8.1	3.2	4.0	45.4	7.9	5.7	7.6	2.5	4.7	5.0	1.8	6.9	45.7	11.3	5.1	2.6	7.9	8.8	17.6	6.8	31.4	5.0	5.8	0.0	0.4	0.0	0.4	0.1	0.5	0.5	0.4	0.4	0.4	0.5	0.6	0.5	0.2	0.2	0.1	1.4	0.1	0.2	4.6	5.0	11.2	6.2	3.9	4.8	4.7	4.4	4.5	3.9	5.9	6.7	3.6	6.4	5.4	12.1	3.4	1.1	1.5	1.7	1.8	8.0	2.7	2.5	3.5	1.5	5.3	5.5	2.1	7.9	4.1	1.5	1.9	1.9	11.6	1.4	2.9	3.9	1.8	16.2	11.6	1.6	1.5	3.4	2.6	1.5	14.0	5.5	6.4	2.4	3.2	16.8	12.8	1.3	2.0	5.9	2.1	10.6	3.4	2.4	3.6	10.3	3.1	2.6	5.2	12.5	17.5	6.9	0.6	2.6	1.6	1.8	4.4	2.0	4.4	7.8	0.0	4.3	2.6	6.3	4.3	2.1	1.4	12.0	2.4	3.2	2.0	0.8
ZNF202	"ZKSCAN10, ZSCAN42"	ENSG00000166261	"Zinc finger protein 202"	O95125	11	123723914-123741675	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 14.7;Spermatogonia: 14.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059229			Approved	"Nucleoli rim,Nuclear bodies,Mitotic chromosome"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoli rim, Mitotic chromosome"	"Nuclear bodies"	"HPA059229: "	"unprognostic (3.12e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.80e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (9.93e-7)"	"unprognostic (2.61e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.35e-2)"	5.7	4.7	5.9	6.7	5.9	5.2	7.6	5.9	6.5	8.1	5.7	6.3	4.4	9.7	9.3	6.0	6.8	4.6	4.5	5.7	5.9	6.2	5.1	5.1	8.9	5.4	5.8	10.4	9.7	5.2	5.9	6.2	5.4	7.2	7.9	6.1	6.0	5.3	6.2	8.4	6.5	7.3	4.8	9.9	6.2	9.8	5.8	6.7	6.9	3.9	8.7	6.9	6.4	6.8	6.0	9.3	15.3	18.5	6.6	10.1	11.9	9.3	7.4	8.5	7.6	10.5	15.7	17.7	8.6	7.2	13.7	14.3	15.9	10.6	11.7	7.3	8.9	31.5	6.6	10.2	9.0	18.5	8.9	7.2	21.0	9.7	28.7	7.3	10.0	14.8	17.1	11.8	11.2	6.3	16.0	25.3	25.2	21.0	12.8	19.2	9.5	6.5	8.3	11.4	11.3	12.6	7.8	9.4	6.2	12.5	17.8	12.8	8.7	16.3	10.5	11.8	9.5	7.6	5.9	12.1	4.3	20.2	10.8	0.0	1.2	0.0	1.7	1.8	1.6	1.6	2.3	2.5	1.9	1.9	2.6	2.4	0.0	1.6	0.7	1.2	2.2	1.7	5.9	5.9	5.9	6.5	5.7	5.9	5.4	5.8	5.4	4.8	5.8	6.8	3.1	6.4	0.5	7.8	3.8	2.9	3.8	1.9	0.6	3.1	3.4	3.2	3.1	2.8	9.7	3.7	0.0	2.2	2.1	1.5	1.9	2.2	5.1	1.4	3.3	3.1	3.0	1.7	8.9	3.5	1.7	2.8	4.6	2.0	3.8	6.0	2.2	1.9	1.8	6.7	8.3	3.9	0.0	2.0	2.0	5.0	1.8	3.1	0.0	3.7	1.6	2.4	1.0	6.6	11.0	3.2	2.4	1.2	3.6	2.5	1.0	1.4	1.3	3.1	6.6	5.0	2.2	14.7	14.5	3.6	3.0	0.8	3.0	3.1	3.2	2.9
ZNF426	MGC2663	ENSG00000130818	"Zinc finger protein 426"	Q9BUY5	19	9523223-9538645	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA029342	Approved		Approved	Nucleoplasm		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA029342: AB_10603007"	"unprognostic (3.64e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.65e-2)"	"unprognostic (6.62e-2)"	"prognostic favorable (3.74e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.77e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.05e-3)"	"unprognostic (8.89e-3)"	"unprognostic (7.41e-3)"	"prognostic favorable (2.57e-6)"	"unprognostic (1.05e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.81e-4)"	5.1	3.3	3.1	3.9	4.0	5.7	6.9	5.4	3.4	5.5	4.9	4.1	2.8	7.6	4.5	20.6	5.8	4.3	5.4	3.2	2.9	4.3	2.2	5.1	4.1	3.4	3.4	9.2	4.3	6.3	2.4	5.6	3.4	5.9	3.8	5.1	4.0	5.3	3.7	4.1	2.9	7.8	2.9	4.7	3.7	4.8	3.8	5.7	6.7	5.5	5.7	4.7	5.8	6.0	5.7	1.8	11.2	11.8	7.4	9.7	6.2	7.1	10.8	9.4	11.4	2.4	2.5	5.7	5.6	6.9	6.6	4.8	11.7	8.4	14.0	2.7	9.0	23.7	9.5	4.3	6.7	0.7	7.4	12.4	7.1	10.5	15.0	10.2	10.2	9.7	9.6	0.5	9.1	0.3	13.7	11.4	14.0	1.3	4.4	7.4	13.9	5.9	5.1	14.7	6.3	8.5	12.1	4.3	9.7	9.5	6.0	5.5	8.3	13.2	7.7	6.0	7.7	6.4	9.7	4.8	1.9	0.3	9.6	10.0	3.2	6.1	8.8	4.5	7.8	7.6	6.8	8.7	3.8	6.5	10.0	9.3	6.7	7.8	6.3	3.4	7.1	3.4	3.1	4.0	5.4	3.4	3.2	2.9	3.4	3.4	3.4	2.9	3.8	6.0	15.0	28.9	26.5	3.3	13.2	3.4	15.6	3.2	12.5	24.8	17.1	14.6	10.1	5.7	12.4	7.3	20.9	12.8	13.4	3.8	21.5	10.9	33.5	11.5	14.2	16.4	3.6	12.6	5.4	4.2	10.2	12.4	5.1	15.5	28.4	22.4	14.3	3.0	7.6	37.0	3.9	4.2	12.2	8.9	1.6	8.2	17.1	8.2	3.6	5.6	11.2	20.1	15.5	4.5	4.7	6.9	5.1	22.2	6.7	13.3	4.7	5.4	14.6	22.0	6.6	17.9	13.2	12.2	11.8	14.7	2.8	14.2	12.1	12.3	6.3	17.9
ZNF560	FLJ31986	ENSG00000198028	"Zinc finger protein 560"	Q96MR9	19	9466355-9498616	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"retina: 2.0;testis: 6.2"	"Group enriched"	"Detected in some"	5	"Early spermatids: 79.2;Late spermatids: 20.1"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 7.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 20.5;HMC-1: 4.8;NTERA-2: 19.7;SuSa: 9.2"									"HPA045439, HPA074438"			Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Nuclear speckles"	"HPA045439: AB_2732520, HPA074438: "	"unprognostic (4.43e-3)"			"unprognostic (8.91e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.43e-2)"		"unprognostic (1.17e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.57e-3)"	"unprognostic (6.33e-5)"	"unprognostic (5.60e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.15e-3)"	"unprognostic (1.65e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.8	2.5	0.0	1.5	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.1	0.0	1.1	20.5	0.0	0.0	1.4	0.0	4.8	2.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	79.2	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.1	0.1	0.0	0.0	4.5	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	20.1	0.3	0.2	0.0	0.0	0.0	0.2	0.0	3.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	9.5	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZNF577	MGC4400	ENSG00000161551	"Zinc finger protein 577"	Q9BSK1	19	51804816-51890950	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 39.2;Early spermatids: 56.3;Late spermatids: 60.6;Oligodendrocytes: 50.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA041499, HPA046761"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli"		"HPA041499: AB_2677516, HPA046761: AB_2679791"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.17e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.51e-3)"	"unprognostic (2.81e-3)"	"unprognostic (2.72e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (2.03e-4)"	9.4	7.2	11.9	5.4	15.0	4.2	12.2	14.2	13.2	14.3	8.0	14.5	4.6	11.7	7.1	6.8	12.7	8.0	12.2	11.5	16.1	13.6	6.8	7.9	5.5	14.0	12.3	27.1	8.8	14.9	8.4	9.3	13.3	18.4	6.6	16.9	12.0	11.3	7.2	20.6	9.0	7.2	10.2	12.7	8.9	18.8	13.5	7.7	18.7	9.1	5.7	11.1	9.3	21.0	1.6	0.1	7.8	9.5	13.1	14.1	0.0	9.3	3.4	3.5	7.1	1.0	1.3	1.6	0.9	4.3	5.2	2.5	3.1	1.9	1.9	0.0	9.0	15.6	0.2	1.4	10.2	3.4	5.1	11.1	5.8	5.2	1.5	10.9	1.8	0.0	3.5	0.1	4.5	0.0	9.7	4.4	9.0	0.0	0.2	4.2	3.9	2.9	5.8	3.4	3.2	1.6	2.3	1.1	8.0	7.9	1.6	3.7	1.2	6.4	8.8	1.8	3.4	6.3	0.0	2.0	1.7	0.6	10.6	4.4	1.6	3.7	0.9	2.5	2.7	7.2	1.8	2.2	1.8	3.5	2.2	1.4	0.6	3.3	2.0	2.0	0.9	1.1	11.9	15.0	14.2	13.2	11.5	16.1	14.0	12.3	13.3	10.2	13.5	21.0	8.8	0.0	2.6	14.4	4.0	4.5	3.7	4.0	2.2	12.2	8.1	7.9	8.5	4.3	3.0	18.4	10.4	7.2	4.8	2.7	39.2	4.3	56.3	7.2	7.4	6.6	3.0	2.1	20.1	1.1	5.4	6.3	4.1	5.6	5.1	9.8	7.1	1.8	5.7	6.7	19.3	4.7	2.0	2.2	3.7	60.6	8.1	6.7	0.0	9.4	4.0	15.2	1.0	26.2	50.1	1.2	1.9	12.8	0.9	5.9	5.1	4.9	3.0	9.9	0.0	6.9	7.6	12.3	14.0	4.2	5.3	4.5	2.5	4.2	4.4	3.0
ZNF850	ZNF850P	ENSG00000267041	"Zinc finger protein 850"	A8MQ14	19	36714383-36772825	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 5.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 8.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 15.2;NTERA-2: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029299	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA029299: AB_2672987"	"unprognostic (1.35e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.38e-3)"	"unprognostic (7.78e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.00e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.49e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.37e-3)"	0.8	0.6	0.7	1.0	0.6	5.1	0.9	2.4	1.0	0.7	0.9	0.7	0.6	0.7	0.3	1.0	0.7	0.8	1.6	1.5	0.7	0.6	0.9	0.7	1.5	0.9	0.7	1.2	0.6	1.0	0.5	3.1	0.8	0.9	1.0	1.0	0.7	0.7	0.4	1.2	0.6	0.8	0.3	1.1	0.7	2.6	0.7	0.7	0.7	0.5	0.8	0.5	0.5	1.4	0.3	1.7	3.7	6.0	0.8	0.2	7.0	2.2	1.3	1.5	1.8	1.3	0.4	1.2	5.1	0.4	7.6	1.1	2.6	0.5	2.7	0.8	2.3	15.2	0.3	1.2	1.0	1.8	8.6	1.0	0.1	2.3	0.0	0.5	1.3	1.8	4.4	0.8	3.6	0.8	2.7	1.7	11.9	0.6	1.0	1.7	7.8	1.1	0.7	7.5	2.4	3.8	3.5	0.2	0.5	5.0	1.5	3.3	2.9	3.6	5.9	2.1	3.7	1.4	2.7	3.2	0.0	0.9	5.6	1.8	1.2	0.9	1.3	1.3	1.7	2.7	1.6	1.1	1.1	1.7	1.8	2.0	1.9	1.3	1.5	1.2	1.2	2.2	0.7	0.6	2.4	1.0	1.5	0.7	0.9	0.7	0.8	0.3	0.7	1.4	2.4	0.0	0.0	0.7	1.7	2.2	1.3	0.5	1.8	1.1	1.9	1.5	5.1	1.5	0.2	3.7	0.0	4.4	1.3	0.3	0.0	1.0	8.0	1.6	1.5	2.9	0.0	5.7	1.3	0.7	5.4	3.0	0.5	2.4	0.0	3.6	7.1	2.1	1.3	5.0	1.0	3.5	2.0	2.2	2.1	3.3	1.2	0.8	3.6	1.9	0.5	1.2	2.1	3.0	3.7	0.6	0.4	0.4	0.7	0.8	0.1	0.7	0.2	0.5	0.0	2.5	1.6	5.9	5.7	1.1	3.4	2.9	1.1	1.7	0.8	0.9